ࡱ> HJ i M bbjbj== WWKu l8 8 8 8 | | | 4 hp W (222w;RRRRRRR$jZ \R| R<8 8 22 xW<<<8 Z2| 2{L<R<N<iB> s1x | gG2 ; XL:GW0W; ]?8 ]gG< 8 8 8 8 National VA Pain Outcomes Working Group NATIONAL VA PAIN MANAGEMENT COORDINATING COMMITTEE VHA PAIN OUTCOMES TOOLKIT February 2003  SHAPE \* MERGEFORMAT  DEPARTMENT OF VETERANS AFFAIRS 810 Vermont Avenue, N.W. Washington, DC 20420 VHA PAIN OUTCOMES TOOLKIT TABLE OF CONTENTS  TOC \o "1-2" \h \z \u  HYPERLINK \l "_Toc29952424" SECTION 1: INTRODUCTION  PAGEREF _Toc29952424 \h 2  HYPERLINK \l "_Toc29952425" Veterans Health Administration (VHA) National Pain Management Strategy  PAGEREF _Toc29952425 \h 2  HYPERLINK \l "_Toc29952426" Outcomes Toolkit Objectives  PAGEREF _Toc29952426 \h 2  HYPERLINK \l "_Toc29952427" Definition of Outcomes Measurement  PAGEREF _Toc29952427 \h 2  HYPERLINK \l "_Toc29952428" Why Measure Pain Outcomes?  PAGEREF _Toc29952428 \h 3  HYPERLINK \l "_Toc29952429" SECTION 2: SELECTING OUTCOMES MEASURES  PAGEREF _Toc29952429 \h 4  HYPERLINK \l "_Toc29952430" Pain Outcomes Focus  PAGEREF _Toc29952430 \h 4  HYPERLINK \l "_Toc29952431" Type of Pain  PAGEREF _Toc29952431 \h 4  HYPERLINK \l "_Toc29952432" Practice Setting  PAGEREF _Toc29952432 \h 5  HYPERLINK \l "_Toc29952433" SECTION 3: MEASURING PATIENT-FOCUSED OUTCOMES  PAGEREF _Toc29952433 \h 6  HYPERLINK \l "_Toc29952434" Measuring Pain Intensity  PAGEREF _Toc29952434 \h 7  HYPERLINK \l "_Toc29952435" Measuring Pain Interference  PAGEREF _Toc29952435 \h 9  HYPERLINK \l "_Toc29952436" Measuring Emotional Distress  PAGEREF _Toc29952436 \h 10  HYPERLINK \l "_Toc29952437" Measuring Physical Capacities  PAGEREF _Toc29952437 \h 12  HYPERLINK \l "_Toc29952438" Measuring Employment Status  PAGEREF _Toc29952438 \h 15  HYPERLINK \l "_Toc29952439" Measuring Healthcare Utilization/Costs  PAGEREF _Toc29952439 \h 17  HYPERLINK \l "_Toc29952440" Measuring Patient Satisfaction  PAGEREF _Toc29952440 \h 21  HYPERLINK \l "_Toc29952441" Multidimensional Pain Outcomes Measures  PAGEREF _Toc29952441 \h 24  HYPERLINK \l "_Toc29952442" SECTION 4: PROCESS OUTCOMES MEASURES  PAGEREF _Toc29952442 \h 26  HYPERLINK \l "_Toc29952443" Measuring Process Outcomes  PAGEREF _Toc29952443 \h 26  HYPERLINK \l "_Toc29952444" SECTION 5: SPECIAL ISSUES  PAGEREF _Toc29952444 \h 31  HYPERLINK \l "_Toc29952445" Evaluating Medication Use Outcomes  PAGEREF _Toc29952445 \h 31  HYPERLINK \l "_Toc29952446" Measuring Family and Social Outcomes  PAGEREF _Toc29952446 \h 37  HYPERLINK \l "_Toc29952447" Measuring Pain Outcomes in the Cognitively Impaired  PAGEREF _Toc29952447 \h 38  HYPERLINK \l "_Toc29952448" Using CPRS GUI and Vista Software to Track Pain Outcomes  PAGEREF _Toc29952448 \h 42  HYPERLINK \l "_Toc29952449" VHA External Peer Review Program (EPRP)  PAGEREF _Toc29952449 \h 51  HYPERLINK \l "_Toc29952450" SECTION 6: WEB LINKS FOR OUTCOMES RESOURCES  PAGEREF _Toc29952450 \h 52  HYPERLINK \l "_Toc29952451" REFERENCE LIST  PAGEREF _Toc29952451 \h 53  HYPERLINK \l "_Toc29952452" APPENDIX I  PAGEREF _Toc29952452 \h 62  HYPERLINK \l "_Toc29952453" VHA Customer Satisfaction Survey Questions Pertaining To Pain  PAGEREF _Toc29952453 \h 62  HYPERLINK \l "_Toc29952454" APPENDIX II  PAGEREF _Toc29952454 \h 64  HYPERLINK \l "_Toc29952455" Attributes of a Successful Pain Management System  PAGEREF _Toc29952455 \h 64  HYPERLINK \l "_Toc29952456" APPENDIX III  PAGEREF _Toc29952456 \h 66  HYPERLINK \l "_Toc29952457" Examples of a Medical Record Pain Audit Tool  PAGEREF _Toc29952457 \h 66  HYPERLINK \l "_Toc29952458" APPENDIX IV  PAGEREF _Toc29952458 \h 67  HYPERLINK \l "_Toc29952459" Examples of Possible Patient Education Survey Items  PAGEREF _Toc29952459 \h 67  HYPERLINK \l "_Toc29952460" APPENDIX V  PAGEREF _Toc29952460 \h 68  HYPERLINK \l "_Toc29952461" Duke University Medical Center Competency Questionnaire  PAGEREF _Toc29952461 \h 68  HYPERLINK \l "_Toc29952462" APPENDIX VI  PAGEREF _Toc29952462 \h 74  HYPERLINK \l "_Toc29952463" Members of the VA National Pain Outcomes Workgroup  PAGEREF _Toc29952463 \h 74  HYPERLINK \l "_Toc29952464" APPENDIX VII  PAGEREF _Toc29952464 \h 75  HYPERLINK \l "_Toc29952465" Members of the VA National Pain Coordinating Committee  PAGEREF _Toc29952465 \h 75  VHA PAIN OUTCOMES TOOLKIT SECTION 1: INTRODUCTION Veterans Health Administration (VHA) National Pain Management Strategy VHA has initiated a comprehensive national strategy for pain management. The overall goal of the new VHA National Pain Management Strategy is to prevent pain and suffering in persons receiving care in the veterans healthcare system. The specific objectives of this strategy are to: Provide a system-wide VHA standard of care for pain management that will reduce suffering from preventable pain. Assure that pain assessment is performed in a consistent manner. Assure that pain treatment is prompt and appropriate. Include patients and families as active participants in pain management. Provide for continual monitoring and improvement in outcomes of pain treatment. Provide for an interdisciplinary, multi-modal approach to pain management. Assure that clinicians practicing in the VHA healthcare system are adequately prepared to assess and manage pain effectively. Outcomes Toolkit Objectives The VHA Pain Outcomes Toolkit was developed by the HYPERLINK \l "appendix6"VA National Pain Outcomes Workgroup, a subgroup of the  HYPERLINK \l "appendix7" VA National Pain Management Coordinating Committee, as part of the VHAs National Pain Management Strategy. The toolkit was designed to assist healthcare providers and facilities devise methods and implement processes to measure pain treatment outcomes. Measuring the effectiveness of pain treatment and pain service delivery mechanisms is critical to the VHAs goal of improved pain treatment services. Definition of Outcomes Measurement Outcomes measurement refers to the systematic collection and analysis of information that is used to evaluate the efficacy of an intervention (Clark & Gironda, 2002). Systematic collection means that data are gathered at multiple time points using the same methods or instruments. Analysis refers to the process of condensing and examining the data to identify meaningful trends or changes. Analysis may indicate that changes in processes or practices should be undertaken to improve treatment outcomes or to remove system barriers to care. Usually, in clinical settings outcomes measures are collected before and after an intervention with the assumption that any changes observed in the measure can be attributed to the effects of the intervention. However, it is important to remember that other known or unknown factors also could account for the observed changes, particularly in healthcare settings where multiple interventions or events may have transpired between the initial assessment and the post-intervention assessment. Therefore, multiple episodes of data collection are preferred as they facilitate the identification of trends in the data that may be more reliable indicators of intervention-related change. Why Measure Pain Outcomes? There are several reasons that pain treatment outcomes monitoring are an integral part of todays healthcare delivery systems. First and foremost, treatment outcomes data are critical to insuring that patients with pain receive effective and timely care. Outcomes data can be used to direct treatment decisions to maximize success, to generate pain treatment guidelines that in the past were based only on anecdotal observations of treatment effectiveness, and to identify service delivery system problems or barriers. Second, many government agencies, accreditation bodies, professional societies, and other organizations now require the collection and analysis of pain outcomes data. Within the VHA, the National Pain Management Strategy includes objectives for using outcomes to monitor the effectiveness of pain treatment. Outside the VHA, pain outcomes measurement now is required by some major healthcare accreditation agencies. For example, the Rehabilitation Accreditation Commission (CARF) was one of the first to develop elaborate outcomes standards for pain treatment programs. More recently, standards for pain management across the spectrum of health care service delivery settings have been adopted and applied by the Joint Commission for the Accreditation of Healthcare Organizations (Rehabilitation Accreditation Commission, 2002). Other national and local bodies also have begun to recognize the necessity of monitoring the effects of pain treatment. Pain treatment guidelines, such as those developed by the Agency for Health Care Policy and Research (Agency for Health Care Policy Reform, 1992, 1996) and the American Pain Society (American Pain Society, 1995). Similarly, healthcare insurers have expressed an interest in the cost effectiveness of pain treatment (Kulich & Lande, 1997), and may require that treatment effectiveness be established before claims will be paid. SECTION 2: SELECTING OUTCOMES MEASURES Selecting appropriate outcomes measures is the key to developing a meaningful outcomes monitoring system. Three factors should be considered as part of the outcomes selection process (Clark & Gironda, 2002): Pain outcomes focus (patient focused or process focused) Type of pain (acute, chronic, or pain at end-of-life) Practice setting Pain Outcomes Focus Patient focused outcomes measures focus on changes in individuals pain experience following interventions. To quantify change, measures must be administered at least twice (before and after treatment). For treatments spanning lengthy time intervals, repeated administrations (e.g., every month) may provide a more detailed picture of change. Patient focused measures often are used to evaluate a single patients response to treatment. When they are used collectively to evaluate a specific treatment intervention or program of interventions, they serve as aggregate outcomes measures. The most common patient focused outcome measure is pain intensity. Other measures might include pain-related interference, emotional distress, or physical capacities. Process focused measures focus on the pain service delivery system, and usually are components of performance improvement activities. In some cases measures may be collected only once, but more often they will be collected repeatedly over time to evaluate trends in the measures or to assess the impact of a system intervention. Results may be used to evaluate how well the pain service delivery system is meeting facility goals, regulatory statutes, or accreditation body (e.g., JCAHO) standards. Common measures include pain clinic waiting times, adequacy of pain assessment and treatment documentation, or compliance with patient pain education standards. Type of Pain The selection of outcomes measures should include a consideration of the type of pain most often treated in the setting of interest: Acute pain typically refers to pain etiologically related to an injury, disease, or medical procedure (e.g., post operative pain) that is expected to be transitory. Cancer pain is used to identify pain associated with active cancer. Chronic pain is used to identify longstanding pain (typically pain that persists beyond the expected timeframe for healing) that is not due to cancer and is not expected to resolve on its own. Chronic pain may be constant (i.e., present all or most of the time), or episodic (i.e., periods of constant pain with intervening pain-free intervals). Pain types are not necessarily mutually exclusive. An individual with acute or cancer pain also may simultaneously experience chronic pain from an unrelated condition. Distinctions between pain types are important as appropriate treatments and associated outcomes measures may vary for each. For example, if acute pain is the focus, primary measures might include pain intensity and pain medication side effects. When chronic pain is the focus, measures of psychosocial functioning, pain interference, or other outcomes domains likely are as important as pain intensity measures. Practice Setting Practice setting refers to attributes of the pain service delivery environment. Pain treatments may range from minimally complex (e.g., medication management) to highly technical (e.g., dorsal column stimulator implants). In general, pain service settings that require minimal resources and utilize uncomplicated treatments may not warrant elaborate, expensive, and time-consuming outcomes measurement practices when less complex approaches would suffice. In contrast, more complex treatment settings requiring greater resource investment or patient risk may want to utilize broader, multi-domain outcomes measures in order to assess change in a variety of pain experience areas. The rational underlying this variation in outcomes approach is twofold. First, from a cost-benefit perspective, when resource investment is greater, such as in complex pain treatment settings, it is reasonable to expect that outcomes should be improved. Utilization of more comprehensive outcomes measures that assess function in a greater range of domains may provide evidence of a greater range of treatment-related improvements. Second, complex pain treatment settings are likely to treat individuals with more complicated and severe pain conditions and increased pain-related dysfunction that extends across multiple domains of function. Therefore, more elaborate measures of outcomes may be needed to accurately reflect both the extent of pain-related disability and the degree of improvement attained. SECTION 3: MEASURING PATIENT-FOCUSED OUTCOMES There are a multitude of patient focused pain measures available to practitioners. Only brief descriptions of the most popular measures are included in this document as many have been reviewed in detail elsewhere (cf, Turk & Melzack, 2001). Numerous experts in the field of pain and pain management have encouraged a multidimensional perspective of pain that promotes measurement of several key domains of the experience of pain when conducting comprehensive pain assessments and/or when evaluating outcomes of pain management efforts (cf, Block, Kremer, & Fernandez, 1998; Gatchel & Turk, 1998; Turk & Melzack, 2001). Most commonly these include the domains of pain intensity or severity, pain interference (variously measured as perceived disability, deficits in physical capacity, decline in social or family relationships, and changes in employment status or performance), and emotional distress. Kerns (1996), in particular, has argued that these domains should be considered primary, as opposed to secondary, outcome domains. Additional outcome domains that are often viewed as important or critical include healthcare utilization and costs as well as patient satisfaction. The selection of specific patient focused measures should include a consideration of demonstrated reliability and validity. Reliability refers to the consistency of test results when administered under identical circumstances (Johnston, Keith, & Hinderer, 1992). Two common indices of reliability include measures of internal consistency, that is, the degree to which items of a measure are intercorrelated, and test-retest reliability, or the degree of stability of the measure over a specific period of time. The typical statistical index of internal consistency is the alpha statistic. Alphas range from 0 to 1.0 with higher alphas indicating greater reliability. In general, indices above .70 are considered adequate for clinical purposes. Test-retest reliability commonly is expressed as a correlation, with indices above .70 generally indicating adequate stability of the measure. Reliability is necessary for a measure to be valid, but measures can be reliable but not valid (Green, 1992). Validity refers to how well the measure assesses or captures what it was designed to measure (Johnston et al., 1992). There are a variety of methods used to evaluate the validity of a measure which most often is expressed using simple correlations. For example, one index of the validity of a new measure of pain severity for persons with chronic pain might be the overall correlation between scores on the new measure with those on an already accepted measure of pain intensity. Note, however, that these validity coefficients will be much smaller than the instruments reliability values. Typically, validity coefficients that fall in the .30 or higher range provide good support of a measures validity in the dimension assessed, although coefficients as small as .15 or lower also may support validity depending on the characteristics of the measures examined. Several pain accreditation bodies (e.g., Rehabilitation Accreditation Commission) and professional associations (e.g., the American Congress of Rehabilitation Medicine) require that facility or program outcomes measures have demonstrated their reliability and validity (Johnston et al., 1992; Rehabilitation Accreditation Commission, 2002). Whenever possible, measures used to track VHA pain outcomes should conform to these standards for reliability and validity. However, note that some patient focused pain outcomes measures do not have such supporting data available. In these cases additional caution should be exercised so as to avoid conclusions that may be erroneous. In addition, it is preferable that, when available, pain outcomes measures used in the VHA have been validated with samples of veterans. Measuring Pain Intensity Pain intensity is the indicator used most often to evaluate the efficacy of pain treatments. Intensity measures fall into three general categories: Numeric Rating Scales, Visual Analog Scales, and Verbal Rating Scales. Visual Analog Scales and Numeric Rating Scales consist of a single item to quantify the intensity of current, usual, least, or worst pain. Research indicates that least and usual pain ratings provide the best estimate of actual pain intensity  QUOTE "(Jensen, Turner, Turner, & Romano, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00((Jensen, Turner, Turner, & Romano, 1996)\01\03\00!\00\00\00\00\00\00\1BM_\01\00\00\00x&  \00~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\00 & ~\00\00 ~\00&h\00 ~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00 & ~\00\00 ~\00&h\00 ~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Jensen, Turner, et al. 1996 #360\00 \00 (Jensen, Turner, Turner, & Romano, 1996). Numeric Rating Scales (NRS). Numeric rating scales utilize a numeric range (typically 0 to 10 or 0 to 100) to quantify pain intensity, can be administered in oral or written form, and are the most commonly used method of assessing pain levels. Anchors parallel those described above. Patients are instructed to choose a single number from the 11 or 101-point options that best represents their pain. The NRS has been found to be valid and reliable, and to be sensitive to changes in acute, cancer, and chronic pain. The numeric pain score utilized in the VHAs Pain as the Fifth Vital Sign initiative relies on an 11-point NRS measure. In the VHA version of the measure, standardized anchors (0 = no pain and 10 = worst pain imaginable) have been selected to encourage consistency across institutions and settings. The VHAs Pain as the 5th Vital Sign Toolkit (VHA, 2000: document available at  HYPERLINK "http://www.vachronicpain.org" www.vachronicpain.org) may serve as a helpful resource for adoption and utilization of this measure. Visual Analog Scales (VAS). Visual analog scales rely on a visual cue (usually a ten-centimeter line anchored with the phrases no pain and worst possible pain or excruciating pain) to evaluate pain intensity. Usually the line is horizontal, although vertical presentations (e.g., the pain thermometer) also are available. Instructions require that patients bisect the line at the point matching their current, usual, best, or worst level of pain. The pain score is the length of the segment starting at no pain and terminating at the point indicated by the respondee. Research has indicated that the VAS is a valid and sensitive measure of pain intensity in patients with acute, cancer, and chronic pain  QUOTE "(Ogon, Krismer, Soellner, Kantner Rumplmair, & et al, 1996; ; Breivik, Bjornsson, & Skovlund, 2000)"  ADDIN PROCITE \11\05 \19\02\00\00\00c(Ogon, Krismer, Soellner, Kantner Rumplmair, & et al, 1996; ; Breivik, Bjornsson, & Skovlund, 2000)\01\05\004\00\00\00\00\00\00\1BM_\01\00\00\00x&  \00\10! ~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\00\04\00x\00\00\00\00\00\10\00x ~\00P0 ~\00\00\03x&\00\00\00\00\00\00\00\00\00\04\00x\00\00\00\00\00\10\00x ~\00P0 ~\00\00\03x\02\00\00\00\00\00\00\00~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00~\00&h~\00\1D\00x\00\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Ogon, Krismer, et al. 1996 #3190\00 \00 (Ogon, Krismer, Soellner, Kantner Rumplmair, & et al, 1996; ; Breivik, Bjornsson, & Skovlund, 2000) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\0B\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%De Conno, Caraceni, et al. 1994 #4210\00%\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00b\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Breivik, Bjornsson, et al. 2000 #10\00#\00 . Comparisons between horizontal and vertical line presentations have yielded mixed results, but there is some evidence that a horizontal orientation may improve sensitivity of the measure  QUOTE "(Ogon et al., 1996; Jensen, Turner, Romano, & Fisher, 1999; Breivik & Skoglund, 1998)"  ADDIN PROCITE \11\05 \19\02\00\00\00U(Ogon et al., 1996; Jensen, Turner, Romano, & Fisher, 1999; Breivik & Skoglund, 1998)\01\07\00\0C\00\00\00\00\00\00\1BM_\01\00\00\00V \00~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_p~\00\00M_@\00\00\00`\00j\00x82\03x&\00\00\00\00\00\00\10\00xx\00M_p~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\00\00\00~\00P~\00&hP~\00\1D\00x\00\03x\18\00\00\00\00\00\00\00\00\00~\00P~\00&hP~\00\1D\00x\00\03x\02\00\00\00\00\00\00\00~\00p~\00&hp~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00p~\00&hp~\00\1D\00x\00\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Ogon, Krismer, et al. 1996 #3190\00 \00 (Ogon et al., 1996; Jensen, Turner, Romano, & Fisher, 1999; Breivik & Skoglund, 1998) QUOTE ""  ADDIN PROCITE \11\05 \19\02\00\00\00\00\01\00\00f\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FJensen, Turner, et al. 1999 #60\00\1F\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1CBreivik & Skoglund 1998 #180\00\1C\00 . Verbal Rating Scales (VRS). Verbal rating scales consist of words or word-pairs used to describe pain that are rank ordered along a continuum of severity. A score is assigned to the chosen descriptor based on the empirically derived ranks of the chosen words (Jensen & Karoly, 1992). Perhaps the most widely known VRS is the McGill Pain Questionnaire (MPQ; Melzack, 1975a) which consists of 20 lists of descriptors of the sensory, affective, and evaluative dimensions of pain (Melzack, 1975b). The standard scoring procedure yields a Pain Rating Index (PRI) which is computed for each of the three pain dimensions and may be summed to provide an overall PRI. The PRI is sensitive to change and has been validated for use with acute, cancer, and chronic pain populations  QUOTE "(Davis, 1989; Lowe, Walker, & MacCallum, 1991; Sist, Florio, Miner, Lema, & Zevon, 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00X(Davis, 1989; Lowe, Walker, & MacCallum, 1991; Sist, Florio, Miner, Lema, & Zevon, 1998)\01\07\00\06\00\00\00\00\00\00\1BM_\01\00\00\00XZ\00@~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_\10~\00\00M_@\00\00\00`\00j\00x82\03x\1F\00\00\00\00\00\00\10\00xx\00M_\10~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\00\00\00~\00@~\00&h@~\00\1D\00x\00\03x(\00\00\00\00\00\00\00\00\00~\00@~\00&h@~\00\1D\00x\00\03x\02\00\00\00\00\00\00\00~\00\00~\00&h\00~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00\00~\00&h\00~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\0FDavis 1989 #800\00\0F\00 (Davis, 1989; Lowe, Walker, & MacCallum, 1991; Sist, Florio, Miner, Lema, & Zevon, 1998) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00^\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FLowe, Walker, et al. 1991 #1960\00\1F\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00*\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FSist, Florio, et al. 1998 #1400\00\1F\00 . From a practical point of view, the NRS or the VAS may be preferred to the MPQ or other verbal scales as pain intensity measures as their results can be treated as ratio-level data which allows for greater latitude in analysis. When choosing between the VAS and the NRS, the former may be preferred when the greatest measurement precision is desirable, while the benefits of the latter are easier administration and scoring. Other validated pain intensity measures that might be considered include the Faces Pain Scale  QUOTE "(Bieri, Reeve, Champion, Addicoat, & Ziegler, 1990)"  ADDIN PROCITE \11\05\19\02\00\00\003(Bieri, Reeve, Champion, Addicoat, & Ziegler, 1990)\003\00l\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FBieri, Reeve, et al. 1990 #4230\00\1F\00 (Bieri, Reeve, Champion, Addicoat, & Ziegler, 1990), which was originally developed to assess pain in children but has been validated for use with the elderly  QUOTE "(Herr, Mobily, Kohout, & Wagenaar, 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00((Herr, Mobily, Kohout, & Wagenaar, 1998)\00(\00m\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FHerr, Mobily, et al. 1998 #4240\00\1F\00 (Herr, Mobily, Kohout, & Wagenaar, 1998), and the Pain Thermometer  QUOTE "(Choiniere & Amsel, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00\19(Choiniere & Amsel, 1996)\00\19\00$\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1CChoiniere & Amsel 1996 #3200\00\1C\00 (Choiniere & Amsel, 1996). Measuring Pain Interference Measures of pain interference assess the nature and degree that pain negatively impacts one or more domains of functioning. Reductions in pain interference are important goals for treatment, and outcome measures sensitive to these changes should be incorporated into any outcomes package used in settings where prolonged pain is an issue. Sickness Impact Profile (SIP). The SIP is a frequently used 136-item measure of perceived impairment  QUOTE "(Brown, 1995; Williams, 1988)"  ADDIN PROCITE \11\05 \19\02\00\00\00\1D(Brown, 1995; Williams, 1988)\01\05\00\06\00\00\00\00\00\00\1BM_\01\00\00\00hY \00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00`\00j\00x82\03x\0E\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\10\00xx\00M_\10~\00\00M_@\00\00\00`\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_\10~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\0FBrown 1995 #950\00\0F\00 (Brown, 1995; Williams, 1988) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Williams 1988 #820\00\12\00  with excellent test-retest reliability (.92) and internal consistency (.94;  QUOTE "(Bergner, 1981)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0F(Bergner, 1981)\01\03\00\08\00\00\00\00\00\00\1BM_\01\00\00\000\1F \00\10~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00 `\00j\00x82\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Bergner 1981 #3560\00\12\00 Bergner, 1981). The instructions for the version most often used with individuals with pain were altered by Turner and Clancy  QUOTE "(Turner, 1988)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0E(Turner, 1988)\01\03\00\07\00\00\00\00\00\00\1BM_\01\00\00\000\1F \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\11Turner 1988 #3600\00\11\00 (1988) to reflect pain-related impairment rather than general physical impairment. The SIP contains two Domains (Physical and Psychosocial) and a total of 14 subscales used to assess pain interference across a wide range of functioning. The SIP scales have been found to be sensitive to changes in functioning resulting from multidisciplinary pain treatment  QUOTE "(Jensen, Strom, Turner, & Romano, 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00'(Jensen, Strom, Turner, & Romano, 1992)\01\03\00 \00\00\00\00\00\00\1BM_\01\00\00\00Z \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03xA\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Jensen, Strom, et al. 1992 #1670\00 \00 (Jensen, Strom, Turner, & Romano, 1992), and they possess good concurrent validity in chronic pain and cancer pain patients  QUOTE "(Beckham, Burker, Lytle, Feldman, & Costakis, 1997; Watt Watson & Graydon, 1989)"  ADDIN PROCITE \11\05\19\02\00\00\00P(Beckham, Burker, Lytle, Feldman, & Costakis, 1997; Watt Watson & Graydon, 1989)\01\05\00,\00\00\00\00\00\00\1BM_\01\00\00\00Z \000~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00~\00~\00&h~\00\1D\00x\00\03x\1B\00\00\00\00\00\00\00\00\00~\00~\00&h~\00\1D\00x\00\03x\02\00\00\00\00\00\00\00`~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00`~\00~\00&h~\00\1D\00x\00\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Beckham, Burker, et al. 1997 #3510\00"\00 (Beckham, Burker, Lytle, Feldman, & Costakis, 1997; Watt Watson & Graydon, 1989) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00p\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Watt Watson & Graydon 1989 #2140\00 \00 . Based on the frequency that this instrument has been used in the pain research literature, the SIP is the gold standard for detailed assessment of self-reported pain interference. Roland and Morris Disability Index (RMD). The RMD is a 24-item scale comprised of 23 SIP items and one additional item (Deyo, 1986). The RMD correlates most closely with the SIP Physical scale, while the association with the SIP Psychosocial items is much lower  QUOTE "(Jensen et al., 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00\15(Jensen et al., 1992)\00\15\00\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Jensen, Strom, et al. 1992 #1670\00 \00 (Jensen et al., 1992). The scale has demonstrated good internal consistency  QUOTE "(Hsieh, Phillips, Adams, & Pope, 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00&(Hsieh, Phillips, Adams, & Pope, 1992)\00&\00g\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Hsieh, Phillips, et al. 1992 #4180\00"\00 (Hsieh, Phillips, Adams, & Pope, 1992), sensitivity to change  QUOTE "(Jensen et al., 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00\15(Jensen et al., 1992)\00\15\00\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Jensen, Strom, et al. 1992 #1670\00 \00 (Jensen et al., 1992), discriminative validity  QUOTE "(Leclaire, Blier, Fortin, & Proulx, 1997)"  ADDIN PROCITE \11\05\19\02\00\00\00)(Leclaire, Blier, Fortin, & Proulx, 1997)\00)\00[\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Leclaire, Blier, et al. 1997 #4060\00"\00 (Leclaire, Blier, Fortin, & Proulx, 1997), and, when used with chronic low back pain patients, stability  QUOTE "(Jensen et al., 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00\15(Jensen et al., 1992)\00\15\00\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Jensen, Strom, et al. 1992 #1670\00 \00 (Jensen et al., 1992). The RMD has been utilized in a number of pain outcomes studies, and is useful as a brief measure of self-perceived disability. However, data suggests that it may be less sensitive to some psychosocial aspects of the pain experience than the SIP. Oswestry Low Back Pain Disability Questionnaire (ODQ). The ODQ is a 10-item questionnaire assessing pain and pain-related limitations in daily activities  QUOTE "(Fairbank, Couper, Davies, & O'Brien, 1980)"  ADDIN PROCITE \11\05\19\02\00\00\00+(Fairbank, Couper, Davies, & O'Brien, 1980)\00+\00h\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Fairbank, Couper, et al. 1980 #4190\00#\00 (Fairbank, Couper, Davies, & O'Brien, 1980). Testees choose 1 of 6 response options for each item, and scores are summed across items. The ODQ has evidenced adequate stability  QUOTE "(Davidson & Keating, 2002)"  ADDIN PROCITE \11\05\19\02\00\00\00\1A(Davidson & Keating, 2002)\00\1A\007\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DDavidson & Keating 2002 #3700\00\1D\00 (Davidson & Keating, 2002) and internal consistency  QUOTE "(Hsieh et al., 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00\14(Hsieh et al., 1992)\00\14\00g\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Hsieh, Phillips, et al. 1992 #4180\00"\00 (Hsieh et al., 1992), as well as discriminative validity  QUOTE "(Leclaire et al., 1997)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Leclaire et al., 1997)\00\17\00[\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Leclaire, Blier, et al. 1997 #4060\00"\00 (Leclaire et al., 1997) and sensitivity to change  QUOTE "(Davidson & Keating, 2002)"  ADDIN PROCITE \11\05\19\02\00\00\00\1A(Davidson & Keating, 2002)\00\1A\007\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DDavidson & Keating 2002 #3700\00\1D\00 (Davidson & Keating, 2002). ODQ item content suggests that it may be most useful for patients with more severe limitations or disability (Baker, Pynsent, & Fairbank, 1989). Pain Disability Index (PDI). The PDI (Pollard, 1984) is a brief (7-item), easy to use measure of pain interference in physical and psychosocial role performance that has good internal consistency (( = .87; Tait, 1987) and one-week test-retest reliability (ICC r = .91;  QUOTE "(Gronblad et al., 1993)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Gronblad et al., 1993)\00\17\00=\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt!Gronblad, Hupli, et al. 1993 #630\00!\00 Gronblad et al., 1993). Research indicates that it is sensitive to change (Strong, Ashton, & Large, 1994), and it has been validated for use with chronic and post-operative pain patients (Pollard, 1984). Although less comprehensive than the SIP, the PDI may be useful when a short but psychometrically sound measure of general pain interference is desired. Measuring Emotional Distress Significant pain often is accompanied or preceded by emotional distress and emotional status and traits can have a significant impact on treatment outcome. Thus, comprehensive pain outcomes approaches should include methods to assess the varieties of emotional distress. There are numerous emotional distress instruments available for use. The measures that follow were selected based upon on brevity, ease of use, and general acceptance among pain researchers for outcomes assessment. Depression Measures. The Beck Depression Inventory (BDI) is a brief (21-item) measure of depressive symptoms and complaints (Beck, 1987). The BDI possesses adequate psychometric properties  QUOTE "(Beck, 1988)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0C(Beck, 1988)\01\03\00\05\00\00\00\00\00\00\1BM_\01\00\00\00' \00~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\0FBeck 1988 #3580\00\0F\00 (Beck, 1988), and is sensitive to multidisciplinary pain clinic treatment changes  QUOTE "(Kleinke, 1991)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0F(Kleinke, 1991)\01\03\00\08\00\00\00\00\00\00\1BM_\01\00\00\00 \00p~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\10\00xx\00M_ ~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_ ~\00\00M_@\00\00\00 `\00j\00x82\03xT\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Kleinke 1991 #1860\00\12\00 (Kleinke, 1991). A newer version of the BDI (BDI-II) now is available that may be more sensitive to core symptoms of depression  QUOTE "(Beck, Steer, Ball Roberta, & Ranieri, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00,(Beck, Steer, Ball Roberta, & Ranieri, 1996)\01\03\00%\00\00\00\00\00\00\1BM_\01\00\00\008\5C \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\00~\00@~\00&h@~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00@~\00&h@~\00\1D\00x\00\03x\11\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1EBeck, Steer, et al. 1996 #4270\00\1E\00 (Beck, Steer, Ball Roberta, & Ranieri, 1996). A frequently used alternative to the BDI is the 20-item Center for Epidemiologic Studies-Depression Scale (CES-D: QUOTE "(Radloff, 1977)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0F(Radloff, 1977)\01\03\00\08\00\00\00\00\00\00\1BM_\01\00\00\00h \00\10~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03xH\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Radloff 1977 #9330\00\12\00  Radloff, 1977). The CES-D has both high internal reliability (( = .85) in normal populations and good concurrent validity when used with individuals with chronic pain  QUOTE "(Beckham et al., 1997; Radloff, 1977)"  ADDIN PROCITE \11\05\19\02\00\00\00%(Beckham et al., 1997; Radloff, 1977)\01\05\00\0F\00\00\00\00\00\00\1BM_\01\00\00\008\5C \000~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00`\00j\00x82\03x\0D\00\00\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00`\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00`\00j\00x82\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Beckham, Burker, et al. 1997 #3510\00"\00 (Beckham et al., 1997; Radloff, 1977) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00H\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Radloff 1977 #9330\00\12\00 . Anxiety Measures. The most frequently used measure of anxiety today is the State-Trait Anxiety Inventory (STAI). The STAI is a 40-item self-report inventory of state anxiety (current anxiety) and trait anxiety (propensity to experience anxiety). There is a high concordance between pain and anxiety  QUOTE "(Polatin, Kinney, Gatchel, Lillo, & Mayer, 1993)"  ADDIN PROCITE \11\05\19\02\00\00\000(Polatin, Kinney, Gatchel, Lillo, & Mayer, 1993)\000\00q\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Polatin, Kinney, et al. 1993 #4280\00"\00 (Polatin, Kinney, Gatchel, Lillo, & Mayer, 1993), and the STAI is widely used as a pain outcomes measure. It has acceptable psychometric properties (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983), and it is sensitive to change  QUOTE "(Mongini, Defilippi, & Negro, 1997)"  ADDIN PROCITE \11\05\19\02\00\00\00#(Mongini, Defilippi, & Negro, 1997)\00#\00\18\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Mongini, Defilippi, et al. 1997 #2990\00%\00 (Mongini, Defilippi, & Negro, 1997). Pain-related Fear. Recent data suggest that pain-related fear may be a key component in the development and maintenance of pain-related physical disability  QUOTE "(McCracken, Faber, & Janeck, 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00"(McCracken, Faber, & Janeck, 1998)\00"\00y\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#McCracken, Faber, et al. 1998 #4360\00#\00 (McCracken, Faber, & Janeck, 1998). Pain-related fear (also referred to as kinesiophobia) may be defined as the constellation of fearful feelings and avoidance behaviors in anticipation of a re-experiencing of painful sensations or of a re-injury (Kori, Miller, & Todd, 1990). Research has demonstrated that for some individuals with chronic pain pain-related fear may mediate treatment-related improvement  QUOTE "(Vlaeyen, de Jong, Geilen, Heuts, & van Breukelen, 2001)"  ADDIN PROCITE \11\05\19\02\00\00\008(Vlaeyen, de Jong, Geilen, Heuts, & van Breukelen, 2001)\008\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Vlaeyen, de Jong, et al. 2001 #4520\00#\00 (Vlaeyen, de Jong, Geilen, Heuts, & van Breukelen, 2001). The Pain Anxiety Symptoms Scale (PASS; McCracken, Zayfert, & Gross, 1992) is one of the two most frequently used measures of pain-related fear. The PASS includes 40 items distributed across four subscales measuring pain-related anxiety symptoms (cognitive and physiological), escape and avoidance behaviors, and pain-related fears  QUOTE "(McCracken, Zayfert, & Gross, 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00#(McCracken, Zayfert, & Gross, 1992)\00#\00\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%McCracken, Zayfert, et al. 1992 #1690\00%\00 (McCracken, Zayfert, & Gross, 1992). The PASS has adequate internal consistency  QUOTE "(McCracken et al., 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00\18(McCracken et al., 1992)\00\18\00\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%McCracken, Zayfert, et al. 1992 #1690\00%\00 (McCracken et al., 1992), good predictive validity  QUOTE "(McCracken et al., 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00\18(McCracken et al., 1998)\00\18\00y\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#McCracken, Faber, et al. 1998 #4360\00#\00 (McCracken et al., 1998), and acceptable validity  QUOTE "(McCracken, Gross, Aikens, & Carnrike, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00,(McCracken, Gross, Aikens, & Carnrike, 1996)\00,\00\1C\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#McCracken, Gross, et al. 1996 #3050\00#\00 (McCracken, Gross, Aikens, & Carnrike, 1996). The Tampa Scale of Kinesiophobia (TSK; Kori et al., 1990) is perhaps a better measure of pain-related fear. The TSK is a 17-item instrument with items assessing pain-related fear of movement or of pain sensations due to concerns about injury or reinjury (Kori et al., 1990). Recent data suggest that the TSK may be a better predictor of a range of pain symptoms and behaviors  QUOTE "(Crombez, Vlaeyen, Heuts, & Lysens, 1999)"  ADDIN PROCITE \11\05\19\02\00\00\00)(Crombez, Vlaeyen, Heuts, & Lysens, 1999)\00)\00p\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Crombez, Vlaeyen, et al. 1999 #1150\00#\00 (Crombez, Vlaeyen, Heuts, & Lysens, 1999), and it has been found to be a better predictor of disability than pain intensity, biomedical signs and symptoms, or negative emotionality measures  QUOTE "(Crombez et al., 1999; Vlaeyen et al., 1999)"  ADDIN PROCITE \11\05\19\02\00\00\00,(Crombez et al., 1999; Vlaeyen et al., 1999)\00,\00p\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Crombez, Vlaeyen, et al. 1999 #1150\00#\00 (Crombez et al., 1999; Vlaeyen et al., 1999) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Vlaeyen, Seelen, et al. 1999 #4560\00"\00 . A revised version of the TSK (TSK-R; 12 items) now is available that has been validated with veterans treated for chronic pain in outpatient and inpatient settings (Cohen, Clark, & Gironda, 2003; Gironda, Clark, & Young, 2003). The TSK-R demonstrates good reliability, and exploratory (Cohen et al., 2003) and confirmatory (Gironda et al., 2003) factor analyses have identified two factors that account for the majority of TSK-R score variance: fear of (re)injury and morbid somatic focus. The TSK-R can be downloaded from the  HYPERLINK "http://www.vachronicpain.org" www.vachronicpain.org website. Measuring Physical Capacities Physical capacities denotes an individual's theoretical physical capabilities that are limited by physical status variables such as strength, endurance, and range of motion. In contrast, functional capacities refer to an individual's "maximum work abilities"  QUOTE "(Dabatos, Rondinelli, & Cook, 2000)"  ADDIN PROCITE \11\05 \19\02\00\00\00#(Dabatos, Rondinelli, & Cook, 2000)\01\03\00\1C\00\00\00\00\00\00\1BM_\01\00\00\00` \00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00`~\00 ~\00&h ~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00`~\00 ~\00&h ~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Dabatos, Rondinelli, et al. 2000 #890\00%\00 (Dabatos, Rondinelli, & Cook, 2000), or their peak performance in specified tasks. As self-reports of physical capacities among individuals with chronic pain often do not correspond with their actual physical capabilities  QUOTE "(Clark, 1996; )"  ADDIN PROCITE \11\05 \19\02\00\00\00\0F(Clark, 1996; )\01\03\00\06\00\00\00\00\00\00\1BM_\01\00\00\00 \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\07\00\00\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\10Clark 1996 #3230\00\10\00 (Clark, 1996) QUOTE ""  ADDIN PROCITE \11\05 \19\02\00\00\00\00\01\00\00L\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\0EDeyo 1988 #130\00\0E\00 , objective physical capacity measures may serve as better indicators of treatment-related changes in this domain. At present there are no "gold standard" objective outcomes measures of pain-related physical or functional capacity in use within the VHA or private sector health care systems. Instead, a variety of methods have been employed in attempts to quantify treatment related changes in the physical abilities of individuals with pain. Practitioner Ratings. The most common physical capacity measures employed as outcomes indicators in pain clinic settings are practitioner ratings (usually on a 0 to 5 scale) of strength, flexibility, and sensory or motor function. Indeed, practitioner ratings have long been used in neurological evaluations and in assessments conducted by physical therapists or other rehabilitative disciplines. Ratings are based on physical examination findings and on task performance. Advantages of this approach are that physical capacity ratings are easy to generate, require little additional time, and necessitate minimal external equipment. Unfortunately, practitioner ratings are subject to the standard range of observer biases  QUOTE "(Hoyt, 2000)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0C(Hoyt, 2000)\00\0C\00~\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\0EHoyt 2000 #190\00\0E\00 (Hoyt, 2000) and often lack consistent scale anchors, which reduce their reliability and validity. Additionally, despite their apparent objectivity, practitioner ratings are in fact highly subjective since they rely on each individual's clinical experience and internalized schema, which may account for their poor inter-rater reliabilities  QUOTE "(Deyo, 1988; Elam et al., 1991; Lieberman et al., 1996)"  ADDIN PROCITE \11\05\19\02\00\00\007(Deyo, 1988; Elam et al., 1991; Lieberman et al., 1996)\007\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\0EDeyo 1988 #130\00\0E\00 (Deyo, 1988; Elam et al., 1991; Lieberman et al., 1996) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1EElam, Graney, et al. 1991 #170\00\1E\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Lieberman, Dorey, et al. 1996 #160\00"\00 . Observational Measures. A number of observational measures have been employed to quantify changes in the physical capacities of individuals with chronic pain. Several intricate behavioral ratings scales of physical impairment or functional capacities have been developed primarily for pain research (e.g.,  QUOTE "(Follick, Ahern, & Aberger, 1985)"  ADDIN PROCITE \11\05\19\02\00\00\00!(Follick, Ahern, & Aberger, 1985)\01\03\00\1A\00\00\00\00\00\00\1BM_\01\00\00\00x \00p~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00~\00P~\00&hP~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00P~\00&hP~\00\1D\00x\00\03xt\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Follick, Ahern, et al. 1985 #400\00 \00 Follick, Ahern, & Aberger, 1985 QUOTE "(; Keefe & Block, 1982)"  ADDIN PROCITE \11\05 \19\02\00\00\00\17(; Keefe & Block, 1982)\01\03\00\10\00\00\00\00\00\00\1BM_\01\00\00\00hh \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00\10~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00\10~\00~\00&h~\00\1D\00x\00\03xv\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt!Heinrich, Cohen, et al. 1985 #430\00!\00 ; Keefe & Block, 1982) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00w\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\17Keefe & Block 1982 #440\00\17\00 . Typically, these methods utilize trained observers either to record the frequency of key behaviors or to rate observed physical function during a series of standardized tasks. Interrater or interobserver agreement coefficients establish the reliability of measurement, and resulting scores demonstrate the necessary correspondence with alternative measures of the same functions. Observational measures are of limited value in most clinical settings as they require extensive rater training, detailed recording and scoring, lengthy administrations, elaborate data analysis, and, frequently, videotaped records. Nevertheless, if sufficient resources are available, observational measures may be of great value. An alternative type of observational measure that has been used to track general rehabilitation outcomes is the Functional Independence Measure (FIM; Keith, Granger, Hamilton, & Sherwin, 1987). The FIM is a collection of 18-items assessing patients' independence in selected areas of function. Testers must attain a criterion level of competence with the instrument before they begin administrations. Testers then rate the testee's level of independence on each item, based on the tester's observations of their abilities. Good to excellent FIM interrater reliabilities have been reported  QUOTE "(Hamilton, Laughlin, Fiedler, & Granger, 1994)"  ADDIN PROCITE \11\05\19\02\00\00\00.(Hamilton, Laughlin, Fiedler, & Granger, 1994)\00.\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Hamilton, Laughlin, et al. 1994 #1110\00%\00 (Hamilton, Laughlin, Fiedler, & Granger, 1994), and validity with several patient groups has been established  QUOTE "(Dodds, Martin, Stolov, & Deyo, 1993; Oczkowski & Barreca, 1993; Wilson, Houle, & Keith, 1991)"  ADDIN PROCITE \11\05\19\02\00\00\00^(Dodds, Martin, Stolov, & Deyo, 1993; Oczkowski & Barreca, 1993; Wilson, Houle, & Keith, 1991)\00^\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FDodds, Martin, et al. 1993 #480\00\1F\00 (Dodds, Martin, Stolov, & Deyo, 1993; Oczkowski & Barreca, 1993; Wilson, Houle, & Keith, 1991) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DOczkowski & Barreca 1993 #490\00\1D\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FWilson, Houle, et al. 1991 #500\00\1F\00 . Although most VHA and private sector inpatient rehabilitation services use the FIM as an index of function and to benchmark rehabilitation outcomes, the FIM is less useful for measuring pain-related physical capacities or treatment outcomes. FIM items were designed to assess functional capacities in patients with relatively severe disabilities, such as those associated with strokes or traumatic brain injuries. Individuals with less pervasive conditions, such as those with chronic pain, tend to score very high on the instrument even prior to treatment interventions due to their high baseline functional status. As a result, initial FIM scores approach the ceiling of the instrument allowing little room to discriminate function between individuals or to assess treatment-related change. "Biometric" Approaches. Biometric approaches rely on various hardware devices to quantify physical function, capacities, or movement. They may include physiological recordings of autonomic or somatic nervous system activity, measures of motor output (e.g., force, speed, weight), or three-dimensional computerized representations of motion or movement collected during standardized tasks. There are numerous biometric "systems" approaches marketed by private vendors that purport to be reliable and valid measures of functional capacities. Each of these approaches is based on unique combinations of measures and hardware that are presumed to either simulate actual functional behaviors or predict functional capacities. Biometric approaches often are utilized in injury litigation cases or in federal or state disability decisions (e.g., Social Security disability or Worker's Compensation) where questions concerning functional capacities exist. Although the comprehensive nature and precision of biometric approaches to physical capacity measurement is appealing, they are not suitable for general use as pain outcomes measures for numerous reasons. First, they require lengthy administration times (typically 3 to 4 hours or more) that far exceed available time intervals. Second, their hardware cost is substantial (approximately $12,000 to $100,000), and many charge additional fees for each completed assessment. Third, for the most part they were designed to assess work-related performance (i.e., functional capacities) rather than physical capacities per se. Thus, many of the simulated work tasks that form the basis of these biometric approaches may not be relevant to a VHA patient population characterized by multiple disabilities, low rates of employment, and sedentary lifestyles. Performance Measures. Performance measures are those where objective indices of function (e.g., time to complete, number of repetitions completed, degree of incline obtained, grip strength) during an assigned task are recorded and compared either to normative or clinical data or to pretreatment indices of function. Several of these measures have generated substantial research interest and have been found to be reliable and valid indicators of function. For example, the dual inclinometer method of assessing trunk range of motion has been found to be reliable  QUOTE "(Keeley et al., 1986)"  ADDIN PROCITE \11\05\19\02\00\00\00\15(Keeley et al., 1986)\00\15\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FKeeley, Mayer, et al. 1986 #510\00\1F\00 (Keeley et al., 1986), has demonstrated good correspondence with flexion and extension X-ray results  QUOTE "(Mayer, Kishino, Keeley, Mayer, & Mooney, 1985)"  ADDIN PROCITE \11\05\19\02\00\00\00/(Mayer, Kishino, Keeley, Mayer, & Mooney, 1985)\00/\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt!Mayer, Kishino, et al. 1985 #1070\00!\00 (Mayer, Kishino, Keeley, Mayer, & Mooney, 1985), and has been adopted as the "standard" method for assessing spinal mobility by the American Medical Association  QUOTE "(Engelberg, 1993)"  ADDIN PROCITE \11\05\19\02\00\00\00\11(Engelberg, 1993)\00\11\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\13Engelberg 1993 #940\00\13\00 (Engelberg, 1993). Similarly, hand dynameters have been found to be the most accurate available measure of hand strength  QUOTE "(Mathiowetz, Weber, Volland, & Kashman, 1984)"  ADDIN PROCITE \11\05\19\02\00\00\00-(Mathiowetz, Weber, Volland, & Kashman, 1984)\00-\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Mathiowetz, Weber, et al. 1984 #530\00#\00 (Mathiowetz, Weber, Volland, & Kashman, 1984), as long as standardized grip positions are employed  QUOTE "(Mathiowetz, Rennells, & Donahoe, 1985)"  ADDIN PROCITE \11\05\19\02\00\00\00'(Mathiowetz, Rennells, & Donahoe, 1985)\00'\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt&Mathiowetz, Rennells, et al. 1985 #540\00&\00 (Mathiowetz, Rennells, & Donahoe, 1985). However, most performance measures of range of motion or strength lack evidence of validity or reliability. For example, physical therapists traditionally rely on goniometers when assessing range of motion despite concerns regarding their reliability when used in cervical  QUOTE "(Nilsson, 1995)"  ADDIN PROCITE \11\05\19\02\00\00\00\0F(Nilsson, 1995)\00\0F\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\11Nilsson 1995 #560\00\11\00 (Nilsson, 1995), lumbar  QUOTE "(Rondinelli, Murphy, Esler, Marciano, & Cholmakjian, 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00:(Rondinelli, Murphy, Esler, Marciano, & Cholmakjian, 1992)\00:\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt$Rondinelli, Murphy, et al. 1992 #580\00$\00 (Rondinelli, Murphy, Esler, Marciano, & Cholmakjian, 1992), or extremity  QUOTE "(Rome & Cowieson, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Rome & Cowieson, 1996)\00\17\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\19Rome & Cowieson 1996 #590\00\19\00 (Rome & Cowieson, 1996) assessments. Alternatives include more integrated performance measures such as the Physical Capacities Evaluation (PCE; Clark, 1996), which is loosely based on an instrument developed by Woods (1989). The PCE is comprised of a collection of performance tasks that assess extremity and back function. Unfortunately, it is not practical for general clinical use as it requires the availability of a therapeutic pool to administer. Additionally, like other integrated measures which employ subtests or subtasks, the PCE yields a single overall score based on performance on a series of tasks utilizing different muscle groups. As a result, when pain-related limitations are confined to a single body area (e.g., lower extremities), the resulting summed scores tend to minimize the severity of the individual's dysfunction and may mask the extent of actual treatment-related changes that are obtained. Current Status Summary. At present there are no gold standard physical capacities outcomes measures available to pain practitioners. Standardization of assessment methods is lacking, and practitioner ratings of function remain very popular despite numerous studies demonstrating their poor reliability. Although there are a few commercial systems that may eventually provide adequate validation data, they are very expensive and time intensive, limiting their utility for clinical settings. The best-supported performance measures, which tend to be less resource intensive, are the dual inclinometer method of assessing changes in trunk range of motion, and the use of hand dynameters to evaluate upper extremity strength. In settings where rapid assessment is necessary, current alternatives appear limited to goniometer measures or practitioner ratings until alternative approaches are developed and validated. Measuring Employment Status Among the most common criteria used to evaluate chronic non-cancer pain treatment program success are return to work and improvements in disability compensation status. In fact, support for the effectiveness of multidisciplinary pain centers (MPCs) is largely based on data that document the success of these programs in returning participants to work and in closing disability claims  QUOTE "(Flor, Fydrich, & Turk, 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00\1D(Flor, Fydrich, & Turk, 1992)\00\1D\00\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FFlor, Fydrich, et al. 1992 #680\00\1F\00 (Flor, Fydrich, & Turk, 1992). Furthermore, CARF requires that accredited pain rehabilitation programs consider return to work as a key outcome domain  QUOTE "(Rehabilitation Accreditation Commission, 2002)"  ADDIN PROCITE \11\05\19\02\00\00\00/(Rehabilitation Accreditation Commission, 2002)\00/\00\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt2Rehabilitation Accreditation Commission 2002 #1030\002\00 (Rehabilitation Accreditation Commission, 2002). Work status also may be an important variable in evaluating the success of acute or cancer pain interventions in the context of a broad focus on psychosocial functioning. Employment Status Measures. Unlike other outcomes variables, assessment of changes in employment status does not necessarily involve the administration of validated instruments to gather work-related data. Instead, current employment status usually is elicited as a routine component of an initial screening or more comprehensive pain assessment interview. In this context, recent employment history also is elicited and may include assessment of a range of indicators of work functioning. It is important to note that, depending on the goals of the program or intervention and the population being served, return to work may or may not be viewed as a viable outcome. However, a broad array of alternative work-related variables may be reasonable to consider as measures of the effectiveness of the program or intervention. Most commonly, work status is measured as a categorical variable in which the participant is characterized as being employed full-time, part-time, or not at all. Usually student status is coded in a similar manner for these purposes. Persons who report that he or she works to maintain a household and/or provides childcare or other care giving usually is coded as such, as is retired status. Successful outcome usually is measured by an improvement (moving up in categories) in employment status. An alternative to this practice is to consider employment as a continuous variable in which paid work is coded in terms of number of days, weeks, or months over a specific period of time that the individual was employed or unemployed. Outcome is measured as a change in this variable as a function of the pain intervention. Another alternative method is based on an evaluation of progress toward individually established goals for employment. For example, a veteran participating in a chronic pain management program may set a goal of reducing absenteeism from work. Or another veteran receiving treatment for chronic upper extremity pain may have a goal of vocational retraining for an alternative career. Progress toward these specific goals may be used as important measures of successful pain management. Resolution of claims for disability or withdrawal from disability roles that impact availability for employment may be important outcomes for some programs or individuals. However, most experts and available data are consistent in supporting a view that this is often an unlikely outcome. For example, the extensive evaluation that usually accompanies a disability determination, and the strong social and financial incentives associated with receipt of disability compensation support this claim. For some veterans, including retirees or persons already established as being disabled, an increase in avocational activities may be appropriate measure of pain treatment success. Volunteering in a work setting, increases in household chores or activities around the home, initiation of hobbies, or other changes consistent with general productiveness may serve as appropriate outcomes indicators. Measuring Healthcare Utilization/Costs Over the past decade there has been a dramatic change in patterns of reimbursement or payment for healthcare delivery. Historically, healthcare has been delivered almost entirely with an emphasis on health-related outcomes, whereas cost-effectiveness was only a minor concern. This perspective has now been replaced by the need to attend to major societal and economic forces that demand that the costs of care serve as a primary factor in determining healthcare service delivery. In this environment, the only viable pain management system is one that emphasizes efficiency and cost-effectiveness. It has been estimated that over $125 billion is now spent on direct and indirect costs related to chronic non-cancer pain alone (Okifuji, Turk, & Kalauokalani, 1999). The need to balance the delivery of humane pain management and restrictions on the availability of funds for these services is a critical issue. A successful pain management system is one that is able to demonstrate cost-effectiveness, rather than effectiveness alone. Despite several published reports that support the cost-effectiveness of multidisciplinary approaches to pain management (e.g., Ferrell & Griffith, 1994; Turk, 1996), challenges to the strength of these data are common, particularly from the perspective of healthcare system administrators. Federico (1996) for example, emphasizes the need for increased standardization and guidelines for pain care as well as published research data from scientifically rigorous controlled studies that report on the relative cost-effectiveness of pain treatment programs. Cost-Effectiveness. Demonstrations of both effectiveness and efficiency in the management of pain are at the core of any discussion of cost-effectiveness. The availability of multifactorial data using methods proposed in this Toolkit that document improved patient outcomes is an important, if not essential, component of this process. However, as noted above, demonstrations of efficacy of an intervention or program may not be sufficient in the current managed care environment where resources are limited. In addition, it is increasingly important that costs associated with the delivery of pain management services also are assessed using methods judged to be reliable and valid. Ultimately, cost-effectiveness can be judged only through a close inspection of benefits (or harm) for persons receiving pain management services in direct comparison to costs associated with these services. Direct comparison of two or more pain management interventions for the same pain condition and/or sample of patients is probably the most common strategy for examining and reporting on the relative cost-effectiveness of the interventions. For example, Flor, Turk, and their colleagues in their examination of the cost effectiveness of MPCs derived their indices by a comparison of effects of MPCs versus surgical costs for the same conditions (Flor et al., 1992; Turk, 1996). An important concept in discussions of the cost-effectiveness of pain management systems of care is that of cost-offset. Cost-offset refers to the delayed benefits of an intervention that can be operationalized as reductions in healthcare costs subsequent to the intervention that are reasonably believed to be attributable to the pain intervention. For example, pain management intervention cost-offset effects can be attributed if there is a demonstration of a reduction in healthcare system utilization and associated costs during the 12 months immediately following a pain management intervention relative to the 12 months immediately preceding the delivery of the service. Measuring Healthcare Utilization And Associated Costs. There is a wide range of variables that may be targeted for developing estimates of costs associated with pain management services. The most common strategy for examining healthcare system utilization is some method for counting activities best characterized as direct patient care services. Depending on the specific facility, type of program, and population served, and the specific purpose of the analyses, it may prove useful to distinguish between medical and surgical, rehabilitation medicine, and mental health services, and/or pain-relevant utilization versus utilization unrelated to the pain condition. There also may be a specific reason to set a threshold for some categories of service utilization, such as an analysis of extensive utilization of a specific outpatient clinic. Examples of some relevant utilization indices are presented below: Type of Service Site of Service MeasureMedicalEmergency DepartmentNumber of visits Procedures performedInpatientNumber of admissions/ Episodes of care Bed days of care Procedures performedOutpatientNumber of primary care visits Number of specialty care visits Number of specialty clinics with >3 visits in 6 month period Number of pain clinic or other pain-related specialty clinic visits Procedures performedRehabilitation MedicineInpatientNumber of admissions/ Episodes of care Bed days of care Procedures performedOutpatientNumber of visits Procedures performedMental HealthEmergency Department Number of visits Procedures performedInpatientNumber of admissions/ Episodes of care Bed days of care Procedures performedDay TreatmentNumber of days of care Procedures performedOutpatientNumber of visits Procedures performed Costs associated with the use of both prescribed and non-prescribed (over-the-counter) analgesic medications (e.g., opioids) and other medications commonly used for pain management (e.g., benzodiazepines, non-steroidal anti-inflammatories, anticonvulsants, tricyclic antidepressants) are another important measure of healthcare utilization (see Section 5 for more information). Substantial cost savings may be realized by substituting generic or other less expensive medications for those that are more costly, provided that equivalent outcomes are attained. For individual veterans, these utilization indicators can be derived from CPRS GUI (see Section 5 for more information). Utilization of non-VHA services and medications most often require patient self-report and/or reports from significant others. Use of standardized methods for eliciting data related to non-VHA utilization is recommended. Efforts to corroborate these self-report via acquisition of outside medical and pharmacy records, with the consent of the veteran, can enhance confidence in their accuracy. When it is desirable to obtain utilization data for groups of veterans, for example, a cohort of participants in a pain management program, it may be helpful to consult with experts from the local Information Resource Management (IRM) office who may be able to extract summaries or aggregated data for your specific purposes (see Section 5 for more information). Attributing costs to healthcare system utilization is another potentially useful step in the process of examining cost-effectiveness. Costs for most direct patient care services (e.g., outpatient visits, bed days of care in an inpatient medical unit) provided in VHA facilities can be calculated by multiplying units of service by mean unit costs obtained by consulting with Decision Support System (DSS) personnel. Costs for services received in non-VHA settings may be estimated from private sector values for the region in which the service was provided. Pharmacy costs can usually be obtained from local authorities. Additional costs associated with pain-related diagnostic procedures and non-pharmacological pain interventions can be calculated in a similar manner. Once monetary values for services are obtained, changes in actual medical costs occurring from pretreatment to posttreatment can be computed. However, when focusing specifically on medical utilization effects of pain interventions it may be important to distinguish between pain-related visits or costs and those that are attributable to other factors (e.g., preventive health care or unrelated medical conditions) where we would not expect to see any impact of pain treatment. When evaluating the cost effectiveness of pain treatment, costs associated with the provision of the pain management intervention also should be examined. For some multidisciplinary pain centers the intensity of services provided and costs associated with them may be unexpectedly high when administrative and other indirect costs are considered. Equipment and supply costs are also important to include in these analyses. Only then can the potential cost savings of pain interventions be computed accurately. Measuring Patient Satisfaction Patient satisfaction is an important aspect of care that influences patient behavior and treatment outcomes. The American Pain Society Commission on Quality Assurance Standards has stated that patient satisfaction with clinical services received is part of the quality assurance of care delivery. Patient satisfaction is included as an outcome variable in the revised APS Patient Outcomes Questionnaire (APS, 1995). Satisfied patients are more likely to comply with treatment and establish better relationships with their providers, whereas dissatisfied patients tend to comply poorly with their prescribed therapeutic regimens (Aharony & Strasser, 1993; Carr-Hill, 1992). The difficulty in measuring patient satisfaction stems from the heterogeneity of patient satisfaction measures, the lack of clarity concerning the meaning of satisfaction and its relationship to other measures, and whether respondents can separate satisfaction with pain management from satisfaction with other aspects of care such as the caring dispositions of health care providers (Hester, Miller, Foster, & Vojir, 1997; Hudak & Wright, 2000). Factors such as the organizational context and the provider type (chiropractic care vs. primary care physicians) also can influence patient satisfaction reports (Hester et al., 1997; Solomon, Bates, Panush, & Katz, 1997). This discussion is not intended to make specific recommendations or present detailed reviews of patient satisfaction questionnaires. Comprehensive reviews of patient satisfaction measures are provided elsewhere in the literature (e.g., Ferris, 1992; Pascoe, 1983). Rather, general principles are reviewed to assist in choosing a measure based on the users intent, and information concerning the pain-related content of the national VHA customer satisfaction survey of healthcare experiences of patients also is presented. Characteristics of Satisfaction Measures. Patient satisfaction measures differ in their content (focus or substance of the measure) and their method (how the measure is administered and presented). Hudak and Wright (2000) suggest that the content of patient satisfaction questionnaires be classified along four axes: global vs. multidimensional, care vs. treatment outcome, generic vs. disease specific, and direct vs. indirect. Some questionnaires may assess only single dimensions of the pain experience (e.g., pain intensity ratings). In contrast, multidimensional measures are query multiple dimensions of service and care. Examples of multidimensional measures include the Patient Satisfaction Questionnaire (PSQ) and the Client Satisfaction Questionnaire (CSQ; Larson, Attkisson, Hargreaves , et al., 1983; Ware, Snyder, Wright, et al, 1979). The PSQ is a 43-item questionnaire reflecting six dimensions of quality related to hospital care: access to care, availability of services, technical quality of care, interpersonal care, communication, and financial aspects of care. The dimensions of care examined in the CSQ include the physical surroundings, general satisfaction, and the interpersonal and technical aspects. Global measures are considered less informative than multidimensional measures and tend to produce scores that are skewed towards high levels of satisfaction (Ferris, 1992). Multidimensional measures typically are more reliable and have higher levels of validity than the global measures (Sitzia & Wood, 1997). The PSQ and CSQ are examples of generic measures that can be used to assess patient satisfaction in any clinical setting. The content of these measures is broad enough to allow comparisons across conditions and settings, but unlike disease-specific measures, they cannot reflect sources of satisfaction/dissatisfaction unique to a particular disease or health care setting. The Patient Satisfaction Scale (PSS) is a multidimensional disease-specific measure of patient satisfaction designed specifically to assess satisfaction among patients with low back pain (Cherkin, Deyo, & Berg, 1991). If the focus of satisfaction assessment is with care (the patients rating of the quality of the medical care process), a generic measure is appropriate. However, if the focus is treatment outcome (the patients rating of a particular treatment intervention), a disease-specific measure will more precisely gauge patient satisfaction (Hudak & Wright, 2000). Another way to evaluate measures is whether they use direct or indirect scales to assess satisfaction. The PSQ is an example of an indirect method as it assesses patients attitudes about the health system or care in general. The CSQ and the PSS are examples of direct measures that require patients to think about the services they received when answering questions. Direct measures are considered more precise than the indirect measures when probing satisfaction with specific medical encounters or treatment interventions. Patient satisfaction measures also differ in the methods used to administer the instrument. Measures may be factual (what actually occurred) or affective (the patients perception of what occurred), questions may be open-ended or closed, they may be self- or interviewer administered, and they may utilize varied response formats (e.g. 4, 5, or 6-point scales). Each of these methods has their advantages and disadvantages depending on the setting and the users purpose. More detailed explanations of the methods used in patient satisfaction measures are available elsewhere (e.g., see Cleary, 1997; Ferris, 1992; Hudak & Wright, 2000; Ware & Hays, 1988). Choosing Patient Satisfaction Measures. In summary, the following general principles should be considered when choosing a patient satisfaction measure: Multidimensional measures are preferred over single dimension measures due to their wider breadth of information. Multidimensional measures may be supplemented by a global measure. The actual items in the measure should be carefully examined in relation to the clinical setting and patient population. It may be desirable to add questions to address dimensions not covered in the standardized measure. Assess satisfaction with care separately from satisfaction with treatment outcome. Direct measures are preferred over indirect measures when probing satisfaction with specific medical encounters or treatment interventions. Use of both closed and open-ended questions is recommended for a better understanding of patient satisfaction. Interview non-responders and patients who have left the program to probe for sources of dissatisfaction. National VHA Customer Satisfaction Survey. Since 1995, the Office of Quality and Performance has administered a mailed customer satisfaction survey in an effort to systematically assess those ambulatory care experiences identified by veterans as priority components of high quality medical care. Beginning in the spring of 2002, the Survey of Healthcare Experiences of Patients (SHEP) is surveying random samples of all patients seen by a provider. Information about this project and customer satisfaction data is available at the Office of Quality and Performance website,  HYPERLINK "http://vaww.oqp.med.va.gov/DEFAULT.asp" http://vaww.oqp.med.va.gov/DEFAULT.asp The survey results report scores for Veteran Health Service Standards, Overall Quality, and Provider Wait Times. Scores are provided for each VISN and scores are reported at the national, VISN, VAMC, and clinic organization levels. Veterans Health Service Standards (VHSS) are summary scores that reflect patient satisfaction in the following domains: Outpatient Access, Continuity of Care, Courtesy, Education and Information, Emotional Support, Overall Care Coordination, Visit Coordination, Pharmacy (mailed), Pharmacy (pickup), Specialist Care, Patient Preferences. Inpatient - Access, Courtesy, Education and Information, Emotional Support, Physical Comfort, Family Involvement, Transition, Overall Care Coordination, and Patient Preferences. The inpatient survey data domain Physical Comfort includes specific questions about pain experience and treatment. Future analyses of functional status and healthy behavior data from the SF-12V Health Survey is planned. The SF-12V is included in the mailed satisfaction survey to both inpatients and outpatients. The SF-12V includes questions that assess the functional impact of pain. A web-based application is being developed that will support online dynamic access to SHEP data as it is collected with tools to analyze the information more extensively. Questions incorporated in the 2002 National Survey and SF-12V that relate to pain treatment or outcomes are presented in  HYPERLINK \l "appendix1" Appendix I. Multidimensional Pain Outcomes Measures Multidimensional pain outcomes measures are used to assess treatment-related change in several outcomes domains simultaneously. Major advantages of this approach are that they can be used for benchmarking outcomes across facilities (when facilities utilize the same instrument), they tend to be better integrated, and they may be shorter than collections of unidimensional measures that cover the same outcomes domains. Major disadvantages are that they are more complex and may require increased administration, scoring, and interpretation time. Therefore, multidimensional measures are best utilized in intensive chronic pain treatment settings where the measurement of pain-related changes across all outcomes domains is desirable. West Haven Yale Multidimensional Pain Inventory (WHYMPI). The WHYMPI  QUOTE "(Kerns, Turk, & Rudy, 1985)"  ADDIN PROCITE \11\05\19\02\00\00\00\1B(Kerns, Turk, & Rudy, 1985)\01\03\00\14\00\00\00\00\00\00\1BM_\01\00\00\00( \00p~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\00\00\00~\00@~\00&h@~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00@~\00&h@~\00\1D\00x\00\03xr\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DKerns, Turk, et al. 1985 #380\00\1D\00 (Kerns, Turk, & Rudy, 1985) is a comprehensive measure of pain-related functioning that has been identified as one of the most frequently used measures of the chronic pain experience  QUOTE "(Mikail, DuBreuil, & D'Eon, 1993)"  ADDIN PROCITE \11\05 \19\02\00\00\00!(Mikail, DuBreuil, & D'Eon, 1993)\01\03\00\1A\00\00\00\00\00\00\1BM_\01\00\00\00 \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\00~\00\10~\00&h\10~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00\10~\00&h\10~\00\1D\00x\00\03x\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt#Mikail, DuBreuil, et al. 1993 #2770\00#\00 (Mikail, DuBreuil, & D'Eon, 1993). The MPI is comprised of 52 items comprising three sections and 12 subscales. Section one consists of five scales measuring a range of pain-related experiences, including pain intensity, pain interference, negative mood, life control, and perceived support. Section two contains three scales measuring the responses of significant others to the patients expressions of pain. The third section includes four activity scales. The WHYMPI has good internal consistency (( = .70 - .90) and adequate two-week test-retest reliabilities (r = .62 - .91; Kerns et al., 1985). Criterion-related, concurrent, and factorial validity has been demonstrated in numerous studies for heterogeneous samples of persons with chronic, non-cancer pain, and for several specific non-cancer and cancer pain samples, It has been used extensively in outcome research and has been demonstrated to be sensitive to treatment-related change (e.g., Altmaier, Lehmann, Russell, Weinstein, & Kao, 1992; Kerns, Turk, Rudy, & Holzman, 1986). WHYMPI cluster analyses have revealed a three-group typology (dysfunctional, interpersonally distressed, and adaptive copers) of patients with chronic pain  QUOTE "(Turk & Rudy, 1990)"  ADDIN PROCITE \11\05 \19\02\00\00\00\13(Turk & Rudy, 1990)\01\03\00\0C\00\00\00\00\00\00\1BM_\01\00\00\00 \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\00 ~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00 ~\00~\00&h~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\15Turk & Rudy 1990 #770\00\15\00 (Turk & Rudy, 1990). This typology may assist clinicians in attempting to match pain interventions to patient characteristics identified by the WHYMPI. Advantages of the WHYMPI are that it has been validated specifically with veterans, it assesses most of the relevant pain outcomes domains, and it provides an excellent assessment of the interpersonal aspects of individuals pain experiences. Pain Outcomes Questionnaire- VA (POQ-VA). The POQ-VA is an outcomes package developed for use with veterans and consisting of intake (45 items), post-treatment (28 items), and follow-up (36 items) questionnaires. The POQ-VA represents the culmination of a five-year cooperative effort with the American Academy of Pain Management to revise, improve, and adapt a preexisting pain outcomes instrument (the National Pain Data Bank) for use with VA patients experiencing pain. The POQ-VA is the only pain instrument developed specifically to assess treatment outcomes across all of the pain-related domains of functioning identified by the Rehabilitation Accreditation Commission (2002) as essential for comprehensive outcomes measurement. Outcomes domains include pain intensity, pain interference (ADLs, Mobility), Negative Affect, Vitality (activity level), pain-related fear (Fear), vocational functioning, patient satisfaction, and medical resource utilization from intake through follow-up. Core POQ-VA (formerly known as the National Pain Data Bank VA-Version 2.0) scales have been found to have adequate to high internal reliability and good stability  QUOTE "(Gironda, Azzarello, & Clark, 2002)"  ADDIN PROCITE \11\05 \19\02\00\00\00#(Gironda, Azzarello, & Clark, 2002)\01\08\00\01\00\00\00\00\00\00\1BM_\01\00\00\00h\00 \00\00~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\07\00\00\00\00\00Arial\00\00x\00\03x`\00c\00x?\00\00\00~\00\10~\00\02\00\00\00\00\00\00rial\00\00x\00\03x`\00c\00x?\00\00\00~\00\10~\00\09\00\00\00\00\00Arial\00\00x\00\03x`\00c\00x?\00\00\00~\00\10~\00\04\00\00\00\00\00\00rial\00\00x\00\03x`\00c\00x?\00\00\00~\00\10~\00\05\00\00\00\00\00Arial\00\00x\00\03x`\00c\00x?\00\00\00~\00\10~\00\02\00\00\00\00`\00c\00x\09\00\00\00J\00x~\00,\00\00\00`\0082\03x\05\00\00\00\00\00\00`\00c\00x\09\00\00\00J\00x~\00,\00\00\00`\0082\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt$Gironda, Azzarello, et al. 2002 #980\01\04\00\07\00\00\00\00\00Arial\00\00\00T`\00o\01\05\00G\15 \00 \00`\01x\00\02\00\00\00\00\00\00\00\00\00,\00\00\00\01\00\00\00<`\00=\11J\00,\00\00\00h`\00<`\00\09\00\00\00\00\00Arial\00\00\00T`\00o\01\05\00G\15 \00 \00`\01x\00\12\00\00\00\00\00\00\00x82\03x,\00\00\00&\10\00x,\00\00\00\0F\10\00x,\00\00\00 (Gironda, Azzarello, & Clark, 2002), and generalizability coefficients, which are indices of the fidelity of true score measurement (Heaton, Chelune, Talley, Kay, & Curtiss, 1993), indicated excellent scale reliability. Validation studies using veterans treated in outpatient and inpatient pain treatment settings revealed that the POQ-VA demonstrated good concurrent validity in relation to a number of widely accepted gold standard measures of pain-related impairment  QUOTE "(Clark & Gironda, 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Clark & Gironda, 2000)\01\03\00\10\00\00\00\00\00\00\1BM_\01\00\00\00 \00~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\000~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\000~\00~\00&h~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\19Clark & Gironda 2000 #970\00\19\00 (Clark & Gironda, 2000; Clark, Gironda, & Young, 2003), as well as good sensitivity to treatment-related change (Clark et al., 2003). Confirmatory factor analysis has revealed that the POQ-VA scales reflect a stable latent factor structure representing two higher-order factors (emotional distress and pain interference; Young, Clark, & Gironda, 2003). The POQ-VA is available for downloading from the  HYPERLINK "http://www.vachronicpain.org" www.vachronicpain.org website, and also is available in a short form version (POQ-SF). Brief Pain Inventory (BPI). The BPI  QUOTE "(Cleeland & Ryan, 1994)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Cleeland & Ryan, 1994)\00\17\00\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\19Cleeland & Ryan 1994 #230\00\19\00 (Cleeland & Ryan, 1994) is a 32-item inventory that assesses pain history, pain intensity, response to medication/treatment, and pain interference. The BPI has been translated into many languages, and it has been validated for use with cancer and chronic disease pain patients. Factor analyses have identified two-factors of pain severity and pain interference across samples and language versions  QUOTE "(Caraceni et al., 1996; Radbruch et al., 1999; Saxena, Mendoza, & Cleeland, 1999; Wang, Mendoza, Gao, & Cleeland, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00w(Caraceni et al., 1996; Radbruch et al., 1999; Saxena, Mendoza, & Cleeland, 1999; Wang, Mendoza, Gao, & Cleeland, 1996)\00w\00\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt$Caraceni, Mendoza, et al. 1996 #3350\00$\00 (Caraceni et al., 1996; Radbruch et al., 1999; Saxena, Mendoza, & Cleeland, 1999; Wang, Mendoza, Gao, & Cleeland, 1996) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00?\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Radbruch, Loick, et al. 1999 #3250\00"\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00l\00\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Saxena, Mendoza, et al. 1999 #3270\00"\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FWang, Mendoza, et al. 1996 #190\00\1F\00 . Note, however, that psychometric data thus far primarily apply to cancer and chronic disease samples rather than to individuals with chronic non-cancer pain. In addition, although the brevity of the BPI is a potential advantage, its scope is less comprehensive than the other available multidimensional instruments. Thus, although it may be the outcomes measure of choice with respect to individuals with cancer pain other instruments may be preferred when changes across many outcomes domains are important. SECTION 4: PROCESS OUTCOMES MEASURES Process outcomes dimensions or service delivery outcomes  QUOTE "(Clark & Gironda, 2002)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Clark & Gironda, 2002)\01\03\00\10\00\00\00\00\00\00\1BM_\01\00\00\00 \00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00p~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00p~\00~\00&h~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\19Clark & Gironda 2002 #960\00\19\00 (Clark & Gironda, 2002) focus on monitoring and improving pain service delivery systems. Often they are part of facility Performance Improvement (PI) efforts. Accreditation organizations such as JCAHO often focus more on process outcomes, although some JCAHO standards may relate to patient focused outcomes as well. For example, while the patients self-report of pain could be used as a patient focused outcome to determine the effectiveness of pain treatment, when it is used as evidence of compliance with pain screening and documentation policies it is acting more as a process outcome. As a process outcome, the intent of the patients self-report of pain changes from evaluating the effectiveness of the pain intervention provided to evaluating the service delivery system. Generally, the way in which process outcome measures are gathered differs from the manner that patient outcome measures are collected. Process measures usually involve tracking or monitoring aspects of service delivery or patient documentation. Rarely do process measures involve the use of validated instruments. Instead, process outcomes most often are measured by reviewing medical record documentation or facility records. Process outcome measures may be developed to evaluate pain policy compliance or to assess compliance with pain standards promulgated by external organizations such as JCAHO. Often they are used to evaluate the impact of a system intervention designed to improve service delivery. Examples of some pain process outcomes are changes in pain clinic waiting times, compliance with the mandate to routinely collect pain scores as the Fifth Vital Sign, proportion of pain patients undergoing repetitive medical diagnostic procedures, percentage of individuals with significant pain who receive pain education, and others. When developing or selecting pain process measures, one must first define the process that is of interest. Often this may be accomplished by referring to relevant facility or national policies or external pain standards. In this regard, it may be helpful to review the list of attributes of successful pain management systems developed for the VHA/Institute for Healthcare Improvement Pain Management Collaborative Project which is presented in HYPERLINK \l "appendix2"Appendix II. This document defines numerous process standards for pain management excellence that also may be useful as measures of pain process outcomes. Measuring Process Outcomes Process outcome measures data may be extracted from a variety of sources, including medical records (including CPRS), patient interviews or surveys, PI monitors, and local or national patient care data files. Chart Reviews. Chart reviews or audits can be either electronic or paper. Data collection forms and compliance checklists often are used to compare the quality of service delivery provided to an individual patient with system standards of care. In most settings it is not necessary to evaluate every case receiving the targeted service. Instead, a predesignated number of randomly selected charts can be reviewed at established intervals. Samples of some chart review forms are included in HYPERLINK \l "appendix3"Appendix III. Often it will be necessary to revise existing audit tools or to develop new tools to evaluate process outcomes. When developing pain compliance templates or audit tools, developers may find it useful to consult several articles that address this issue  QUOTE "(Clark & Gironda, 2002; Ferrell, Wisdom, Rhiner, & Alletto, 1991; Ferrell, McCaffery, & Ropchan, 1992)"  ADDIN PROCITE \11\05\19\02\00\00\00f(Clark & Gironda, 2002; Ferrell, Wisdom, Rhiner, & Alletto, 1991; Ferrell, McCaffery, & Ropchan, 1992)\01\07\00\10\00\00\00\00\00\00\1BM_\01\00\00\00 \00\10~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03x(\00\00\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03x\02\00\00\00\00\00\00\00~\00`~\00&h`~\00\1D\00x\00\03x#\00\00\00\00\00\00\00\00\00~\00`~\00&h`~\00\1D\00x\00\03x\02\00\00\00\00\00\00\00\10~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00\10~\00~\00&h~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\19Clark & Gironda 2002 #960\00\19\00 (Clark & Gironda, 2002; Ferrell, Wisdom, Rhiner, & Alletto, 1991; Ferrell, McCaffery, & Ropchan, 1992) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00I\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Ferrell, Wisdom, et al. 1991 #9340\00"\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00J\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Ferrell, McCaffery, et al. 1992 #9350\00%\00 . Patient Interviews and Satisfaction Surveys. When process outcomes measures require that data from service consumers be gathered, patient interviews or surveys can be utilized to assess the pain process outcome dimensions. Patient interviews should be structured and standardized so that each consumer responds to identical questions. Opportunities for additional comments can be incorporated at the end of the interview. When designing patient surveys or questionnaires for use, item wording, clarity, and reading level should be considered and adjusted to meet the target populations verbal abilities  QUOTE "(Clark & Gironda, 2002)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Clark & Gironda, 2002)\01\03\00\10\00\00\00\00\00\00\1BM_\01\00\00\00 \00\10~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03x\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\19Clark & Gironda 2002 #960\00\19\00 (Clark & Gironda, 2002). A pain process evaluation tool that includes both a chart audit and a patient interview that was tested for content validity, interrater reliability, practicality of administration and test/retest reliability, is included available from  QUOTE "(Ferrell, Whedon, & Rollins, 1995)"  ADDIN PROCITE \11\05\19\02\00\00\00"(Ferrell, Whedon, & Rollins, 1995)\01\03\00\1B\00\00\00\00\00\00\1BM_\01\00\00\00 \00P~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00@~\00\00~\00&h\00~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00@~\00\00~\00&h\00~\00\1D\00x\00\03xK\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Ferrell, Whedon, et al. 1995 #9360\00"\00 Ferrell, Whedon, & Rollins (1995). Performance Improvement Monitors. Most healthcare institutions have in place numerous PI indicators that are used to track different aspects of care. Often these indicators will overlap with pain service delivery outcomes. For example, medication error monitors will include cases where pain-related medications were dispensed incorrectly. Or, facility clinic waiting times monitors will gather data on pain clinic waiting times as well as on other clinics. Many additional areas of overlap are possible. If existing PI monitors do not cover critical pain service delivery components, consideration should be given for developing new PI monitors that address the relevant pain service delivery issues. For example, a monitor might be established for determining the percentage of patients with pain greater or equal to a trigger value of four who undergo detailed pain assessments. Patient Care Data Files. Aggregated pain service delivery outcomes data also can be extracted from patient care files maintained either locally or nationally. Local files may contain pain scores collected at locally determined intervals that may be aggregated across patients to evaluate changes in the effectiveness of overall pain care provided by the institution. Alternately, facilities utilizing clinical reminders for pain may be able to evaluate various aspects of pain care delivery (see Section 5 for a more detailed discussion). Key Process Outcomes Monitors There are five key pain service delivery processes that are central to excellence in pain care: Comprehensive pain assessment has occurred Treatment/Clinic waiting times are reasonable Patients and their families receive education about pain treatment options and their rights and responsibilities A pain plan of care is present Providers are educated regarding appropriate pain care Pain Assessment. The VHA National Pain Management Strategy mandates that pain assessment is performed in a consistent manner. As stated in the Pain as the 5th Vital Sign Toolkit, reliable and comprehensive assessment of pain is the cornerstone of effective pain management, and that effective pain management hinges on the availability of a thorough and reliable assessment of pain. The importance of pain assessment is highlighted by research showing that the failure to routinely assess pain and pain relief is the most common reason for the undertreatment of pain in U.S. hospitals (American Pain Society, 1999). JCAHO standards ( HYPERLINK "http://WWW.jcaho.org" http://WWW.jcaho.org) that address the importance of pain assessment are: PE.1.4: Pain is assessed in all patients. RI.1.2.8: Patients have the right to appropriate assessment and management of pain Evidence that comprehensive pain assessment is occurring requires that documentation of completed assessments be present in the medical record. Assessments may be in the form of provider consultation reports, provider progress notes, or completed pain assessment templates. Note that the presence of numeric pain scores in the medical record is not sufficient evidence that pain assessment has occurred. Routine pain screening for the presence and intensity of pain, as outlined in the Pain as the 5th Vital Sign directive, should lead to completion of a comprehensive pain assessment when some specific pain intensity threshold is reached (e.g., a pain score of >3 on a 0-10 numeric rating scale). Waiting Times. One of the goals of the VHA National Pain Management Strategy is to assure that pain treatment is prompt and appropriate. Waiting times are an important aspect of this goal. JCAHO also emphasizes the importance of waiting times as illustrated in the following standard: RI.1.2.8: Patients have the right to appropriate assessment and management of pain. Examples of waiting times relevant to pain service delivery adequacy include: Waiting time between clinic referral and first available appointment Waiting time between stated clinic appointment time and the time the patient actually is seen Waiting time between the initiation of a pain medication order and the administration of the pain medication (inpatient setting) Waiting time between the patients pain medication request and the time the medication is dispensed (inpatient setting) Some waiting times may be calculated based on evidence present in CPRS (e.g., number of days between clinic referral and scheduled appointment). Others will require that specific monitors be established to quantify the time intervals. Waiting times and other process measures also can be assessed using patient questionnaires. The American Pain Society Patient Outcome Questionnaire (American Pain Society, 1995) is an example of a questionnaire that examines several process domains including medication waiting times. Patient Education. Patient education is another important component of pain service delivery systems. The importance of education efforts is addressed in the VHA National Pain Management Strategy objective to include patients and families as active participants in pain management. Similarly, the 1992 AHCPR Acute Pain Management guidelines (Acute Pain Management Guideline Panel, 1992) include patient education as one of four major pain management goals. JCAHO standards also address the importance of pain education: PF.1.7: Patients are taught that pain management is a part of treatment. A positive outcome requires an understanding of pain, the risk for pain, and the importance of effective pain management. RI.1.2: Patients are involved in all aspects of their care RI.1.2.8: Patients have the right to appropriate assessment and management of pain. Appropriate components of education for individuals with pain include information regarding diagnosis and prognosis, possible effects on emotional, social, and familial functioning or roles, treatment rights and responsibilities, and available treatment options including their risks, side effects, and known complications. Evidence of patient and family education may be found in general progress notes, specific patient education forms, or patient education templates. Alternatively, pain patients or their family members could be interviewed or surveyed regarding the type and nature of pain education they received. Navas & Sommer (1999) provide information on potential sources for patient surveys. Examples of possible patient education survey items are presented in HYPERLINK \l "appendix4"Appendix IV. Pain Plan of Care. In order to systematically treat pain, a pain plan of care (i.e., treatment plan) should be present in the medical record. Ideally, plans of care should include a description of the pain treatment methods that will be utilized, their frequency, treatment goals, methods that will be used to measure progress towards the stated goals, and evidence that the person with pain was involved in the development of the pain treatment plan. Pain plans of care should be active as long as pain continues to be defined by the patient as a significant problem, and they need to be reviewed and revised whenever significant changes in the persons condition are observed, or when the treatment methods selected have not been effective. JCAHO standards that address the importance of pain treatment plans include: PF.1.7: Patients are taught that pain management is a part of treatment RI.1.2: Patients are involved in all aspects of their care RI.1.2.8: Patients have the right to appropriate assessment and management of pain. CC.6.1: The discharge process provides for continuing care based on the patients assessed needs at the time of discharge. The adequacy of pain plans of care usually is assessed by reviews of inpatient or outpatient records. Chart review checklists can be developed to facilitate these reviews. Exemplary plans will include the components noted above, along with evidence of ongoing reassessment of the individuals pain problems and response to treatment and documentation of any multidisciplinary involvement in treatment. Provider Education. Assuring that providers are educated in appropriate pain management treatment methods is another stated objective of VHA National Pain Management Strategy. The JCAHO standard that directly applies to this issue is: RI.1.2.8: Patients have the right to appropriate assessment and management of pain. Provider education has been recognized as a critical component in the provision of appropriate pain treatment services. The AHCPR Cancer Pain Guidelines  QUOTE "(Jacox, Carr, & Payne, 1994)"  ADDIN PROCITE \11\05 \19\02\00\00\00\1C(Jacox, Carr, & Payne, 1994)\01\03\00\15\00\00\00\00\00\00\1BM_\01\00\00\00 \00\10~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00~\00 ~\00&h ~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00 ~\00&h ~\00\1D\00x\00\03xL\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1EJacox, Carr, et al. 1994 #9370\00\1E\00 (Jacox, Carr, & Payne, 1994) identifies inadequate provider education as a major barrier to effective pain management. In fact, eight of the ten goals of the Cancer Pain Guidelines are related to staff education and competency. Traditional voluntary educational approaches such as continuing medical education (CME) activities have not led physicians to improve how they manage pain or other medical problems  QUOTE "(Davis et al., 1999; Weissman, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\00$(Davis et al., 1999; Weissman, 1996)\01\05\00\0D\00\00\00\00\00\00\1BM_\01\00\00\00H \00\10~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00`\00j\00x82\03x\0E\00\00\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\10\00xx\00M_ ~\00\00M_@\00\00\00`\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_ ~\00\00M_@\00\00\00`\00j\00x82\03xM\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt!Davis, O'Brien, et al. 1999 #9380\00!\00 (Davis et al., 1999; Weissman, 1996) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00N\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\13Weissman 1996 #9390\00\13\00 . Alternatives to voluntary pain CME approaches may include attendance at mandatory training activities, completion of formal web-based training courses, self-study, or experiential-based training. The selection of process monitors for staff education in pain will depend on the pain training approach adopted in each locale of interest. Attendance monitors simply document that staff have participated in the designated pain training. The training activities may take place at the local facility or at regional or national conferences or meetings. Education tracking systems, which are operating at all VHA sites, can be utilized to document staff participation in pain education activities. In contrast, competency monitors require a demonstration of knowledge or skill. Competency approaches to training may utilize knowledge tests to document that participants have demonstrated some criterion level of pain knowledge before credit for the training is awarded. More elaborate approaches may rely on tests of pain knowledge and attitudes administered prior to and following a program of pain education to quantify changes induced by the training activities. Margo McCaffery has developed and validated a reliable test of nurses pain knowledge and health provider attitudes ( HYPERLINK "http://mayuday.coh.org/Instruments/k&a.htm" http://mayuday.coh.org/Instruments/k&a.htm) that could be utilized as a measure of the effectiveness of provider education. An example of a pain knowledge test is included in HYPERLINK \l "appendix5"Appendix V. There are several resources available to all VHA sites to educate clinical staff on pain issues and to assess pain management knowledge. Each VHA VISN Library has received a copy of the following pain management educational resources: 1) Assessing Complicance with the New JCAHO Pain Management Standards for Complex Organizations (includes 2 videos); 2) Pain Management (CD-Rom); 3) Pain Management Patient Education Manual ; and 4) Pain Management: An Interactive CD-ROM for Clinical Staff Development. Contact your VISN Librarian for assistance in locating these items. The CD-ROMs include knowledge tests which are scored for per cent of correct responses. Minimum scores can be selected as a local competency criterion. SECTION 5: SPECIAL ISSUES Evaluating Medication Use Outcomes The multifactorial nature of pain, particularly chronic pain, makes it necessary to evaluate the outcomes of pharmacologic treatment using multiple criteria  QUOTE "(Kozma, 1995; Kozma, Reeder, & Schulz, 1993; Ortmeier, 1997)"  ADDIN PROCITE \11\05\19\02\00\00\00<(Kozma, 1995; Kozma, Reeder, & Schulz, 1993; Ortmeier, 1997)\01\07\00\06\00\00\00\00\00\00\1BM_\01\00\00\00H \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\1D\00\00\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\00\00\00~\00P~\00&hP~\00\1D\00x\00\03x\0E\00\00\00\00\00\00\00\00\00~\00P~\00&hP~\00\1D\00x\00\03x\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00`\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00`\00j\00x82\03xO\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\10Kozma 1995 #9400\00\10\00 (Kozma, 1995; Kozma, Reeder, & Schulz, 1993; Ortmeier, 1997;  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00P\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Kozma, Reeder, et al. 1993 #9410\00 \00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00Q\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\13Ortmeier 1997 #9420\00\13\00 Turk & Okijuji, 1998). For instance, it is not enough that a drug may produce a significant improvement in a specific clinical endpoint, e.g. an improved adverse drug event (ADE) profile. The improved ADE profile also must lead to improved outcomes  QUOTE "(Kozma, 1995)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0D(Kozma, 1995)\01\03\00\06\00\00\00\00\00\00\1BM_\01\00\00\00 \00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03xO\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\10Kozma 1995 #9400\00\10\00 (Kozma, 1995). The ECHO (Economic, Clinical and Humanistic Outcomes) model provides a theoretical framework for the identification, collection and use of outcomes data to assess pharmaceutical treatment alternatives  QUOTE "(Kozma, 1995; Kozma et al., 1993; Ortmeier, 1997)"  ADDIN PROCITE \11\05\19\02\00\00\001(Kozma, 1995; Kozma et al., 1993; Ortmeier, 1997)\01\07\00\06\00\00\00\00\00\00\1BM_\01\00\00\00 \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_\00~\00\00M_@\00\00\00`\00j\00x82\03x\12\00\00\00\00\00\00\10\00xx\00M_\00~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\0E\00\00\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\10\00xx\00M_\10~\00\00M_@\00\00\00`\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_\10~\00\00M_@\00\00\00`\00j\00x82\03xO\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\10Kozma 1995 #9400\00\10\00 (Kozma, 1995; Kozma et al., 1993; Ortmeier, 1997) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00P\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Kozma, Reeder, et al. 1993 #9410\00 \00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00Q\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\13Ortmeier 1997 #9420\00\13\00 . The model proposes causal relationships among diseases, health outcomes and decisions about medical care interventions. The ECHO model assumes that the outcomes of medical care can be classified along three general dimensions: clinical, economic, and humanistic outcomes. These dimensions are defined as follows: Clinical outcomes: medical events that occur as a result of disease or treatment (pain reduction, side effect profile). Economic outcomes: direct, indirect, and intangible costs compared with the consequences of medical treatment alternatives (ER/clinic visits, cost of hospital care, cost of lost productivity, drugs and supplies). Humanistic outcomes: consequence of disease or treatment on patient functional status or quality of life measured along several dimensions (e.g., physical function, social function, general health and well being, sleep, increased activity level, patient satisfaction). The use of the ECHO model should assist in identifying and selecting outcomes for inclusion in pharmacoeconomic analyses, identifying important patient populations for the treatment alternatives of interest, and assessing the relative value of competing alternatives  QUOTE "(Kozma et al., 1993)"  ADDIN PROCITE \11\05\19\02\00\00\00\14(Kozma et al., 1993)\01\03\00\0D\00\00\00\00\00\00\1BM_\01\00\00\00 \00\00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03xP\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Kozma, Reeder, et al. 1993 #9410\00 \00 (Kozma et al., 1993). The application of this model to pain pharmaceutical therapy outcomes is presented in Figure 1. Figure 1. Evaluating Pain Treatment Outcomes: the ECHO Model.               Clinical Outcomes. Figure 1 illustrates the process whereby health care providers evaluate clinical indicators of disease or symptoms (pain intensity, non verbal cues of pain) and make decisions regarding treatment alternatives. Clinical indicators, used as the basis for selection of treatment alternatives, are surrogates for clinical outcomes. Treatment modifiers (e.g., compliance with therapy, side effects, dosing interval) may affect both clinical indicators and clinical outcomes. Pain ratings. Pain rating scales such as the Numeric Rating Scale have been used to monitor pharmacotherapy outcomes. It is important to recognize that pain scales alone are not sufficient to evaluate the overall response to treatment or patient satisfaction with drug therapy. Patients may express satisfaction with treatment despite having severe pain  QUOTE "(Ward & Gordon, 1996; McNeill, Sherwood, Starck, & Thompson, 1998)"  ADDIN PROCITE \11\05 \19\02\00\00\00B(Ward & Gordon, 1996; McNeill, Sherwood, Starck, & Thompson, 1998)\01\05\00\0E\00\00\00\00\00\00\1BM_\01\00\00\00 \00@~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\00\00\00\00~\00 ~\00&h ~\00\1D\00x\00\03x+\00\00\00\00\00\00\00\00\00\00~\00 ~\00&h ~\00\1D\00x\00\03x\02\00\00\00\00\00\00\00~\00 ~\00&h ~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00 ~\00&h ~\00\1D\00x\00\03xR\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\18Ward & Gordon 1996 #9430\00\18\00 (Ward & Gordon, 1996; McNeill, Sherwood, Starck, & Thompson, 1998) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\009\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt$McNeill, Sherwood, et al. 1998 #1590\00$\00 . Even though patients may not experience an improvement in pain intensity, other quality of life measures (general activity and sleep) may improve significantly, resulting in improved patient satisfaction. Additionally, patients may indicate that they still have pain but do not wish to receive a stronger dose of pain medication  QUOTE "(McNeill et al., 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00\16(McNeill et al., 1998)\01\03\00\0F\00\00\00\00\00\00\1BM_\01\00\00\00xX \00\00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x9\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt$McNeill, Sherwood, et al. 1998 #1590\00$\00 (McNeill et al., 1998). Drug related problems. Pharmaceutical care is an outcome oriented, cooperative, systematic approach to providing drug therapy directed at the improvement of all dimensions of health related quality of life  QUOTE "(Hepler, 1996)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0E(Hepler, 1996)\01\03\00\07\00\00\00\00\00\00\1BM_\01\00\00\00 \00~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\10\00xx\00M_p~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_p~\00\00M_@\00\00\00 `\00j\00x82\03xS\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\11Hepler 1996 #9440\00\11\00 (Hepler, 1996). The identification of drug related problems (DRPs) are central to the pharmaceutical care process. Drug related problems have been defined as an undesirable event, a patient experience that involves, or is suspected to involve drug therapy, and that actually, or potentially, interferes with a desired patient outcome  QUOTE "(Hepler & Strand, 1990)"  ADDIN PROCITE \11\05\19\02\00\00\00\17(Hepler & Strand, 1990)\01\03\00\10\00\00\00\00\00\00\1BM_\01\00\00\00\000~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\000~\00&h0~\00\1D\00x\00\03xT\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1AHepler & Strand 1990 #9450\00\1A\00 (Hepler & Strand, 1990). DRPs have been grouped into the following major types: Needing pharmacotherapy but not receiving it (a drug indication) Taking or receiving the wrong drug Taking or receiving too little of the correct drug Taking or receiving too much of the correct drug Experiencing an adverse drug reaction Experiencing a drug-drug or drug-food interaction Not taking or receiving the drug prescribed Taking or receiving a drug for which there is no valid medical indication Since the pharmaceutical care model is applicable to specialty practice, DRPs may be used to monitor and evaluate medication outcomes in pain management. Medical Utilization. Hospital admissions, readmissions, and length of stay have been used to evaluate medication outcomes. Medication use may be responsible for hospitalizations or prolonged hospital stays in cases of therapeutic failure or significant adverse drug events or toxicity. Like hospitalizations, unscheduled clinic visits and emergency room visits also may reflect the effects of pharmacotherapy, and can be used to evaluate medication outcomes. Economic Outcomes. Economic outcomes are described in terms of cost and consequences of treatment and are derived from the direct cost of providing medical care, the direct non-medical costs associated with obtaining care, and the indirect costs linked to lost productivity related to illness. As depicted in Figure 1, economic outcomes have intermediaries introduced from the clinical and humanistic sides of the model. The clinical side includes the direct costs of medical care associated with each treatment, including medication, laboratory, emergency room visit, inpatient hospitalization, and return visit costs. The humanistic side includes productivity costs associated with time lost from work. Direct non-medical costs include expenses for transportation to the hospital or physicians office for treatment, lodging for family members during treatment, and home health care expenses. Economic outcomes may be expressed as ratios of costs to benefits (in dollars), cost effectiveness (e.g., number of painful exacerbations versus treatment expenses), or utility (e.g., changes in quality-adjusted life-years;  QUOTE "(Kozma et al., 1993; )"  ADDIN PROCITE \11\05 \19\02\00\00\00\16(Kozma et al., 1993; )\01\03\00\0D\00\00\00\00\00\00\1BM_\01\00\00\00 \00~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03x\07\00\00\00\00\00\00\10\00xx\00M_P~\00\00M_@\00\00\00`\00j\00x82\03xP\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt Kozma, Reeder, et al. 1993 #9410\00 \00 Kozma et al., 1993) QUOTE ""  ADDIN PROCITE \11\05 \19\02\00\00\00\00\01\00\00\0C\05\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\11Larson 1986 #3540\00\11\00 . Humanistic Outcomes. Humanistic outcomes refer to patient evaluations of the impact of treatment on their lives e.g., health-related quality of life, satisfaction with care, and functional status. Pharmacotherapy may influence humanistic outcomes to the degree that it affects the patients ability to engage in or enjoy his/her activities of daily living. For example, the anxiolytic, antidepressant and hypnotic effects of certain drugs may enhance quality of life while adverse drug reactions such as insomnia, memory loss, or impotence may negatively affect it. Patients may express satisfaction with pain management despite having high levels of pain intensity. In fact, patient dissatisfaction with pain management and their desire for stronger pain medications have been related to the degree at which pain interferes with general activities and sleep  QUOTE "(McNeill et al., 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00\16(McNeill et al., 1998)\01\03\00\0F\00\00\00\00\00\00\1BM_\01\00\00\00xX \00~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x9\03\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt$McNeill, Sherwood, et al. 1998 #1590\00$\00 (McNeill et al., 1998), rather than to pain intensity per se. Recommendations for Medication Use Outcome Measures. Specific recommendations for pharmacotherapy outcome measures are presented in the following table. In many clinical settings it often is difficult to isolate the effects of an individual pain intervention on observed changes in patient functioning or reported distress. Patients may be involved in multiple treatments simultaneously (e.g., pharmacotherapy, physical therapy, psychotherapy), each of which may contribute to observed outcomes in unique ways. Similarly, patients with pain often may be treated with multiple classes of medications which complicate judgments regarding the efficacy of any specific agent. Therefore, when evaluating pharmacotherapy effectiveness it is important to be aware of concurrent treatments or medications that may be contributing to the obtained outcomes. Sometimes it will not be possible to determine the differential effectiveness of each treatment component. Medication Use Outcome Measures Outcome SurrogateOutcome MeasuresWhat to Measure?Clinical OutcomesPain RatingPatients perceived pain ratingPain intensity by means of validated scales e.g., the pain NRS or the VAS.Drug Related ProblemsNeeding pharmacotherapy but not receiving it (a drug indication) Receiving the wrong drug Not taking or receiving the drug prescribed# of patients that are not taking or receiving required pain medication Medication administration errors Compliance behaviorTaking or receiving too little or too much of the correct drug# of patients being under or over treated Experiencing an adverse drug reaction # of patients experiencing an ADE # and types of ADEsExperiencing a drug-drug, drug-food interaction # of patients experiencing a drug-drug, drug-food interaction drug-drug, drug-food interaction sequelaeTaking or receiving a drug for which there is no valid medical indication# of patients receiving duplicate pharmacological agents # of patients on polypharmacyHospitalizationsAdmissions, re-admissions and/or length of stay due to ADEs associated to pain-related drug therapy or failure of drug therapy to control pain.# of hospital admissions or readmissions Time to readmission (days) Length of hospital stay (days) Unscheduled clinic visits, emergency room visits Unscheduled clinic visits, emergency room visits due to ADEs associated to pain-related drug therapy or failure of drug therapy to control pain.# of unscheduled clinic visits # of emergency room visits Outcome SurrogateOutcome MeasuresWhat to Measure?Economic OutcomesDirect cost of providing medical careCost of drugs, re-treatment due to drug failure, hospitalizations, office visits, allied health treatment (PT, OT, RT), laboratory work, X-Rays, prosthetics/medical equipment Drug costs Cost per day of hospitalization Office visit and allied health costs including nursing and pharmacy time Laboratory test costs Radiographic test costs Dollar value of prosthetics and medical equipmentDirect non-medical costs associated to obtaining careTransportation to the hospital or physicians office, lodging, toll & parking fees Transportation and lodging related costs accrued by the patient and caregiver Hired caregiver costsIndirect costs associated with lost productivity related to illnessTime lost from work, reduced productivityLost income from time lost from work or reduced productivity. Include time lost from work of caregiver.Humanistic OutcomesPatient satisfaction with therapyPatient s satisfaction with pharmacotherapy for pain managementPatient satisfaction by means of patient satisfaction questionnaires e.g., the APS-POQDaily functioningPharmacotherapy effects on physical and psychosocial functioning# of adverse drug events Changes in measures of daily activity, physical capacity, social and sexual functioning, mood, pain intensity, sleep, and vitality Measuring Family and Social Outcomes Contemporary models of the experience of pain emphasize the social, and particularly the family, context  QUOTE "(Jacob & Kerns, 2001)"  ADDIN PROCITE \11\05 \19\02\00\00\00\15(Jacob & Kerns, 2001)\01\03\00\0E\00\00\00\00\00\00\1BM_\01\00\00\00\01 \00@~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00~\00`~\00&h`~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00~\00`~\00&h`~\00\1D\00x\00\03xV\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\18Jacob & Kerns 2001 #9470\00\18\00 (Jacob & Kerns, 2001; Otis, Cardella, & Kerns, in press). This perspective encourages attention to the role of the social environment in the development and maintenance of the experience of pain and in understanding processes of adaptation and adjustment. Conversely, the model draws attention to the impact of pain on important interpersonal relationships. Involvement of the family in pain management efforts is explicitly stated as an objective of the VHA National Pain Management Strategy. This objective is most commonly manifested as documented efforts to provide education to family members (and significant others) in the context of patient-oriented pain management. Active inclusion of significant others in the comprehensive assessment of pain, collaborative treatment planning, in the delivery of pain interventions, and in reassessment is indicated by the perspective described above. In certain situations, active participation of significant others in these processes is likely to be critical to effective pain management. For example, the spouse of a demented and uncommunicative veteran may be critical in evaluating pain severity and its impacts on functioning, in the reliable delivery of pain medications, and in assessing the efficacy of the intervention. Education of and active collaboration with the spouse in the development of an intervention plan may be essential. Another example comes from multidisciplinary pain management centers that commonly expect significant others to become active participants in the program. These factors should be considered in the development of a comprehensive set of outcome measures for evaluating individual or program success. Attention to the broader social and cultural context of pain also has been emphasized. Increasingly research has documented reliable racial and ethnic differences in the experience of pain including variables such as pain perception, treatment seeking, and analgesic responsiveness. Attention to cultural diversity factors in the development and implementation of a comprehensive system for effective pain management is critical, and in the delivery of individually-tailored plans for pain management. Measuring Family Outcomes. Consistent with the VHA National Pain Management Strategy objectives and the JCAHO pain management standards is the need for reliable documentation of pain-relevant family education. Development of a system for performance improvement in this domain that focuses on ongoing monitoring, feedback, and performance improvement efforts is indicated. Depending on the scope and goals of a specific pain intervention or program, inclusion of any of a number of family-relevant outcomes measures also may be indicated. The process for selecting these measures should be informed by the principles outlined earlier in this Toolkit. Measures in this area range from those that are broad in scope and not specifically related to pain management (e.g., the Locke-Wallace Marital Adjustment Scale;  QUOTE "(Locke & Wallace, )"  ADDIN PROCITE \11\05\19\02\00\00\00\13(Locke & Wallace, )\01\03\00\10\00\00\00\00\00\00\1BM_\01\00\00\00 \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00~\00~\00\10~\00\0C\00S\00(I_&\0C\00S\00x\00M_\01\00\00\00\00\00\00\00\00\00,~\000~\00 ~\00\00\00\00\00\02\00\00\00\0C\00S\00\01\00\00\00U\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\15Locke & Wallace #9460\00\15\00 (Locke & Wallace, 1959) to those that are behaviorally-specific and pain-relevant (e.g., the significant other response scales from the West Haven-Yale Multidimensional Pain Inventory; QUOTE "(Kerns et al., 1985)"  ADDIN PROCITE \11\05 \19\02\00\00\00\14(Kerns et al., 1985)\01\03\00\0D\00\00\00\00\00\00\1BM_\01\00\00\00 r \00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_~\00\00M_@\00\00\00 `\00j\00x82\03xr\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DKerns, Turk, et al. 1985 #380\00\1D\00  Kerns et al., 1985). Standardized measures of potentially important outcome domains (e.g., significant other adherence to recommendations for pain medication delivery, significant other satisfaction with pain treatment efforts) are not yet available and may need to be developed for a specific purpose. A comprehensive review of the available measures in this area has recently been published  QUOTE "(Jacob & Kerns, 2001)"  ADDIN PROCITE \11\05\19\02\00\00\00\15(Jacob & Kerns, 2001)\01\03\00\0E\00\00\00\00\00\00\1BM_\01\00\00\00( \00 ~\00\01\00\00\00\01\00\00\00\00\00\00\00 \00\00\00\02\00\00\00\00\00\00\00@~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\00@~\00~\00&h~\00\1D\00x\00\03xV\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\18Jacob & Kerns 2001 #9470\00\18\00 (Jacob & Kerns, 2001). Measuring Pain Outcomes in the Cognitively Impaired The assessment of pain to plan interventions and assess outcome relies on strategies for the communication of the patients subjective experience to the clinician. Cognitive impairment can interfere with this communication and poses a difficult challenge to the accurate assessment of pain and pain treatment outcomes. Elderly Veterans. Elderly veterans are a group with a high prevalence of pain and substantial risk for cognitive impairment. Estimates of the prevalence of pain in nursing home settings range from 45% to 80%  QUOTE "(Ferrell, 1991; Fox, Raina, & Jadad, 1999)"  ADDIN PROCITE \11\05\19\02\00\00\00*(Ferrell, 1991; Fox, Raina, & Jadad, 1999)\01\05\00\08\00\00\00\00\00\00\1BM_\01\00\00\00\10t \00p~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00`\00j\00x82\03x\19\00\00\00\00\00\00\10\00xx\00M_@~\00\00M_@\00\00\00`\00j\00x82\03x\02\00\00\00\00\00\00\000~\00~\00&h~\00\1D\00x\00\03x\05\00\00\00\00\00\00\00\00\000~\00~\00&h~\00\1D\00x\00\03xW\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Ferrell 1991 #9480\00\12\00 (Ferrell, 1991; Fox, Raina, & Jadad, 1999) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00X\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DFox, Raina, et al. 1999 #9490\00\1D\00 . The prevalence among community-dwelling elderly has been estimated at between 25% and 50%  QUOTE "(Ferrell, 2000)"  ADDIN PROCITE \11\05 \19\02\00\00\00\0F(Ferrell, 2000)\01\03\00\08\00\00\00\00\00\00\1BM_\01\00\00\00ps \00`~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_0~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_0~\00\00M_@\00\00\00 `\00j\00x82\03xY\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Ferrell 2000 #9500\00\12\00 (Ferrell, 2000); Parmalee,1996). Cognitive impairment is likely to be encountered routinely in assessing pain in the elderly. The overall prevalence of non-dementia cognitive impairment among community-dwelling elderly has been estimated between 10.7% and 23.4% with prevalence increasing by age  QUOTE "(Unverzagt et al., 2001)"  ADDIN PROCITE \11\05\19\02\00\00\00\18(Unverzagt et al., 2001)\01\03\00\11\00\00\00\00\00\00\1BM_\01\00\00\00 \000~\00\01\00\00\00\01\00\00\00\00\00\00\00hI_\02\00\00\00\00\10\00xx\00M_\00~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_\00~\00\00M_@\00\00\00 `\00j\00x82\03xZ\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FUnverzagt, W, et al. 2001 #9510\00\1F\00 (Unverzagt et al., 2001); Di Carlo, Baldereschi, Amaducci, Maggi, Grigoletto, Scarlato, & Inzitari, 2000). The overall prevalence of elderly with dementia has been estimated to be 5% to 10%. Age-specific studies indicate that the prevalence of dementia doubles with every five years of age at least up to age 90 to 95 (Kukull & Ganguli 2000). The likelihood of cognitive impairment and dementia increases with residential placement status. The fastest growing segment of the U.S. population consists of persons older than the age of 85 years with 15% meeting the criteria for dementia (Henderson 1990). Approximately one-half of the U.S. population lives to the age of 75 years and nearly one quarter live to the age of 85 (Berg 1994). The percentage of elders complaining of one or more pain problems is similar between cognitively intact and mildly to moderately impaired persons. However, persons with severe cognitive impairment tend to report fewer complaints (Parmalee, 1996). Nevertheless, fewer verbal complaints does not necessarily mean less pain. It may reflect changes in communication ability associated with cognitive impairment such as reduced initiation of verbal behavior. Failure to report pain should not be assumed to mean the absence of pain. Other groups with cognitive impairment. Pain assessment has not been studied in other adult groups with risk for cognitive impairment such as the developmentally disabled and persons with traumatic brain injury (Schwartz, 1999; Bryant et al, 1999). In the absence of data with other groups, strategies that have proven to have utility with cognitively impaired elders provide a starting point for use with these populations. Instruments developed for use with children also could be of value, but have not been systematically studied for use with cognitively impaired adults (Gagliese, 2001). Clinicians assessing pain in cognitively impaired persons need to consider the multidimensional qualities of pain. Pain has emotional, cognitive, and sensory qualities that are manifested in personal and interpersonal behaviors. These qualities may be assessed through structured inquiry and structured observation. Assessment of the Presence and Intensity of Pain. Assessment of the presence and intensity of pain is accomplished through the use of patient self-report, observational measures and proxy report. Unidimensional pain intensity scales can be used to quantify pain intensity and track that dimension. Most of these scales have not been adequately cross-validated in groups of cognitively impaired adults, so the score on one scale cannot be assumed to reflect the same score on another scale. To assess outcomes across patients, the same scale should be used in the same fashion with all of the persons being assessed. To assess outcomes within a single patient over time, the same scale should be used in same fashion in each assessment. Self-report of pain presence and intensity. Self-report of pain presence and intensity requires that the patient communicate the existence of pain through verbal or nonverbal behaviors and rate the intensity of the pain along a dimension encompassing no pain to the worst possible pain. This requires some degree of abstract reasoning. Several studies have demonstrated that elderly patients with mild to moderate cognitive impairment can respond reliably to measures of pain intensity (Chibnall & Tait, 2001; Ferrell, Ferrell, & Rivera, 1995; Manz, Mosier, Nusser-Gerlach, Bergstrom, & Agrawal, 2000;  QUOTE "(; ; Weiner, Peterson, & Keefe, 1998; )"  ADDIN PROCITE \11\05 \19\02\00\00\00'(; ; Weiner, Peterson, & Keefe, 1998; )\01\03\00\1E\00\00\00\00\00\00\1BM_\01\00\00\008\5C \00p~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\00\00\00`~\00 ~\00&h ~\00\1D\00x\00\03x\07\00\00\00\00\00\00\00\00\00`~\00 ~\00&h ~\00\1D\00x\00\03x.\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\18Chibnall & Tait 2001 #70\00\18\00 Weiner, Peterson, & Keefe, 1998) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00*\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DManz, Mosier, et al. 2000 #30\00\1D\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Weiner, Peterson, et al. 1998 #210\00"\00  QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00>\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Ferrell, Ferrell, et al. 1995 #230\00"\00 . Reliability can be increased by referencing the question in the here and now and using the same instrument repeatedly over time as a cognitively impaired individuals ability to use self-report scales can improve with practice. The interviewer needs to focus the assessment question in order to obtain the most accurate results for interpretation. It is helpful to ask the patient How much pain are you having right now? instead of How much pain have you had over the last week or month. The latter questions require additional integration of information and demand more cognitive ability  QUOTE "(Ferrell, 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\0F(Ferrell, 2000)\01\03\00\08\00\00\00\00\00\00\1BM_\01\00\00\00 \00~\00\01\00\00\00\01\00\00\00\00\00\00\00?\00\00\00\02\00\00\00\00\10\00xx\00M_p~\00\00M_@\00\00\00 `\00j\00x82\03x\05\00\00\00\00\00\00\10\00xx\00M_p~\00\00M_@\00\00\00 `\00j\00x82\03xY\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\12Ferrell 2000 #9500\00\12\00 (Ferrell, 2000). Techniques drawn from the assessment of childrens pain might improve reliability and validity of self-report (McGrath & Gillespie, 2001). Clinicians should inquire about the patients definition of pain to determine to what extent the patient perceives pain as a sensory, emotional, and behavioral event. This will help the clinician in educating the patient about the use of the self-report tool and aid in the interpretation of the individuals response. It also can be helpful to calibrate the tool for use with a single patient by asking him or her to describe painful events that have been experienced that correspond to different pain intensities. Patients can be prompted with common events that occur in a clinical setting such as needle sticks. There are four main forms of pain intensity scales that have been studied for use with the cognitively impaired elderly: Verbal Descriptor Scales, Numeric Rating Scales, Visual Analog Scales and Facial Picture Scales. Different patients show different abilities to complete each of these forms, so if a patient is not able to complete one type of scale, it is worthwhile to try an alternative form. Up to 83% of mild to moderately impaired elderly and 30% of severely impaired elderly are able to complete at least one type of scale  QUOTE "(; )"  ADDIN PROCITE \11\05\19\02\00\00\00\04(; )\00\04\00>\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt"Ferrell, Ferrell, et al. 1995 #230\00"\00 (Ferrell et al., 1995; Manz et al., 2000) QUOTE ""  ADDIN PROCITE \11\05\19\02\00\00\00\00\01\00\00*\02\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1DManz, Mosier, et al. 2000 #30\00\1D\00 . Verbal Descriptor Scales ask the patient to choose a phrase to describe pain intensity. The Present Pain Intensity Scale of the McGill Pain Inventory is one standard example. Completion rates between 65% and 79% have been demonstrated in samples of cognitively impaired adults  QUOTE "(Herr & Garand, 2001)"  ADDIN PROCITE \11\05\19\02\00\00\00\15(Herr & Garand, 2001)\00\15\00m\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\18Herr & Garand 2001 #8840\00\18\00 (Herr & Garand, 2001;  QUOTE "(Krulewitch et al., 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\19(Krulewitch et al., 2000)\00\19\00n\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Krulewitch, London, et al. 2000 #8850\00%\00 Krulewitch et al., 2000). The Numeric Rating Scale asks patients to rate their pain on an eleven-point range from no pain to worst possible pain. Many cognitively impaired patients can respond to a verbal presentation of the scale, while others may require a graphic presentation of the pain numerals. Both vertical and horizontal presentations have been found to be effective. Some patients prefer a vertical presentation in the form of a pain thermometer. Between 47% and 58% of cognitively impaired adults were able to complete this scale (Herr & Garand, 2001). Facial Picture Scales consist of a series of progressively distressed facial expressions. The patient is asked to pick the face that corresponds to their current level of pain intensity. These tools were designed for use with pediatric populations. Limited data is available regarding their use in cognitively impaired adult populations. The Faces Pain Scale and the Wong-Baker Faces Scale are examples of this class of instrument. Unfortunately, these scales are likely to tap affective components of pain as well as pain intensity which can complicate interpretation. Completion rates for the Faces Pain Scale in cases of mild to moderately impaired elders range from 50% to 76%. Only 20% to 41% of severely impaired patients may be able to complete the scale  QUOTE "(Manz et al., 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\13(Manz et al., 2000)\00\13\00W\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1FManz, Mosier, et al. 2000 #8800\00\1F\00 (Manz et al., 2000;  QUOTE "(Scherder, 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\10(Scherder, 2000)\00\10\00o\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\13Scherder 2000 #8860\00\13\00 Scherder, 2000;  QUOTE "(Krulewitch et al., 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\19(Krulewitch et al., 2000)\00\19\00n\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Krulewitch, London, et al. 2000 #8850\00%\00 Krulewitch et al., 2000). The Visual Analog Scale is a 10 cm horizontal or vertical line with anchors at each end of no pain and worst possible pain (or some analogous phrase). This tool is easy to complete, but is thought to require more abstract thinking ability than other tools (Gagliese, 2001). Completion rates in cases of mild to moderately impaired elders ranged from 52% to 76%. Only 41% of elders with severe impairment were able to complete the scale  QUOTE "(Krulewitch et al., 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\19(Krulewitch et al., 2000)\00\19\00n\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt%Krulewitch, London, et al. 2000 #8850\00%\00 (Krulewitch et al., 2000). In cases of mild to moderate impairment, clinicians may choose to utilize a verbal descriptor scale or numeric rating scale depending on patient ability to complete the scale. In cases of severe impairment, patients are likely to prefer a verbal descriptor scale. Observations of pain behaviors along with self-report can help to strengthen confidence in self-report ratings. Observation of pain behaviors. In cases where patients are not able to provide a reliable self-report, pain behaviors can be assessed to help determine the presence and intensity of pain (turk, et al., 1985; fordyce 1976). These include cues such as changes in posture and gait, nonverbal vocalizations, facial expressions and changes in usual behaviors. However, many of these behaviors are not specific to pain and can be easily misinterpreted in cases of cognitive impairment. Behavioral observations also are subject to inadequate sensitivity. Severe cognitive impairment can limit the patients behavioral repertoire even in the presence of pain (Oberlander, Grunau, Pitfield, Whitfield, & Saul, 1999). Family members can aid clinicians in identifying pain behaviors. However, surrogate reporting of pain tends to be inaccurate. Family members tend to overestimate pain intensity, while health care providers tend to underestimate pain severity (Desbiens & Mueller-Rizner, 2000; Weiner, Peterson, & Keefe, 1999; Bowman, 1994). Observation of pain behaviors must occur in a structured manner to have validity. Target behaviors need to be identified for each patient .The assessment should take place when these behaviors are most likely to occur. Staff members need to be trained to reliably identify the behaviors (Keefe, Lumley, Anderson, Lynch, Studts, & Carson, 2001). Observations of facial reactions have been shown to be good indicators of pain in adults with cognitive impairment, but require extensive training and equipment (Hadjistavropoulos, LaChapelle, MacLeod, Snider, & Craig, 2000; Hadjistavropoulos & Clark, 2001). Pain behavior checklists can be helpful in guiding assessment. Assessment of pain behavior should include observation during rest and during movement or usual daily activities  QUOTE "(Hadjistavropoulos et al., 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00 (Hadjistavropoulos et al., 2000)\00 \00{\04\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt0Hadjistavropoulos, LaChapelle, et al. 2000 #8950\000\00 (Hadjistavropoulos et al., 2000;  QUOTE "(Weiner, Pieper, McConnell, Martinez, & Keefe, 1996)"  ADDIN PROCITE \11\05\19\02\00\00\004(Weiner, Pieper, McConnell, Martinez, & Keefe, 1996)\004\00\5C\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt!Weiner, Pieper, et al. 1996 #4070\00!\00 Weiner, Pieper, McConnell, Martinez, & Keefe, 1996). However, there is a lack of checklists that have demonstrated adequate validity and reliability in adults with cognitive impairment. The Checklist of Nonverbal Pain Indicators is a six-item checklist that has been developed to assess pain behaviors at rest and during movement in cognitively impaired elderly. It also incorporates a verbal descriptor scale. It has demonstrated reliability and validity in an initial study with patients with hip fractures  QUOTE "(Feldt, 2000)"  ADDIN PROCITE \11\05\19\02\00\00\00\0D(Feldt, 2000)\00\0D\00,\01\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\10Feldt 2000 #8960\00\10\00 (Feldt, 2000;  QUOTE "(Feldt, Ryden, & Miles, 1998)"  ADDIN PROCITE \11\05\19\02\00\00\00\1D(Feldt, Ryden, & Miles, 1998)\00\1D\00\06\00\003C:\5CProgram Files\5CProCite5\5CDatabase\5CPainCombined.pdt\1EFeldt, Ryden, et al. 1998 #170\00\1E\00 Feldt, Ryden, & Miles, 1998). However, the instrument has not been validated in other types of pain. In addition, the checklists reliability has not been tested in groups of differing degree of cognitive impairment. Assessment of Other Dimensions of Pain. Pain is a complex, multidimensional experience that includes cognitive, emotional and behavioral factors as well as pain presence and intensity. Assessment of pain in persons with cognitive impairment should include attention to mood and beliefs that affect the patients pain experience and contexts that affect the patients pain behavior. Specific instruments for use of assessment of these components of pain have not been studied in patients with cognitive impairment. However, clinicians should consider including standard instruments for use with patients who have mild to moderate cognitive impairment. Summary and Recommendations. Research on assessment of pain in cognitively impaired adults has focused on elderly adults with dementias. The results of many studies suggest that most persons with mild to moderate cognitive impairment can provide reliable report of pain intensity using standard numeric-rating scales. Verbal descriptors scales are easier to complete for some patients, especially those with more severe impairment. Persons with cognitive impairment seem to have the most difficulty with the Visual Analogue Scale. One way to help facilitate better understanding of the pain intensity scale rating with a patient is to establish the intensity rating of a past, common pain event, such as stubbing a toe or having a mild burn. The patient is then instructed to compare that pain intensity from that event to the pain condition being assessed. This technique can be used with numeric rating scales or verbal descriptors. Observations of pain behaviors strengthen confidence in self-report ratings. It is important to assess pain behaviors using a standardized format and to assess pain both at rest and with movement. Surrogates such as medical staff and family members can provide important adjunct information about pain behaviors, but surrogates tend to underestimate or overestimate pain intensity. Using CPRS GUI and Vista Software to Track Pain Outcomes Document the Pain Score Vital Sign. In 1999, the Vitals/Measurements package, Version 4.0, was enhanced to include a pain score as the 5th Vital Sign. All facilities that are using the VHA Information Systems and Technology Architecture (VistA) and Computerized Patient Record System Graphical User Interface (CPRS GUI) can enter pain scores electronically when other vital signs are entered. This can be done in the Vitals package, and from the CPRS GUI Cover Sheet, or Encounter Form under the Notes tab. The pain score is supposed to be recorded in every patient record at regular intervals to document changes in pain intensity. Instructions for recording a pain score in the computerized patient record can be found in the Pain as the 5th Vital Sign Toolkit ( HYPERLINK "http://vaww.va.gov/pain_management/508FrameTest2.htm" http://vaww.va.gov/pain_management/508FrameTest2.htm). Instructions for Viewing and Entering Vitals in the Computerized Patient Record System (CPRS) User Guide, GUI version. If you have questions about the software or the instructions, please contact your local Information Resources Management (IRM) service office or your local Clinical Application Coordinator (CAC). Document Information Relating to Pain Management. Sites can use Clinical Reminders and Reminder Dialogs to record data related to pain management as progress note text, or encounter data, such as vital signs and health factors. As a decision support tool, Clinical Reminders: Provide timely information about patients health maintenance schedules Assist in compliance with VHA performance measures Assist in compliance with Health Promotion and Disease Prevention Guidelines Assist in targeting patients with particular diagnoses and procedures or site-defined criteria Provide pertinent information for clinical decision making Reminder Dialogs can be created and linked to Clinical Reminders and accessed from the CPRS GUI Notes during Progress Note editing. Reminder Dialogs can be set up to: Prompt for data entry of information to resolve/satisfy Clinical Reminders Provide reminder resolution by recording Health Factors and Education Topics Add text to progress notes Update patient encounter data and Vital Signs Place orders The Health Factors and Education Topics that are recorded to resolve the reminders can later be used to report on pain management outcomes. Clinical Reminders for Pain Management Sponsored by the VA National Pain Management Coordinating Committee. As a continuation of VHA's commitment to pain management, the National Pain Management Strategy Coordinating Committee has sponsored the development of pain reminders and reminder dialogs that sites can use to document pain management in the patient's electronic record. These reminders may be used independently of one another, or as a group, depending on local preferences and installation methods and they were designed to be used with either inpatients or outpatients. Pain History Pain Management Education Clinician Pain Plan of Care Clinician Pain Reassessment Nurse Pain Plan of Care Nurse Pain Reassessment Criteria for the development of these reminders were: The reminders should meet or exceed existing JCAHO and CARF requirements regarding pain assessment and treatment The reminders should be consistent with existing (e.g., Post Operative Pain) and forthcoming (e.g., Chronic Opioid Therapy) treatment guidelines The reminders should be of some use for local pain treatment outcomes monitoring These reminders and reminder dialogs are posted to the Clinical Reminders website under Examples and How-tos ( HYPERLINK "http://vista.med.va.gov/reminders/Pain.htm" http://vista.med.va.gov/reminders/Pain.htm). The packed reminders and dialogs can be downloaded by sites as local reminders and adapted to the needs of the individual site. There are also background and instructional documents for each reminder, as well as tips for using the reminders and a pain history self-report form that can be printed and given to patients to fill out prior to data entry. Example: Pain History reminder dialog  Example: Pain History reminder dialog expanded  A number of Health Factors are recorded as the reminders are processed that resolve the reminders, and provide data for outcomes reports. This is an example of some health factors created by processing these reminders dialogs: Category Health Factor Date V-PAIN ACCEPTABLE V-PAIN ACCEPTABLE 0 11/13/2002 V-PAIN EDUCATION BARRIERS V-PAIN Patient/Family Outcome 11/15/2002 V-PAIN HISTORY V-PAIN HISTORY RECORDED 11/13/2002 V-PAIN LEAST V-PAIN LEAST 4 11/13/2002 V-PAIN NEW PAIN CATEGORY V-PAIN NEW PAIN 11/13/2002 V-PAIN PLAN OF CARE V-PAIN CLINICIAN PLAN OF CARE 11/13/2002 V-PAIN CLINICIAN REASSESSMENT 11/15/2002 V-PAIN NURSE PLAN OF CARE 11/13/2002 V-PAIN NURSE REASSESSMENT 11/15/2002 V-PAIN PRIMARY PAIN LOCATION V-PAIN LOC ABDOMEN 11/13/2002 V-PAIN USUAL V-PAIN USUAL 8 11/13/2002 Creating Local Clinical Reminders and Reminder Dialogs to Record Data on Pain Management. Sites can create their own local Reminders to prompt users to enter the pain score or to document information on pain management. Many sites have already created a pain screening reminder to remind staff to record pain scores for every patient. If the reminder was due, it would display on the CPRS GUI Coversheet. Sites could set the reminder logic to make the reminder due: If the patient did not have any pain score Once a year if the current pain score was =< 3 Once a month if the pain score was > 3 Sites do not have to create pain reminders and dialogs from scratch. Since the Pain, the 5th Vital Sign Toolkit was released in the winter of 1999, many sites have developed reminders and reminder dialogs related to pain screening, pain assessment, and pain management. If you find another site that has pain reminders and dialogs that work well for them, they might be willing to share them directly via the Reminder Exchange Utility. Or they may have posted them to the Clinical Reminders Examples and How-tos web page. In any case, users should work closely with their local Clinical Application Coordinator (CAC) to develop Clinical Reminders and Reminder Dialogs that are appropriate for their needs. Reporting Pain Management Outcomes. Users can retrieve information about pain management outcomes from the electronic patient record using the reporting functionality of Health Summary and Clinical Reminder packages. Ad Hoc Health Summary Reports The Health Summary application provides ad hoc reporting functionality that can be used to create a quick, one-time reminder report. Users can select items from a list of Health Summary components to create an ad hoc report that contains information about pain reminders, health factors and education topics. These are some of the components that provide pain management information: CLINICAL REMINDERS BRIEF (CMB) CLINICAL REMINDERS DUE (CR) CLINICAL REMINDERS MAINTENANCE (CM) CLINICAL REMINDERS SUMMARY (CRS) PCE EDUCATION (ED) PCE EDUCATION LATEST (EDL) PCE HEALTH FACTORS ALL (HF) PCE HEALTH FACTORS SELECTED (SHF) Example setup for an ad hoc Health Summary Report  EMBED PBrush  Example display of an ad hoc Health Summary Report  Once the user has designed a report that provides useful information, users should contact their local CAC. The CAC can create a Health Summary report with the same parameters and add it to the list of Health Summary reports that displays on the CPRS GUI reports tab and allows access by multiple users at the site. Example of Health Summary report output  The CPRS GUI Reports tab will only produce Health Summary reports for the current patient. The Health Summary options in the roll and scroll version of Health Summary provides the means to produce reports for several patients at one time: Patient Health Summary Option - displays or prints a health summary for one or more patients, or a group of patients by location, such as the operating room, ward, or clinic. Ad Hoc Health Summary Option - lets users select any or all health summary components and assign component characteristics for one or more patients. Range of Dates Patient Health Summary Option - lets users print health summaries of a specified, pre-defined health summary type for multiple patients. After patients are selected, the user can pick a date range. Data for summaries is based on the date range. Visit Patient Health Summary - lets users print health summaries of a specified, pre-defined health summary type for multiple patients. Hospital Location Health Summary - lets users print or display on your screen health summaries for all patients at specific or multiple hospital locations (ward, clinic, or operating room).  XE "Hospital Location Health Summary option"  Developing Health Summary Reports. For more information on creating Health Summary Reports, users should consult the Health Summary User Manual and Health Summary Technical Manual located in the VistA Documentation Library (VDL) ( HYPERLINK "http://vista.med.va.gov/vdl/" http://vista.med.va.gov/vdl/). Contact your local Clinical Application Coordinator for assistance in creating Health Summary reports. You could also talk to other sites to see what Health Summary reports they have found to be useful. Additional assistance may be obtained by participating in the Clinical Reminders conference call that is held the third Friday of each month. This is a forum where sites can share information and ask questions related to reminders and reminder dialogs. Refer to the Clinical Reminders website for information about past and future presentations ( HYPERLINK "http://vista.med.va.gov/reminders/confcalls.htm" http://vista.med.va.gov/reminders/confcalls.htm). Clinical Reminder Reports. Clinical Reminder Reports can be a powerful data extraction tool for measuring pain outcomes. They can be created to report summary or detailed level information about pain reminders that are due or reminders that have been satisfied. Reminder Reports also can provide clinical coordinators with data extracted based on reminder definitions. Reminder Reports: Provide a tool for tracking compliance with reminders Can look at overall performance for a stop code or provider panel, or can drill down to a team of patients or to a single clinic Can measure change over time Reminder Reports can be set up for: Individual patients, location, OE/RR team, PCMM provider or PCMM team Inpatient, outpatient, selected hospital locations All clinic stops, selected clinic stops, or selected clinic groups Previous encounters or future appointments Encounter beginning and ending date range Effective due date Detailed or summary report output Reminder category or individual reminder Reminder reports can be used to: Identify outpatients in a panel who have reminders due Aggregate reporting for a service line Create patient specific reports for intervention Identify inpatients with a reminder due Identify patients who are scheduled for a clinic visit in the next month who need an intervention Identify patients who have left the clinic in the past week who have missed an intervention Track patient education Track patients with certain characteristics or needs Selection criteria can be saved in a report template so the report can be run on a recurring basis. Example of a Detailed Reminder Report - lists due patients for a single reminder  Example of a Summary Reminder Report - totals applicable/due counts for multiple reminders  Reminder reports can be printed as a formatted report or as delimited output so the data can be exported to a spreadsheet program, such as Microsoft EXCEL. These data then can be presented in a variety of formats. Example of a reminder report with delimiters (^) that can be imported into a spreadsheet:  Clinical Reminders used to trigger reminder reports do not have to be the same as the reminders that are displayed. Separate reminders often are needed for reporting versus cover sheet assignment . Refer to the following sites for further information about reminder reports: VistA Documentation Library (VDL)  HYPERLINK "http://vista.med.va.gov/vdl/" http://vista.med.va.gov/vdl/ Clinical Reminders web page:  HYPERLINK "http://vista.med.va.gov/reminders/" http://vista.med.va.gov/reminders/ VistA University web page:  HYPERLINK "http://vaww.vistau.med.va.gov/vistau/default.htm" http://vaww.vistau.med.va.gov/vistau/default.htm Reminder Reports Presentation: Reminder Reports for Provider Feedback and Performance Tracking:  HYPERLINK "http://vista.med.va.gov/reminders/confcalls.htm" http://vista.med.va.gov/reminders/confcalls.htm Contact your local CAC for assistance in creating reminder reports. You could also talk to users at other sites to see what reminder reports they have developed for pain management. VHA External Peer Review Program (EPRP) The VHA Office of Quality and Performances Performance Measurement Program (PMP) establishes a set of performance monitors that are consistent with the strategic goals of the VHA and designed to assure quality, access, and satisfaction with care provided in VHA facilities. As a step toward the establishment of the performance monitors, the PMP calls for the development of performance indicators. Once the precise definitions of the indicators and scientifically sound methods for data collection and validation have been developed, these indicators have the potential to be established as performance monitors with established thresholds for benchmarking performance. The External Peer Review Program (EPRP) supports the VHA Performance Measurement Plan by conducting a systematic review of a representative sample of medical records each quarter to monitor compliance with standards, and reports progress toward established goals to VHA leadership. At the current time, records are sampled from primary care clinics and eight additional ambulatory settings (e.g., cardiology clinic). Consistent with the VHA National Pain Management Strategy, the PMP included a pain-relevant monitor in their FY00 and FY01 reports. EPRP reported quarterly on the proportion of records sampled that had a documented pain score (i.e., 0-10 numeric rating of pain intensity) in the immediately preceding 12 months. By the fourth quarter of FY01, 98% of records sampled nationally had a documented pain score in the preceding 12 months. Subsequently these performance monitors were discontinued and a new set of pain-relevant monitors that are more consistent with the current state of activities in the VHA system have been developed. Beginning in FY02, the PMP and EPRP instituted three new pain-relevant performance indicators. Once the scientific validity of these indicators are established via a period of monitoring, these indicators have the potential to be designated as performance monitors upon which facility and VISN performance will be evaluated. These pain indicators are: Percent of patients with pain assessed on a scale of 0-10 on the most recent visit Percent of patients with pain reported > 3 with an intervention recorded Percent of patients with a pain intervention recorded who had a follow-up assessment (pain management effectiveness evaluated). It may be reasonable to consider using these EPRP indicators as targets for performance improvement, as process measures, and/or as outcome measures for evaluating the performance of organized system for improving pain management. SECTION 6: WEB LINKS FOR OUTCOMES RESOURCES Chart reviews:  HYPERLINK "http://www.cityofhope.org/prc/web/pdf/pain_audit_tools.pdf" http://www.cityofhope.org/prc/web/pdf/pain_audit_tools.pdf International Association for the Study of Pain-Desirable Characteristics For Pain Treatment Facilities  HYPERLINK "http://www.iasp-pain.org/desirabl.html" http://www.iasp-pain.org/desirabl.html JCAHO standards:  HYPERLINK "http://www.jcaho.org" http://www.jcaho.org  HYPERLINK "http://www.partnersagainstpain.com/html/inst/inst.htm" http://www.partnersagainstpain.com/html/inst/inst.htm Pain Outcomes Instruments National Pain Data Bank-VA Revised version:  HYPERLINK "http://www.vachronicpain.org" www.vachronicpain.org Tampa Scale of Kinesiophobia-Revised:  HYPERLINK "http://www.vachronicpain.org" www.vachronicpain.org Provider Education:  HYPERLINK "http://www.cityofhope.org/prc/web/html/rn_needs.htm" http://www.cityofhope.org/prc/web/html/rn_needs.htm  HYPERLINK "http://www.cityofhope.org/prc/web/html/brief_pain.htm" http://www.cityofhope.org/prc/web/html/brief_pain.htm  HYPERLINK "http://www.cityofhope.org/prc/web/html/rehab_professionals.htm" http://www.cityofhope.org/prc/web/html/rehab_professionals.htm  HYPERLINK "http://www.cityofhope.org/prc/web/pdf/Knowledge%20and%20Attitudes%20Survey.pdf" http://www.cityofhope.org/prc/web/pdf/Knowledge%20and%20Attitudes%20Survey.pdf  HYPERLINK "http://www.cityofhope.org/prc/web/pdf/controlling_pain.pdf" http://www.cityofhope.org/prc/web/pdf/controlling_pain.pdf  HYPERLINK "http://mayuday.coh.org/Instruments/k&a.htm" http://mayuday.coh.org/Instruments/k&a.htm Rehabilitation Accreditation Commission- Pain Program Standards/Outcomes Assessment  HYPERLINK "http://www.carf.org" www.carf.org VHA CPRS Clinical Reminders and Reminder Reports VistA Documentation Library (VDL)  HYPERLINK "http://vista.med.va.gov/vdl/" http://vista.med.va.gov/vdl/ Clinical Reminders web page:  HYPERLINK "http://vista.med.va.gov/reminders/" http://vista.med.va.gov/reminders/ VistA University web page:  HYPERLINK "http://vaww.vistau.med.va.gov/vistau/default.htm" http://vaww.vistau.med.va.gov/vistau/default.htm Reminder Reports Presentation: Reminder Reports for Provider Feedback and Performance Tracking:  HYPERLINK "http://vista.med.va.gov/reminders/confcalls.htm" http://vista.med.va.gov/reminders/confcalls.htm VHA Learning Catalog) http://vaww.sites.lrn.va.gov/VACatalog/ (Type in Pain in the left search box to locate pain resources) VHA National Customer Survey Information  HYPERLINK "http://vaww.oqp.med.va.gov/DEFAULT.asp" http://vaww.oqp.med.va.gov/DEFAULT.asp VHA Pain as the 5th Vital Sign Toolkit  HYPERLINK "http://vaww.va.gov/pain_management/508FrameTest2.htm" http://vaww.va.gov/pain_management/508FrameTest2.htm VHA Pain Management Website  HYPERLINK "http://vaww.va.gov/pain_management/" http://vaww.va.gov/pain_management/ VHA/DOD Post Operative Pain Guidelines  HYPERLINK "http://www.oqp.med.va.gov/cpg/pain/pain_base.htm" http://www.oqp.med.va.gov/cpg/pain/pain_base.htm REFERENCE LIST Agency for Health Care Policy Reform, Acute pain management: Operative or medical procedures and trauma, Pub. No. 92-0032, U.S. Department of Health and Human Services, Washington, D.C., 1992. Agency for Health Care Policy Reform, Management of cancer pain, Pub. No. 94-0592, U.S. Department of Health and Human Services, Washington, D.C., 1996. Aharony, L., & Strasser, S. (1993). Patient satisfaction: what we know about and what we still need to explore. Medical Care Review, 50(1), 49-79. Altmaier, E.M., Lehmann, T.R., Russell, D.W., Weinstein J.N., & Kao, C.F. (1992). The effectiveness of psychological interventions for the rehabilitation of low back pain: A randomized controlled trial evaluation. Pain, 49, 329-335. American Pain Society, Quality improvement guidelines for the treatment of acute pain and cancer, JAMA, 274, 1874-80, 1995. American Pain Society (1999). Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain (4th ed.). Glenview, IL: Author. Beck, A. T. (1987). Beck Depression Inventory. San Antonio, TX: The Psychological Corporation. Beck, A. T., Steer, R. A., and Garbin, M. G., Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review., 8, 77-100, 1988. Beck, A. T., Steer, R. A., Ball Roberta, & Ranieri, W. F. (1996). Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67, 588-597. Beckham, J. C., Burker, E. J., Lytle, B. L., Feldman, M. E., & Costakis, M. J. (1997). Self-efficacy and adjustment in cancer patients: a preliminary report. Behavioral Medicine, 23, 138-42. Berg R, Franzen M, Wedding D (1994) Neurological disorders. In Screening for Brain Impairment, 2nd ed. Springer Publishing: New York Berg, L. (1994). A wish list. Alzheimer Disease and Associated Disorders, 8 Suppl 1, S373-4. Bergner, M., Bobbitt, R.A., Carter, W.B., & Gilson, B.S. (1981). The Sickness Impact Profile: Development and final revision of a health status measure. Medical Care, 19, 787-805. Bieri, D., Reeve, R. A., Champion, G. D., Addicoat, L., & Ziegler, J. B. (1990). The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain, 41(2), 139-50. Block, A.R., Kremer, E.F., & Fernandez, E. (1998), Handbook of pain syndromes: A biopsychosocial perspective. Mahwah, N.J.: Lawrence Erlbaum. Bowman, J. M. (1994). Perception of surgical pain by nurses and patients. Clinical Nursing Research, 3(1), 69-76. Breivik, E. K., & Skoglund, L. A. (1998). Comparison of present pain intensity assessments on horizontally and vertically oriented visual analogue scales. Methods & Findings in Experimental & Clinical Pharmacology, 20, 719-24. Breivik, E. K., Bjornsson, G. A., & Skovlund, E. (2000). A comparison of pain rating scales by sampling from clinical trial data. Clinical Journal of Pain, 16, 22-8. Brown, D. (1995). Quality assessment and improvement activities should be incorporated into our pain practices. Pain Forum, 4, 48-56. Bryant, R.A., Marosszeky, J.E., Corrks, J., Baguley, I.J., Gurka, J.A. (1999). Interaction of posttraumtic stress disorder and chronic pain following traumatic brain injury. Journal of Head Trauma Rehabilitation, 14(6), 588-94. Caraceni, A., Mendoza, T. R., Mencaglia, E., Baratella, C., Edwards, K., Forjaz, M. J., Martini, C., Serlin, R. C., de Conno, F., & Cleeland, C. S. (1996). A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain, 65, 87-92. Carr-Hill, R. A. (1992). The measurement of patient satisfaction. Journal of Public Health Medicine, 14(3), 236-49. Cherkin, D., Deyo, R. A., & Berg, A. O. (1991). Evaluation of a physician education intervention to improve primary care for low-back pain. II. Impact on patients. Spine, 16(10), 1173-8. Chibnall, J.T. (2001). Pain assessment in cognitively impaired and unimpaired older adults: A comparison of four scales. Pain, 92(1-2), 173-86. Chibnall, J. T., & Tait, R. C. (2001). Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales. Pain, 92(1-2), 173-86. Choiniere, M., & Amsel, R. (1996). A visual analogue thermometer for measuring pain intensity. Journal of Pain and Symptom Management, 11, 299-311. Clark, M. E. (1996). MMPI-2 Negative Treatment Indicators Content and Content Component Scales: Clinical correlates and outcome prediction for men with chronic pain. Psychologica -Assessment, 8, 32-38. Clark, M. E., & Gironda, R. J. (2000). Concurrent validity of the National Pain Data Bank: Preliminary results. American Journal of Pain Management, 10, 25-33. Clark, M. E., & Gironda, R. J. (2002). Practical utility of outcome measurement. R. S. Weiner (Ed.), Pain management: A practical guide for clinicians (6th ed., ). Boca Raton, FL.: CRC Press. Clark, M. E., Gironda, R. J., and Young, R. W. (2003). Development of a comprehensive pain outcomes measure: Psychometric characteristics of the Pain Outcomes Questionnaire-VA version. Manuscript in preparation. Cleary, P. D., & Edgman-Levitan, S. (1997). Health care quality. Incorporating consumer perspectives. Journal of the American Medical Association, 278(19), 1608-12. Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129-38. Cleeland, C.S., Schall, M., Nolan, K., Reyes-Gibby, C.C., Paice, J., Rosenberg, J.M., Tollett, J.H., & Kerns, R.D. (2002). Rapid improvement in pain management: The Veterans Health Administration and the Institute for Healthcare Improvement Collaborative. Manuscript submitted for publication. Cohen, B. N., Clark, M. E., & Gironda, R. J. (2003, March). Assessing fear of (re)injury among chronic pain patients: Revision of the Tampa Scale of Kinesiophobia. Poster session presented at the 22nd Annual Meeting of the American Pain Society, Chicago, IL. Crombez, G., Vlaeyen, J. W. S., Heuts, P. H. T. G., & Lysens, R. (1999). Pain-related fear is more disabling than pain itself: Evidence on the role of pain-related fear in chronic back pain disability. Pain, 80, 329-339. Dabatos, G., Rondinelli, R. D., & Cook, M. (2000). Functional capacity evaluation for impairment rating and disability evaluation. In R. D. Rondinelli, & R. T. Katz (Eds.), Impairment rating and disability evaluation. Philadelphia: W.B. Saunders Company. Davidson, M., & Keating, J. L. (2002). A comparison of five low back disability questionnaires: reliability and responsiveness. Physical Therapy, 82(1), 8-24. Davis, D., O'Brien, M. A., Freemantle, N., Wolf, F. M., Mazmanian, P., & Taylor-Vaisey, A. (1999). Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? Journal of the American Medical Association, 282(9), 867-74. Davis, G. C. (1989). The clinical assessment of chronic pain in rheumatic disease: evaluating the use of two instruments. Journal of Advanced Nursing, 14, 397-402. De Conno, F., Caraceni, A., Gamba, A., Mariani, L., Abbattista, A., Brunelli, C. et al. (1994). Pain measurement in cancer patients: a comparison of six methods. Pain, 57(2), 161-6. Desbiens, N. A., & Mueller-Rizner, N. (2000). How well do surrogates assess the pain of seriously ill patients? Critical Care Medicine, 28(5), 1347-52. Deyo, R. A. (1988). Measuring the functional status of patients with low back pain. Archives of Physical Medicine Rehabilitation, 69(12), 1044-53. Di Carlo, A., Baldereschi, M., Amaducci, L., Maggi, S., Grigoletto, F., Scarlato, G., & Inzitari, D. (2000). Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. Journal of the American Geriatrics Society, 48(7), 775-82. Dodds, T. A., Martin, D. P., Stolov, W. C., & Deyo, R. A. (1993). A validation of the functional independence measurement and its performance among rehabilitation inpatients. Archives of Physical Medicine Rehabilitation, 74(5), 531-6. Elam, J. T., Graney, M. J., Beaver, T., el Derwi, D., Applegate, W. B., & Miller, S. T. (1991). Comparison of subjective ratings of function with observed functional ability of frail older persons. American Journal of Public Health, 81(9), 1127-30. Engelberg, A. (Ed.). (1993). American Medical Association guides to the evaluation of permanent impairment. (3rd ed.). Chicago: American Medical Association. Fairbank, J. C., Couper, J., Davies, J. B., & O'Brien, J. P. (1980). The Oswestry low back pain disability questionnaire. Physiotherapy, 66(8), 271-3. Federico, J.V. (1996). The cost of pain centers: where is the return? In J.N. Campbell & M.J. Mitchell (Eds.), Pain treatment centers at a crossroads: A practical conceptual reappraisal. Seattle: IASP Press. Feldt, K. S. (2000). The checklist of nonverbal pain indicators (CNPI). Pain Management Nursing, 1(1), 13-21. Feldt, K. S., Ryden, M. B., & Miles, S. (1998). Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture. Journal of the American Geriatrics Society, 46(9), 1079-85. Ferrell B.R. & Griffith, H. (1994). Cost issues related to pain management: report from the cancer pain panel of the Agency for Health Car Policy and Research. Journal of Pain and Symptom Management, 9, 221-234. Ferrell, B. A. (1991). Pain management in elderly people. Journal of the American Geriatrics Society, 39(1), 64-73. Ferrell, B. A. (2000). Pain management. Clinical Geriatric Medicine, 16(4), 853-74. Ferrell, B. A., Ferrell, B. R., & Rivera, L. (1995). Pain in cognitively impaired nursing home patients. Journal of Pain and Symptom Management, 10(8), 591-8. Ferrell, B. R., McCaffery, M., & Ropchan, R. (1992). Pain management as a clinical challenge for nursing administration. Nursing Outlook, 40(6), 263-8. Ferrell, B. R., Wisdom, C., Rhiner, M., & Alletto, J. (1991). Pain management as a quality of care outcome. Journal of Nursing Quality Assurance, 5(2), 50-8. Ferrell, B., Whedon, M., & Rollins, B. (1995). Pain and Quality Assessment/Improvement. Journal of Nursing Care Quality, 9(3), 69-85. Ferris LE (1992). A guide to direct measures of patient satisfaction in clinical practice. Canadian Medical Association Journal , 146: 1727-31. Flor, H., Fydrich, T., & Turk, D. C. (1992). Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain, 49(2), 221-30. Follick, M. J., Ahern, D. K., & Aberger, E. W. (1985). Development of an audiovisual taxonomy of pain behavior: Reliability and discriminant validity. Health Psychology, 4, 555-568. Fordyce, W. E. (1976). Behavioral methods for chronic pain and illness. C.V. Mosby Company: St. Louis Fox, P. L., Raina, P., & Jadad, A. R. (1999). Prevalence and treatment of pain in older adults in nursing homes and other long-term care institutions: a systematic review. Canadian Medical Association Journal, 160(3), 329-33. Gagliese, L. (2001). Assessment of pain in elderly people. In D. Turk and R. Gatchel (eds.) Handbook of Pain Assessment (2nd ed., pp. 111-33). New York: Guilford. Gatchel, R.J. & Turk, D.C. (1998), Psychosocial factors in pain: Critical perspectives. Guilford Press: New York. Gironda, R. J., Azzarello, L., & Clark, M. E. (2002). Test-retest reliability of the National Pain Data Bank V. 2.0. American Journal of Pain Management, 12, 24-30. Gironda, R. J., Clark, M. E., & Young, R. W. (2003, March). A confirmatory factor analysis of the Tampa Scale of Kinesiophobia- Revised. Poster session presented at the 22nd Annual Meeting of the American Pain Society, Chicago, IL. Green, B. A primer of testing (1992). In A. E. Kazdin (Ed.), Methodological issues & strategies in clinical research. Washington, D.C.: American Psychological Association, 1992. Gronblad, M., Hupli, M., Wennerstrand, P., Jarvinen, E., Lukinmaa, A., Kouri, J. P., & Karaharju, E. O. (1993). Intercorrelation and test-retest reliability of the Pain Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their correlation with pain intensity in low back pain patients. Clinical Journal of Pain, 9, 189-95. Hadjistavropoulos, H. D., & Clark, J. (2001). Using outcome evaluations to assess interdisciplinary acute and chronic pain programs. Joint Commission Journal on Quality Improvement, 27(7), 335-48. Hadjistavropoulos, T., LaChapelle, D. L., MacLeod, F. K., Snider, B., & Craig, K. D. (2000). Measuring movement-exacerbated pain in cognitively impaired frail elders. Clinical Journal of Pain, 16(1), 54-63. Hamilton, B. B., Laughlin, J. A., Fiedler, R. C., & Granger, C. V. (1994). Interrater reliability of the 7-level functional independence measure (FIM). Scandinavian Journal of Rehabilitation Medicine, 26(3), 115-9. Heinrich, R. L., Cohen, M. J., Naliboff, B. D., Collins, G. A., & Bonebakker, A. D. (1985). Comparing physical and behavior therapy for chronic low back pain on physical abilities, psychological distress, and patients' perceptions. Journal of Behavioral Medicine, 8(1), 61-78. Henderson, A. S. (1990). Epidemiology of dementia disorders. Advances in Neurology, 51, 15-25. Hepler, C. D. (1996). Pharmaceutical care. Pharmacy World and Science, 18(6), 233-5. Hepler, C. D., & Strand, L. M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47(3), 533-43. Herr, K. A., & Garand, L. (2001). Assessment and measurement of pain in older adults. Clinical Geriatric Medicine, 17(3), 457-78, vi. Herr, K. A., Mobily, P. R., Kohout, F. J., & Wagenaar, D. (1998). Evaluation of the Faces Pain Scale for use with the elderly. Clinical Journal of Pain, 14(1), 29-38. Hester, N. O., Miller, K. L., Foster, R. L., & Vojir, C. P. (1997). Symptom management outcomes. Do they reflect variations in care delivery systems? Medical Care, 35(11 Suppl), NS69-83. Hoyt, W. T. (2000). Rater bias in psychological research: when is it a problem and what can we do about it? Psychological Methods, 5(1), 64-86. Hsieh, C. Y., Phillips, R. B., Adams, A. H., & Pope, M. H. (1992). Functional outcomes of low back pain: comparison of four treatment groups in a randomized controlled trial. Journal of Manipulative and Physiological Therapeutics, 15(1), 4-9. Hudak, P. L., & Wright, J. G. (2000). The characteristics of patient satisfaction measures. Spine, 25(24), 3167-77. Jacob, M. Casey, & Kerns, R. D. (2001). Assessment of the psychosocial context of the experience of chronic pain. In D. C. Turk & R. Melzack (Eds.), Handbook of pain assessment (2nd ed., pp. 362-384). New York: Guilford Press. Jacox, A., Carr, D. B., & Payne, R. (1994). New clinical-practice guidelines for the management of pain in patients with cancer. New England Journal of Medicine, 330(9), 651-5. Jensen, M. P., and Karoly, P. (1992). Self-report scales and procedures for assessing pain in adults. In D. C. Turk & R. Melzack (Eds.), Handbook of pain assessment (2nd ed.). New York: Guilford Press. Jensen, M. P., Strom, S. E., Turner, J. A., & Romano, J. M. (1992). Validity of the Sickness Impact Profile Roland scale as a measure of dysfunction in chronic pain patients. Pain, 50, 157-162. Jensen, M. P., Turner, J. A., Romano, J. M., & Fisher, L. D. (1999). Comparative reliability and validity of chronic pain intensity measures. Pain, 83, 157-62. Jensen, M. P., Turner, L. R., Turner, J. A., & Romano, J. M. (1996). The use of multiple-item scales for pain intensity measurement in chronic pain patients. Pain, 67, 35-40. Johnston, M.V., Keith, R.A., and Hinderer, S.R., Measurement standards for interdisciplinary medical rehabilitation, Archives of Physical Medicine Rehabilitation, 73(supplement), S3-S23, 1992. Keefe, F. J., & Block, A. R. (1982). Development of an observation method for assessing pain behavior in chronic low back pain patients. Behavior Therapy, 13, 363-375. Keefe, F. J., Lumley, M., Anderson, T., Lynch, T., Studts, J. L., & Carson, K. L. (2001). Pain and emotion: new research directions. Journal of Clinical Psychology, 57(4), 587-607. Keefe, F.J., Williams, D.A. & Smith, S.J. (2001) Assessment of pain behaviors. In D. C. Turk & R. Melzack (Eds.), Handbook of pain assessment (2nd ed., pp. 170-187). New York: Guilford Press. Keeley, J., Mayer, T. G., Cox, R., Gatchel, R. J., Smith, J., & Mooney, V. (1986). Quantification of lumbar function. Part 5: Reliability of range-of- motion measures in the sagittal plane and an in vivo torso rotation measurement technique. Spine, 11(1), 31-5. Kerns, R. D., Turk, D. C., & Rudy, T. E. (1985). The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain, 23, 345-356. Kerns, R.D. (1996). Psychosocial factors: Primary or secondary outcomes? In J.N. Campbell & M.J. Mitchell (Eds.), Pain treatment centers at a crossroads: A practical conceptual reappraisal. Seattle: IASP Press. Kerns, R.D., Turk, D.C., Holzman, A.D., & Rudy, T.E. (1986). Comparison of cognitive-behavioral and behavioral approaches to outpatient treatment of chronic pain. Clinical Journal of Pain, 1, 195-203. Kerns, R.D., Wasse, L., Ryan, B., Drake, A., Booss, J. (2000). Pain as the 5th Vital Sign Toolkit. V.2.. Washington, D.C.: Veterans Health Administration. Kleinke, C. L. (1991). How chronic pain patients cope with depression: Relation to treatment outcome in a multidisciplinary pain clinic. Rehabilitation Psychology, 36, 207-218. Kozma, C. M. (1995). Outcomes research and pharmacy practice. American Pharmacy, NS35(7), 35-41. Kozma, C. M., Reeder, C. E., & Schulz, R. M. (1993). Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clinical Therapeutics, 15(6), 1121-32; discussion 1120. Krulewitch, H., London, M. R., Skakel, V. J., Lundstedt, G. J., Thomason, H., & Brummel-Smith, K. (2000). Assessment of pain in cognitively impaired older adults: a comparison of pain assessment tools and their use by nonprofessional caregivers. Journal of the American Geriatrics Society, 48(12), 1607-11. Kukull, W. A., & Ganguli, M. (2000). Epidemiology of dementia: concepts and overview. Neurologic Clinics, 18(4), 923-50. Kulich, R. and Lande, S. D., Managed care: The past and future of pain treatment, APS Bulletin, 7, 4-5, 1997. Larson D, Attkisson C, Hargreaves W, et al. (1979). Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning, 2,197-207. Larson, S. J. (1986). Surgical treatment of pain in patients with spinal cord injury. Journal of the American Paraplegia Society, 9(3-4), 51-3. Leclaire, R., Blier, F., Fortin, L., & Proulx, R. (1997). A cross-sectional study comparing the Oswestry and Roland-Morris Functional Disability scales in two populations of patients with low back pain of different levels of severity. Spine, 22(1), 68-71. Lieberman, J. R., Dorey, F., Shekelle, P., Schumacher, L., Thomas, B. J., Kilgus, D. J., & Finerman, G. A. (1996). Differences between patients' and physicians' evaluations of outcome after total hip arthroplasty. Journal of Bone and Joint Surgery, 78(6), 835-8. Locke, H. J., & Wallace, K. M. (1959). Short marital-adjustment and prediction tests: Their reliability and validity. Marriage & Family Living. 21, 251-255. Lowe, N. K., Walker, S. N., & MacCallum, R. C. (1991). Confirming the theoretical structure of the McGill Pain Questionnaire in acute clinical pain. Pain, 46, 53-60. Manz, B. D., Mosier, R., Nusser-Gerlach, M. A., Bergstrom, N., & Agrawal, S. (2000). Pain assessment in the cognitively impaired and unimpaired elderly. Pain Management Nursing, 1(4), 106-15. Mathiowetz, V., Rennells, C., & Donahoe, L. (1985). Effect of elbow position on grip and key pinch strength. Journal of Hand Surgery. American Volume, 10(5), 694-7. Mathiowetz, V., Weber, K., Volland, G., & Kashman, N. (1984). Reliability and validity of grip and pinch strength evaluations. Journal of Hand Surgery. American Volume, 9(2), 222-6. Mayer, T., Kishino, N., Keeley, J., Mayer, S., & Mooney, V. (1985). Using physical measurements to assess low back pain. Journal of Musculoskeletal Medicine, 2, 44-59. McCracken, L. M., Faber, S. D., & Janeck, A. S. (1998). Pain-related anxiety predicts non-specific physical complaints in persons with chronic pain. Behavior Research and Therapy, 36(6), 621-30. McCracken, L. M., Gross, R. T., Aikens, J., & Carnrike, C. L. M. Jr. (1996). The assessment of anxiety and fear in persons with chronic pain: A comparison of instruments. Behaviour Research and Therapy, 34, 927-933. McCracken, L. M., Zayfert, C., & Gross, R. T. (1992). The Pain Anxiety Symptoms Scale: Development and validation of a scale to measure fear of pain. Pain, 50, 67-73. McGrath, P.A. & Gillespie, J. (2001). Pain assessment in children and adolescents. In D. C. Turk & R. Melzack (Eds.), Handbook of pain assessment (2nd ed., pp. 97-118). New York: Guilford Press. McNeill, J. A., Sherwood, G. D., Starck, P. L., & Thompson, C. J. (1998). Assessing clinical outcomes: patient satisfaction with pain management. J of Pain and Symptom Management, 16(1), 29-40. Melzack, R. (1975a) The McGill Pain Questionnaire. In R. Melzack (Ed.), Pain measurement and assessment. New York: Raven Press. Melzack, R. (1975b). The McGill Pain Questionnaire: Major properties and scoring methods. Pain, 1, 277-299. Mikail, S. F., DuBreuil, S. C., & D'Eon, J. L. (1993). A comparative analysis of measures used in the assessment of chronic pain patients. Psychological Assessment, 5, 117-120. Mongini, F., Defilippi, N., & Negro, C. (1997). Chronic daily headache. A clinical and psychological profile before and after treatment. Headache, 37, 83-87. Navas, M. & Sommer, C. (1999, March). Providing effective pain control. Federal Practitioner, pp. 37-40, 43-44. Nilsson, N. (1995). Measuring passive cervical motion: a study of reliability. Journal of Manipulative and Physiological Therapeutics, 18(5), 293-7. Oberlander, T. F., Grunau, R. E., Pitfield, S., Whitfield, M. F., & Saul, J. P. (1999). The developmental character of cardiac autonomic responses to an acute noxious event in 4- and 8-month-old healthy infants. Pediatric Research, 45(4 Pt 1), 519-25. Oczkowski, W. J., & Barreca, S. (1993). The functional independence measure: its use to identify rehabilitation needs in stroke survivors. Archives of Physical Medicine and Rehabilitation, 74(12), 1291-4. Ogon, M., Krismer, M., Soellner, W., Kantner Rumplmair, W., & et al. (1996). Chronic low back pain measurement with visual analogue scales in different settings. Pain, 64, 425-428. Okifuji, A. , Turk D.C., & Kalauokalani, D. (1999). Clinical outcome and economicevaluation of multidisciplinary pain centers. In A.R. Block, E.F. Kremer, & E. Fernandez (Eds.), Handbook of pain syndromes: Biopsychosocial perspectives (pp. 77-98). Mahwah, NJ: Lawrence Erlbaum. Ortmeier, B. G. (1997). Conducting clinical and health economic outcome studies in an ambulatory setting. Journal of Ambulatory Care Management, 20(4), 10-6. Otis, J., Cardella, L., & Kerns, R.D. (in press). The influence of family and culture on pain. In R.H. Dworkin and W.S. Breitbart (Eds.), Psychosocial and psychiatric aspects of pain: A handbook for health care providers. Seattle, WA: International Association for the Study of Pain Press. Parmalee, P.A. (1996). Pain in cognitively impaired older persons. Clinics in Geriatric Medicine, 12 (3), 473-488. Pascoe, G. C. (1983). Patient satisfaction in primary health care: a literature review and analysis. Evaluation and Program Planning, 6(3-4), 185-210. Polatin, P. B., Kinney, R. K., Gatchel, R. J., Lillo, E., & Mayer, T. G. (1993). Psychiatric illness and chronic low-back pain. The mind and the spine-- which goes first? Spine, 18(1), 66-71. Pollard, C. A. (1984). Preliminary validity study of the pain disability index. Perceptual and Motor Skills, 59(3), 974. Radbruch, L., Loick, G., Kiencke, P., Lindena, G., Sabatowski, R., Grond, S., Lehmann, K. A., & Cleeland, C. S. (1999). Validation of the German version of the Brief Pain Inventory. Journal of Pain & Symptom Management, 18, 180-7. Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401. Rehabilitation Accreditation Commission. (2002). Standards Manual: Medical Rehabilitation (Revised ed.). Tucson, AZ: Rehabilitation Accreditation Commission. Rome, K., & Cowieson, F. (1996). A reliability study of the universal goniometer, fluid goniometer, and electrogoniometer for the measurement of ankle dorsiflexion. Foot and Ankle International, 17(1), 28-32. Rondinelli, R., Murphy, J., Esler, A., Marciano, T., & Cholmakjian, C. (1992). Estimation of normal lumbar flexion with surface inclinometry. A comparison of three methods. American Journal of Physical Medicine and Rehabilitation, 71(4), 219-24. Saxena, A., Mendoza, T., & Cleeland, C. S. (1999). The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. Journal of Pain & Symptom Management, 17, 27-41. Scherder, E. J. (2000). Low use of analgesics in Alzheimer's disease: possible mechanisms. Psychiatry, 63 (1), 1-12. Scherder, E.J. (2000). Visual analogue scales for pain assessment in Alzheimers disease. Gerontology, 46(1), 47-53. Schwartz, L. (1999). Pain in persons with cerebral palsy. Archives of Physical Medicine and Rehabilitation, 80(10), 1243-6. Sist, T. C., Florio, G. A., Miner, M. F., Lema, M. J., & Zevon, M. A. (1998). The relationship between depression and pain language in cancer and chronic non-cancer pain patients. Journal of Pain and Symptom Management, 15, 350-358. Sitzia, J., & Wood, N. (1997). Patient satisfaction: a review of issues and concepts. Social Science and Medicine, 45(12), 1829-43. Solomon, D. H., Bates, D. W., Panush, R. S., & Katz, J. N. (1997). Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Annals of Internal Medicine, 127(1), 52-60. Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press. Strong, J., Ashton, R., & Large, R. G. (1994a). Function and the patient with chronic low back pain. Clinical Journal of Pain, 10(3), 191-6. Tait, R. C., Pollard, C. A., Margolis, R. B., Duckro, P. N., & Krause, S. J. (1987b). The Pain Disability Index: psychometric and validity data. Archives of Physical Medicine and Rehabilitation, 68(7), 438-41. Thomas, A. M., Fairbank, J. C., Pynsent, P. B., & Baker, D. J. (1989c). A computer-based interview system for patients with back pain. A validation study. Spine, 14(8), 844-6. Turk, D.C. (1996). Efficacy of multidisciplinary pain centers in the treatment of chronic pain. In M.J.M. Cohen & J.N. Campbell (Eds.), Pain treatment centers at a crossroads: a practical and conceptual reappraisal. Seattle, WA: International Association for the Study of Pain Press. Turk, D. C., & Rudy, T. E. (1990). The robustness of an empirically derived taxonomy of chronic pain patients. Pain, 43, 27-35. Turk, D.C, Meichenbaum, D & Genest, M. (1983). Pain and behavioral medicine: A cognitive behavioral approach. The Guilford Press: New York Turk, D.C. & Melzack, R. (2001), Handbook of Pain Assessment, Second Edition. New York: Guilford Press. Turner, J. A., & Clancy, S. (1988). Comparison of operant behavioral and cognitive-behavioral group treatment for chronic low back pain. Journal of Clinical and Consulting Psychology, 56, 261-266. Unverzagt, F. W., Gao, S., Baiyewu, O., Ogunniyi, A. O., Gureje, O., Perkins, A., Emsley, C. L., Dickens, J., Evans, R., Musick, B., Hall, K. S., Hui, S. L., & Hendrie, H. C. (2001). Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology, 57(9), 1655-62. Veterans Health Administration, (2000). VHA national pain management strategy, Pain Assessment: The 5th vital sign, Author, Washington, D.C., 27-29. Vlaeyen, J. W., de Jong, J., Geilen, M., Heuts, P. H., & van Breukelen, G. (2001). Graded exposure in vivo in the treatment of pain-related fear: a replicated single-case experimental design in four patients with chronic low back pain. Behavior Research and Therapy, 39(2), 151-66. Vlaeyen, J. W., Seelen, H. A., Peters, M., de Jong, P., Aretz, E., Beisiegel, E., & Weber, W. E. (1999). Fear of movement/(re)injury and muscular reactivity in chronic low back pain patients: an experimental investigation. Pain, 82(3), 297-304. Wang, X. S., Mendoza, T. R., Gao, S. Z., & Cleeland, C. S. (1996). The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain, 67(2-3), 407-16. Ward, S. E., & Gordon, D. B. (1996). Patient satisfaction and pain severity as outcomes in pain management: a longitudinal view of one setting's experience. Journal of Pain and Symptom Management, 11(4), 242-51. Ware J. E., Snyder, M. K., Wright R, et al. (1983). Defining and measuring patient satisfaction with medical care. Evaluation and Program Planning, 6: 247-63. Ware, J. E. Jr, & Hays, R. D. (1988). Methods for measuring patient satisfaction with specific medical encounters. Medical Care, 26(4), 393-402. Watt Watson, J. H., & Graydon, J. E. (1989). Sickness Impact Profile: A measure of dysfunction with chronic pain patients. Journal of Pain and Symptom Management, 4, 152-156. Weiner, D., Peterson, B., & Keefe, F. (1998). Evaluating persistent pain in long term care residents: what role for pain maps? Pain, 76, 249-57. Weiner, D., Peterson, B., & Keefe, F. (1999). Chronic pain-associated behaviors in the nursing home: resident versus caregiver perceptions. Pain, 80(3), 577-88. Weiner, D., Pieper, C., McConnell, E., Martinez, S., & Keefe, F. (1996). Pain measurement in elders with chronic low back pain: traditional and alternative approaches. Pain, 67(2-3), 461-7. Weissman, D. E. (1996). Cancer pain education for physicians in practice: establishing a new paradigm. Journal of Pain and Symptom Management, 12(6), 364-71. Williams, R. C. (1988). Toward a set of reliable and valid measures for chronic pain assessment and outcome research, Pain, 35, 239-51. Wilson, D. B., Houle, D. M., & Keith, R. A. (1991). Stroke rehabilitation: a model predicting return home. Western Journal of Medicine, 154(5), 587-90. Young, R. W., Clark, M. E., & Gironda, R. J. (2003, March). A Confirmatory Factor Analysis of the National Pain Data Bank Version 2. Poster session presented at the 22nd Annual Meeting of the American Pain Society, Chicago, IL. APPENDIX I VHA Customer Satisfaction Survey Questions Pertaining To Pain VHA 2002 Inpatient Customer Satisfaction Survey 31. When you had pain, was it usually severe, moderate, or mild? Severe Moderate Mild Didn't have pain 32. How many minutes after you asked for pain medicine did it usually take before you got it? 0 to 5 minutes 6 to 10 minutes 11 to 15 minutes 16 to 30 minutes More than 30 minutes Never got pain medicine Never asked for pain medicine Didn't have pain 33. Do you think that the hospital staff did everything they could to help control your pain? Yes, definitely Yes, somewhat No Didn't have pain 34. Overall, how much pain medicine did you get? Not enough Right amount Too much Didn't have pain 35. Sometimes people who are in pain don't ask for pain medication. Was this true for you? Yes No Didn't have pain 36. If you answered yes to the question above, was it because... You were concerned it might be habit forming A patient should expect to put up with some pain You felt it would be a bother if you asked for it No one told you pain medication was available You were concerned about possible side effects You were concerned about what might happen if you mixed pain medications with your other medication Other Questions from SF-12V on 2002 Inpatient and Outpatient Surveys 60. During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? (Outpatient question 68) Not at all A little bit Moderately Quite a bit Extremely 68. Have you been treated by a VA provider for chronic pain in the past 12 months? (77) Yes No 69. If you have been treated by a VA provider for chronic pain, please rate the effectiveness of your pain treatment? (Outpatient question 78) Poor Fair Good Very Good Excellent The above questions address patient satisfaction with different domains of their pain management experience. These domains include staff disposition to treat pain (questions 32-34), pain interference with activities of daily living (question 60), and treatment effectiveness (questions 34, 69). The National VHA Customer Satisfaction Survey - Survey of Healthcare Experiences of Patients is an instrument that can be used for benchmarking purposes and comparisons across VA Medical Centers. APPENDIX II Attributes of a Successful Pain Management System (Cleeland, Schall, Nolan, Reyes-Gibby, Paice, Resenburg, Tollett, & Kerns, 2000). Selection of important measures for assessing process outcomes of a pain management system may be informed by consideration of several key attributes of a successful system of care. The following list of attributes of a successful pain management system were developed by the planning committee and core faculty for the VHA/Institute for Healthcare Improvement Pain Management Collaborative Project chaired by Charles Cleeland, Ph.D. Operationalization of these attributes and translation or selection of specific measures or indicators of process and/or outcome may be a reasonable approach to establishing the effectiveness of a pain management system of care. Assessment is routine and timely Pain ratings are obtained and documented as the 5th vital sign during every clinical encounter, including telephone follow-ups and following drug administration Pain screening and assessment is completed on admission and documented Protocols for assessment consistent with good clinical practice are developed Access to appropriate level of treatment Pain management is provided by a multidisciplinary team with the primary care provider as the central link An integrative treatment plan is informed by a comprehensive pain assessment Specialty consults are available to the primary care provider Referrals to specialized pain clinics are made when needed Treatment protocols in place and understood Protocols are available for the most common conditions and are used to establish care plans Reminders for adherence to the care plan are built into the system Standards for time between assessment of pain and action and for response time for medication requests are established Healthcare providers knowledgeable An educational plan is in place at the institutional level Different strategies including one-on-one consultations, unit based programs, and grand rounds are considered Providers have competencies to manage 80% of the conditions they see Patients and families are knowledgeable A plan for education is in place Educational information about pain is supplied to all patients and caregivers Educational information is provided prior to admission or surgery, and is part of discharge planning The impact of the education is monitored and the need for additional interventions determined Pain management standards in place A facility-wide policy for pain is established that meets JCAHO standards A standard nursing policy is established for pain management Limits are set for acceptable variation for key parameters within the system Performance improvement plan in place System goals for key outcomes are agreed on A schedule for review of progress is established Necessary improvements to the system are identified and implemented APPENDIX III Examples of a Medical Record Pain Audit Tool Medical Record Review - Pain Management James A. Haley Veterans Affairs Hospital, Tampa, Florida Patient: Date: Diagnosis: Unit / Clinic: Pain assessed using 0 10 scale at initial contact: % Yes % No Pain Score: ________ Type of Pain: % Acute % Cancer % Chronic % No Pain Pain Assessment in Progress Notes: % Yes % No % NA Assessment includes: % Quantity % Location % Quality % Duration % Patient s Goal Pain recorded on Vital Sign Flowsheet/ GUI % Yes % No % NA Why: _____________ Pain Scale Used % Yes % No Highest Pain Score: ______ Lowest Pain Score: ______ (Pain level reported most often in last 48 hours or 3 mo) Most frequent level: ______ The plan of care addresses pain Medical: % Yes % No % NA Nursing: % Yes % No % NA The plan of care was altered if pain > 3 or the patient s goal not met % Yes % No % NA Pain education documented % Yes % No % NA Effectiveness of medication evaluated using 0  10 scale % Yes % No % NA (was plan evaluated at next clinic visit?) Was pain management included in DC plan /instructions? % Yes % No % NA Was pain education included in DC plan / instructions? % Yes % No % NA APPENDIX IV Examples of Possible Patient Education Survey Items I received an explanation of how may pain would be relieved. Disagree Not Sure Agree I would have liked a better explanation. Disagree Not Sure Agree Please rate the adequacy of explanation of what was done for you. Excellent Very Good Good Fair Poor Please rate the adequacy of answers to your questions. Excellent Very Good Good Fair Poor When you had questions to ask did you always get answers you could understand? Yes No Not Sure How much information was given to you during your hospital stay/visit? Not enough Right amount Too much I didn't need or want information Were you informed of the next step in your health care? Yes Yes, sometimes No Were you told of the medication side effects before going home? Yes No Not necessary, I knew the information Not necessary, no medications Were you provided with enough information to know how to care for yourself after discharge from the hospital? Yes No APPENDIX V Duke University Medical Center Competency Questionnaire (Reproduced with the permission of Shashidhar Kori, M.D.) [Q1] What is your specialty? (A) Pediatrics (B) OB/GYN (C) Medicine (D) Surgery (E) Psych (F) Family Medicine (G) Other Please enter your response here >> ---------------------------------------------------------------- [Q2] (Complete the blank). Studies indicate that more than _____% of the cancer pain experienced by terminally ill patients can be effectively controlled using currently available oral therapies. (A) Twenty (B) Ninety (C) Fifty (D) Fifteen Please enter your response here >> ---------------------------------------------------------------- [Q3] The addition of psychological intervention (e.g., relaxation training, imagery, activity pacing) to medical management can result in a significant improvement in pain relief. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q4] Patients often describe bone pain as: (A) Shooting (B) Deep and aching (C) Spasms and cramping (D) Colicky Please enter your response here >> ---------------------------------------------------------------- [Q5] Which of the following classes of drugs can be effective adjuvants to morphine when treating specific types of pain? (A) NSAIDS (B) Antidepressants (C) Anticonvulsants (D) All of the above Please enter your response here >> ---------------------------------------------------------------- [Q6] When titrating morphine, the dose should never be raised by more that 25% over a 24-hour period. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q7] Which of the following are true about NSAIDS? (A) NSAIDs are contraindicated in patients allergic to aspirin. (B) NSAIDs should be used with caution in patients with renal dysfunction. (C) NSAIDs can be useful analgesics in patients with cancer pain. (D) All of the above are true. Please enter your response here >> ---------------------------------------------------------------- [Q8] To calculate the equivalent daily parenteral dose of 30 mg of oral morphine, divide the oral dose of morphine by 3. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q9] The most appropriate oral regimen for a patient requiring 80 mg of intravenous morphine in the preceding 24 hours is: (A) Propoxyphene and acetaminophen (Darvocet) (B) Tramadol (Ultram) (C) Continuous release oxycodone plus oxycodone immediate release for breakthrough pain (D) Oral meperidine (Demoral) Please enter your response here >> ---------------------------------------------------------------- [Q10] When pain related to nerve damage or dysesthesia occurs, which of the following may be an effective adjuvant to morphine: (A) Amitriptyline (Elavil) (B) Scopolamine (C) Gabapentin (Neurontin) (D) Both A and C above Please enter your response here >> ---------------------------------------------------------------- [Q11] Due to concerns about addiction and tolerance, morphine or other strong opioids should not be used in patients with nonmalignant chronic pain. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q12] Completing a history and physical are the first steps of an effective assessment of all types of pain. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q13] When beginning opioid therapy it is useful to do which of the following: (A) Initiate therapy for constipation (B) Tell the patient that drowsiness and pruritis may improve (C) Encourage the patient to take the medication only when in severe pain (D) Both A and B above Please enter your response here >> ---------------------------------------------------------------- [Q14] Appropriate agents for PCA (patient controlled analgesia) include all of the following except: (A) Morphine (B) Meperidine (C) Fentanyl (D) Hydromorphone Please enter your response here >> ---------------------------------------------------------------- [Q15] Most patients on opioid therapy require individually titrated doses of potent bowel stimulants such as: (A) Senna (Senokot) (B) Bisacodyl (Dulcolax) (C) Docusate (Colace) (D) Either A or B above Please enter your response here >> ---------------------------------------------------------------- [Q16] If a patient's pain is relieved by distraction, the pain is most likely psychogenic in origin. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q17] When a patient can no longer swallow, all of the following are appropriate alternative routes of opioid administration except: (A) Transmucosal (B) Subcutaneous (C) Intramuscular (D) Rectal Please enter your response here >> ---------------------------------------------------------------- [Q18] Health care providers accurately assess the pain of patients. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q19] Children feel less pain than adults. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q20] Clinically significant respiratory depression is a common problem when appropriately dosing opioids in the management of moderate to severe pain. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q21] Relaxation, visualization, and distraction are examples of techniques useful to treat which of the following types of pain: (A) Neuropathic (B) Visceral (C) Acute (D) Malignant (E) All of the above Please enter your response here >> ---------------------------------------------------------------- [Q22] All of the following are true about meperidine (Demerol) except: (A) Meperidine is useful to treat rigors. (B) Meperidine increases the risk of seizures. (C) Meperidine is the drug of choice to treat sickle cell pain crises and post op pain. (D) Meperidine is more likely to cause chemical dependency than morphine. Please enter your response here >> ---------------------------------------------------------------- [Q23] The dosing of Percocet is limited by the following: (A) The amount of opioid in the product (B) The amount of acetaminophen in the product (C) The amount of aspirin in the product (D) The amount of ibuprofen in the product Please enter your response here >> ---------------------------------------------------------------- [Q24] Long-acting opioids have the following advantages over short-acting preparations: (A) More consistent blood levels (B) Less potential for abuse (C) Convenience of dosing (D) All of the above Please enter your response here >> ---------------------------------------------------------------- [Q25] Patients with chronic pain syndromes can build up their activity level most effectively if they try to do as much as they can and let pain be their guide. (T) True (F) False Please enter your response here >> ---------------------------------------------------------------- [Q26] All of the following are true about codeine except: (A) The active metabolite of codeine is morphine. (B) Codeine in combination with acetaminophen is a schedule III compound. (C) 60 mg of codeine is a stronger analgesic than 600 mg of ibuprofen. (D) Nausea and vomiting is common with codeine. Please enter your response here >> ---------------------------------------------------------------- APPENDIX VI Members of the VA National Pain Outcomes Workgroup Michael E. Clark, PhD, Chair Clinical Director, Pain Program (116B) James A. Haley Veterans Affairs Hospital 13000 B. B. Downs Blvd. Tampa, FL 33612-4798 813.972.2000 x7484; 7112; 7114 Fax: 813.978.5867 e-mail:  HYPERLINK mailto:michael.clark2@med.va.gov michael.clark2@med.va.gov Website:  HYPERLINK http://www.vachronicpain.org www.vachronicpain.org  Robert Kerns, PhD Chief, Psychology Service (116B) VA Connecticut Healthcare System 950 Campbell Ave. West Haven, CT 06516 203.937.3841 Fax: 203.937.4951 e-mail:  HYPERLINK mailto:robert.kerns@med.va.gov robert.kerns@med.va.gov  Michael H. Craine, PhD Section Chief, Psychology (116B) Denver VAMC 1055 Clermont St. Denver, CO 80220 303.399.8020, ext. 2577 Fax: 303.393.5076  HYPERLINK "mailto:michael.craine@med.va.gov" michael.craine@med.va.gov  Ruth Markham, EDS 4179 Riverboat Rd. Suite 200 Salt Lake City, UT 84123 801.904.4545 Fax: 801.904.4782 e-mail:  HYPERLINK mailto:ruth.markham@med.va.gov ruth.markham@med.va.gov  Julie A. Jones, RN, CNS Black Hills HCS VABHHS 500 North 5th Street Hot Springs, SD 57747 605.745.2000, ext. 2469 Fax: 601.745.2802  HYPERLINK mailto:julie.jones2@med.va.gov julie.jones2@med.va.gov  Mitchell Nazario, Pharm. D. Pharmacy Service (119) San Juan VAMC 10 Casia St. San Juan, PR 00921-3201 787.641.7582, ext. 11476  HYPERLINK "mailto:mitchell.nazario@med.va.gov" mitchell.nazario@med.va.gov  APPENDIX VII Members of the VA National Pain Coordinating Committee John Booss, MD Director, Neurologyfield based VAMC (200) West Haven, CT 06516 Phone: 203.932.5711; ext. 3544 Fax: 203.937.4755 e: HYPERLINK mailto:booss.john@westhaven.va.gov booss.john@westhaven.va.gov  Martha Bryan, EdD Assistant Director, Health Services Research and Development Service 1400 I Street, Suite 700 Washington, DC 20420 Phone: 202.408.3665 e:  HYPERLINK "mailto:martha.bryan@hq.med.va.gov" martha.bryan@hq.med.va.gov  Michael E. Clark, PhD Clinical Director, Chronic Pain Rehabilitation Program (116B) Bruce B. Downs Blvd. Tampa, Fl 813.972.2000 x 7484; 7112; 7114 fax: 813.903.4847 e:  HYPERLINK mailto:michael.clark2@med.va.gov michael.clark2@med.va.gov Audrey Drake, RN, MSN, CNAA Program Director, Nursing (118) VACO 810 Vermont Ave. NW Washington, DC 20420 Phone: 202.273.8424 fax: 202.273.9066 e:  HYPERLINK "mailto:audrey.drake@hq.med.va.gov" audrey.drake@hq.med.va.gov  Robert Kerns, PhD Chief, Psychology Service VA Connecticut HCS West Haven, CT 06516 Phone: 203.937.3841 fax: (203) 937-4951 e:  HYPERLINK mailto:robert.kerns@med.va.gov robert.kerns@med.va.gov  Ruth Markham, SLC OI 295 Chipeta Way Salt Lake City, UT 84108 Phone: 801.588.5842 fax: 801.588.5004 e:  HYPERLINK "mailto:ruth.markham@med.va.gov" ruth.markham@med.va.gov  Jack Rosenberg, MD VISN 11 Coordinator for Pain Mgmt. 2215 Fuller Road Ann Arbor, MI 48105 Phone: 734.936.5842 fax: 734.769.7056 e:  HYPERLINK mailto:jackrose@umich.edu jackrose@umich.edu Richard W. Rosenquist, MD Dir., Pain Medicine Division Dept. of Anesthesia University of Iowa Hospitals Iowa City, Iowa 52242 Phone: 319.356.2320 fax: 319.356.2940 e:  HYPERLINK mailto:richard-rosenquist@uiowa.edu richard-rosenquist@uiowa.edu  Paul Rousseau, MD ACOS for GEC VAMC; 650 E. Indian School Road Phoenix, AZ 85012 Phone: 602.277.5551 fax: (602) 222-6514 e:  HYPERLINK mailto:ArizonaMD@aol.com ArizonaMD@aol.com Charles D Sintek, MS, RPh, BCPS Clinical Pharmacy Mgr. (119B) VAMC; 1055 Clermont ST. Denver, CO 80220 Phone: 303.393.2806 Fax: 303.393.4624 e:  HYPERLINK mailto:charles.sintek@med.va.gov charles.sintek@med.va.gov  Anne Turner Health Education Officer Employee Education System Suite 500 Medical Forum 950 22nd St., North Birmingham, Al 35203 Phone 205-731-1812 ex 310 Fax 205-731-1824 e:  HYPERLINK "mailto:anne.turner@lrn.va.gov" anne.turner@lrn.va.gov  Jane H. Tollett, RN, PhD National Pain Management Coordinator VHACO (114) 810 Vermont Ave., NW Washington, DC 20420 Phone: 202.273.8537 Fax: 202.273.9131 e:  HYPERLINK "mailto:jane.tollett@hq.med.va.gov" jane.tollett@hq.med.va.gov  PAGE 67 PAGE 1 TREATMENT ALTERNATIVES NSAIDS; TCAs Anticonvulsants Opiates; Adjuvants Surgery; Radiotherapy Economic Outcomes ER/clinic visits, hospitalizations, cost per successful treatment, cost per quality adjusted life-years, ratios of cost to benefit Treatment Modifiers Compliance with therapy, fear of addiction, tolerance, fear of worsening disease, good patient, side effects. Drug related problems. Product Specific: dosage forms, dosing interval, pharmacokinetics. Costs Cost of drugs, re-treatment due to drug failure, clinician visits, allied health costs (PT, OT, RT), transportation, prosthetics, medical equipment. Clinical Indicators Pain Numeric Rating Scales or Visual Analogue Scales, Non-verbal cues of pain, grimacing, guarding Clinical Outcomes Pain reduction, side effect profile, medical utilization External Controls Formularies Drug Restrictions Clinical Guidelines Patient Management PAIN Humanistic Intermediaries Side effects, satisfaction with therapy Humanistic Outcomes Physical function, pain, emotional distress, sleep, sex, social relationships, vitality, activity, satisfaction TITLE:TEST SUMMARY^TEMPLATE:TEST REPORT START:9/13/1974^END:1/29/2002^RUN:1/29/2002 5:05:19 pm ^^INDIVIDUAL LOCATIONS ONLY 0^ELY 660GC_GENERAL MEDICINE^^ 1^Advanced Directives Education^24^22^GENERAL MEDICINE 2^IHD Elevated LDL^0^0^GENERAL MEDICINE 0^PATIENTS^25^^GENERAL MEDICINE 0^ELY 660GC_ONCOLOGY^^ 1^Advanced Directives Education^13^12^ONCOLOGY 2^IHD Elevated LDL^1^0^ONCOLOGY 0^PATIENTS^15^^ONCOLOGY End of the report. Jan 20, 2000 5:09:11 pm Page 2 Clinical Reminders Due Report - Summary Report for 1/20/2000 # Patients with Reminders Applicable Due ---------- ---- 1 Mammogram 0 0 2 Weight 8 6 3 Blood Pressure Check 8 7 Report run on 8 patients. End of the report. Jan 20, 2000 5:17:32 pm Page 2 Clinical Reminders Due Report - Detailed Report for 1/20/2000 Blood Pressure Check: 7 patients have reminder due Date Due Last Done Next Appt -------- --------- --------- 1 DINARO,MUCHO (3779) 8/28/1998 8/27/1998 None 2 ESSTEPON,GLORD (3234) 1/20/2000 N/A None 3 HOLMES,SHERLOCK (5377) 1/20/2000 N/A None 4 HOOD,ROBIN (2591P) 8/19/1999 8/18/1999 None 5 MARLEY,JACOB (5678) 9/4/1998 9/3/1998 None 6 TEST,KEVIN (5734) 2/3/1999 2/3/1997 None 7 TRAT,JACK (2342) 1/20/2000 N/A None Report run on 8 patients. Applicable to 8 patients. End of the report. );<=TUVWrstuij}u}}h`0JmHnHuj0JUmHnHuj U jU0JOJQJ^Jja >*B*Uph0J j0JUCJOJQJ\^JaJ jCJOJQJU\^JaJ5CJOJQJ^JaJ5OJQJ^J5CJ OJQJ^JaJ jUjUmHnHu jU 5CJaJ#([\]^);<($@&a$$]a$$a$ -]^,x+a/01234567RSTUpqr|nZ&jC >*B*UmHnHphuj UmHnHu0JOJQJ^JmHnHu&jM >*B*UmHnHphuj UmHnHujUmHnHumHnHu0JOJQJ\^JmHnHuj0JUmHnHu&jW >*B*UmHnHphu0JmHnHu mHnHu#5O X q + O  ~ 5 tW`() $ ./0IJKLMNOPQlmno󵽵݃|yyk|a_0JOJQJ\^Jj/>*B*Uph0J j0JUj UmHnHu0JOJQJ\^JmHnHu&j9 >*B*UmHnHphu0JmHnHu mHnHuj UmHnHujUmHnHumHnHu0JOJQJ^JmHnHuj0JUmHnHu#     ()*+789Rӹ۫ue0JOJQJ\^JmHnHu&j>*B*UmHnHphujUmHnHujUmHnHumHnHu0JOJQJ^JmHnHu&j%>*B*UmHnHphu mHnHu0JmHnHuj0JUmHnHu j0JUjU jU"RSTUVWXYZuvwx     ïџޑˊyomfm^fmfjU jU0JOJQJ\^Jj>*B*Uph0J j0JUjUmHnHu0JOJQJ\^JmHnHu&j>*B*UmHnHphu0JmHnHu mHnHuj0JUmHnHumHnHujUmHnHujUmHnHu$     5 6 7 8 P Q R k l m n o p q r s 뻳뻳wjnUmHnHu&j>*B*UmHnHphujxUmHnHujUmHnHumHnHu0JOJQJ^JmHnHu&j>*B*UmHnHphu mHnHu0JmHnHuj0JUmHnHu j0JU& $ % & ( ) * + , - H I J K h i j ɽɯɽߩߡ}ɽoɽߩߡ[&j>*B*UmHnHphujZUmHnHu0JOJQJ\^JmHnHu&j>*B*UmHnHphu0JmHnHu mHnHujdUmHnHujUmHnHumHnHu0JOJQJ^JmHnHuj0JUmHnHu&j>*B*UmHnHphu#     - . / H I J L M N O P Q l m n o ïѡѡqj<UmHnHu&j>*B*UmHnHphujFUmHnHu0JOJQJ^JmHnHu&j>*B*UmHnHphu0JmHnHu mHnHuj0JUmHnHujPUmHnHujUmHnHumHnHu,          5 6 7 8 \ ] ^ w x y { | } ~  ƾ֞|zszkszsW&j>*B*UmHnHphuj(U jU0JOJQJ\^Jj>*B*Uph0J j0JU mHnHuj2UmHnHujUmHnHumHnHu0JOJQJ\^JmHnHuj0JUmHnHu&j>*B*UmHnHphu0JmHnHu"    . / 0 2 3 4 5 6 7 R S T U w x y 󽶳󃽃oaj UmHnHu&j>*B*UmHnHphu0JmHnHujU jU0JOJQJ^Jj>*B*Uph0J j0JU mHnHujUmHnHujUmHnHumHnHu0JOJQJ^JmHnHuj0JUmHnHu& RSTmnoqrstuvмޮЌޮ~jUmHnHu&j{>*B*UmHnHphujUmHnHu0JOJQJ^JmHnHu&j>*B*UmHnHphu0JmHnHu mHnHuj0JUmHnHumHnHujUmHnHu)   567PQRTUVWXYtuvwǻǭǻߧߟ}ǻoǻߧheeWhj]">*B*Uph0J j0JUj!UmHnHu0JOJQJ^JmHnHu&jg!>*B*UmHnHphu0JmHnHu mHnHuj UmHnHujUmHnHumHnHu0JOJQJ\^JmHnHuj0JUmHnHu&jq >*B*UmHnHphu"w 1234>?@YZ[]^_`ab}~ڭ mHnHu0JmHnHuj0JUmHnHuj$UjI$>*B*Uphj#U0JOJQJ^JjS#>*B*Uph0J j0JUj"U jU0JOJQJ\^J.~   %&')*+,-.IJKLɽɯɽߩ~v~~nnZ&j+'>*B*UmHnHphu0JmHnHuj&U jU0JOJQJ\^Jj5&>*B*Uph0J j0JU mHnHuj%UmHnHujUmHnHumHnHu0JOJQJ^JmHnHuj0JUmHnHu&j?%>*B*UmHnHphu"`,[i/ikm 7$8$H$]7$8$@&H$7$8$H$@&]$]a$() $ L}~    9:;Tl&j)>*B*UmHnHphu0JmHnHuj(U jU0JOJQJ\^Jj!(>*B*Uph0J j0JU mHnHuj0JUmHnHuj'UmHnHujUmHnHumHnHu0JOJQJ\^JmHnHu$TUVXYZ[\]xyz{:;<=GHĪĪuĪj+>*B*Uphj~+Uj+>*B*Uphj*U jU0JOJQJ^Jj *>*B*Uph0J j0JU mHnHuj0JUmHnHumHnHujUmHnHuj)UmHnHu.HIbcdfghijk ()*,-./ӹ۫xogj`.U0JOJQJ^Jj->*B*Uph0Jjj-UmHnHujUmHnHumHnHu0JOJQJ^JmHnHu&j,>*B*UmHnHphu mHnHu0JmHnHuj0JUmHnHu j0JUjt,U jU(/01LMNOû嚗~w~ow~wjL0U jU0JOJQJ^Jj/>*B*Uph0J j0JUjV/UmHnHujUmHnHumHnHu0JOJQJ^JmHnHu&j.>*B*UmHnHphu mHnHu0JmHnHuj0JUmHnHu$GHIbcdfghijkOPkoɽɯɽߩwfXwF#j1CJOJQJU^JaJ5CJOJQJ\^JaJ 56CJOJQJ\]^JaJ>*CJOJQJ^JaJ5CJOJQJ^JaJCJOJQJ^JaJjCJOJQJU^JaJ mHnHujB1UmHnHujUmHnHumHnHu0JOJQJ^JmHnHuj0JUmHnHu&j0>*B*UmHnHphuv6OPmo %(&((($@&a$] @& & F=7$8$H$GH]^x %(&(((P(Q()))),,,D/غغخغ؄ugu6CJOJQJ]^JaJ56CJOJQJ]^JaJ5>*CJOJQJ^JaJ>*CJOJQJ\^JaJ56CJOJQJ^JaJCJOJQJ\^JaJ5CJOJQJ^JaJ#j22CJOJQJU^JaJCJOJQJ^JaJ0JCJOJQJ^JaJjCJOJQJU^JaJ$((P(Q(!)")[))))))++,,--C/D/Q/R// *$9D@&[$\$$*$9D[$\$a$*$@&*$^ & F*$`*$$a$$@&a$D/Q///~0000W3\333i4{4P:S:::II(KKKKKK{N|N}NNNNN筞ydSdyy <B*CJOJQJ^JaJph)j<B*CJOJQJU^JaJph&jB*CJOJQJU^JaJph 6B*CJOJQJ^JaJphB*CJOJQJ^JaJph 5B*CJOJQJ^JaJph5>*CJOJQJ\^JaJ6CJOJQJ]^JaJ6CJOJQJ^JaJCJOJQJ^JaJ5CJOJQJ\^JaJ //~0022536373833h4i4z4{4Z5[5&7'7P:Q:S::*$@&*$$*$9D@&[$\$a$$ & Fy*$9D[$\$a$$*$9D[$\$a$::v;w;#?$? C CoFpFIIIINNRR+g,grrssuu R*$ *$9D[$\$ *$9D@&[$\$*$NNNNNP$QQQ.R/RYRZR[RpRqRRRUU V V ["[$[пЮНЉreЉP?P <B*CJOJQJ^JaJph)j<B*CJOJQJU^JaJph0JCJOJQJ^JaJ,j2B*CJOJQJU^JaJph&jB*CJOJQJU^JaJph B*CJH*OJQJ^JaJph 6B*CJOJQJ^JaJph 5B*CJOJQJ^JaJphB*CJOJQJ^JaJph >*B*CJOJQJ^JaJphB* CJOJQJ^JaJph$[[[\\\\\\\\\]]]^]`]6^8^^^dddeeeexfyfzf{fff'g(g)g+gEgǶܧ𧜋Ƕn >*B*CJOJQJ^JaJph<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJ <B*CJOJQJ^JaJph)j<B*CJOJQJU^JaJph&jB*CJOJQJU^JaJphB*CJOJQJ^JaJph$EgFg0hHhqhh.j/jjjFpGpHpppppQqRqTq^q_qrrrssttttOtPt޳ӢӳӢӢއs^)j<B*CJOJQJU^JaJph&jB*CJOJQJU^JaJphB* CJOJQJ^JaJph<CJOJQJ^JaJ j<CJOJQJU^JaJjCJOJQJU^JaJ 6B*CJOJQJ^JaJphCJOJQJ^JaJB*CJOJQJ^JaJph#5>*B*CJOJQJ^JaJph Pt#u$u%uXuYuuuuuvvvvvvw w w.w/wwwwxx x&x'xzyyyyyzz>~?~@~]~_~i~j~ƷƷƷƷƷƷƷƷrƷƷƷ#6>*B*CJOJQJ^JaJph >*B*CJOJQJ^JaJph 5B*CJOJQJ^JaJph 6B*CJOJQJ^JaJphB*CJOJQJ^JaJph&jB*CJOJQJU^JaJph)j<B*CJOJQJU^JaJph <B*CJOJQJ^JaJph,ux x&x'xzy{y}~;<]^ϥХ|~h*$^h*$@&*$(*$^( *$9D[$\$ *$9D@&[$\$PQj468TV68hj45fg[\!"ÒĒŒƒ~ȷȷݨݨ<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJ <B*CJOJQJ^JaJph)j<B*CJOJQJU^JaJphB*CJOJQJ^JaJph&jB*CJOJQJU^JaJph-~[\]rsەܕɖʖЗї TUtu+,-BC;≮̸̸̸̸̸̸̸̸̸̣̣̣̣̣ <B*CJOJQJ^JaJph)j<B*CJOJQJU^JaJph&jB*CJOJQJU^JaJphB*CJOJQJ^JaJphCJOJQJ^JaJ6CJOJQJ^JaJ6>*CJOJQJ^JaJ2<lq֛כ ؜ٜڜopqŞƞ}~۟ܟˠ̠ɡʡ]^sz͹ͤ͹͹ͤ͹͹ͤ͹͹ͤ͹͹ͤ͹͂ 6B*CJOJQJ^JaJph <B*CJOJQJ^JaJph)j<B*CJOJQJU^JaJph&jB*CJOJQJU^JaJphB*CJOJQJ^JaJph >*B*CJOJQJ^JaJph#6>*B*CJOJQJ^JaJph3z#$,6bcjklGHI_`ϥХʧЧԧէh,.0HJLѱѠѱrr`Ѡѱ#56B*CJOJQJ^JaJph >*B*CJOJQJ^JaJph 5B*CJOJQJ^JaJph<CJOJQJ^JaJ j<CJOJQJU^JaJjCJOJQJU^JaJ 6B*CJOJQJ^JaJphCJOJQJ^JaJ& ja6B*CJOJQJ^JaJphB*CJOJQJ^JaJph%L֬ج -.ְװtvxR`bܹ޹ (*45:ŹŹŹŹŹ >*B*CJOJQJ^JaJph# jaB*CJOJQJ^JaJph 6B*CJOJQJ^JaJph<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJB*CJOJQJ^JaJph478 9:!"$9:|}UVW'(JK ɺɺ6CJOJQJ^JaJ>*CJOJQJ^JaJCJKHOJQJ^JaJB*CJOJQJ^JaJphjCJOJQJU^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJ:')kl{7$8$H$$*$9D@&[$\$a$$*$9D[$\$a$ #$?@bc !9:TUZ[\9:./01#j3CJOJQJU^JaJ B*CJH*OJQJ^JaJph 6B*CJOJQJ^JaJphB*CJOJQJ^JaJph<CJOJQJ^JaJ j<CJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ4')<Z\45 (*,FJ^`CDE "$<>*+*ɻحح؜؜؜؄؜؜>*CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJ6CJOJQJ]^JaJ5CJOJQJ\^JaJB*CJOJQJ^JaJphCJOJQJ^JaJ0JCJOJQJ^JaJjCJOJQJU^JaJ4*,67vxz)*+ACMN'F=>>?GIST   6CJOJQJ^JaJ>*CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJE{|  "#/0LMJ$K$''))**,,../000W0$*$9D[$\$a$7$8$H$  # $      EFMNO~ 34kl9:;hi!"CDi6CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJJ/0L    !!!!!R"S"""k#l#m###K$e$,.00W043W35566:癍癍ud!@B*CJOJQJ^JaJphCJOJQJ\^JaJ>*CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJjCJOJQJU^JaJ5>*CJOJQJ^JaJB*CJOJQJ^JaJph >*B*CJOJQJ^JaJphCJOJQJ^JaJ5CJOJQJ\^JaJ'W0X022g4h466::;;>>AAAAAA;B>;B*CJOJQJ^JaJ;CJOJQJ^JaJB* CJOJQJ^JaJph 6B*CJOJQJ^JaJph6CJOJQJ^JaJ5CJOJQJ\^JaJ5CJOJQJ^JaJCJOJQJ^JaJ >*B*CJOJQJ^JaJphB*CJOJQJ^JaJph-BBBBBBgaaaa$If$$IflF ,"   0"6    4 laBBBBB CC C!C,CJCjCCC|dvvvvv|vvvvvv$If$$IflF ,"   0"6    4 la CDDD#DJD[DpDqDrD}DDDDvvv,$$IflF ,"   0"6    4 la$If DDDDDDDD!E2EGEHEIEWEvdv$$IflF ,"   0"6    4 la$If WEnEEEEEEEEEGGIIvvttttt$$IflF ,"   0"6    4 la$If I]K^K@PAP?R@R_R`RWWYZ__icjcxeye h hhhZi7jjk & Ff@&7$8$H$7$8$@&H$data h3hkl1n2nfngnhnnnnoopp+t,tGtHtItTtUtVtYtt±naO#5B*CJOJQJ\^JaJph0JCJOJQJ^JaJ#jr5CJOJQJU^JaJjCJOJQJU^JaJ0J5CJOJQJ^JaJ&ja45CJOJQJU^JaJ j5CJOJQJU^JaJ5CJOJQJ^JaJ5>*CJOJQJ^JaJ>*CJOJQJ^JaJCJOJQJ^JaJ6CJOJQJ^JaJkkkknnoopqqqqssVtWtYtttdwew*$ *$9D[$\$ *$9D@&[$\$ & Fr^ & Fftdwewwwwww|z}z~zzz6{7{b{|bdf΄Є  ./҉؉މ>U\^ȹȨȹȹȨȹȎȹȨȹȂȂȂȂȂȹȨ6CJOJQJ^JaJ jaCJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ6>*CJOJQJ^JaJB* CJOJQJ^JaJphB*CJOJQJ^JaJph3 &ΙϙԜ֜؜&,Ҟ؞*+,AB{̟͟')34ȼ厀ȼȼ6>*CJOJQJ^JaJB* CJOJQJ^JaJph0JCJOJQJ^JaJ#j5CJOJQJU^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJ6CJOJQJ^JaJCJOJQJ^JaJjCJOJQJU^JaJ2?@AB?@hi|}*+  '(@&`$*$9D[$\$a$$*$9D@&[$\$a$ !4פؤڤ:;<@AhiƨǨhij׮ݮSTmnoz{ (ȺȟȍӀtth>*CJOJQJ^JaJ5CJOJQJ^JaJ0JCJOJQJ^JaJ#j6CJOJQJU^JaJ6CJOJQJ^JaJ5>*CJOJQJ\^JaJ5CJOJQJ\^JaJCJOJQJ^JaJjCJOJQJU^JaJ j<CJOJQJU^JaJ<CJOJQJ^JaJ(WXY\z{|ijk#AU5CJOJQJ^JaJ>*CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJ0JCJOJQJ^JaJ#j97CJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ8[\"#ABm & FP@&`  ``2356lmaZ[fgs^ & F< & FQ & FO` h^h`Ubdw23DEghi}~ou*,gxrsڹvjj[jCJOJQJU^JaJ>*CJOJQJ^JaJCJH*OJQJ^JaJ0J6CJOJQJ^JaJ/j76B*CJOJQJU^JaJph3f 6B*CJOJQJ^JaJph3f)j6B*CJOJQJU^JaJph3f5CJOJQJ^JaJCJOJQJ^JaJ6CJH*OJQJ^JaJ6CJOJQJ^JaJst8t34}  _`tu` & F;h^h` & FQ0@Bjk  qƺƺƩƩƩƑƑƑ|k 6B*CJOJQJ^JaJph3f)j6B*CJOJQJU^JaJph3f6CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJ>*CJOJQJ^JaJCJOJQJ^JaJ0JCJOJQJ^JaJjCJOJQJU^JaJ#jy8CJOJQJU^JaJ(uz{lm./} & F[$@&a$$`a$  @&``0ARuҹznbbbbTn5>*CJOJQJ^JaJ6CJOJQJ^JaJ5CJOJQJ^JaJ0JCJOJQJ^JaJ#j:CJOJQJU^JaJjCJOJQJU^JaJ 6B*CJOJQJ^JaJph3fCJOJQJ^JaJ0J6CJOJQJ^JaJ)j6B*CJOJQJU^JaJph3f/j86B*CJOJQJU^JaJph3f@ B D            3 4 5 \ ^   hijIJLVW/@~^ _ ` t u !!!!!ɽɽɽɨɨ(jCJOJQJU^JaJmHnHu6CJOJQJ^JaJCJOJQJ^JaJjCJOJQJU^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJB}~  !!!!&!(!)!*!+!-!0!1!2!3!4!5!7!8!:!;!=!>!?! & F[!%!&!'!+!,!-!/!5!6!8!9!;!*CJOJQJ\^JaJ5CJOJQJ\^JaJ>*CJOJQJ^JaJ5CJOJQJ^JaJCJOJQJ^JaJ(jCJOJQJU^JaJmHnHu2?!@!B!C!D!G!H!I!J!K!L!N!P!Q!R!T!U!V!W!X!Z![!\!E#F#{0|0  & Fs n na0w0x0|00J1K1c12(5*5,5H5J566666 7 7/:0:1:H:I:<<<==>>BBCDBGDGFGlGpGGG[H\H]H`HuHK#KKKKKǻǻ؟ǻǻ6CJOJQJ^JaJ>*CJOJQJ^JaJ5CJOJQJ\^JaJ6CJOJQJ]^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJ>*CJOJQJ\^JaJjCJOJQJU^JaJCJOJQJ^JaJ5|0::::;L;r;;;<<<<>>_H`HzI{I|I}I~IIJ n  & Fx  8^ & Fu & FsJJOOSSSSSSSWT$$IflF,"t 0 06    4 la $$Ifa$  8^ K O"O$OPOROOOPSSSSSSYYYr]]V^^4_5_<_b_____cccFcHc&l?lToUoȺȩț|țȊpȊbȮ5>*CJOJQJ^JaJCJOJQJ\^JaJ6CJOJQJ]^JaJ 56CJOJQJ\]^JaJ5CJOJQJ\^JaJCJaJ>*CJOJQJ^JaJ5>*CJOJQJ^JaJCJOJQJ^JaJjCJOJQJU^JaJ j<CJOJQJU^JaJ<CJOJQJ^JaJ&SSSSST'TrTsTTTTnndd $If~$$IflF,"t 006    4 la$If $ $Ifa$ TTTUZU[U\U}U~UUUUUUq~$$IflF,"t 006    4 la$If $If UVV'V(VJVKV_V`VaVVVVV{qq{{{p{qq{{ $If$If~$$IflF,"t 006    4 la VVVVGWWWWWWAXjXkXX{q{ q $If~$$IflF,"t 006    4 la$If XXXXXXXkYYYYYY{qq{h th" $If~$$IflF,"t 006    4 la$If YYYYYYYYZTMC $If $ $Ifa$$$IflF,"t 0 06    4 la $$Ifa$ th"YYYZZZZZZZD[E[\[][{q $If~$$IflF,"t 006    4 la$If ][u[v[[[[2\3\\\\\\]{qq{dqq $If~$$IflF,"t 006    4 la$If ]F]G]q]r]]]]]]]C^{\nd{ $If $ $Ifa$~$$IflF,"t 006    4 la$If C^D^V^^^^4_5_6_7_8_9_:_{{{{{uoooo `$If~$$IflF,"t 006    4 la :_;_<_b_c_dd-j.j%l&lmmP|Q|||}}JPabrsŕ !$*$9D[$\$a$ 1$7$8$@&H$ UorosoSrTrUrlrmrss-stLwNwPwxwzw4y5yTyUy0|1|2|G|H|Q|R|||}}~~~~~0tft;<CJOJQJ^JaJ#j;<CJOJQJU^JaJ j;CJOJQJU^JaJ;CJOJQJ^JaJ>*CJOJQJ^JaJ5CJOJQJ\^JaJ5CJOJQJ^JaJjCJOJQJU^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJ(024>?;@AZ[$&*<@DҊӊ}~HV(qs󫝫}q}e6CJOJQJ^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJjCJOJQJU^JaJ;CJOJQJ\^JaJCJOJQJ\^JaJCJOJQJ^JaJ;<CJOJQJ^JaJ#j;<CJOJQJU^JaJ j;CJOJQJU^JaJ;CJOJQJ^JaJ#sGi•4~"#$DEFPQUVWYʼʈ|j\j|j\j|j\j|;<CJOJQJ^JaJ#j;<CJOJQJU^JaJ;CJOJQJ^JaJ j;CJOJQJU^JaJ;<CJOJQJ\^JaJ&j;<CJOJQJU\^JaJ;CJOJQJ\^JaJ#j;CJOJQJU\^JaJCJOJQJ\^JaJCJOJQJ^JaJ>*CJOJQJ^JaJ$ŕƕZ[qref34+,67 !ƤǤ]^_noV_߫$)>{|23456^_ij  )n()HI89/4I/0MN6CJOJQJ^JaJCJOJQJ\^JaJ<CJOJQJ^JaJ j<CJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJE78׹عٹ Իջ+,IFGqr?սձգձՋ}};CJOJQJ\^JaJ;CJOJQJ^JaJ>*CJOJQJ^JaJ;>*CJOJQJ^JaJCJOJQJ\^JaJ6CJOJQJ^JaJ<CJOJQJ^JaJCJOJQJ^JaJjCJOJQJU^JaJ j<CJOJQJU^JaJ1745  HI & F37$8$H$$*$9D[$\$a$$*$9D@&[$\$a$1$7$8$H$?@A`acdwxy9_xy345ABDElm-./KL 0I*սձձՋ}qCJH*OJQJ^JaJ>*CJOJQJ\^JaJ5CJOJQJ\^JaJCJOJQJ\^JaJ5CJOJQJ^JaJ>*CJOJQJ^JaJ6CJOJQJ^JaJ<CJOJQJ^JaJCJOJQJ^JaJjCJOJQJU^JaJ j<CJOJQJU^JaJ,HIJ~8\./ghi!"TUڻxfڻWHjSCJOJQJU^JaJj<CJOJQJU^JaJ#j;CJOJQJU^JaJ5CJOJQJ^JaJ5>*CJOJQJ^JaJB*CJOJQJ^JaJphCJOJQJ\^JaJ>*CJOJQJ\^JaJ0JCJOJQJ^JaJ#j:CJOJQJU^JaJjCJOJQJU^JaJCJH*OJQJ^JaJCJOJQJ^JaJO68+x[\ & Fn7$8$H$7$8$H$! & FR h[$\$^ ! & F^[$\$![$\$ & F323jkm!#$ST:;D4$d%d&d'd-D7$8$H$M NOPQ^ & Fm7$8$H$7$8$H$ & Fn7$8$H$D{|"1n{"_3p}4$d%d&d'd-D7$8$H$M NOPQ^UeprZZ[=>0Mzk`YJjCJOJQJU^JaJ OJQJ^JjOJQJU^JjCJOJQJU^JaJ#j|A CJOJQJUV^JaJjCJOJQJU^JaJCJOJQJ\^JaJ>*CJOJQJ\^JaJ5CJOJQJ\^JaJCJOJQJ]^JaJ6CJH*OJQJ^JaJ6CJOJQJ^JaJ>*CJOJQJ^JaJCJOJQJ^JaJXY{6Z[ & Fg & F3]]?/0uy'(78JK  & Fi & Fh[$\$uy!#$PQȼ蛭n`>*CJOJQJ\^JaJ#jfCJOJQJU^JaJ5CJOJQJ\^JaJ0JCJOJQJ^JaJ#j1eCJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ<CJOJQJ^JaJ#j<CJOJQJU^JaJCJOJQJ^JaJ>*CJOJQJ^JaJ 68STLMwxyڧڏNJ{i{\{{0JCJOJQJ^JaJ#jOgCJOJQJU^JaJjCJOJQJU^JaJCJaJ.j5CJOJQJU\^JaJmHnHu56CJ\]aJ(jCJOJQJU^JaJmHnHu<CJOJQJ^JaJ OJQJ^J5CJOJQJ\^JaJCJOJQJ^JaJCJOJQJ\^JaJ! DE,Vi6gMeSh^h & FT[$\$ & FjSUVWXYZ[\]^_`abce     ) pq^ & Fl & Fk  ()ghi<=>mnq()*+TƴƢƗtg[9CJOJQJ^JaJCJOJPJQJ^JaJ5>*CJOJQJ^JaJ OJQJ^J5CJOJQJ\^JaJ56CJ\]aJ#jrjCJOJQJU^JaJ#j9iCJOJQJU^JaJCJOJQJ^JaJ0JCJOJQJ^JaJjCJOJQJU^JaJ#j8hCJOJQJU^JaJq()*,TU    {|$*$9D@&[$\$a$$*$9D[$\$a$ & F2 & F2 IJO'*+MNOcdfg׶ȩל׊ȩxȩfȩ#jnCJOJQJU^JaJ#jnCJOJQJU^JaJ#jmCJOJQJU^JaJ0J'CJOJQJ^JaJ0JCJOJQJ^JaJ#jkCJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ5CJOJQJ\^JaJB*CJOJQJ^JaJph#NO*fpk~0 it01$7$8$H$^`001$7$8$H$^`01$7$8$H$,-WXYno123fgjkl:ٺٺ蚉}i}Wٺ}#j0sCJOJQJU^JaJ&jq>*CJOJQJU^JaJ>*CJOJQJ^JaJ j>*CJOJQJU^JaJ5CJOJQJ\^JaJ#jqCJOJQJU^JaJ0JCJOJQJ^JaJ#j1pCJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ5CJOJQJ^JaJ":;<z{~+,01yz{ ®š…t\Nt0J6CJOJQJ^JaJ/jx6B*CJOJQJU^JaJph3f 6B*CJOJQJ^JaJph3f)j6B*CJOJQJU^JaJph3f&jw>*CJOJQJU^JaJ&ju>*CJOJQJU^JaJ>*CJOJQJ^JaJ0JCJOJQJ^JaJ j>*CJOJQJU^JaJ&j}t>*CJOJQJU^JaJ tu&'(DEdeHI456٨ٖلr#j}CJOJQJU^JaJ#j|CJOJQJU^JaJ#j{CJOJQJU^JaJ#jzCJOJQJU^JaJ0JCJOJQJ^JaJ#jzCJOJQJU^JaJCJOJQJ^JaJjCJOJQJU^JaJ5CJOJQJ^JaJ)tFK 6`*+TEFm1$7$8$H$ & Fl & Fk01$7$8$H$^`06`()+<>QTU CDFmnʫٝʫyʫgʫ#jCJOJQJU^JaJ#jCJOJQJU^JaJ#j7CJOJQJU^JaJ5CJH*OJQJ^JaJ0JCJOJQJ^JaJ#j&CJOJQJU^JaJjCJOJQJU^JaJ5CJOJQJ^JaJCJOJQJ^JaJB*CJOJQJ^JaJph(L  !F""/##$h%%K& 0*$^`0 0^`0 00*$^`001$7$8$H$^`0 0*$^`0 0*$^`001$7$8$@&H$^`0Y    !!!!,"0"2"5"F"d"""""""#####y$$G%^%%% &:&&&&& ((R((()))**+&++,+-3-̽贪̏ 56CJOJQJ\]^JaJCJH*OJQJaJ>*CJOJQJaJCJOJQJaJ6>*CJOJQJ]^JaJ6CJOJQJ]^JaJ>*CJOJQJ]^JaJCJOJQJ^JaJ>*CJOJQJ^JaJ8K&'(()**/+,,<--k..//001\2033 0^`0$ 2`P.X( ` 0p@ "d&0^`001$7$8$H$^`0 h0*$^`03-~----T.Y.]......./////$000j112222333354e4444q55<6`6b6g7o7'8S8897:b:g:: ;;;?<Y<<<>.>>??@<@@CJH*OJQJ^JaJCJOJQJ\^JaJ>*CJOJQJ^JaJ6>*CJOJQJ]^JaJ6CJOJQJ]^JaJ>*CJOJQJ]^JaJCJOJQJ^JaJA3r456z7z89t:;;g<<;>&?@@TA(BBoCED$ 2`P.X( ` 0p@ "d&0^`001$7$8$H$^`0 $0^`0a$01$7$8$H$^`0@7AHAABpBB3CaCD:DDDDEvEE%F8FFF:G\G]GGGGGsH|H I4IVIIRJ{JJKKKNKKL9L~LLLLhMMO-OOOPPcQQRRR SBS`SSSZTyT U%UUUXVpV+WeWWWCJH*OJQJ^JaJ>*CJOJQJ]^JaJ>*CJOJQJ^JaJCJOJQJ^JaJMEDD EEDFFhGGH?IIJ+KKBL*MM7OOPQRS $0^`0a$$ 2`P.X( ` 0p@ "d&0^`001$7$8$H$^`0SlSTT1UU|VoWWXxYBZ[[T\]]r^3_9`` h0*$^`001$7$8$H$^`001$7$8$H$^`0WWWxXXHYlYZZZZ[[C\K\\\]]B^d^^^%`.`````.axa5bPbbbccccddee]ftfffffmggggghiij%jjjjckkkز̮ؠ>*CJOJQJ]^JaJ>*^J>*CJOJQJ\^JaJCJOJQJ\^JaJ>*CJOJQJ^JaJCJOJQJ^JaJ6>*CJOJQJ]^JaJ6CJOJQJ]^JaJ?`a[bbc ddfffg)h)i1jjtk4llm7nn0*$1$7$8$H$^`001$7$8$H$^`0 0^`0$ 2`P.X( ` 0p@ "d&0^`0kk l'lllXmmn.nnnoohpppp qqqGrfrrrrrwss't3tttt5uv+vvvwwwsxxxxDymyyyyzWzz{{{x{ص5CJOJQJ\^JaJCJOJQJ\^JaJB*CJOJQJ^JaJph3'>*@B*CJOJQJ\^JaJph!@B*CJOJQJ^JaJph>*CJOJQJ^JaJCJOJQJ^JaJ7noyp=qqrrsF۲>*CJH*OJQJ^JaJ>*CJKHOJQJ^JaJCJKHOJQJ^JaJ>*CJOJQJ^JaJCJOJQJ^JaJ>*CJOJQJ]^JaJFЀnUdX1$7$8$H$^`$ 2`P.X( ` 0p@ "d&0^`0 h0*$^`001$7$8$H$^`0U)ȑY ;Z7$8$H$@&01$7$8$@&H$^`0 0^`001$7$8$H$^`0;KԒ&.` =`b˜SjÞĞGfz֟ߣ<=´蚎B*CJOJQJ^JaJphCJOJQJ\^JaJ5CJOJQJ\^JaJ6CJOJQJ^JaJ5>*CJOJQJ^JaJ5CJOJQJ^JaJCJH*OJQJ^JaJ>*CJOJQJ]^JaJCJOJQJ^JaJ>*CJOJQJ^JaJ2!6Nl}~ݙEz{֚3`Û 7$8$H$˜̜k  žÞĞDEޣߣ@&@&01$7$8$@&H$^`07$8$H$<=fgҥ _ɦʦ˦'jA & F. & F- & F, X & F+=fgѥҥɦʦ˦&'@A#DEX{ŪƪSy\Ǭɬ)JdƮBxhڰHٲ:CJOJQJOJQJ CJOJQJ5CJOJQJ56OJQJ5CJOJQJ\^JaJ<CJOJQJ^JaJCJOJPJQJ^JaJCJOJQJ^JaJB*CJOJQJ^JaJph5CJOJQJ^JaJ8#$EWX{|ƪRSyz׫$*$9D@&[$\$a$$*$9D[$\$a$ & F1 & F0 & F/ X*+YZ[\JƮBTH 8^`8 & Fq^$*$9D@&[$\$a$$*$9D[$\$a$$*$9D@&[$\$a$ҳBlܴhص z<%A&vֹXstûĻ  QRp'(TUVopz{̳̱jCJU0JCJjCJU jCJUCJ5CJ55>*CJOJQJ^JaJCJOJQJ^JaJ5CJOJQJ^JaJ5CJOJQJ\^JaJ: CJOJQJ5CJOJQJ:CJOJQJ6lh ζж8:<%AB7$8$H$@&$ `*$9D[$\$a$` & Fq^&'vֹ Xstt}~ûĻ**@&@&7$8$H$4FZm~ԼռSν$78ab۾]kl*l|%&:Ut4p|}  M*MH|} ,cS* `2e5r&'h *  +,UV  ,-VWTkQ*Q>?2OnoEFVgh*hGde},fvw/0@QR*R{|6cdt2sY*Cx@z{BClm7[|*B?yzHh  @&]*NOPQRSp q$9FX$If$a$]@&]@&]`a=>lmn()*ABDE^3jCJUj7CJUCJH*0JjTCJUjiCJUCJj0JCJUj0JCJU55CJCJ0JCJ jCJU>+=ln$$Ifl0,"LL04 la$IfDEF^nun$$Ifl0,"LL04 la$If3JXe~@&n$$Ifl0,"LL04 la$If5678Ggr  az K`j$If$a$@&67UննՕrgՕU#jڌCJOJQJU^JaJCJOJQJ^JaJ 0JCJOJQJ^JaJmH sH #jCJOJQJU^JaJCJOJQJ^JaJmH sH #jCJOJQJU^JaJ0JCJOJQJ^JaJ#j CJOJQJU^JaJjCJOJQJU^JaJCJOJQJ^JaJ5>*5CJOJQJ^JaJ!',@Uj|| |$$IflFN 6$  N 0$    4 la$If#PQ{|}012IJLMN  LѴѢѓсo#j^CJOJQJU^JaJ#jCJOJQJU^JaJCJOJQJ^JaJmH sH #jCJOJQJU^JaJ#jɍCJOJQJU^JaJCJOJQJ^JaJCJOJQJ^JaJmH sH jCJOJQJU^JaJ 0JCJOJQJ^JaJmH sH +#8LKL  !$If$IfLMNaj+H\ |||||||||||||$If|$$IflFN 6$  N 0$    4 la\z   ,L^s$IfWX$TU:;jᯤyfPff+j CJOJQJU^JaJmH sH %jCJOJQJU^JaJmH sH CJH*OJQJ^JaJ0JCJOJQJ^JaJ#j CJOJQJU^JaJCJOJQJ^JaJCJOJQJ^JaJmH sH  0JCJOJQJ^JaJmH sH #jUCJOJQJU^JaJCJOJQJ^JaJmH sH jCJOJQJU^JaJ-AS |||||||||||||$If|$$IflFN 6$  N 0$    4 la$>O%7$Ifjkl #%<>2:ƻ5CJOJQJ\^JaJ OJQJ^JCJaJCJaJ0JmHnHu0J j0JUCJCJOJQJ^JaJCJOJQJ^JaJ0JCJOJQJ^JaJjCJOJQJU^JaJ#jCJOJQJU^JaJ5zpgagh]h&`#$ $@&]a$]|$$IflFN 6$  N 0$    4 la  ^#<2i$a$(;<AB\     8o $a$:;<AB\  78+,]^`abܿܚu<B*OJQJph<OJQJaJOJPJQJ^JaJ OJQJaJ<OJQJ^J <B*ph<B*CJ PJaJ phOJQJ^JaJ <OJQJ^J<OJQJ^JaJOJPJQJ^JaJOJQJ^JaJCJOJQJ^JaJ 6CJ$]CJaJCJaJ+ +,Ds$?Tj~?rT1K^_`ab $@&]a$,&P1h/R / =!"#8$8%+&P1h0/R = /!"#$%(&P1h/R / =!"#$h%DdWD  3 @@"?Dd?J  C &AVALOGOb36@\ / GlagWn6@\ / GlagPNG  IHDRUgAMA|QIDATxO6p ZhS(ktU^"v] : D"|9*cD~=!]xѽ;=u-dQyl1ϘgGOOoO=׫g>?*L>A&zWԍv]>F]!C~a}Œcd{a CPI,9 ^9mƬcKcWf yr6#[K53;._Œyff=S uTp%;,QjwaKK6MلCF}ծU)|3*f}ŠСS..=dY [b3TmW.+atDh-u~ٽncϼPms l+Ji#YtִKPu{%l TzlGS܊ b#uKn*vU v[o~UFb3OkܾF;nY/B l"+/"iAnYKmĬJ4 iΝ9=v?:ysVٝMlkGn.>)4Pn;5|NvӚ΅lk[jJl6ra1}wb lOԁVze\͡YiSɹZPzfm=y%峚5 ;u!3OѦ.V\lz蝲q1~|S!V N4Kݍm,f6 x.RpQ6d;(؎ۥdf]:¦sXݙYǬgc+5ҋb:3ŒPd ?/ߛ|AH(-sn<ق@;jl<6*(X#饖|.I&A#h[X:W3:y@+ٵ?D?bSF~٭ӾԖ},灕 Qx޻A(x?=dI8s)’l̦15ku&Z>k+G+7=j=~+e=@iD(ŁVr=nF])̺& C, MXìKVzw .- uade(]#)[ZK-Oc~JK{&5@d~X?q^wnZʑENסhݸꎄZv$ÅVمzI>X`':W Ж, % u1@fghhE(feK^ZTuWn=ْPZdco vGhiSt̊@`@'k#R䳁[;WM7gWm<l}sw}="IENDB`{DyK  _Toc29952424{DyK  _Toc29952424{DyK  _Toc29952425{DyK  _Toc29952425{DyK  _Toc29952426{DyK  _Toc29952426{DyK  _Toc29952427{DyK  _Toc29952427{DyK  _Toc29952428{DyK  _Toc29952428{DyK  _Toc29952429{DyK  _Toc29952429{DyK  _Toc29952430{DyK  _Toc29952430{DyK  _Toc29952431{DyK  _Toc29952431{DyK  _Toc29952432{DyK  _Toc29952432{DyK  _Toc29952433{DyK  _Toc29952433{DyK  _Toc29952434{DyK  _Toc29952434{DyK  _Toc29952435{DyK  _Toc29952435{DyK  _Toc29952436{DyK  _Toc29952436{DyK  _Toc29952437{DyK  _Toc29952437{DyK  _Toc29952438{DyK  _Toc29952438{DyK  _Toc29952439{DyK  _Toc29952439{DyK  _Toc29952440{DyK  _Toc29952440{DyK  _Toc29952441{DyK  _Toc29952441{DyK  _Toc29952442{DyK  _Toc29952442{DyK  _Toc29952443{DyK  _Toc29952443{DyK  _Toc29952444{DyK  _Toc29952444{DyK  _Toc29952445{DyK  _Toc29952445{DyK  _Toc29952446{DyK  _Toc29952446{DyK  _Toc29952447{DyK  _Toc29952447{DyK  _Toc29952448{DyK  _Toc29952448{DyK  _Toc29952449{DyK  _Toc29952449{DyK  _Toc29952450{DyK  _Toc29952450{DyK  _Toc29952451{DyK  _Toc29952451{DyK  _Toc29952452{DyK  _Toc29952452{DyK  _Toc29952453{DyK  _Toc29952453{DyK  _Toc29952454{DyK  _Toc29952454{DyK  _Toc29952455{DyK  _Toc29952455{DyK  _Toc29952456{DyK  _Toc29952456{DyK  _Toc29952457{DyK  _Toc29952457{DyK  _Toc29952458{DyK  _Toc29952458{DyK  _Toc29952459{DyK  _Toc29952459{DyK  _Toc29952460{DyK  _Toc29952460{DyK  _Toc29952461{DyK  _Toc29952461{DyK  _Toc29952462{DyK  _Toc29952462{DyK  _Toc29952463{DyK  _Toc29952463{DyK  _Toc29952464{DyK  _Toc29952464{DyK  _Toc29952465{DyK  _Toc29952465uDyK  appendix6uDyK  appendix7DyK www.vachronicpain.orgyK <http://www.vachronicpain.org/DyK www.vachronicpain.orgyK <http://www.vachronicpain.org/DyK 'http://vaww.oqp.med.va.gov/DEFAULT.aspyK Nhttp://vaww.oqp.med.va.gov/DEFAULT.aspuDyK  appendix1DyK www.vachronicpain.orgyK <http://www.vachronicpain.org/uDyK  appendix2uDyK  appendix3DyK http://WWW.jcaho.orgyK ,http://www.jcaho.org/uDyK  appendix4!DyK +http://mayuday.coh.org/Instruments/k&a.htmyK Vhttp://mayuday.coh.org/Instruments/k&a.htmuDyK  appendix5IDyK 5http://vaww.va.gov/pain_management/508FrameTest2.htmyK jhttp://vaww.va.gov/pain_management/508FrameTest2.htm!DyK +http://vista.med.va.gov/reminders/Pain.htmyK Vhttp://vista.med.va.gov/reminders/Pain.htmeDd:!E50  # AbUyӉ.a~ҝ2=HnUyӉ.a~ҝPNG  IHDR=C7sBIT3 sRGBOIDATx^=$IWE; ','TG(@(ZBO6ډGi'ja]'Y#pB704=",-#"3"yȊt77{3 @C |^oC @ |o^zS|j@ ݇wS!@ +UW>*?>Hq)sRLdߧ>O/>_|*ի?R>i'AO~d_)_|$.r̫O~R_dNǁ'㑘 ܻ3rD[? 6`ZDL80<'/#q99?'E'¸?R^rJ"M|q=.0t|.6șJoZw"S"GOq(ܪ828l>o_'ӫ?ix&-2߇18eƑP8_@{<8ixQmvL]|ӟx<̧?qpf+r y9ξu ZdǎyAB.xd9Z:;㱯5}yOe=2ΧCZi4VHIsoVOs#2ipp6C3sҗO1ի? WaT%Sx<F93qUNpC3ss<_*jwwibˇLx832q*3CqE_%y|>9cBɬ&FzxveKvs,2 -y4Ac93hu}gx5z\rͤSyǼ\|%c5/Uԛbf9+kn.܆fFL'ZG#q.Ruƞ=Pzz%YkFҾ9k C#0MeÈq-9c8 u̹Oc02^i5y&\G:c.㪌Ȭs{/Y4>k ez2OԱ YЗolx;% Yj\걼\_\$O%/=9?_.ZbKiJҿ&b: yqsqgH8SV7rު4.`wǼ|!vi$4FAӛ9k<ǓSOeF6qu̴3j2MFW יf>NE#mYcuYՔ:zeֻY=2Fi32ce$eĻ=ua5ٗ9S%JS+S7&sՌtV̈-=F ږ92:Z鯱jݗo~M_|>zkZۖȐuq{UFjo+m~WCj.q 71QnzzxQzx,7#;o%&9gq%2  |QnjMh3>sI@n]WG1]zۤx5WvΌ.xbx󭥹:b&kium~3Fҗ[WV⾜Κl:#\/6yە$lN/>~䗟tY J^^8n3,}YL;vamg`Q8fJǧ?q%hqgX>ԕZwit\ˑhH/9z~p^HlѣӊŻ~Y+q+JWS}9gC=!j1лߙݕ@Ϛqus]|]q.6هiJx_4c ( {++ܼ.n8֝{uEcܳ/\-q{ RsUdJ~%/7eWW~1&}x<p=gRKx;LZw?W/{.e~Żq^OMec١~>|_~]4Aw^KF(e}ݗ𩜗{tDzw#Oo3uQ7eiҮ6svc)nE6M x8ce3-3ŽLQ>ȑ !<ߖwV_k}^ϕ\!uvRff1.8obkkͱ\㉹35W?6+%w$up|Z+)Ot|{Yj9}20N߇lxi=edeeZ_ˌ;ec_.u!ަ=r<֕QLxqjz^zbhx`'2ǿM{u"f|&|gdha }yΠx0i׾̡ܪ+/no3MvJo|*^3 eĹrjn{I|}3sax3sDi2veǺa\/>ǽ c$ =6ye2ō{) |Os̴C/ar1U1>蠖,Avȿ}ݲ"TwW8({a}?{ww!z{{.]^zdYAL=KPe^w~6~JNxgϿ?}roA8 _K_w>5{u7хߴ>_A;\Wݦ8ٟ@z4{X_]_⚽溏5z#w{^iȰ"{K{4/d/Fp<.I7N4vn0\6 ECFo7ٵۿRz5˯˧|߆e_YG^E+咣UW]YiW߾^EqOe.W߼ :٥^˕zɵ?bUc=I|/s"f7;JwZFÛJ}7ꞇxZ}3Ž|:Xz]kʼ=?1f2Y 2b'>JzcׄƾqC'Y/o2YbGo;qޕE\׊kZL+xa_HqL%ӻ5l1%2NkXe\ѧizyv~_R5iڮv{Z;\ŧ5Z;eu<+˴">V;K~]/&];~1~Wp{~h04]{h׼vqNu]Gݩ]#c0轪Ǻ~u;NY|W{/G/_[};_4皽y:>ul׽ap\,f ӌ|su^1f]?~_*_e~ 9 7XHbȞeϺp&Zљ_ r2wau,\Vʵ)#/Xp{~9P/UR}50+1cܵRf9{/f]5X5܅rY#gknm^>o.4&û/? \Ws_VCnWӇE˱0y?[Jʧ?6\H^~YYT/WE3|*6]kҖa5]ed/p_ ņ;ط2{'iCn ~oRm*-t֗uR~kRg-yY>q>h|edrK.UǼ<3և\8 }x?󝃉 _wלʺz0:\k>pok~Mn~o3V ͕L4j:\/ -˼vM1*#IY׿iI[{7)}&=pZzrDZtGP];W9akE1jo]仗qx'ɮ<}~72o3oh+ xs_˽̧踯xrk^ss_q#{APz:;LWeC{-koic~d7ܕ%+!?>o~D·2FBr>ASXbut㱌GwovwY\̺od;N|: 5Muq7غq>o&l-ÇvE\d7xq^^i>{k~ݏw_ z];7Ur{_1pcp߳i샒5cлT˝X\n{Ðˣ}qd_5;+W޾կy:}R|~&..^i>R7ç{ZCU\2Wu].6_Z]W1/qdxo_n]^u|z">]&ͪ.)3hV~9c˧]Rr]5Wzz':j7cf/w"$:O]Ak${\~9b+n~,"LPCh~qVdaȕU"SDp8jwK=oFiD<«V׻\sZ}4Y=nD1ܦgN3:o|='so 'ޅҕ=ί'<'o¸"0{s,gE@t,yOx8rSn?4 '|zVF>=2XOg|^Ϯ4<'y\A>TJW9X"J^|OOPz{|p3D9y|8!O?4cԗ݅H$~eF DH"=ʎB2n-D!&I{Uu93Ae:>mm|2c}"yhPA6}ͥ|H٣Rƌx+gƻTML[Cy:~3yxЧy}ox}UsQfA>wVownJ =I=rPriL()+]燌Yse.au\e_ {e]'/TOdܼ_ٽ'/凡_^I$w,5pzcPz?p2k~CvEz5=|/ v _u+boy<}͹^2qxlaԸ=fy;7ɮ|7̤&yx.s~Z5O6G2u~CT~7--MW~ 5t\<_1Ixxh?MX)x;r5/{S+>+rUt=!:ͱp=l3Axl zfWsf8K0u!*K=-ʷW̆4]]{Ȧ.sqk7&h]/9FPǓw׻ LW8JtE2O};Z|]{Db_}>8cCG>Gp9S,՞WOK/Oc`y<{&=]('ޥOvO0X2gJ!Mi99gybMs2^zFY;3qZ;L3&{܁v1 itony9t^_si\#sgyn֗ϰ4kZz>o4 몶9N.:U{}roͧǜҞwLP|X˥OfI2r.'OֵLq\xxl-m~V-ϡ> T_mؾ_ϱnfOܙg&{ͯWƫT5ZidӒh?!;ԽgO\_$] 1_^ߌWǫsJu_s6{p_q!x{ͣ͏2~5f^7Ou֤YRJ+25iy_Sooo/:_ˇVj´ٸq+ݙ4m_'M7|Su\r 7#5{Ts{?^获zq]|Wb{kź\1q_ZΓ٫hV'd޸uiPxco \?FnϗT=\Ӿp;3Ӻ|"ܮz;eʽE9O+׼^` RphyykFQ'~~zyެOYs<*iT8ۛzwne{c%})5?}?Ӝ"l7 rsOjJE_~7kF|YR23ߴe8AnƷ6>XG+Aqb>>R}8>{r;+ɋ=WfWY| ~nUĬo`[r2*^cP0sMLN "+N<&v^W;pY*oϏw'^gj"E;{een>2rzX۝}|/OJA>.{鳱ed,u/ל$go#nw 9ˮk9E Lqq_X喝^ 5O}sݑX[auFDoVOܪۙ˳+|Dr_D? #x,_mGxٱ,2'_7v1qp\6=R.0#5JҮ|{>j~s\6xev\q9/Tǧ/QWz&{ͳ={͓_v\qC_>ey3jӹsOWG5?Y'b7{d@15G-@ @` ܆=X @Aݗ>~1$pp{D/ @&?[|@ <'7晧>' @c ??C @`$PL=1 + @V!Pk>JHؒcVQ! @x*B @`k57[ h)y24=.A3ӱ޺c:tD_yIZ*K";sYã ݣ͝|ii}پ錥h[wl&P)܌h0&hWZ4V;asyeJ-N:FT)5εi2;eH;mt$nmndO%ʧ$ӆo%sˬTҏ.r%M6Tdu[zFRfi ;<1o[ԳzCVZ]g%W:sq"K{Dv(. ZջL#@?<997S% UQi~^,Sۥdv,:kuʬLfZnWKIR3IM% GT/l $ ͔Nw,A%;ִ4HY]Mҳ c]}Qac i g*MW_Ʈ[CY5Y=WwJzJ4sΥ+-"O tɪ%)mWGF*u=V4GE|.Bק ̒[8C5<8ٹ yYXfJ$f|d%,+ K%Ր`Kِ_y)@]a~o}@WR>ۋ@*_w*@\Yj| ճuK磁>k^\#zճzZ̈C idWS?Ůg[(]RY %›8 :Rq548~JD)݊Q@ ND'p L! @uM @Sc!@K|A3@ "@jTX@  5߯o  @?1 @`H4 @x*On @/R @Sc!@K|A3@ "@jTX@  5߯o  @?1 @`H4 @x*On @/R @@15݇o B @`;!F_z gҰ~H @Y DyxcC忳.@ <&{?g?DzL+$R^ZT:l}aug+X)Y9JMhujzU\-ŃߨJ lǾfZ]M8P)ݱ$~fyH`\D9fۚ%6LVH$PͥΦVwbAKFP}rTi43;r!KL[wn ӥ=zu2:$~2!&saVZsMϗ.rW,Xp9ܯ|(.}蒦UsȪSsTi{junT.4?KOg9UUzg)eU=P4*\evh4AMR%\-H*~3}fhUL{2ZũUHk*_7Ӄ.i myH~3E]*`7kBˣ|;K,;+ⵒ`BYqY)*Mf:.5ˎBZs al\ ,^;gVN |i& H`|I&cq<5h*SfY[N"Sh(61T&YK@<8wX"v+? q\C.6fi>Yq*Ct֕s!jkVuOpR WJԊlVcK-JˋX+3Pld[߂6LA=g֛mYHhmٔn>~-MJ2P*/$sV[>T.fG/^"!@މ%3­Fg't5tƍҨ%C>&JSuZ>U>)ETX ~ʳ⦒!dW)U蚅tVRVȫ˪=je+6!׻ap6lY*m1mΎxg5JWؓف-ʬux@hSD5_95Q:حZr8AE$ph?NGP q H~ngj~g.e;kEsvErW@@75<¶O1@ @oj8@ @`SQjZ6 @8+Rz @F`C]@  5?g  @`H0ԅ @8+Rz @F`C]@  5?g  @`H0ԅ @8+Rz @F`C]@  5?g  @`H0ԅ @8+Rz @F`C]@  5?g  @`H0ԅ @8+Rz @FC73u!@ W!Ǡa_z gW  @% -?k"A @ko>/))zUۛjL_&VYaus[Ig]>MUV`՝7b@{ ~j6Ȗ=&*u֨J$:4ҸD剾g  @3аռ(rTggh)3a.Llڒ2Ѧd[2VfI4Iپ$L-E%tNEɺC2cukVl04,UiQPi:WlOy:uYJMt+];smi˒J]@xN~"N %UL4]iY]DI*&DB*e9*w6){GCiz] 0Q [ 2"zŨZQiW) } |%W]Y9㯔upSuM5ֆJW"a놚zѨRCLݛY}f5䪠O=jAXCK4Y KuӓU4"*bbX%EWO)tɼM"0koEYf-9S8 g,pz&J4V G~TjTdM=J$W͑!jǛY3@ >) %mhY?5ӼQqJAI=4 '!0cyHo=K'uO3K;mmG@?d;7xg @q<B)F@ @ "8@ @`S36l!@ Kl7OĻ @8(R:!@Fl@  5?P @lHQ @8(R:!@Fl@  5?P @lHQ @8(R:!@Fl@  5?P @lHQ @8(R:!@Fl@  5?P @lHQ @8(R:!@Fl@  5?P @l^|eK8#V~\=3 qʯTҶjEZX9Y/M=y @x4(Kmj3]Q(k4:dJEW R2͹RvC < -Gkw&'4j3r{TImexgEA @`E=ybyՅ@OIܓ"Fa@ SsɃf=WQ|ҬnSiV d-+ @X@;5[GBۺ۹",jKnu @Fj6gcoZ_ -я>#U-i۲ F, @Jj7O @ 7ON $C @^sA @w @j~4@ 6R6#J@ @H& @ &ajj+B @ <7MRs_zїynX@ SsM67 @ @ K`\ im/>3UEi>ZX$AZ)yXbխ^} 1@vB`\̣\Lg%qI,~ nGG6PLd?L@oΖ4Мt>m=Σ e @!:̵B̾<'yxϚ*s䅪37Ӓi+kPIOۖ-Sj{̏d*@ΑO# odTJ\ $*lGVg-RiYc<=I!3Uf6{TH˧>r)s!##BC wG9zyOٗl(&͓uEIJ"^d/ZIf/olVGg ì;-fC^=멦^3+LT=a~oK1;<1Ƨ33,  @Q| - %הWSrsO%8Kj^Ԗ.HSZ~ȕJ[4lfE<Jf d)Jley}fJ-M8$ÞS*TUVUDz(\2J&̈RӐdH7iHYr\IJP(e#Dd5wg*ȺJfWl멍*3{l4 v3=s2qdԳ%7w#ԅ @){5Il_ї[lMjiF7a?ۥ  XCa @ pU-F& @M`;A @`;۱E2 @f05wQ ( @ $Ij.W/3OI!@ "~jIOrt"v @X?5t!- 뷝ֻSuﺜN"ykw, 4JҖ wDԀ @`k+dbܵpw`W$'I4`}F۴UZQUT7엙REmgVlrGi,Y)iɬMo~!!@X@ȡ]<&[ҦQ+mźzֳշ|_%A 3);JfzV 7U3=a36 @8#= Tڹߐ]ĵʗ,rژ}GY,iN5d  ˾@o)nR#ۈk/i[V I%hvT7tGV󭁔mZo6D@J` -Bnp`)+ͣ.ڇ6յvym(M4YeJY$l힍(fVTȖJѕXMѰfeFM (0ftAm@l\t3=ӧjOg?M @{&p!)+3{dٵo;K~q@@[%$')sLZk@Nn"B @&ajޭ!@ H͟ @ G{ :A C  SG_;"* @8Uj.W/3 @O<&??O_ 4 @xrIő!- ?|lL}EbG4ӶuMStTY>wlZgfITERNvSM-)Q?jew2x Y4,'p\̣\" ܦ}9@?5R[BԘ ͛j4w@q)9=8TYla9X hS2pBD~d'_w,\h,<e,+(aQ9yey;=:$ջWR YR}DWvVofMI4t4WZ_X6lE,%9i)&ޗO=2JVwDWT%l6iɒ|#lu/wǒPݩ?>K6Gkb;5eFѕy.n[wgzZYaT tqZT z0D\2 " 52)iY[K{9+J#mVTF;J^ζ ~|=|G_ ><7z,QfetPO5̢Y YwV:6&C[ ;dw^Ț~vi>gs-x;vRFrrvnnN}T\]O{DSf}Шv7Xjg3#HDxgimXF* %3K!]o=` "gq*2MTp_;?s-Y]<.5u>U@o$ZVw@,/,Htryιva9D¬pK,WiJCg:W"ROݬيH; ߣte()zǩSJ1DHSUxz`m6J;W@+'{Kg)0 B?9uxGbn{æ;p`w¾iJ] umDZ p<߿~:uj}7K%"Ly C8̒Ϧe UZrf/%Dχ!]V lE dI糅jif]',d7R vr1ٜ>).e2KY@:B*8ɆHO_^h.vt陨xmȶ=εWW>YJʗ4,JI;DǪRAnfbF?j:QW ҒVB4'm1YDOG{jx38 uGYW 8ДY|*mfsIY=$>wdg:4 φ:v=곶F]m"Q,\7g ٮ=+S|0~@Q@ 'p\2^%g @8暔l$G!@yRscH˭C%}/S__ؿz_;YbC[Bf뵎状7{tGhcBKK:<ЮU[4; wTYHG[B}ffTSyT 9Ij.KQ^.%.m({-ƨ[l}alMT5.LFgm-hۍCCJ$w\G{jn/e!>`p*Gc2M%;&)@t,67B3}SuXT5ԗF|g5ϦuIͥd'ýٓ,FDjV`i񎧻.njژTHkX$gDZX꣊;J2f*ݾR#62;hg=מN0IOe?DK@%?kXqbkΘh`ݹ4%i{e+ɳ3f?欑!5jV;Qqiæ3.nXhs- Zg&iRZ,I/d9J2s3btPoENm p9S4UT4D Y)ѧYTl-߬E kJٌ%'~R폞iGK5C1-5iQsL=`idn1cKL6M²ߛV O$;wRU&2Y۪!`ttqha̎MungsHuZaA=vdB^eڭ Mğ0u67өԹ*%SObܠuX(ֆ1۟{gbǧΘLUxUB l6^6gm(SzTQuE 6XH|!KuZw\8BQ {Z9j q([h}o,iSYVHaBUڢ\IfiSusPl#OUjAy ږ,5Q)Y5Dv8֏c&cmt>D7r2Tyz :r=˪4@-4١'sMpыKÚL2Xec2yf`Dj*dNq~TEz%tM%s 3FODQ {廾\eJ R/ҡ9 aRYiz%uaeU^ꢑTEef褷4]\Pϭ+KA2Y'TPChjb{5Xɴݶdfw4!gʒ׻,=j4s"MZ(ҊVRe$seVtΠRZiQ^+5gCK|vDejْQ%57u|@i:Qd b]TX҆fn{qNJќ3K*-%-ÅVR2(fU/wNUVWx3;+}`UdIuE٠3XR{'@j>CaWd3ş)* tԕ񱣢䜔JIbڴ-<tj,fQ)MPtH._=zRvijQZkltM=AnH %<DdIfZئٓفXNfΧKխh6*%~"Kg9TI#\:8rGT4G336A%=-1?ӣeYB\L"K8ў,U)A$,GyK]8[E&LMMu4vaC {4\8yXL`XW=TrF2TZޏ`}fv!y0տۢ}=;H@o @兑]8X(* zQ8k{P B Ќ%-sOfYA aQYWwHp+̻B};y65:Kj.%?$v۩qnXGÜVᶹJ+VHI̊UV1<^NYBWZvkx iiH[CqɆwDZ6JgU@:O#Jy:ȬX, ƐY>.o#6bE(ڳ@)l*Ei⡢g~jf)؝ "f$_DNA8)K̎NF}!tYKCe|8#9d7+5$InjXv%U"+OiъbJok=gm{T9_y:@w,t Ņ7R[kZW_4bzl!;2+f6ݱ\U$4\+:LU|_rR77Y+G*9mnfKS:3qiFU%ۭkfU#3&y%ZEMɧ-3H`X`u3l'+;¤ gO+xH#'K֝CPpۅKf/+2J}yza ,R3~6tX*c]icotPѧe lO5rh8L58g(:g p6'53=@D*u=)* !uOOe,o ; X15?Ɇrپ/9uTPQrP.ߢQdB %<,=s$^83#JmzRj}`4KyBy,}lD: g&p݉ @%@j~\ߡ9 @ʝ@ p\C ܉1 @%@j"m-Ȅzo}̣y=7[?%4Z[¡i@XH<Pn(7J[w,~qm VZ0DfU,5.nTHUtnG@(@^=BT "}Mv큤P2Ozmct^ZI[Qi]U&bMg-YA Jٓ}*ٔ(t/˓R9= Β"wV>`vm0DДPqG ]idOv 3.8(@0]c.Ã2b ye2lgbcJ|e̩LMhD*SJi&IKRϨʡRugKF'=iB% e}ڴT=RQfV]GT>~s{\S\w}&Z @9_g-H4Kq֝ɔe´JVRtilC9EzΪ^<"v *o)㺡X Y3K;,(~J1@xEG9G"K= iMi[دS6橍z2zS%wf ݎ~TRtiQZ!Mw.ԳwV @`ВN65WV)\.k6i[ֳh5dge6ʹg)9x,* UrV^d΍yQ'^Y*GV̎>PPCZN)uSzvl*ճi{qs0Tn P!Fr_n /fQf^7O6v՗{M@ ''$)~ʆ)Ss\Dٓ~V7T)I̬!A~Ċ] Iݶ=WcauC x{(Q @ 51 @ @CC2 @؜i @J @H7GL @ 5P  @6'@j9b @e @ 9R @<H=(@ o @ !@jD@ lN|s4@ Rs%@ @`s#@ x{(Q @ 51 @ @CC2 @؜ S}h @+8Uj.W/3+B  @6$p\͟o>!BDC @` IͅFH-C 6zo;֥N鳝@>MC^p څltENh+bvXQʼn{tH8ʐ-2_[$,Gy?~1pBni8ŮҨGۅ -pŞiYf)?K(K6zdngʣISK 8|Kll[,,*6wlW տۢf>C굖G'ph2M`M%.O$Tq\\iV%y H[YfTƒ|g5ϦAR2cuF\G!el ))[ĺTҙTJ4ճⵦV>JTDqbcFPJ㺣b'fO!"2dwz02S`"uJQ$!m%;zf hTCz֏4&gY}syx%e4)VW4G),vҊQnMVʌzC6L%෽־8%F])ö9=ݢJvnǐg6lJTQI4Jzh˙:p:7ykMSgoZ)*hVN{f}O${"S!<%L3; dCKWqƊLj*\X٢[C%|@fٞ s{) Y2nQV ʘ[֭`i*s\2G ݞ?R[|Pf -I_I=3K ApZ@:Gzއ}Zy*cV gO2vVG[15?Ɇrپ/93 n~Ra,E=xy,%>O߉0C៵SI@ [5(@ Nɀj @R8 @ 9Q@ ] 5߅P @HܣnvS{d }J-g5iQw\IյP"g;%6WˉNs:;lXv$OGh, ԞXLw_{exPT B^z!5ϸ 5m QNh͓Ɩ,NZYPtQ/ͬ̊푱:FWYۭC+rI\rJYGΊ:zssI(4>>eǺ4MddQgM9ݧTӾY2E49b= n,2Z+5gCK us!G&y-fCgenvns^4KY-f5#=jV YExӺ$KJ-WO3 ӇbYO hXUtdѐ^XҔ1;wۊYUIK-?`(C拜"Í Z\ymz_dUd|kTjm/e%e Xa'5=j50 @` o>g @!ᶛ/_xռx@ @`?Ԝq @ <5Rv?C ~|& @OMݏ @!aj~g& @'MRs_%g @ 暔l$G6{p9:@ rkp|nRABwݹE[[zZrn[#7}YOfOjA 5SsY2׼'6 K 璸gO`.购RZ*0ۡJʭI7aG͜ە(@X95d5)׃R$zi=n%>%%m٥MϪigIbTJeR8޴Kў-qIouVN/*<i$ @Dy溭%w^q,i$[t}×K=TOIOygsV ;u^"R~4+Q״z,3mlt1 @X95_rGQ_22! HWy*C kԭHHk5ezޡL@/%ZKK(5k|T:P >+oh J=-!AEs$M#t#JT8*=r dmyZF+WN"=JFW;Z%2<0m(뗙K+(KƉ?bTHJ̤~lвǶ/,wKꎾZ XkRnK^ecHлc[sbGou}2BQ 5ݥdBAn^Z8=W}|Z[J+ҭyxg;=kydng'%^"=4(@ݥC%HK+iu+A-LmkzhźVMV*{+L{XV:9]f,)E%=SscOY+l~Y., = ԳڷJUШjQ>=( ъ\* +3|Zi6Y/jk퍎lT,A5Zل\Qт+^&`h~V 䒞Hvv^T[] O)_VH xh1*dMY!Lhf5,)o} _oigLΒC1PqspO۝ѸΦ)@XN`wZ~_~V_2!W邤I+Y2ʟVwf!ATS4,To6)iK+.Da $|E~}[i(KfwX?FJB& -@HÁŧlbfXQjԽQ(]VJIf=T+dz"dOfS^HK Kf!g<.:++,h6nKqh>Rdm8-uU;5nv&G[CY eyp$vOyz=]$r*.T.dEu@VLwEx\KlA! +ͯ+sPB<*Iu@v=o_Q5}>>Ԃ SDa@ t 5FGE@ I|MȂ @@7]궐 @8撑|/9s( @ {L5)InBa-U @ [{LVH-,6K\wZ\n~}`dm?7ϣ=!@RsY2r-,sJ.wz͕Oݑ tU-Py6%t kmgQ%8KFydngd:Y  lJu% HZ=Yv+jnZI̓|IK'G.vE3S[5,"VFE"=EY"KJ2Sm+B RҊYRn= 5N "A>޶RjwvUl': l*;E<5r_ͤKiFͨzVӶzEJFs͒Y3W$ @]3@ @EԼE!@ pwL# @h 5os@ ܅]0 @ZH[ @w!@j~4@ R!> @]3@ @EԼE!@ pwL# @h 5os@ ܅]0 @ZH[ @w!@j~4@ R!> @]ĩ. @ pCu|p@ @n$݇^nRi@C @Ԝ @vA|n@ @ ל @c|o~6k}j @ g"2r噜 @;&ohR^x}Vl h<o22;~EBأPV3(ljg6F$9: ijgZdd?vB =0/!Q@ ל @. (@ 3}qTr߉QɴbE<>%'fB!NT TssX7Y=|le8Xj_Lk|!r7^#KSj@ZZҲ\&Vq`v*_*i3`cgd`CG}L:+}|n+!B"'n3nGw=<DgGA_9)g̴_F>nE!Qj}*ިUlϵ'l(qVz[]Dsf"2p[dKzsFMtOgKěNߟyhP?v3R+J @xԜo' @}.o1~gyY8xG @x{K.IxeV@sE[\T,}er%@K ܭrPW@@ $0;56;o9by_|/(6ڝou"nP+(@ \9F&E#E  @'#NKمsI*IXZIdؓL_$6\l$i"t,PYa _,ý @`Z ZْM)T{F|ѳ5eXm"#u~ZNPOdP  =敼|I]S${Iveu⛦n+sE5u _~K"g. C c,@pG`Q>% D, @8.Ɔ8ΒݛT><2$;+ 3h G9,iPْMDezfzb#뤭,|?F,POL)@DKYx;tCIxvDYYJgR華&zӒV%s;Au8L][ @Z\Z! @( 5'6 @ pJ@ @Ԝ @. (@ Rsb @ @j 7 @H͉@ .܀ @ 5' @ pJ@ @Ԝ @. (@ Rsb @ @j 7 @H͉@ .܀ @ 5' @ pJ@ @Ԝ @. (@ Rsb @ @j 7 @H͉@ .܀ @ 5' @ pJ@ @o>~1_  @ ){W/qji @.gRp R @ȎLj~7 h @P3PB @ @j 7 @32),8Lh׾fM ϲ"*jRB@ |yznp444Vd 9yR  @yH"CRK*yD3 @ V%;Zk궀ߐ*Qt^> oNH4P$z)iR1SEdFQ @jʪk󚘦MVZ8jBlYUpϗM BY&/ @3(37#%m\ZrYMķj^kޱО8Kjə%d.gC @jmmi}]( )(τӟZ @$pn.o[+ޛr4 2MVl @':do>]eZhw-ҊG# -ꖪ*UQ@iM!jfv%P2*q e @Kw^zڦQB,O@ E@RnhYKu@ @|HGzx>c @~h@ H͟@ ]QM @ @jL @ ^6PIENDB`Dd:(EE0  # Ab:-!:V֕>Hn-!:V֕>PNG  IHDRKQsBIT3 sRGBIDATx^,Ia14h4fk̓d!NIn fJyyyJ"M|q;0 |Wl3"DBDP5#q`(q}Ѿӟތ>k_Ic0տ1a<FB&cx|dqDn:ܗxa5f>Û[_ u"aϡbNOX5_ib˯2O\ s%\3,rȹ_25O޺;bBɬ&Ү {+3_@Gcɰo-#ВK3!/juw,gZ3r<Ժz<Èyˁ4Gs̢o#Eɱ҆J%;mQCͱDȶeglRr7i#QAژ л:k^xj8ck/Tx,^jUzטx fF,G ZG۱q.RuŞ=Pvz#YkFҾ9[\MZl[Gj9ֿh/3pF[xq&icxsdJe56ǷoXrqWeDGfkeLV5f̵0zߎUS#u(/%/rR{lx;%_~zge2rͪRFrq{|;s7o72qm["C^!;WCs۱<^c07ÐO\{\jvyZu0^&Ypk};Br\zj%hkK:Tֹj/9k=(۸C;!'"nAn~3|Z/UxXG7b(Xq\ֳ91pX_#E;!~x;/Y?1\/QYjZ5^~Wr))f5.ȝ|~ߗ+?=kR5r<복t|?/WuwY/5_ ?{7f{oܬk29zom= ѵ۷o?W>UNjW_ko\SsyD}Hzڋċҋc=rPZb aƽ7(a`gh>d4oB԰'}x?]tnUָ_e93_w#ûo-,ԝ{0qյaH}hwJ__YQr;kxw4+Iٜ^|t}g?.AZ+}/qN:l V4j>[7?O>O? ǗRWZWr;0K9l~~_EֆeJyˢՔp_vls942WrN_+g;[hʼ~j9V7}őwjnSt81}Zv\Ua9̀{Bѽe/+o+Þ=tpƑ W3@J̓V+ejhZ2_oߗ]ݗC~8a^~s&; 弔սtͤzauRv^/~xw3/+qU[Xvv:Wv^2B)s~9~*e^~zDzw#_ψf:k?52ݤoJvE!3{eOQv+*-0g̱}xeUء֘)Jy?9r]!îj ϿיHᶿ\gwa(e챑3'w~u}--?[9^s٩cǿRrkĵ__k^^iӚX&,e#m Qq8Ƶa*y\Sam|(##W6c;_?%K:8VkfE~=Y3:92qJ_~sp~Ǵ[/qnՕ sC&;Ow3 ;mqnx۟C%f _ߍj͡*$c]Xw]; )s{=?{W/ /d]AH757Ǘ|o8iw G2iWa\NVj$)׷-+KNtO/^>l5]m^s~^o~xrWzdYA,=KTe^/Ͽҿi>kpϿJ%]_~ROJR.ӯ҆8amSgZw]>kێw5U1%5VWחf#g9{ͯ=H_{^qܾaE3e_Mu]~15Ò$~|1ɔͽՆY;JǏ?]K̡J!X *+>|?m:\uU]R.9\|uX/w"M^Eq[e./>~W+tp=^u\;ĸ*1]J~g[$uH[u}5rY){ֿӮn%涒:"+a8W_{\Waqm X>Zz[kɼ??1/]exd8Xo%%&GO|TWw\={]- bpgeh<+zo=ovcpr{Wr[+kEfL^2s=ƴq^>]^>սS&qڹ:v>ղ}%këX/ou_u|\墝·3u>*fvuY/2/NR߭˯qSKYݾ+?m04zh׼va.u]Gݩ]#cu{Uݎu;F^~\R|_Əf_$fwXk0Z^s.Y6,c:~_*7Zz&eiLgn%O5 r%筄tF?i,??^~|K+m.4._^IH}YMO]MdK|ïu嗕drU$yy:cKʧRzݦXC-_ڒ<˒?-/iľ+i*Io{<&)/+.նҢ]Ak}YGO+嗺&u֒UrLru?OYt5)YaiLTӔ5ܬ_G'9{ͯ:vیgns%6]5ﮗKMC2o.?dedy:)xI3wy^Z3; u;JڹI)֡e,_>577=S3;TQ9ut_=Vfǒp];Oɺݑ,dŊzY3i׸x3f=roRC[ u,Fx.=Eu)}\M׊bP)]u^{;v]Yk>|yG[edzcqk}/2=˹9{k}͇cf -RNj\2?\5 -lIi[oҎLO3n+KVWV/|#r>1OiF?q-vYG7=xv*nwzˬ+F}ryʧt^tYO/ͭ_|6jgki>+|$)_V{ v9{x5gm?}eXgvWq=^k~Ǖ{.(Jnk>ܛZ_/zjVoz:G>[ ]IMIU]RUZA^>>v۪;Awk5x81|z9Fr/jݱޏE$ܞ wl1nߊ<JdK\mnޓzvk6h{/M$#iuͿz?wL1&Lm}&Xpy~8νYƞr>.E q~{}v}S{s@{զoc}hLP3O[ zݱ><4OdR^FB}VQqwQmQw)ca3]㑡V[}s'5O7%oj.ʌ;ȯ{E[+W;\K I=rTrqL*)+]^}͇׌Yse.iu\^s95ut9=y5ʼ}φ鞉k7r^~zDq^swk?nH'˽>dW͍_d^sS'ko=]1o:_<{k^yvr{/sk~E8_=jXU׼_n2]g&yp.s~\5ʏ6g2u~Chen[[TvOk~wwTkrlyy$Yaiisˏ?7izĻ?Z\~OwwrEbgXnDz3dX;ֻ^bOs >LPkr6g5\`|=vIn5dr[eqx2 Uev:PW2ܳE6=ww=(DݰECrm|qcdʽEZ~<ʹ}{x3^Yz/xX-'7eo:VkoNܟ3Bzyi9gyrM=rC_8_{&9A%w`_ -w4v>k{^p֗{. kCvnmܾCyf}Y;)A~UYXWuxwBhO˛{xoևҞ,LP|X˥OfI2z.'Oֵ홠XcG[[Vϡ> T_uھR?r%5׹g&{ow_=y_۳gPͽ<תM#˅GpGc65=_C΋QR_hko4J]bI{=_P|pSʏӡwuDfǹ]5rw>Ȕ{|s\/W蹯ys=0`ӿ nRx&|O8~z~j9~tTM;ݱs |}_}͏z_O_u[/";GR7W}әQwf79,5 3ƽ(!?|ks냍}>q/ iٓ/ontY!O^72wS}I8*^ cٵve\{ύ, "+N<.^W ;pYw'f f"E;{2{Q"^,vǿ>Rˏe{mo~ ؝rM= e*Ώ\:Fc/bnp c4م"'Iv7xޞ:]b~+po۬}r=F^k~|Se|Gs\5wy{0썇5o|^nv՝sWG5?['bknjj>O @ % -K`@ <SjIR7ro~}5  @ؚ@ gwGZ'C @Dž_|nW͝ @Rx+nszi @Hw 9@ ] 5߅P @ @%~i1 @ %`3nvNjI@ $ Ow[ LT @H4@ $@j> @ P#7#?kZiKzhzRQ**C:e@ @`=Elj>8 @ S[V&5' @ &!E Y @( DTԜ @SL@vP9_Q#j%ڜdU(D: @YW5OvXZ{%gt(egŮL)>YE.{VY; @M`J)F$b KgQmetF, @+(q >n q%%'/D @5KFws詮'݊6nkT! @K`Usu$nx%pq*nH딁 @@&l؞Ɏeq"G7~Zmk.q @ @%0{ռuDXC @3D$Vop޿y %@ 'y C <&{8m@ @\X5?? @X5?P @\j~gs@ T k\2_з @8=kRyI#@@ "U>ᝥoɝ ey2gmKlY]!ܱK\u7BOcW!@j.KY^.咸I,ډ~ nVDfDu]f%Y]`xRْ@9OH(C@Wߦ6{@ٷ'TKT%/Ttќ<_,[ mP^3؆jzڶlZܫf~&Su|x33muդmRj&Vd=ڵHƺ<#mI>/Bf,n/}tSnH]@SWmn,YS,G2)3Z2K7,+jj7Ľh'EXM ]w-}]T[Qe[^^Nd0]wQO/3uOOi @$;OdK%NkʻJwO%KNj^֖.LZPٵ%g+oD7`Y*S^;WyNR QVN}_nMt&2oA\|:k"rVT3]vɠb6n1K󪯅z;k7 -( @#Q&%^ $/-<+Y&LvnŶX&nWH\lݜ,䪔hHWlu(lh$ݰZn(GAt53K3ۻ Y f6,p/j=l !@5$)YxyfE'*/M,Qo/h @*"ٹ͒3@W""@rf;-$X'M`jA @`jܒJm?RN֝r^;׭ݱ$l`I[6K4܉Q ˒o/AUtMJz\՞d^ҾN 6sIxwfj<B{6t @@ ^5_C65פ'F]w%XѬuJ+Zf/?JJ3n5ҕrGe,Y%eI̮7yj)6 @Wmn,YSx㖴iqVF؊m[l/qR]/4w[펚 ]c̈Sz !@/H ',{nk}#Kײ% KE\R͢8 yO\6ڭTk[@_XkZ @$/@}_[Y-B\n frnCoɻIۢ2Uj2ʜW=WZ6D@K`/{Q&%^ $Tm{,: UPhk[ŬQMvYmvFƳgZf<{ЌpMypy|TF!抢t #@*5c$)Yxyf_MH7w5 O5(@x Hv.i3?BԀ\[lȔeyC^-]ӈ+ B ?b5FqU,㾖iMD @oj? @ jp@ W&+{!@vDU9U @^}l @Vw T @xeWߦ{e:? Ӎ_@ |g5 ?iaR_L[@ |LIixHveK^5/)1 @x$Y/y$/eIȇ?ȡG: @O`^sRB <@pռTn-@ `SG<B HFv[Y@ pf?kMI%9zp9  @`OX5rNUcXHޞ_SwT|ZƧ%^`egRR;Q FG%\fI/!Zyn7+G(ۥoMGRB9_Yyw.'+ .f`QWCi=caGu2jӡS%ϲ/P#OHmLIfuhhӘj1yA7zGճH.uMgd:ci٦nNp=turnkOry Jyk-Dd %qY{VYr7&r(oDH׵2G4pR0M29uޕ P'tvk^Zl :ﬕvqaƳQwPd. Pѐ25o~ne{nFD@L0ˬ W]ٴ ߙ:V_kZ$`X2d7Btw;ByHW5Oυ@iӽ*u, I[xֻfU'?RS,q= 1II@fUndCK2>}tyI z7Q’lRs #T9Zu[ܼj[k%SJB.ץj*ufVyۖ6JPWR+G5JōI߅lRF-$ 1B*6xh~I#$f#Lo}T9"'#b7h vpIn[m\el雑 lOimCK,O^4T{r4YxyfX忔@=2"`,@F-\&=hB ֺ>R~Je:t Ve:/WvbݫyyX1*H+ӲW/=X<~ g *5֒?&)O1≤%^cxuы@L@E05a& @̡@ pTGzC 9 @G%@j~Tϡ7 @;ہ~Ko[ݩ(!GZQ A5-Z]F#%@j;M֝ k[x1V1miۡ{ݶ֍ZsL@ YyVG,zLӟZ QGdZ-[&ݥrzD{ۄ{|/\wO<&RBm^ x]*5e2]Sy0U`H[@)_rs̚nRψL[G\tN.jL8Ϛ>.4aQ7>gcY{T ʤTdͺMkp /s)i:@-̠l:6eA$E(-KۭwUWw'#Hg㫔עh9a -xng!@`SlhqjeS,),زp]_;RhmE*T$̮VFꯆD,9e6/*-riWO YTAR ݙ%˭Zn̔ʻj4Q7\ܭ>5ldMnv--MC<+nh!5]bޅzJ>p;ޱro=]& X15gCˁ&[<%gWOmaɖݓqV7(I̬!Gp.C a_,kF-@9R; @^x;!@vN|B=@ W!@j*N@  5߹P @U @`^C;wA /YV|Ыz7g @n |ǔ@~jHj~AQRHy@ C(Ss:6P @<HK, @84RC!@C|e$}y, @RC>|3? @ ߹@ } 5_?_ }'qr<[fc'5&i5l̨x2t964)auG{LvO;2Rx:MSs6lZlE5Hn\ROYjmԭL-zFp˸ YI)"fF\?#l =Pf~Ip=],;}s Jn57BQ-fulɑqlR  pksl2 n7,e~%yaCɮVZkߕY˥tafƽ8Wӽv{Ɍ=9O8$x7> ~iۏE @8R8 @@ ^@  5?1 @ HEl @8R8 @@ ^@  5?1 @ HEl @8R8 @@ ^@  5?1 @ HEl @8R8 @@ ^@  5?1 @ HEl @8R8 @@ ^@  5?'p9&@ /x>]V @ @j~s+ @vK||/-jbrުR;sw[J[=:-imR\r65tHnAԸh|CG!@jBytױ5C ~V58eta7|X\5Vx^Ma 'k \YvhJ|d%tGY]J j</?Htj4@ަa1=Iw;1VFQ,T|q6/)}Z\S>s -䗶25k.nx&2tXTqi|q$YWep~X7Bn8vEe'*.n!&)jA$PZҨi֝Cr$5gܠ2F ؎9ZnKYKZs0!(LXI@ @j>@N{c A؈@dFM#%@??CIp) @ 8R8+JB @`CE4 @H( @ o @ 5$ @6$@j~}o==w̕b&D7d*]][ؖa! @ @I(w]VF[>2Uj<ճCCOh T(@ -Rmbki64@ 0,lJ^7ۍ-$rFI@ Uev^']ynU2݆jz @x<Rlf{~,߭>[hv ^0M$ @Ho<&=iX#b .K e֍$A ,$6O}Jݷ0{BUVOھh>\¼v@ pPeYffYΪA!@Fl@  5?P @lHQ @8(R:!@F|hl~B{6c @n\nxn" @'$@j~: @D|odp8IX%XKRZWnC]=K5M P5ەk54RۜZVOJc3?;(1Քyn DU,VAH͗ՉθD75V}dRi*xWW =m.P@"#[JZQi _$ Yi]K\OycZ fu 6$.=|n}Wy Ÿisۧ RR2w'u-#g(lhIUJez=IxEZ%2YseIz'jjwCQ/=d YJC#m7J`#A|7mJz={"_X=%rz5OZ{MijZXSkW+ۺV[_JD3SvAU7(tG Yefۢ8dL=/,@G!@jdl[']%ܼ]ˬy+DZ˪+nd$kI[fB09dJ> #I#*:Ѻ?gj@q o;wI2[R7.I2muդP-(ivW%m]8;%X2[RmԊ 6EcpywL/-)ų%HM x&$O}Jg{eHھh>e%މ5Q!mNg 3;}QY-VN6̎]v(.F#r2Cd GՏ PifRp ]UVXRguտki|;e|`^zn6|+ͰKGQU^M# }(SL7iԬ;I͇~|V @ l杴ܕk^: @H>ioLB& @ Rmc~' @ H_<0 @`/H  @xqCvi' C lG6׼~܀d@ @zPE@ @`SKgwKi8^] ATքFCy%kې5x`ڰ,h}e\ۇ|qș"Qaz@C aaH2fXm!*B`iwjJ2AEhn{#9מ{})Τ enCVNCdXVfc-N6YCm9LWZCq/7L~CɂVFH=#meF" oR~pB{Vw'Qkuf*ۅNnMjzRሞn4&5O=&pXtMB6Ґ[favf݆jlq.ʬ(ī>5դFZZ=ώ`Ņ5 J-q 0+7k['C[`uS\$E"9onӓ(ʔ-CwCiQ͛mha_+_;]#KKk*#NJﲉ!(˙HS%![>t -r]ܽpגbEɮ(aF0*%5$lF-꥞lFoɻ ,)ih) uqYpm;3iK:\#9#\뒓,r;B0#Ò.kCF|NdH\T* m=el)mR==Iwg;G1&i ;'D-;"m9 ֳYީt{EVԼ&-^Ag[qZ>v$7|Qk#ȼN; ~Ym F݌ ykN9#\c>k(#]mowbX;m2N膍mj,r՘ʡ܈HdE  ;*GT1qXC:4#T>JעH 5K~q kϗ)hyM3!ugy8N#.  "5^a?:k"R&ݒy@=.ވ2݆_`Ԝ -7Nk;!p>L4ֳg2+U:+e∇5nCQ+h\׹kIc|X5O&D.?O@ =`iۏ m@ $61 @`H4 @xIӶ;% !@ 5Lwl}n)lC @NMzPEA @`S+݊,_#dV ` %d!תRf -e'dRd3Z ;vW9]9nv@4H͗R@!o_=iHYFCUVs+>mNfʗL LW_f$͖?ѫt#v'.S sʦU P"H#V+#Sy%%I(aAA 6V|ٗSkYe 굯a \츽Xf95j*x$I_({s@`k|L+ VAŶv !@H6G'L @x.Ru@  H @ c;D߅P @Ho^M5o}M @{!@j~ȡk/C@  5_rSd+Qj,Jn9kBwBXYիM2Jk|J'5$܆"\ިP;֚,];d<=KD '@jgLSXfGl9GgKI;jٶb;Z|<ۺjU;Z 3JjT Вhp-`I5̭5YhHQ4Z%yv>E2 ?!6ܤYfM/lrV< jI_3$+/+7E+]*!bQճvnf{>kZ[ZᒭVopG[y`Z!5ڭGnQ6%@j273n6bghR 1jzKRANܒg0,K4 }QSYz5b53/T쪬SXz4 l.0ɛ2o!Z_avC@yњ$p5S̠LZfw+ Z>4j봩9ݒKRn+eNofҵ2mUnseXngN&)/A 9*n]^E )WgLE@ 0$\~,_Ab]g4zE2/NM,TRG7AI@ '@jg5q;UYͭY)i DԼ@ pte Z&ugy8H$)F@ s惃|jiwKԃ @84R}rѡ @{&@jg @  5!gc* @ IN= @Mtݗi @9R;^;w$A  ,'U-g5ZnCIg[)j2#9kX[&92v҇5L=]zN܃C  p +8|~ηOja[,;Z[˶ҙz)DΤtD w SސYi[ה6'υܵ7Z!tIǛ.lPCy-N\,`( @ 5_!$G\8ڔwx+A2@Q&ؐyv1ie*\in[|KnCzxm=mjka5a{P%1b X滈Zv5;_[EEKeYo!-='*~;ӒJ)SUʾIpKړ zF̬]Ibݥ$W\z߲z#/6Yi]om@mDHw2k&+_/ Ɠ JD;,o[W+YSXVMfi$rj^+/u hJdwkԅ 4/ $v6^qkMg˷ lNUiDzM_^ilZyvK MR ʉkiON2|=@Zަ'=Iw̝tcLEI_罬=9&*56-3]Aꮔז|Zj-fmRp;ѭ$85$Y`le#arJh!D r@, @R0H@ lJ|mdQy-tUԏŲu+3+fU&ڷv*mmCnVHv׏.)֐Ҙ%g}<٪RNL|OF%&(I) kO _=aG=Z*o diKI<'=rFPz$R@ N@/fU( @8 MSs6$-4!XB@{c4A]@ 5\Ƥ/ (w $# @RsB @ @j 7 @H͇H?Nt" @ 5M5o}n#  @]G^  @6%@jo}'3 ZRƨVZR*nt0𚥮R(qFDH])SV3QeHxJOitEh]QQ tg"; ->lfWsW2l?S젵H͗:N-7{VY Oubm~)%nejaWO-V'3L#k$i)*K66TRr۩9]Mj<垟`XȧFWGXJ`4|7]\ˍZ˽Tl=XQ/~ JXP+#5_2f9H49OԤZnw2 6TS>$$d[ROZi*J V54COW% XOrPEVgx+`2m#䳀 F,EFH(Fll{֏"AJ/4nOimkfZ\Uqތtg.q̠e#3lhHj+˞#vɈf1D[RFT:"k 5wY JVѓi.&uUȌUk* ȸzfkuu[>SX53jXDfZwCy[& ݰۡ莁>wqn0LGStvv/[u\iu8S;;M]vvg66fx/AC|5_gpx*ݝ? j}; Hsr t@j0K(S.k*zMf {v>P8aCۖ2qoN xCm1z; R$.>%ϩ2 r;aڛe~nGvn.Ņg#g\BuIWsbyXZ.ϷxD%WIwvmmxl뤺*_Z*KZ-JnzNKYf{ }5Xgt%z#B.}0`~*h}RM*UuyYN^<(GP*@>oB*.$6hzΧ>%A;KzBm&UOھh>e%Ή5Q!ed/d JEdQPB-92V\!}dl*غadB3$jbk(R.Z4ԏ2knMI;r2 ʡ۵@eTuĊdu7x^opw]\6*Z@#z;Vh szSZt/YY̍جyBitv5(T7ik֝Cr?;5z|#rpO'S%:;N؉ |HǵԜ -OLX{?'% rκl'-i~\D⑩>qӏCpPt>)j#@j>PJ{c w(e i~Td! 1xL+&B`TRHc~DA @`#E, @ 5Ƌ @؈6NN;7rb!@ @j~t_ݗ@ lGmzP @ DG!٧<%>ۯ?t1{ڃ%e2joD4mHp Vt)dMLNJmwY3Kk5Ԓ]kRw{c=ivgspDZ{pP;*6BP ZD gxMʪy~I,#HG(3,"^ӬLV,tZiP.9M7QT%PdɤT^*A l$he뒗/2vS t˯Zr @v݂|W Fbw ن:0b)QRasYMe4OK LyQQV]ܺ&siRT~Hy#6dZNZZ7"memM44Вk2ݏ25̶CU/;df ՐpU,SKƚzi7)(@\3]u"r#WFD̬sGbKf7aߥ4ʑ@J76d^IJ'NjԹVϢ=PRfMI eu9ҽxPj.ނJ3={䕊;TZʗSoUMDCUzy Xʔ3 52=k*R"kFUzyVC'\Z66JovYFd> JXie(fkS1tM0>8ܨcȒMk#/qkQ'Y$ Y)ljKt3SClYqJn*O:gLq\3} ݁[ivsnEwP )'{^LinL"JSJ{ao2ZHfIu[ 9GQ@JmI:Ng{[&m^4tĚԐʆB1S2ɖ%I%23W6df&k${ijmKdf]kh6Z 65zݰz_#W+ejGk7ݰAnCq2w q %pG]\3mF]i~a 5ovK>2Eʘ)lߌ+ 0ZoFllw4> )hyM-ͺ<|Hg>3r߳h$ $Rw҃ M/Xl榔"{-w" Y\Ds +t;Tik[~0B l:L|NPhHt{)VP`#PGǴr>`A|pSc~t$ @ k @ pB't*&A c;D? @HonJ5o}EI@  5s\zPuP6 @Qȡ9==XT>Dܠ< a2̩yWҰNWy=i~`zk=vG,ZKsG-+B{[~0XO gow_dBiSO-1ae])XxQ@mC#͜@8RK+&ܞhVym.hkꨙ m/Ȩj@®6#oEdg CW4m!,]WWHsp~ڻ@mYΠ6'Ӓdn:;"Gx.1~6/$ƞw/ ܊Bc^7JK=@ӎ-] dkԋCMֆ6ة-=Ke,c[]&K5=  M FfFƴ$Y7}IX$Jƫ/eU\<ճ ?|˼zF8I'2']'Llڍ&)o2Ls۶69]%kq;jtvťBev#dYȵ>#Vn(Tꢛ*VP飮׺2RrxxI|e ya[ܡe;K$n@F턲,,m} bYC"5ʖɌ-/l(3!>jX~u}Ve̛PnseX6"D#!!N i6G4fs drY0}u3Z&jlߵCm4Z(TKʶ\2hWq;E0hk#m0>#0ݱz1zEvjoźTO˲fFjtguUͶڟnzRR%ޥ.OLs&+p0QE{wC+C;WiԜ -7wjG A` ii(o2EY/AXA{м\A?Dl> ~yyO#kbSɫ뿺MG8dZq%kc4$5X/Tp`, @# ?6mA @JԜ @.nH?N]8 % @H_h}M @{!@j~믽x = @NJ|]cz7솲6'o&ǽ=mylŕYURJ35iɰlmA~a|`.or wnn;ɥQSz]Q /<>;IfՒf2eO39eCYy1ֲ2[KAխXK blnޚ׽l)S4"G BK u[X=ZϺNʿ׵׵i^jv Vƒ1 &+aZRD k{ya9ʺ`鸮Ʒw VTWl(Wm|T#jdJyĜJ]2,*ٰ* 9E%C*}!NF|C%rnh;mOU]d>`*B.*^wnBlޕfe$*A&a򑆒%ai^ KYF ٞTqC m(e*CC8"RV˱5\-b zWpCD,ۏbtн-*#P&avՃ脏 d 2&B$ XK㡝֏# eΚK 6l-P ՔIVʻ\&=MmnɕҤ)3ROI>p *WqU) @ަ6=Iw;3ڧ}{|JӽkRC ʖӞ͘m򼅬{,A#WR ,%7eSɚlʷzq#U@ym7[ 3 3k~)67&Kf{îCĒTRZX}Ũ˸e!w^Gp5:ԎPfy6 <@gܤjYw@a+?kP @'5:0/~S{ЦDٯ۶hL0Vlh [\ZHr W3ݶ6̜A s e5i\]V 3(.ISrEom{)?G|vE'Ie<370|X<6ܒO ڷo-E$hVs75O%%5K{[N4ܞT6mj5WKw#ƺnX5ߪ*ҺJ5QYoT_lhw!W.詁TS)N>Npv,{!ZFjNZ-5K;Z;*]3-8{&F(fN rBzN{pBy@ݞ椑4jRĽe$;ÊruZR`(\ 6 ؤTaMD3p?˞<8 QS)t6c}MH6w YFYd-ͪdm&YlT/ۭ1t!.v[䣠EG:7zG0nh / :#e.q#嗇N7]񓵮]Mdp)+: 1&G"9}3fTCpkhӎXwʜ172R crd>*SH^n$ed$Z"T&AZK.Բd+RkakE͢Sv%&ٕVxaq-zA=e,{r!ysn vchY>yRd!Aa-FܮlГ Mlhe6pqcu^8TFL4UzG\6q3cʩRWUxzě2X6X)2IRw_ߤm= 4|ogl>IW}a2{iGmw[!5As =e`mtUl};\+gc#Omf|-Q=gT*/nzFIiPj=bfvms*\}x7mȒ N?ɆdX %S76D΋sr<;L)z,VD6XdLq&m G®ʞ钯Y2Ŋ% a#2A"dv{G06j~烱$v1]w;]cJn MGv8 ۻLm( Ǚ%<YKQtPd5tmqi;%8z7zbzTz3>PG&n|uy3t#dY4M2|TkFH@ʠ {/r瞒~Ϻ1F sM xM /ݳ^2vuJegaeoMx|lT v˫)3Po6Bmy6"%LRzǂcs=Q8Ɩ:0_CEU @ >VgD@  hkVBث&pz,V餞Z|(CLyZ2hj@t(Y6'݆dD,֎qS@Ͷ+r3:v}diqn褘UR,*_m4K2JE-Z)d)hd*yj.lK ʍ,kҮAX ri)YhKQmr}TֺU{DΆw-ȷDfp"A`-+> wJ6gY2١4Ӟ2hQVrzvWΎnj]duIf925we8sv,-߻ ͈d˭]ht/{7dsE:;&RSad^؋>WΑ`@se?}I' -P V$G$%r9T;BK% ک~.gMj=>kfbi{izMZ>ڵ]֐JO"<۹nŚJٜX0kJ-%-ÅXVw?) b 7:Q6cfRXelx̤ם=7idz"7h' !<)!54v]-^OfԕqFEt(q$#%U3'4 HDFٔEA׎;kS;Hw/ ի[8GFvm-JB1k&lPɚLWo-lsD;In|YVJpWJKe @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pNӯX@ p8e( @ pN9U @;&9̎j @g#%/G3= @{%[~w׼/w*`WJZ0M=[sI>橴~1P3s'agE3:KqŖ\:-ԡ&01_g3v7m,]n$F˓T}¯j.KY^.hY7xxcS[*F[ W'".)e25(SUrF2穴=8E-qn5]bEcKZ]:X(*[3pB/WAjW@Ƈn,iG*6ɊW(<{mr$ $GqdWnjR:e(Ȩ$&kST0EmъRS@Ee2]*#kKukxk5е Y}i]Օ,qCscx6]idf6,A&RD`mf4LvyStxhwcx =3K3Bg_tXڣM6T}ikGEw,jעr *#6 iZ 23'uKejCzRX٤T4UpR!cZ|GpkHnO]ltlFViBvl˯UG ؃PW>Y2V$ܘ/!aڈ5w]ƶ5HYM)]Tșp -H~Ro,?Ş{YRYef+Sf72Mmk=z#;~cwrC1c>rõ!m(Z@|'"ٹK pń`>$2VﶨPM%g ][ḠOK&)fiqB/>Kl|F^,*I&^xajä“r;h#DꮥSh>AkWfZfvxn/.@uI'9[7םeD'ZEܽOIRw_߼}͒e[*pi&)&c'UQXgfy2UokQ\xIrq ,># ˩яX*z 3kF~_h*/P)<ϛqkMnQ3 q6 (I*M2CW{͓ӷ)AODvfZjqJC9|w8˪Ǣ#K!d90C=lTYJf["2d<.4RV`0Hk W`Le<&WGn'T15kc]#S TpM̓bxx^,Zׯ٭[TНQ6AHv6K5Fgev1,A4)Bz9γGB:/鸼$MgD@6,JHJC@KKK[%kK)|}o9uV^b[d(( A@HB(&_LF`?/賚{ͭ_%_=)OMj}`gi: ױ(vK`^ tA1@ W#y{!@vJU: @^q @) I@ԣ@ p\qߢkEnōjw^[ޖNEmdBl=3y;7[?%*?Okn!@ ̎kH2rDQںf o˨erԊGv=Ҋn[F[nxt t-ڮuguĢ#dԂ  5,[jo6w ޵#&Lw{[}&7q%Jwh.RH n4-k]3|W`к CqڮY2ȴ.Sݥ̚\&/t [oӬ !M*]/Yڃ=3QR,͠A8|O*Vt[lBԬml6i#l4Nɖt[o4zxՀhtek3湣m Vl>+{GeuCq6xQFMJ5t$Ҭ;Y5zMַ4tuK5IvȜ" 8V_p,@>gWGnB}]AizԊPOg}.5!l|E4:]+N`uR@ 5'L);>UÀ 7 @vA|n@ @ t~7a5g0Y@J6K5}P<"xYg?mG㙮ޢޡ櫳})Pҙ\gMFc'Xpg͡\;cԀ @!7#?koޗT($AB@ lD,Jrw_KMy|J£Z6R @8짟k) @rxI͟$4 @xix fB =~ @/BE @{'Bj>n]3=X {v] @B+zt9Q9CﲖmzjP @[X!5oۅj.g͹2zrP.[q)p ?! @6Leu.S%VǸ2U@+l[R%ki O=0 ){$Y&].GZZ.O @/H9H dՒm*3 T @xIk˃̓Y~DEE  @<45զe:ޭ%A[:w q"D6T"Zz@ <45lܞcImFvif7Wijmd<B CS3@ K|]H @L3Q  @ 5_' @ 0LpT @H4@ $\oXwoh]+[;g?hRAϗ2[9 XX=hѡ=F/;)>Knc)ӕ| Z CSs{;ͼ}ޝPyIշп+{cZ>4*6u+jo!s8[@@MkjO̎kn݅RQ}^s$mϪm5.u\%.|:v7j Yód*͸@h#|vY+ tjwjΈ.%QIݡưU xH5e")\59-/Uې䟵}h[OL{kQC ])jRCKJn#me-ja[2N~Pt}ԭ$M~ql z݈I1_*4DZ7gZ g t840,0|VRW9 T} [mKnr Gb[^ʜK̙Z.!@`-IXT2^<=}n*.um̔t<[ZDTg7$īGk`FIst]vEivY  P#>#o.uCPu3  kuGMt8POdFH((4@ S>㇯?4桅Q8 Q AO@# |m}mISw|# @vDu!@ 5P ^ݾh/~  ' 5x @=Rs" @ @j 7 @H͉@ Rs{O嵠N5ׅXة'Se,-޿Y,)#XlVӾXYLW$3]łꖔ>TZ]Myӭ-ޅ 8çdf|5Q=-/2%} nPfdz^f祐3dƍ7m(%!@8: [׉˺Z+3%3[wmt)ErA%W#8|QmZM^GI@ΐkWܭɶ.*ۓBibvM:۸\A/iȴ_MO{]! L7bA&V5TIlw QJ5=K3*} @( S,|_`!X@@  O۶)ߖ$<| *$  &/":vM*CNG MϰtŠ] /ߵP ?cJ]H͟1ڄ @8)([R @D m"o;Y5ߓ @Ҫyݰ@  5? @HOF @/~}w$5" @HwQj&|e@ @ B@2H^GR @3 rR|@ j:RB @`R9Ԩ@ Y{7M{_sDÊRt}Ï @ToY$)~T>) wRs @ ~j]H @,Ϊl@ lM cZ@ R& A @`k@n @g{ߤ|o@ lJ@so% 2G8 @ʛ'לX @. (@ Vj=e4QaJ\"3bHCöSW6bn59Jxh l? 䠴n1Ԧfq-z] @653ʊ.69|eu+5?9  \7H(My8m>Zn)[ 6MmaDՋ@@ gQYnt<#u:2D&Mx*De-NZ|f/<좵4-mmekTm)@^@'5rlhHF*UKbm"5%{X'\ 2+JB  В%yvU{r+JspJ7=kHˬkŊ!  2t#xܨ+xYL&qV0qXB @9Ie)Zޒ3ElCKŬ,Z-%z4j[)( @8:Vj^fjٞqR~6ɔtWz#-?-QVPVe{V'? @x:9OW @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#@j~>b @! m( @ p>)A !݆ @#_|Oɶt7}|vb @vE_S]2 @81]wRtĖc @F@v8E@ I+!@@NBE@ W 0-5_DH`IeR=nYxYRvHu@ =t[Ơi}/5j ,I1@ #)LI- @G$Z5ܵJmݿ!U|$o-\Q :I-=cSӤaBt @9V͓UsYS]U51-wHp֊زb7y> /BIf9 + @ 4ˌHI%ֆ\VS2mXh/m$D5L23!@H`~j>Y:i (s 2OjA CSsnnzq t5Hb#e"  @Omz?矾U֪%+pgb.|4X+nhQVRUbτH Q3ݝ@|d5 @8.o퇯?LK͏kmW, @" C7:r @ p>O#O< @`?H 4 @xi/~ @@Ӯ(& @xAg/h5&C @`>\?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~I Root Entry  F`U;Data ٔWordDocument ObjectPool 0H;`U;_1100682108 F0H;0&a;Ole CompObjMObjInfo  FPBrushPBrushPBrush9q Oh+'0 , H T ` lxOle10Native M Ole10ItemName1Table ]SummaryInformation(       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~M BMM 6(A`M BBB̲̲̲BBBBBBBBBBBB񀀀MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMBBBMMMMMMMMMMMMMMMMMMMMMUUUBBBMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMwww겲BBBMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMBBBMMMMMMMMMMMM999999MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMBBBwwwꖖBBBMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMBBBMMMMMMMMMBBB999MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM999999MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMBBBMMMMMMMMMMMMMMMMMMMMMBBBwwwBBBMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMBBBMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMUUUMMMUUU999MMMMMMMMMUUUMMMMMMMMMMMMMMMMMMMMMMMMMMMUUUBBBMMMMMMMMMUUUUUUMMMMMMMMMMMMMMMMMMMMMMMMMMMUUUMMMMMMMMMMMMMMMMMMwwwBBBwwwUUUwwwfffז񤠠wwwfffwwwfffwwwMMMBBB겲ꆆˆMMM񖖖㲲BBBBBB݆___BBB999㤠BBBBBB׆ˆwwwㆆfffMMM㖖wwwMMMײ̲wwwUUUfff___BBBUUUwwwזwww݆wwwfff񙙙fff񖖖wwwזUUUwww񙙙fff___fffwww　̖fffwww񙙙UUUffffffMMM___񤠠wwwwww___fffwwwUUUMMMꆆ___www񙙙ꖖMMM___wwwfff㲲fffݲwwwwww___fff333www˲wwwwwwffffff̲UUU׀ݙݖwww"""UUUUUU___fff___fff___MMMwww___ˤwwwwwwUUUwwwUUUUUUBBBMMMUUU999BBBUUUUUUMMMfffwwwwww___fffㆆfff999wwwUUUUUU___wwwfffUUUUUUwwwwww999wwwUUU___fff˲wwwwwwfffwww___יfff___UUU___㖖fff999wwwUUU㖖___ꀀwwwBBBfffwwwfff　______fffUUU___ffffffMMMז񙙙UUU______fffwwwwwwwww̖fff㖖fffwwwݤfffwww999UUUBBBUUUMMMMMMUUUMMMwww333BBBꀀUUUMMMfffBBB___wwwfffwww999MMMˤ___www___fff񆆆UUUwwwfffMMMwww333UUUfff___999MMMwwwUUUUUU ̤"""www___UUU"""ffffffיUUUfffUUUfff___UUUMMMwwwUUUwwwUUUUUUfff___wwwUUUUUUffffffMMM999fffwwwUUUUUU ___fffUUUMMMꖖwwwBBB"""MMM999UUU___UUU̖UUUBBBUUUfff___UUUݤ333fff___MMM___"""BBBfff999BBBUUUMMM̆wwwBBBfffMMM݀זfffffffffMMMwwwwwwMMMMMMfffMMMwwwfff׆www̖fffwww999fff̖wwwפ񀀀999ˤBBBBBBMMMMMMMMMBBBMMMMMMUUUMMMwwwUUU񀀀UUUwww㲲MMMMMMwwwݖMMMBBB겲MMM˲333BBBfff BBB___fffUUUݲwwwMMM___ݙfffˀ̖UUUBBBBBBBBBBBBUUUMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBUUUBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBUUUBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB999̲BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBMMMBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB999BBB݆BBBfffffffffffffffUUUMMMwwwffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffMMMꀀfffffffffffffff999ㆆBBBזfffײUUUfffㆆBBB̆fff˲MMM̤"""fffㆆBBBwww̆fff̲MMM̲fffㆆBBB___̆fff˲MMM̤wwwfffㆆBBB׆fff̲MMMfffㆆBBB㤠UUU333wwwㆆBBBㆆBBBㆆBBBㆆBBBㆆBBBㆆBBBㆆBBBㆆ̆999ㆆBBBㆆBBBㆆ̤BBBㆆ񲲲ˤ̙BBBㆆ겲̤̤BBBㆆꤠˤ̖999999999999999BBBBBB999999BBB999BBB999BBB999BBB999999999BBBBBBBBBBBB999999999999BBB999BBB999999BBBBBB999BBBBBB999BBBBBB999___BBB999999999999BBB999999999999999999999BBB999999BBBBBBBBBBBB999999BBB999999999BBB999999999BBB999BBB999999BBB999BBB999BBBBBB333̙BBBㆆ겲˲333񲲲UUṲBBBㆆꤠ̤333UUU̙BBBㆆ겲פMMM̤999UUṲBBBㆆꤠ̤www׀999333ffffff333www̤fff___999www333BBB______999___fffUUU999fff999fff______999ffffff999fffBBB)))333_________999˖BBB999999333www999___̤333UUU̙BBBㆆꤠMMM̲fff999　wwwMMMMMMMMM㤠̖fffUUUBBBBBBMMMfffwwwUUUUUUݙUUU___fffwwwUUUwwwBBBUUUBBB̖fffBBB겲fffffffffBBBUUUBBBfffwwwUUUBBBMMMפBBBMMMBBBꖖwwwݤBBBˤ̖999UUU׀www999999999999999www333BBB___UUU̙BBBㆆ겲)))˲wwwUUUUUU333wwwBBBMMM999fffwww333񀀀MMMfffwwwUUUUUU333fffBBBwwwfff___wwwUUUwww___fffwwwMMM)))BBBwwwBBBBBBfffUUUBBBUUU___"""wwwBBB)))UUUUUUUUU999___UUU___)))BBBꖖwww)))fffBBBUUUˤ999겲wwwUUU___333999׆333wwwMMMMMMꖖMMMfffUUU̙BBBㆆꤠMMM˖999999333333BBB̖www___BBB999BBB)))BBB999wwwBBBwwwwww___UUUwww333׀fff̖wwwBBBBBB˖fff999999BBBBBBwwwBBBBBBfffMMMݤBBB999"""BBBUUṲBBBפfff___999BBBMMM"""wwwUUUBBBMMM㤠___MMM333wwwfffUUṲBBBㆆꤠ̤MMMꀀ333̤333MMM999׀ײfff333̤333999www˲999999999݆̲BBBפfffBBB999BBBBBBwwwwww333˖999MMMffffffUUU̙BBBㆆ겲MMMMMM̲̆MMMfffˤ̤ˤ̲̆MMMfffˤ̤̤̤˲ˤBBBUUU___999MMMfffײ___UUṲBBBㆆꤠ˲ˤ___wwwי˲˲999______UUU̙BBBㆆꤠ̤999UUUˤBBBㆆ겲̲̀˲˲333UUṲBBBㆆꤠˤפ̲̤wwwי___ݲˤ333___̙BBBㆆꤠ̖BBBwww___www___wwwfffwwwwww___www̆MMMwww̤ꤠ˲̙BBBㆆꤠ˖BBBMMMUUUݤwww"""BBBfffwww___׆UUUwwwBBBˤ̤BBBㆆꤠז___www___wwwfffwwwUUU999UUUwww___wwwז)))BBBwwwBBBײ˙BBBㆆפfff̆BBB̤BBBㆆ̖˲fff̖)))BBB̙BBBㆆ˙BBBㆆ̤BBBㆆ̤BBBㆆ˙BBBㆆ̙BBBㆆ˙BBBㆆ겲ݖwwwwwwwwwwwwwwwwwwݤݤ)))˙BBBㆆ333wwwwwwwwwwww999겲fffפ˖̲̲̙ז̲̲˲̤999̤BBBㆆ999ײBBBꤠfffפˤBBBfffMMMUUUfff̙www999www333___BBB___fffBBBffffffwwwUUU999˙BBBㆆ999̲̲BBBꤠfffפ̤̖UUU___UUU___fffwwwfffBBBwwwUUUUUUUUUUUUwwwwwwwww333̤BBBㆆ333ꤠBBBꤠfffݲ̲999̲UUUfff___UUU999̲BBBMMM___www)))fffwwwMMM333fffwww)))fff___UUUfffMMM999̤BBBㆆ999BBBꤠfffפ̤MMM999fffפMMM333999ˤBBBㆆ999ײBBBꤠfffפ̲"""BBBwww___MMMBBBfffwww333˙BBBㆆ999UUUBBBꤠfffפ333̙BBBㆆ겲999___wwwUUUMMM___UUUfffUUUwwwwww______wwwfff˖MMMwww___MMMUUUUUU___))))))""")))333BBBꤠfffפ̙BBBㆆ999wwwUUUMMMwwwfffwwwUUUUUUffffff㲲wwwUUUMMMUUU݆___wwwㆆUUU___fffUUUMMM___UUUfffײBBBꤠfffݤ999̤BBBㆆ999wwwBBBfff"""fffBBBwwwwww̲BBBꤠfffפBBB̙BBBㆆ999˲BBBꤠfffפBBB̤BBBㆆ999wwwwwwfffMMM̲BBB겲fffפBBB̤BBBㆆ999MMM___MMMUUU___999UUUUUUwwwBBBfffMMMwww)))MMM___MMMMMMUUUUUUUUUMMMMMMfffwwwUUUיUUUUUU_________wwwfffUUUMMMUUU̲BBBꤠfffפBBBˤBBBㆆ999˲UUUfff̖______wwwUUUUUU___fff___UUUUUUUUUUUUUUU______UUUfffwww݆UUUMMMUUU̲BBB겲fffݤBBB̙BBBㆆ999MMMfffUUU㤠MMM___UUUwwwBBBffffffMMMfffUUUfffffffffUUU999UUUUUUMMMUUUUUUfffwww񲲲___wwwfff___wwwwwwwwwfffUUUBBBfff̲BBBꤠfffפBBB̤BBBㆆ999UUU׀www999wwwˤUUUUUUfff̤fffUUUwwwUUUMMMfffwwwwwwꀀ)))www˲UUUMMM̲BBBꤠfffפBBB̙BBBㆆ겲999wwwffffffBBBwwwwwwMMMMMMMMMˀ___˲BBBꤠfffפBBB˙BBBㆆ999̲BBB겲fffݤBBBˤBBBㆆ999UUU999ײ333̲BBBꤠfffפBBB̤BBBㆆ999MMM999fff999BBBfffBBBMMM999BBBMMMBBBUUUBBB겲___MMM̲BBBꤠfffפBBB˙BBBㆆ겲999MMMBBBfff̆UUUfffBBBMMMfff___fffffffffMMM񲲲UUUUUUUUUMMMwwwUUUMMMUUUꀀMMM˲BBBꤠfffפBBBfff̤BBBㆆ겲999UUUfff̖"""wwwUUUfffwwwUUUUUU"""___wwwUUUMMM333___fff999UUU_________wwwUUU񖖖fff333̆UUU̲BBBꤠfffݤBBBㆆㆆ̤BBBㆆ999wwwBBBUUUBBB̤UUU___UUUUUUUUUfffwwwUUU㤠UUU999MMMBBBBBB̙wwwUUU___BBBUUU̲BBBꤠfffפBBBUUU___fff񖖖wwwMMMMMMwwwUUUUUUwww___)))̖___www______MMMײ̖fffݖwww񖖖wwwUUUMMM̙BBBㆆ999www___UUUMMMUUU___MMMUUUBBB̖UUU̲BBBꤠfffפBBBUUUUUUfff999fffMMMMMM___UUUfff"""UUUBBB̆wwwfffwwwwww___fffUUUwww___fff999UUUUUU̙BBBㆆ999wwwwwwwwwwwwwww̲BBBꤠfffפBBBꀀBBBwwwwwwwwwUUUwww)))UUUwww"""MMMUUUfffUUUBBB999wwwUUU___BBBffffffUUU___MMM݀MMMwwwUUUwww333wwwUUUUUU___˙BBBㆆ999www̲BBBꤠfffפBBB㲲wwwfffMMM___ㆆ̤MMM̖˙BBBㆆ999fffݙfffݙפ㤠MMMUUU̲BBB겲fffפBBBㆆMMMMMM999UUUfffBBBUUṲBBBㆆ999ˆ333פUUUwwwMMMfffˀUUUwwwwwwwwwMMMMMMwwwˆ___MMMפ___UUUBBBBBBUUUMMMfff̲BBBꤠfffפBBBˤBBBㆆ999___fffי"""ffffffwwwUUUBBBfff___fffUUUUUU񆆆UUU_________MMMfffUUUffffffffffff___ꤠUUU___fff___UUUfff̲BBBꤠfffפBBBBBB̤BBBㆆ999___BBB333fff999www333fff______ffffffMMMwwwfffUUUUUUBBBwwwfff"""ffffffffffffwwwwwwwwwwwwBBBUUUBBBwwwwwwffffffUUUwwwUUUꙙ___ffffffffffff̲BBBꤠfffݤBBBBBB___wwwBBBfffBBB333݆wwwffffff___wwwwww"""www"""___fffwww̙BBBㆆ999UUUfffUUUUUUMMMMMMUUUBBBUUUUUṲ___UUUBBBwww̲BBBꤠfffפBBB___񙙙wwwwwwUUU___)))fffMMMwwwfff______wwwBBB̆333̤BBBㆆ999MMMfffwwwMMMMMMfffUUUBBBwwwfffwwwݲMMMfffUUUMMM̲BBBꤠfffפBBBwwwfff׀MMMMMMwwwwwwfffwwwfff˖ˆwwwBBBwwwfffꆆ___UUUUUU̙BBBㆆ333̲BBBꤠfffݤBBBㆆUUUfffMMMꤠݙUUUꤠwww񆆆񤠠̤BBBㆆ999BBBfffMMM̲BBB겲fffݲBBBBBBfffMMMUUUBBBUUUwww̙BBBㆆ333MMMUUUfffUUUffffffMMM___MMMMMMMMMfffUUU)))999UUU___wwwMMM999UUUMMMwwwפUUUMMMwww___MMM___MMMMMMBBBUUU___UUU̲BBBꤠfffפBBB̤BBBUUU___BBBfff999ㆆ999̲____________MMMfff̲UUUfffݤUUUffffffffffff___fffUUUUUU___UUU˲BBBꤠfffݤBBB̙BBBBBB___999MMM999ㆆwwwMMMBBBMMMBBBfffUUU)))wwwㆆ999MMMfffUUU㖖fffUUUfffwwwݖ̙UUUUUU̙wwwUUU333ꀀfff݆www___www　BBB׆BBBwwwUUUUUUUUUUUUBBBꤠfffפBBBwwwMMMBBBwww)))UUUwwwBBBMMMfff̤BBBMMM񀀀UUUfffffffff___י˙ㆆwww___MMM񆆆fffffffff񀀀ㆆ999UUŬݖײffffffMMM̲ꆆꆆwwwㆆBBBMMMUUUMMMUUU333ꤠfffפBBBwwwfffBBBMMMUUUMMM㤠UUUݖfff̙BBB___www___fffffffffUUU"""MMMMMMㆆwww___wwwBBB񆆆___wwwwwwUUU񀀀ㆆ겲999fff___ffffffwwwUUU___׀BBB______겲ffffffMMMwww___ݖ㤠fffפBBBfffפfff______wwwBBBMMMUUUMMM)))㲲wwwfffwww̙BBBfff겲˲MMMMMMfff㖖񀀀MMMBBBMMMݖfff______fff񀀀ㆆ999פfffפBBBwwwBBBfffUUUMMMMMMUUUUUUMMMfff̙BBBfffˆwww̆MMMㆆ999)))MMMݤfffפBBB___ffffffBBB̤BBBݙㆆ999MMMwwwBBBBBBMMMMMM񤠠wwwMMM̙MMMwww겲UUUݤfffפBBBݤ̙BBBㆆ999̲UUUfffMMMffffffffffff̤___̙˙fffwwwUUUݤfffפBBB̤BBBㆆ999wwwMMMUUU___"""˲˲wwwwww"""̖www˲UUUפfffײBBBwwwwwwwwwfffwww̙999MMM̤ㆆ999wwwBBBBBBUUU___MMMwwwUUUBBB̤BBBfffUUUݤfffפBBB______UUUwwwMMMUUUˆfffwwwUUUˤBBBwwwBBBMMM999ꙙwwwMMMBBBˀwwwwwwUUUfff999UUU999MMMMMMUUUㆆ999̲___fffwww̲www___BBBݲfffפBBBUUUUUU___999UUUMMMUUUזUUU݀___fff̤BBBwwwUUUMMMMMMwwwUUUMMMUUU___fffwwwfffMMMUUUfff݆̖݆̖www___ݤMMM˲יMMM___MMMUUUwwwUUUㆆ999񖖖ײݤfffפBBBwwwBBBwwwwwwUUUwwwBBBUUUUUU̙UUUUUU񆆆______̙BBBffffffwww333UUUBBBMMMUUUUUUwww___˙ffffffwww999wwwwwwݲㆆUUU___333fffˤwwwwwwBBBUUUㆆ999ײfffפBBB㤠wwwfffMMMMMM̆UUU̙BBBMMMMMM___UUUMMM)))MMM999UUUUUUwww___fffBBBꖖUUU㖖___˲wwwMMMUUU___UUUㆆ999MMM　ݤfffפBBB㖖MMMMMMݲ̤BBBMMMBBBwwwMMMMMMꤠffffff̀׆ˆMMMwwwfffㆆ999___MMM___פUUU　___wwwUUU___ffffff݆ꀀݤfffפBBB˙BBBݤㆆ999www___999BBB񲲲______fffUUU___ݙ񆆆ꀀݤfffפBBB̤BBBㆆ999wwwwwwMMMwwwfffwww___fffMMMUUU)))www___www　ݤfffݲBBBBBB___UUUfffMMMBBBfff999___wwwBBB999www̙BBBㆆ999fffBBBUUUUUU　UUUwww˙___זMMM񀀀ݤfffפBBBMMM񀀀www___UUU___wwwBBBffffffUUUUUUMMMBBBUUU˙BBBwww___ꆆㆆ999MMMMMMMMMwwwfffBBBUUUwww񤠠BBBݤfffײBBB񀀀___ꀀMMMMMMwwwwwwUUU___www񆆆wwwffffffUUU"""UUUfff___̤BBBwwwMMMMMM999ꙙwwwMMMBBBˀUUUMMMㆆBBBfffMMM333MMMMMMwwwײUUUㆆ999פfffײBBBז___fffMMM___ꀀwww___UUU)))MMM̤BBBwwwUUUMMMUUUwwwUUUUUUUUUUUUfffwwwfffUUU̖UUU______UUUwwwMMM񀀀겲fff___MMMUUUfffUUUㆆ999333ײfffݤBBBMMMwwwMMMUUUUUU___fffUUUMMMwwwMMMMMM˙BBBffffffwww333___BBBMMMUUUUUUwww___˙UUU˖UUU___UUUUUUwwwꀀיwww___www񆆆BBBUUUㆆ겲999___BBBMMMfff___UUUwwwݤfffפBBB̙BBBUUUMMM___UUUMMM)))BBB999UUUBBBMMMBBBUUUfff___񀀀UUUUUUㆆ999fffUUU333BBBUUUUUUfffݤfffפBBBUUU̙BBBMMM999wwwMMMfffBBBwwwwwwwwwBBBUUU___ㆆ999wwwMMMUUUUUUwwwfffwwwUUUfffݤfffפBBBfffMMM999ffffffײ___񙙙MMMwww̙BBBݲפㆆ999fffMMMUUUwwwײfffפBBBwwwfffUUUUUUUUUݤwww˲UUUMMM___www̤999ㆆ999fffMMMUUŬ"""ݤfffפBBBwww㖖MMMMMMUUUMMM___999www___MMMUUUwwwUUUwww˙BBBㆆ999פfffפBBBwwwMMMfffBBBMMMMMM___ݙfff___BBB̤BBBwwwㆆ333___www"""ݤfffݲBBBUUUffffffMMM̖̤BBBMMMwwwBBB̖MMMwwwMMMwwwײBBB̆wwwwwwwwwBBB݀BBBㆆ999wwwBBBfff999UUUfffwwwwwwwwwwwwBBB׆BBBUUUfffMMMfffUUUBBBMMMfff___fffMMMfff___fffMMMfffݤfffפBBBˤBBBfffUUUfffwwwˆfff___www___UUUUUUUUUfffUUUUUUfff___fff___www___ㆆ999fffMMMMMM___www̖wwwwwwUUUfffUUU˲UUUfff㖖זffffff___ffffffUUUUUUfffפfffפMMMBBB___UUUUUUUUUUUUUUUUUU______UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUBBB˙BBBfffUUUwwwwwwUUUfff""")))www333www___wwwMMMfff___UUUfffUUUfff___BBBㆆ999www______UUUMMM___wwwˆfffUUUwwwˆ___fff˲UUUwww333MMM___̙UUUfffwww333www겲fffUUUwwwUUUUUU___̤UUUfff݆˖fffݤfffפ˲̙BBBfff̲)))MMMwwwMMM333MMM㤠UUU___UUU___˲BBBBBBfffMMMㆆ겲999fffUUUBBBUUUMMM999fffwwwMMMwwwUUUBBBꤠMMMUUUwwwfff___MMMMMMwwwfffwwwUUUBBBfff___fffUUUݤfffפ̙BBBfff˖ݲײ999___UUUBBBwwwwwwMMMㆆ999ffffff"""MMMBBBꤠMMM)))˖fffUUUMMM___ݤfffݤ̤BBBݤˤㆆ999ݤ̲ꤠפfffݤ̆333̀wwwwwwfff999wwwfffwww333fff̀___̤BBBㆆ񲲲333UUUwwwwwwݤfffפ̖999UUU999UUUfffMMMUUUBBB񤠠fffBBBUUUfff̙BBBㆆ999fff___wwwfffꆆ　fffUUUwwwזݤfffפ̲___fffUUUUUUUUUfff___UUUfff___wwwBBBUUUfff̙BBBfffBBBUUUㆆ999___MMMUUUfff㲲www___MMMMMMיwwwfffݖꀀ___www˲UUUfff___ݖזפfffݤBBBwwwwwwBBBBBBwwwwwwfffwwwBBB333999זUUṲBBBMMMwww㙙MMM999ײwwwMMMfffUUUUUU999BBB񤠠׀MMM999fffㆆ겲999fffUUUUUU___www̖UUUUUUUUUfffUUUwww)))fff̤זfffffffffUUU___fffwwwwwwfffזݤfffפBBBfffBBBfffˤBBBfff___UUUwwwUUŬfffUUUMMMݙ___fff񆆆UUUfffUUUfff񆆆ㆆ999wwwfffMMMUUU333ffffffwwwffffffwwwfffUUUUUUfffBBBwwwUUṲUUUfffffffffUUUwwwUUUBBBMMMwwwזݤfffפ˲fff̙̖̙BBBfffMMMwww"""___񀀀fffUUUUUUMMM___ז___fffUUUMMMwwwUUU___ㆆ999fffBBBMMMMMMUUU̙UUUMMMݤwwwזݤfffפˤBBBfffꆆBBBMMM̀MMMfff___MMMMMMꖖwwwwwwfffBBB999MMMㆆ999MMMMMMUUUUUUfffMMMMMMMMMMMMwwwݤfffפ̙BBBfffwwwwwwˆㆆ999פfffפ̤BBBݤיㆆ999ㆆwwwݤfffפ̙BBBㆆ999___BBBwwwˆ___̀fffwwwwww___MMMBBBwwwwwwMMMBBB333UUUݤfffפ̤BBBㆆ999fffUUUUUU___www̖ݤUUUfff___˲UUUfffBBBwww___UUUfffMMMUUUݤfffפ̖˙BBBMMMUUUwwwㆆ999MMMUUUUUUwwwwwwwwwMMMwwwfffwwwffffff___　BBBfff___UUUMMMwwwwwwUUUUUUݲfffפ̤̤BBBMMMwwwwwwMMM999MMMwwwꙙBBB___www񀀀___BBB999wwwBBB___BBBBBB___MMMBBBBBBwwwMMMwwwfffBBBㆆ999fffUUU333UUUײ333ݲ______UUUUUU___פfffפ˲˲̤̤BBBfffUUUMMMfffwwwfffMMM"""UUUwwwfff˲fff݆www̖wwwUUUݖUUU___wwwݖUUUMMMfffwwwMMMUUUUUU˲ffffff___fff̆ㆆ999wwwMMMMMMBBBUUUUUUfffUUUMMMUUUUUUݤfffפ˲˲BBBBBBBBBBBBMMMBBBBBBUUUˤ˙BBBfffUUUMMMfffwwwMMM___fffMMM___UUUwwwfffUUUUUUUUU___ݖUUUfffUUUUUUwww""")))BBBwwwfffwwwfff)))___fffˆㆆ999ݲfffפ̲̲MMMפUUUˤ̤BBBfffUUU___999MMMBBBMMMUUUfffwwwBBBꖖꙙBBBffffffwwwMMMMMMwwwUUUUUUUUUMMMwwwUUUMMMㆆ999999פfffפ˲̲MMM̙UUUˤ̙BBBfff˖MMMwwwˀfffBBBwwwㆆ999fffBBBMMMwww㙙MMMwwwwww̲BBBMMMfffwwwwwwwwwUUU)))fffMMMꙙfffMMMUUUfff"""UUUwwwݤfffײ˲̲MMM̙UUUˤˤBBBݤꤠˤㆆ999fffUUUMMM___wwwˆUUU___UUUˤwwwㆆ׀UUUwww___fff___̲wwwMMMUUUUUUwwwUUUפfffפ˲˲MMMˀUUṲ̤BBBㆆ999MMMMMMUUUMMM___333fffUUṲwwwwwwݲUUUMMM999fff̙www㤠BBBUUUUUUwwwfffUUUݤfffݤ˲̲MMMݲUUUˤ̤BBBㆆ999fffUUU999　MMMMMMBBBwwwwwwUUUMMMMMMMMMMMMUUU___݀wwwUUUݤfffפ˲˲MMM̙UUUˤ˙BBBfffUUUㆆ999ffffff___wwwwwwꤠMMMBBB"""fffMMM333ݤfffפ˲̲MMM˖UUUˤ˙BBB333MMMMMMBBBUUUMMMwwwMMMBBBBBB񤠠׀MMM999fffㆆ999ݤfffײ˲˲UUUUUṲ̙BBBwwwMMMwwwMMMUUU˲fff___wwwMMMݙ___fff񆆆UUU___UUUfffꖖㆆ999UUUݤfffפ˲˲___UUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUBBB999999BBB999BBBBBBUUṲ̤BBBfffwwwBBBfff̤UUU___˲fff333___׆___fffUUUMMMwwwUUU___ㆆ999UUU___UUU񲲲fff___׆UUUffffffffffffMMMݲfffפ˲˲˙BBBwwwMMMUUUBBB񆆆UUUfffMMMײwwwwwwfffBBBBBBMMMㆆ999fffMMMUUU___wwwfffUUUUUUˤwwwwwwˆfff______ݖMMMUUUݤfffפ̲ˤ̙BBB999̀fff___BBBwwwˆㆆ999wwwUUUMMM___ˆwww___fffUUUפwww׆BBBMMMffffff___fffUUUUUUפfffݲ˲ݤˤ̤BBBיㆆ999wwwwwwMMMMMMfffݖUUUfffUUU___ffffffffffff______UUUUUUݤfffפ̲ݤפ˲˲ˤ̲㖖㤠񖖖ˤ̙BBBㆆ999fffBBBfffwwwwww　fff______UUU㤠MMMMMMݤfffפ̲̲˖˲ݲ˲˙˲̤˙BBBㆆ999MMMMMM겲fffUUUMMMݤfffפ˲̲˲ˤ˲˖ˤˤ񤠠ꤠݖ̤̙BBBwwwMMMㆆ겲999񤠠겲ݤfffݤ˲˲˲˲ˤ̲˙ˤײˤ㙙̤ˤBBB񆆆ꙙUUUfffBBBBBBwwwMMMwwwBBBMMMUUŬBBBBBB___BBBwwwBBB999MMMㆆ999___333ݤfffפ˲˲̲˲ꤠ̤̤̖̲̤ˤ̤BBBwwwㆆ݆wwwMMMיwww___999fffMMMˤ_________www݆wwwUUUfff___wwwUUUㆆ999___BBBwwwwwwwwwwwwUUUMMMˤwwwfffUUUfffUUU___̤݀fffUUU333___ݤfffפ˲˲˲ˤ˲˲ˤ̙BBBwww݆wwwBBB"""___fff___ ___UUUUUUUUUwwwUUU)))___UUUUUUㆆ999fffUUUMMM___̆______̤www񙙙񆆆333MMM___wwwUUUBBB̤wwwUUU)))wwwMMMUUUݤfffפ))))))))))))333))))))333˲̤̤BBBfffBBB___fffBBBUUUMMMUUUMMM___˙BBBBBBfffwwwfffBBBwwwwwwꖖUUUㆆ999MMMUUUUUUwwwwwwfffUUUwwwfffwww999wwwffffffUUṲMMMUUU___ꆆꖖUUUݲfffפפBBB˲˲ˤ̤BBBBBB̖____________݀ㆆ999fffMMMwwwꀀUUUwww̲wwwUUUffffffUUUפfffפMMM999˲̲MMMײ񲲲̤ˤBBBㆆ999MMMUUUwwwꆆ___333MMMMMMfffwwwݲfffݤUUU999̲˲999̙̤ˆ˲̤񖖖ˤˀ񤠠˖ꤠ㲲̲̙񤠠ײ̤̙BBBㆆ999ݤfffפfff999999̲999̤˲ײꤠ˲˲̲겲̙˲㲲񤠠ꤠ㙙ˤ̤BBBㆆ999UUUMMMMMMפfffפ333̀999˲˲BBB̤̲פ˖ꖖפ̲י̲פ̲˲̤㲲̲ꤠݙ̲ˤ̙BBBㆆ겲999www___UUUwwwwww񖖖fffUUU)))wwwBBB___MMM___MMM񤠠999UUU___BBBwwwMMMfff___ꆆ㖖fffwwwꆆMMM___wwwUUUפfffפ̤UUU겲333999˲̲BBB̤ˤ̲̲˲ݙ̙̤˙BBBwwwꤠwwwMMMUUUwwwMMM___׀MMMUUUUUU񤠠www______ㆆ999fffUUUffffff񆆆fffwww񆆆wwwUUUUUUBBBwww____________wwwꆆUUUwwwwwwUUUݙwwwUUUݲfffݤ333www999̲˲999999333333UUUˤ̤̖̤̲ˤ˲ˤˤBBBwwwꆆfffwwwfffז̆㤠ffffffwwwUUUfff___UUUwwwˀㆆ999MMMMMMfff˖fff___񀀀UUUMMMUUUㆆUUUMMM___MMMMMMwwwUUUffffff㖖BBBUUUUUUUUṲMMMMMMUUUݤfffפ___999̤̤BBBfffזꆆffffffwwwꆆwwwfffwwwwww999fff___wwwfffUUUㆆ999fffUUUwwwז___fffwww___UUUUUUwww___www___www㖖MMM___wwwUUUפwwwMMMUUUפfffפUUU999˲ˤ˙BBB___MMM______UUUMMM̤ײMMMUUUfffwwwㆆ겲999fffUUUfff999wwwfff݀wwwwwwwwwMMMݤfffפ̆333999˲˲ˤ̤BBB___MMMwwwwwwㆆ겲999ݤfffݤBBB˲̲MMMײݲ̤̤BBBㆆ999___fffݤfffפ˲˲999ˤ̤ˆ˲̲ˤݤ˲̲ˤˤ˖ˤˤˤ̙BBBㆆ999999999MMMMMMꤠBBB̤BBBײMMM999wwwMMMזݤfffפ˲˲999ˤ˲ײ񤠠˲̤񲲲ײꤠ˲̙ݲꤠݲ̤̙BBBㆆ999fffBBBפMMM̤fff񲲲fffUUUwwwfffUUU㤠______fffMMMMMMMMMMMMfffˆ______wwwfffUUU̖ݤfffפ""")))"""""""""̲̲999̤̲פ˖̲̲㲲̲˲˲ײ˲ˤ˙BBBㆆ999wwwMMM)))fff___UUṲwww___BBB___UUUwwwfffffffffBBB___UUUfffwwwUUUUUUMMMUUUפwwwfffBBBfff)))񀀀fffUUU̖ݤfffפײ999˲˲BBBˤˤ˲˲̤̤˲ˤˤ˙BBBBBB̖BBBMMMwwwfffUUUwww　BBBㆆ999wwwfffBBBwwwUUUUUU333___wwwUUU999)))fffUUUwwwBBB)))׆wwwUUUˀfffBBBfffUUUUUUUUUfffBBBfffUUUݖݲfffפUUUfff999˲˲999999999333UUṲ̤ˤ̲ˤˤ̲̤BBBfffUUUfffwwwfff___fff______wwwfff___UUUUUUUUU׀　׀　UUUfff___wwwㆆ999fffMMMMMMUUUUUUMMMMMMMMMwww___MMMUUUזݤfffפUUU999˲ˤˤBBBUUUwww___fff______UUU˲wwwMMMfffUUUMMM___wwwזUUUfffwwwwww׆UUU___333̆ㆆ999fff______wwwfff___݀www___񤠠fff___פfffפUUU999˲̲̤BBB999˲˲)))MMMBBB̲wwwMMMUUUwwwfffBBB999MMMײwwwㆆ999ꤠݤfffݤ̤)))UUU___999˲˲̙BBBݲꀀMMMUUUꤠㆆ999ײ㲲ݤfffפMMMwww999˲̤̤BBBㆆ999___wwwי___UUUwww___www̆˙wwwMMM̖ݤfffפ̤fff999˲ˤ̙BBBㆆ333fffBBB)))fffMMMfffffffffBBBwwwffffff񆆆UUU̖ݤfffݤUUUwww999˲ˤ̤BBBㆆ999MMMUUUfffˀfffBBBפ______MMMwwwffffffwwwwwwwwwBBBUUU̖ݲfffݲ̖fff999˲񲲲̙BBBㆆ333fffMMM　זwww___MMMUUUזפfffפfff333̙̤BBB333MMMwwwUUUffffffUUŬBBBUUUBBB׆fffUUUㆆ999MMMMMMBBBݤ)))BBBUUUBBBwww)))MMMfffݤfffݤ999̙BBBwwwfffwww___̖MMMfffㆆ999ݤfffפ㲲̤BBBfffffffffUUUUUUfffwwwBBBfff̖MMMfff___fffwwwㆆ999BBBwwwפfffפ̙BBBwwwfffwwwwwwfff㙙BBBUUUwwwwwwBBBUUUwwwwwwfffㆆ겲999fffMMM___wwwMMMwwwUUUfffMMMMMMˆwwwUUUfffwwwUUU___UUU___wwwUUUUUUUUUUUUBBB___wwwMMM̲___333̖www___UUUUUU______wwwUUUfffUUUUUUBBB񀀀ݤfffפ̙BBB999̀ffffffㆆ999fffMMMfff　UUU___ffffffBBB_________fffUUU______MMM׆___UUU񀀀___ꀀפfffפ̙BBBꤠㆆ999MMMMMMfff񲲲UUUUUUꀀUUU___www___ꖖ999UUU___"""MMMfffwwwwww___UUUwww˙wwwwwwMMMזUUU񀀀___MMM　ݤfffפUUUBBB)))999999999999999333̤BBBㆆ999fffMMMfffwww　ײUUUwwwwww)))www˲MMM___˖wwwwwwזwww______ꀀݤfffפBBB̲UUU̙BBBㆆ999fffwwwwwwfffwwwwww"""fffwwwUUUwwwwwwݤfffפBBBBBB"""UUṲBBB___ㆆ999פ̙fffײBBB___UUU)))___UUU̙999ꙙwwwפMMM333BBB׀BBBwwwMMM999񖖖wwwwwwBBBMMMUUUwwwMMMBBBㆆ999wwwfff___UUUݤ___ffffffffffffffffffwwwfffפBBBUUUUUU"""UUUUUUUUUˤBBBMMMUUUUUUfff̆___UUUwwwMMMUUU___wwwUUUUUUBBBUUUMMMMMMfff___wwwfff˲ㆆ999BBBBBBMMMBBB񤠠fffUUUMMM㲲BBBݖꖖ___MMMꆆMMM___̤BBBMMMUUUMMMBBBMMMBBBfffݲ)))fffפBBBUUUUUU"""UUUBBB UUṲBBBwwwfffMMM MMMwww"""MMMUUUUUUwwwUUUUUUfff___www)))UUU̙fffffffff999fffwwwfffㆆ999fffBBBݤ　MMM333___fff______UUUUUUˤ______fffwwwUUU___MMMMMM񆆆wwwfffݤ"""fffפBBB___UUU"""UUUˤUUU̙BBBfff񲲲BBBMMM___BBBBBB999BBBUUUUUUMMMUUUwwwUUUUUUMMMMMMMMMMMM333BBBㆆ999wwwMMM)))fffUUU　UUUUUU______www wwwBBBfff㤠UUUwwwݙ___fff___fff̆UUU______UUU񀀀fffײז)))fffפBBB㖖UUU)))wwwBBBBBBUUU̙BBBUUUMMMwwwUUUUUUfffㆆ999www___BBBwwwUUU　ˀBBBMMMwwwUUU)))UUU׆333UUUfff㖖UUUMMMBBBfffBBBMMMUUU___UUU񀀀fffݤ___fff"""fffפBBBMMM"""UUṲBBB̤פㆆ999fffUUUwwwfffBBBfff___fffwwwfffݤMMMwww"""fffפBBB"""fff˙BBBㆆ999wwwwwwwwwwww݆wwwwwwݤ˲___BBB"""fffפwww333333333333999333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333)))www___333333333333333333333333333333333333333333333333333333333333333333333333333333999333999333333333333̤BBBㆆ999wwwݤ̲www"""fffݲ̙BBB___ㆆ999̙㤠㙙יUUUMMMݤ"""fffפ˙BBB333MMMꤠBBBBBBMMM999MMMUUUwwwBBBfffUUUBBBㆆ999___יMMMwwwwww___MMM___fff̆UUUMMM___MMM___ˀUUUUUU˖זwwwMMM̆UUUݤ)))fffײ̤̤̤פ̲˲˲̤BBBwwwMMM񆆆______UUUUUṲMMMˤffffff___wwwMMMMMM___UUUfff񀀀ㆆ999fffMMM)))fffꆆUUUwwwwwwBBBffffff______݆UUUUUUwwwUUUUUU___fff___ז)))fffwwwUUU̖UUUפ"""fffײMMMfffwwwfff___wwwwwwwwwwwwwww999wwwUUU___www___fffUUUwwwwwwfffMMMMMM___999BBBBBBUUUfffפ333wwwMMMBBBBBBfffwwwUUṲBBBwww񖖖___UUUUUUUUU333fffwwwfff)))______UUUfff"""fffUUUfffㆆ999wwwfffffffff___wwwwww　fffwwwfff___fff___UUUfffwwwUUUfffUUUwww___www)))ffffffUUUffffffwwwwwwwwwwwwMMMUUUײ333fffݤBBB㤠UUUfffBBBfffwwwfff)))www___MMMMMMfff___UUUwwwUUUUUUfffwwwBBBUUUUUU___www999fff̤wwwUUUUUUMMMwwwwww___˙BBBfff___񆆆BBBBBBUUUfff̖UUUUUUwwwwwwUUUMMM㲲MMMBBBfffㆆ겲999fffMMM　MMMMMMMMMfffUUUUUUזUUUݤfffפBBBפwwwwwwfff___wwwwwwBBBUUUwwwffffff___)))www___www___wwwUUUUUU̲wwwwwwwwwfff___wwwwwwBBBMMM999___fff___wwwwwwפwwwMMMBBBUUUfffwww)))̙BBB999wwwwwwMMM___www______񤠠ㆆ999MMMMMMꙙfffMMMwww)))wwwײwwwݤˤfffפBBB겲wwwפ̲ˤפUUUwwwBBB̲̤www999̙BBB񤠠㤠ㆆ999ݤMMMUUUUUUUUUUUUUUUUUU___fffפwww999MMM___̀UUU999www̤wwwwww̲̙BBBㆆ999___BBBײ)))fffפ̤999ㆆ999___MMMUUUwwwUUU　MMMwww___UUUUUUUUUfffUUUfffUUU______݆UUUMMMfffUUUUUUMMMBBBBBBݤ)))fffפ˙BBBㆆ999fffMMM___ㆆUUUwwwwwwfff˖ffffffwwwwwwUUUwwwUUUUUU______fffפ̤)))fffפ̤BBB333UUUMMM999BBBUUUwwwBBBMMM999ㆆBBB̀ㆆ333MMMMMMwwwݤ___fffㆆ___זMMMfffזwww___fffUUU___ݙwww___UUUUUUݤ̤fff"""fffݲ̲̤BBBwwwBBB___BBBMMMUUU___wwwㆆ999fffMMMˆㆆㆆꆆ㖖˖㙙　񖖖___ݤ˲___)))fffפ999ˤBBBfffwww)))______www999UUUㆆ999fff___fffwww񤠠fffUUUMMMUUU999פwww"""fffפBBB˙BBBfffMMM333UUUMMMMMM999ݖㆆ999ݤwww"""fffפBBB׆׆̙BBB___̆˙ㆆ)))3333333333333333333333333333333333333333333333333333f33333333ݤ)))fffפBBBUUUUUUꖖ겲fffMMMUUUMMM׆___www݆fffwww___wwwꤠfff겲ݤfff̙BBBㆆ"""f̙̀̀f׀f̀33̙̙̀ff̙3ff̙̙̀̀̀׀f׀33f׀̙̀ff̀f̀f̙33f׀3f̀f̙f̙̀יf̀f3f̙̙̙̀̀f3ݤ)))fffݤBBBUUU___)))ffffff___UUUffffff___UUUwwwUUUwwwwwwfffwwwUUU___̤BBBㆆ"""̙̀׀3ffff33̙̀f̙3ffffff̙̙ˀ̙̀̀̀fff̙̙f3̙3f̙̀̀3̙̀f̀f̙3̀3f̙f̀3̀3̙̀ff3̙̙3̙̀f̙3ff̙3̙̀3f̀3פ"""fffݤBBBUUUUUUwww___UUU___ffffff______UUUˤMMMfffMMMwww___fffwwwwww___fff___ffffffMMM333̤BBBㆆ)))̙̙̙̀׀3f̙݀3fי3̙3f̙̙̙̙̀׀̙̙3̙̙f̀3̙̙3f̙̙̙̀̀3̙̙̙̀ff̙̙̀3̙̙̙̙̀3̙̀f3̙̙̙̙̙̀3̙̀3ݤ333fffפBBBUUUUUUUUUUUUwwwMMMMMMMMM̙BBB___www___זfffwwwㆆ"""̙̙3ˀ̙̀f̀3̙̀f̙3f̀f̙̀י3̙̙3̙f̙̀݀3f̙݀3f̙̙̙̀f̙f3f̀3ݙff̙̙f̙̀f̀f̙3̙̙̙̙̙3̙̙3ݤfffפBBBㆆUUUBBBBBB̙BBB񖖖　MMMBBBfff999___"""BBBBBBfffUUUMMMfffBBBݤUUUㆆ)))̙̙33ˀ3̙̀f̙f̙̙̀̀33̙̙̙̀3f̙3fff̙̙̀ff̙̙3f̙׀̙3̙̙33fפ˲fffݤBBB̤BBBwwwUUU___UUUfffwww̖ffffffUUUUUU______wwwMMMffffffMMM___ז___ㆆ"""3ff̀3333ffff̙333f̀f̙333ff̙33ݤ̲BBBMMMMMMBBBBBBMMMBBBMMMfffפMMMBBBUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUMMMˤBBBwwwUUUMMMwww"""www̆___UUUUUUfffUUUwwwwww999fffMMMUUUꆆfff̲___ㆆ333̙̙ff̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙fff̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙ff̙̙̙̙̙3f3̙̙̙̙̙̙̙f33̙̙̙̙̙̙̙̙̙f̙̙f̙̙f̙ffffݤ)))fffפ˲̙BBBwwwBBB999MMMUUUMMM___BBBMMMUUU___BBBfff___MMMUUUBBBfffwwwUUUㆆ999̖̖UUUUUUݤ"""fffפˤBBB___MMMMMM___UUUㆆ999___wwwݤꙙwwwwww겲___fffwwwfffMMMMMMfff񀀀ݤfff׆　UUUfff݀ˀfff___UUU___UUUUUUݤ)))fffפ̙BBBㆆ999fffMMM)))wwwwwwUUUwwwUUU݀fffwwwwwwfffUUUMMMMMMfff333___㖖___fffMMMUUUffffffUUU______UUUפUUU"""fffפfff̲BBBUUUwww999fff999333UUUBBBfffffffffwww999fffwwẁfff333www̤BBBㆆ999wwwwwwMMMUUUwww___333MMM___fffUUUwwwMMM333UUUUUUwww___MMMfffMMMfff___wwwffffffUUU)))UUUfffUUUݤBBB)))fffפBBBݲUUU˖fffUUUBBB___fffײBBBBBB　___UUUMMMUUUfffꖖ̙BBBㆆ999fffBBB　______fff___MMMfff______UUUwwwUUUUUUݤ̀)))ffff̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙ݤwwwMMM___MMM)))MMMBBBMMMfffwww999BBBwwwUUUMMMUUUݖMMMBBBUUU___www)))UUUBBB̤BBBפfffㆆ999MMMMMMꤠ999UUUffffff˙UUUMMM999ݤ̤"""wwwff33f̀f̙3333f̀f33333f̙3f̙33f3f̀3f̀3f̀3f̙33f3ff3̀3f̀3̀3㤠999˖MMMfff׆BBBBBB ___UUU"""MMMUUUBBB׆BBB___BBBfffwwwBBBwww˙BBBꙙ333MMMBBBMMMBBB)))MMMUUUwww㙙___fff񆆆BBBBBBwwwwwwwwwMMMUUUBBBݲUUUㆆ999ݲ"""wwwff׀̙̙3f̙̙3f̙׀̙̙̀3f̙̙3̙ff̀f̙f̙3̙̙3̙̙3̙f̙f̙̙3̙f̙3f̙ff̙̙̀3̙̙3̙̙3f̙̙̙3f̙ff̙ff̙̙3f̙3f̙̙3̙̙̀3̙̙3f̙̙̀3̀̀3ꤠ999ݤwwwUUU999www999̤BBBMMMwwwUUU______MMMwwwUUUfffwwwUUUפUUUUUUUUUfff___UUUfff̖ㆆ999999999BBBBBBMMMBBBBBB999ꤠ)))wwwff̙̙̙̙̀̀̀̀f̙3̙ff̙3̙̀f̙f̙̙̙̙̙̀f̙3̙̙̙̀3̙̙̀3̙f̙̙̙f̙3̙̙3̙̙f̙ffˀ̙̀3f̀f̙3̙̀̀3礠̙̤̙̙̤BBBwwwfff___999UUUfffMMMwwwUUUפwwwwwwMMMfffUUUUUU)))999wwwfff̲MMMwwwwwwfff___UUUwwwㆆ999___fff___wwwffffff̤wwwwww______UUUfffwwwwww333wwwfffffffff̆fff999fffBBBMMMUUUMMMfffwwwUUUBBBꤠ"""wwwff̙̙̙3̙̙ff̙̙̙̙̀׀̙̙f̙̙̀ff̙̙̙̙3̙̙̙̀f̙ff̙̙f̙f̙̙ff̙f̙̙̙̙̀̀f̙̙f̙̙̙3̙̙̙33̙̙̙3̙̙̙̀̀3̙3̙f̀̀3ꤠ˙BBBwwwMMMMMMBBB"""BBBfffUUU׆___fffwwwMMM999MMMUUUUUU___UUUMMMBBBUUUUUUㆆ999fffMMMUUU㖖MMM̖www_______________MMMBBBfff׆UUU㤠BBB겲)))wwwff̙ff3̙̀̀̀f̙̙f̙̙̙̀̀33̙ff3̀׀̙̙̀̀33f̀f̙3̙̀̀3㤠̤BBB999̀)))̀www999ㆆ999MMMMMMfffwwwMMMזfff999fffUUUffffffwww___333UUUUUU˲BBBꤠwwwff̙̙̙̀̀̀f̙3̙̀fי3̙ݙ3̙̀3̙̀י3fݙ33f̀f̙3̙י3׀3礠̙BBBㆆ999fffMMM̤㖖UUUfff㙙fffˤ___fffwwwUUUBBBUUU̲BBBꤠwwwff3겲ˤBBBㆆ999fffMMMUUUUUUBBB333UUUBBB999___www333˲BBBꤠ̀BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB___㤠̤BBBㆆ999999ꤠ̤BBBMMMㆆ))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))""""""""""""""""""MMM㤠˙BBBwwwMMM___BBBwwwײ̆MMMBBBBBBˀMMM999MMMㆆݤ˙BBBUUUMMMfffwwwwwwwwwUUU겲wwwfffwww___fff___̆BBB񀀀UUUfffwwwUUU___UUUwwwݖㆆ񲲲___פ̤wwwwww̙BBBwwwwwwwww999www̤wwwwww___BBBwww___wwwffffff999___www___fffwwwUUUMMMwww"""UUUBBBㆆ333פ̙MMMwwwזBBB׆̖333MMM㲲BBB˲BBB̆׆׀̤BBB̙BBBˆBBBwww݆BBBײBBB̤BBB̲www̤BBBUUU　UUU񤠠wwwfffMMMBBBMMM񤠠UUU___MMMfff겲UUUBBBBBBMMMwwwㆆ999 333ײMMM̤fffMMMMMMUUUwwwMMMMMMMMM___̖wwwwww݆BBBUUUwwwwwwBBBUUUㆆUUUMMM㲲www׀MMMwwwMMMUUUMMMwwwwwwwwwwww˙BBB333̲BBB̖MMMfffˆㆆ999BBBMMMffffffMMMUUU)))㖖wwwfffUUUwwwBBBBBBBBBwwwBBBwwwMMMwwwMMM___UUU񆆆wwwUUU񤠠MMM999___wwwMMM˲wwwUUUפUUU̲fffMMMUUU___wwwBBBMMMMMMfffwwwUUU___BBB___wwwUUUUUUUUU___UUUUUU999UUUwwwMMMMMMMMMwwwwwwwww̙BBBݙㆆ999www　MMMUUU___݆UUU______UUŬfff___wwwMMMwwwיBBB˙fffUUŬ___UUUUUUUUUMMM̲UUUUUUפUUU___999BBBBBBwww___"""999999wwwfffMMMfffBBBMMM___fffMMMMMMwwwBBBMMMBBB______999)))wwwwww999UUUfff___999www̤BBBㆆ999UUUBBBMMMUUUUUUUUUBBBBBBUUUfffMMM___UUUMMMwww㖖ꙙBBBMMMUUUMMM"""www___wwwUUUUUUUUUBBB)))___BBBMMMUUUפUUU㲲fff999wwwBBB999ז̤fff̙BBBㆆ999wwwˤBBBMMMUUUUUUMMMMMM׆___wwwUUUMMM999̆wwwBBBwww999˖MMMUUUMMMfff___UUUMMM"""___ז___UUUפ̖999fff̙333̀wwwwww˙BBBㆆ999333MMMBBBMMMUUUwwwMMMMMM)))׀wwwBBB999פ̙BBBwwwMMMfff񆆆BBBwwwUUUwwwwwwMMMBBB׆BBB̖BBBꀀㆆ겲999ݲݲפˤBBBUUUMMMfffwwwwwwwww˲UUU겲fffwww___UUUMMMUUUBBBUUU񀀀___fffwwwㆆ333ݤˤBBBwwwwwwwww999www̤wwwBBB___999www___wwwfffMMMfffwwwBBBfffUUUfff___ㆆMMM))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))"""UUU겲񤠠BBBUUU　MMMꤠwwwfffMMMUUUfffUUUffffffUUUMMM999"""ݤBBBwww˲ㆆ̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̲̙̙̲̙̙̙̙̙̤̙̙̙̙̙̙̤̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙BBB333̲___UUUMMM333ㆆꤠ33f33f33f33f33f333fffff3f3ff3ff3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fff3fff3fff3fff3ffffffffffffffffffffffffffffffffffffffffffffff3fffff3fff3fffffffff3fffffff3fff3fff3f3f3fff3fff3f3f3f3fff3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f33f333̙3f3̙3̙33̙3̙3̙3̙33̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3f3ff3f3f3f3f3f3f3f3̙fBBBㆆ񤠠MMMꀀ3f3ff3f3f3ff3f3f3ff̙̀3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fff3fff3fff3f3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffff3fff3fffff3fff3f3ffff̙3ffffff̙33ff̙3ff̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙fwww______fff_________fff33̙fBBBㆆ񤠠MMM疖̀3̙̙3י̀3̙̙̀̀3י3f̙̀ff3יf3˙3ˀ̙̙ff3̙̙̀̀3˙3̙̙̀3ff̙̙3ff3̙̙ff̙̙f3f333f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fff3fff3f3fff3fffff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffff3fffffffff3fffff3f3fffff3fffff3fff3f3ff̙3ffff3f3f33f33f3f3̙3f3̙3̙3f̙3̙3̙33̙33̙33̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙33̙fBBBㆆ̙ff3fff333f̙̙̙̀33̙̙fff̙̙ffffffff̙̙f3fffff̙̙3̙fffff3̙̙3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fffff3fffffff3fff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffffffffff3fff3fff3fffffff3f3fff3ff̙3ff̙3̙3ff̙3ff̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙33̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙33̙fBBBㆆ񤠠UUUfꖖ̙̙3̙̙̀ff̙̙̙̀fffff̙f̙ffff̙̙̙3̙3fff3̙̙3̙f3f˙3̙3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fffff3fff3f3fff3fffff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffff3fffff3fffffffff3fff3ff̙3f3ff̙3fff3f3f3f̙3ff̙3f33̙f3̙f̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙ײ33̙fBBB񙙙wwwUUUBBBwwwwwwBBBMMM999ꖖwwwݲUUUBBB񤠠BBB̆MMMwwwUUU___BBBㆆ̙̀fff̙̙f̙̙3̙̙̀f3f̙̙fff̙3̙ff׀f̙̙ff3fff̙3fff3fݙ3̙̙3f̙̙3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fffff3fffff3fffffffff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffff3fffff3fff3fffffff3fff33̙ff3f33f3̙3ff3̙3̙3̙3̙f̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙ײ33̙fBBBUUUUUUUUU______ffffffUUUfffwwwUUUUUUݖUUUfffUUUUUUMMMݤfffˆfff______MMMUUUffffff___fffㆆ񤠠___f̀wwwffwwẁ̙̙3̙י3̙̙̀fff̙̀3fff3fff3f3ff3f3f3ff3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fff3f3fff3f3fffff3fff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffffffffffffffffffff3fff3fffff3f33f3fff3fff3fff3̙3ff̙3f3̙3f3̙3f3̙f̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙33̙fBBBUUUMMM______̤UUUwww"""MMMfffwwwUUU)))BBBwwwUUU̙fffMMM___fff)))wwwwww___999___333ㆆꤠffff̙̙ff9993̙̀ff3f3f33f3f33f3f3f3f3f33f333f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fffff3f3fff3f3fffffffff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffffffffffffffffffffffffffffffffffff3fff3fffffff3fffffff3f3fffffffff3ff3̙3f33ff3̙3̙3f3̙33̙3̙3ff3̙3̙3̙33̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙33̙̲33̙fBBB___ꙙUUUwwwUUUUUUUUUUUU̖___wwwfffUUUUUU___UUUMMM㤠MMM___fffMMMㆆ񤠠33wwwwwwfffwwwBBB3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3fff3fff3fffff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff3fffffffffffffffffff3fffff3fffffffff3f3f3fff3fff3fff3fff3f3f3f3f3f3f3fff3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f33f3f33̙3̙3̙3̙3f3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙33̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙3̙fʦf33̙fBBBUUU___MMMMMMUUUMMMwwwㆆ񲲲333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333f33f3ffff3ff3f3ff3ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff̙fffff̙fffff̙f̙f̙f̙f̙f̙f̙f̙f̙ff̙f̙f̙ff̙f̙f̙f̙f̙f̙f̙f̙ff̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙f̙3̙3̙3̙3̙3̙3̙3̙f̙f̙fBBBㆆBBBㆆBBBffBBBUUUMMMMMMUUUBBBBBBBBBBBBMMMMMMUUUUUUUUUBBBBBBBBBBBBMMMUUUMMMUUUUUUBBBBBBBBBBBBMMMMMMUUUUUUUUUBBBBBBBBBBBBMMMMMMffㆆBBB̙̀ffㆆBBBfff̀ff̙̙̀f̙3̙׀3f̙̙̙̙̀̀̀̀3̙̙3ff̀ㆆBBB3̙̙3̙̙̀̀f̙̙f̙̙̀3̙̀f̙33̙̀̀f̙f̙̀ffㆆBBBffff̙̙̙̀̀3f̙fˀf̙̙̙̀3f̙̙̙̙̀̀f̙f̙̀ffㆆBBB̙fff̀3̙̙f̙̙̀݀3ݙ3̙̀̀̀י3̙̙̙ffffㆆBBB̙̙̀̀ݙ33̙̙̀̀wwwㆆBBB̙3333ff̀wwwㆆBBBffBBBBBBBBBBBBBBBUUUUUUMMMMMMMMMBBBBBBBBBBBBUUUUUUUUUMMMMMMBBB999999999UUUUUUUUUUUUMMMBBBBBBBBBBBBUUUUUUMMMUUUMMM999ffㆆBBBㆆBBB999ㆆBBB㖖BBBwwwUUUwwwBBBwwwפ񀀀MMMBBB"""ㆆBBBwww˲UUU겲fffwwwUUUUUUUUUMMMUUUBBBfffUUŬfffUUUㆆBBBwwwfffwwwwwwBBB___999wwwUUUwwwfffMMM___MMM___fffUUU׆UUUwww999UUUMMMㆆBBBfffMMMMMMfffUUUfff___MMMMMMwwwBBB___MMM___ㆆBBB___UUUMMM___ˀㆆBBBꙙㆆBBBㆆBBBㆆBBBfffㆆBBBꖖMMMwwwꤠfffUUUUUUfffwwwwwwwwwUUUUUUBBBݲUUUㆆ999MMMfffwwwfff___MMMffffffUUUUUU______UUUfff̙ㆆBBBwwwfffꖖwww)))___www999fff333wwwfff̲MMMwwwwwwfff___UUUwwwㆆBBBfffꆆwww̲fffUUUMMM___UUUUUU___UUUMMMBBBUUUUUUㆆBBBfffˤMMM999ㆆBBBݤㆆ999ㆆ)))_________UUU____________UUU______UUU_________UUU____________UUU__________________UUU___UUUUUU_________UUUUUU______UUU____________UUU____________UUU_____________________UUUUUU______UUU___UUU____________UUU___UUUUUU_____________________UUU______UUU___UUU___UUU____________UUUUUU______UUU____________UUU______UUU_________UUU____________UUU__________________UUU___UUUUUU_________UUUUUU______UUU____________UUU____________UUU_____________________UUUUUU______UUU___UUU____________UUU___UUUUUU_____________________UUU______UUU___UUU___UUU____________UUUUUU______UUU____________UUU______UUU_________UUU____________UUU__________________UUU___UUUUUU_________UUUUUU______UUU____________UUU____________UUU_____________________UUUUUU______UUU___UUU____________UUU___UUUUUU_____________________UUU______UUU___UUU___UUU____________UUUUUU______UUU____________UUU______UUU_________UUU____________UUU__________________UUU___UUUUUU_________UUUUUU______UUU____________UUU____________UUU_____________________UUUUUU______UUU___UUU____________UUU___UUUUUU_____________________UUU______UUU___UUU___UUU____________UUUUUU______UUU____________UUU______UUU_________UUU____________UUU__________________UUU___UUUUUU_________UUUUUU______UUU____________UUU____________UUU_____________________UUUUUU______UUU___UUU____________UUU___UUUUUU_____________________UUU______UUU___UUU___UUU____________UUUUUU______UUU____________UUU______UUU_________UUUfff""" UUU999fff̆______MMM999wwwBBB333999UUUwww999___wwwUUUMMMBBB333wwwwwwMMMfffפ999___fffBBBfffwwwfff___̀333׀fffffffffffffff999333UUUפwwwBBBfffffffffMMMBBB̀333___̲wwwMMMMMM BBB333wwwUUUBBBBBBUUU___wwwfffUUUMMMUUUwwwffffffMMM㙙BBBUUU̲MMMMMMBBBꀀfffBBBݤwwwUUU㙙BBB㲲wwwMMMUUUBBBBBBBBB˙999BBB333UUUBBBwwwwwwfffUUUBBB　wwwwwwיBBBBBBUUUfffMMMUUU___ffffffMMMꙙBBBffffff___MMMBBBffffffBBB999UUUfffMMMfffBBBwwwfffUUU___www˲ffffffwww """___UUUBBBUUUfffUUUMMMBBBꀀfffMMM______999MMMfff)))___MMM___UUU999̲MMMfffBBBUUUMMMBBBfffwwwfffBBB___)))wwwBBB999UUUBBB___UUU999___ffffffBBBꆆUUUUUUfffUUUBBBfff___BBBBBBffffffMMM̤wwwUUUwwwwwwUUU___̖MMMBBBwww333UUU___BBBBBBUUU___UUU999999333wwwUUUUUUMMMUUUזBBBwww݀999UUUBBBUUUMMM999www׀999___333MMM999MMMwwwUUUwww׀BBBMMM___wwwUUUMMMז333BBBײfffUUU___999999333___MMMBBBBBB___MMM)))www___MMMݖBBBwww999MMM___BBBMMMMMM"""___̤˲̖˲ˤˤ̤̲̖̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙̙ꙙפݤwwwꤠʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦUUUʦʦʦʦʦʦff̙ʦʦ̲̲̙̀ʦʦʦff999̙̙999fffʦ̙fʦʦʦ___999ʦf999fʦʦ̙999ffʦBBBUUUʦ̙f̙ʦfff̙̙ʦʦʦʦʦʦʦʦʦʦʦfBBBMMMʦʦBBBMMMʦfffʦʦʦUUUʦʦUUUBBBʦff̙ʦff̙f999fʦ___̙ffʦʦʦUUUʦMMMBBBʦff999̙fʦMMMʦʦ___999___UUUwwwffffffBBBUUUwww___̀www999www̤___BBB)))BBBUUUwwwUUUUUU___999̲999UUU999___www999999ffffff999______BBBfff˲̲ˤ̲̙̀ʦʦʦ̙f33MMMfff̙̙ffʦ̙̙ffMMMUUUBBBʦʦBBBff3ffʦ̙ffBBB)))fffffMMMf̙ʦʦʦʦʦʦʦʦʦBBBʦfffffʦʦ̙UUUʦʦʦBBBʦ̙ʦff3ʦ̙fffʦ̙MMMfMMM̙BBBfffʦʦ___ʦʦʦffMMM999ʦUUUʦʦ̤wwwUUUUUUUUUfffMMMMMMwwwfff999UUU___UUUMMMMMMUUU___fffBBBUUUBBBBBBMMM̤㤠BBB̲wwwUUṲBBBBBB̤BBB̲̲̤ꤠ񲲲񙙙񤠠̖̀ʦʦʦ̙fMMMUUUfffʦ̙ffff3ffUUUUUUMMM̙̙fMMMMMMffʦ̙ffffff̙f̙UUU̙)))BBB̙fʦʦʦʦʦʦʦʦʦBBBʦ̙fffffʦʦffffʦʦʦBBBʦfff999fffʦʦ̙fffʦ̙BBB̙̙UUUʦ___fʦʦʦ___̙ʦʦffwwwBBBfʦff3ʦʦ̤www̖MMMUUU___fffMMMwwwBBBUUÙ333BBBfff999UUUUUUMMMUUU___wwwBBBwwwwwwMMMUUUBBBUUUBBBMMMBBBwww999www"""333MMM㖖wwwBBBwww333fffBBB˲̲̤ˤ̤̙̙̀ʦ̙ʦBBBʦBBBfffʦ̙ffʦ̙ffMMMUUUBBBBBBf33ffʦ̙ff̙999̙ʦ___UUU̙f̙UUUʦʦʦʦʦʦʦʦʦBBBʦfffMMMUUUʦʦMMM̙ff̙UUUʦʦʦfff999MMM___BBB̙f333ʦʦʦffff333___BBBBBBʦUUUʦʦ̤wwwײ̆UUUBBBBBBwww̤333)))wwwBBBfff333999BBBfff333999___BBBwww333 BBB999999333999999wwwBBBUUU˲˲ˤ˙ݲ˙̙999333MMM3̀ʦʦʦ333̙f̙ffffff̙)))ffʦʦ̙ffffffffffUUUʦʦ___fUUU̙fff̙f̙ʦffff3̙f___fff3ʦʦʦʦʦʦʦʦʦUUUfffʦʦʦʦffʦʦwww̙ffffʦ̙)))ffUUUfUUU̙ʦʦʦʦff3ffff̙fʦUUUffff̙ffʦʦ̲___ffffffwwwfffMMM̤BBB999fff̀wwwפwww̖999̲˲̙˲̲̖̖3ff̲33̀ʦʦʦ̙̙f̙ʦf̙ʦʦʦʦʦʦ̙fʦfʦʦʦʦfʦʦ̙̙ʦʦʦʦʦʦ̙ʦ̙̙f̙ʦʦʦʦʦʦʦʦʦʦf̙fʦʦʦʦʦʦʦ̙ʦ̙ʦʦ̙̙fʦʦʦ̙ʦʦfʦʦʦ̙ʦʦʦʦʦʦ̙ʦ̙fʦʦfʦ̙ʦʦʦ̲ˤ˲̲̲ז˲˲˲̙3f33̀̀ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦʦʦʦ̙̲̲̙˙f33"""̀ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦ˲̆׆UUU̲̙f3f̖ʦf33wwwMMMUUUʦʦ̙̙ʦʦfffʦʦf̙fʦʦf̙ffffʦʦfʦʦffʦʦ̙̙fʦʦffʦfʦʦwww̙ʦffʦʦfʦfffwww̙̙̙ʦfʦʦffffʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦwww̖www˙˲פזwww׀www׆wwwwwwwwwwwwwwwwwwwwwwww̲̲̤̙www___wwwwwwfffwwwwww˲wwwפwwwˤffffffˤ̙wwwwww̆www˙fffBBB̙fffwwwwww˲˲㲲יwwwBBB"""f BBB̙̤̀׀www˲׆wwwݤיwww333fffʦʦUUUBBB̙f̙̙̙ʦ̙̙999ffʦʦff̙̙)))f̙ʦ̙BBB___ʦ̙ʦ̙̙ʦMMMfff)))̙ff̙ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̲"""333BBBMMMBBBwwwfff)))fff)))""")))BBBfffBBB)))fffMMMMMMfffwww999wwwMMM999̲̀wwwMMMMMMBBBwwwUUUBBBMMMfffUUUfffwwwUUUwwwwwwwwẁfff___MMMMMMUUU___MMMUUUBBBUUUUUUUUUwwwMMMfffwwwwwwwwwBBB___wwwwww˲̲פ̤ꤠפ̙̀ݙff333ff333̀999MMM___www׀̆wwwfffwww___ffffffUUUBBBwwwʦʦ̙̙___333ffʦ̙ ʦʦ̙ff̙fff̙̙___ʦʦʦ̙ʦʦ___)))ʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦʦ999999333)))BBBwwwwww999fffwww"""333"""www___BBBwwwUUU999UUU333333UUUwwwwwwBBB˲̆wwwUUUUUUBBBwwwwwwUUU999UUUMMMUUUײMMM333www___MMMBBB̆UUUMMMBBBwwwUUUBBBUUU___BBBBBBBBBBBBUUUwwwfffUUUMMMꖖwwwwwwMMM333UUUBBBfff˲www˲̤񤠠񲲲㙙˙fMMM3ffwww3ff̀BBBffffff___׆wwwffffffwwwfffMMMMMMfffʦʦʦ)))fffʦ̙BBBfffffMMMff3ʦʦʦ333ffʦUUUBBB___fff)))̙ʦʦʦ̙fff___f̙ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̲"""www)))___999fff___www___fffBBB999)))MMM㲲BBBBBBwwwMMMwww333UUU333___www"""BBB̲̆BBBfff___wwwUUUMMMUUUBBBfffBBBBBB333BBBUUUBBBUUUMMMUUŬפMMMUUUBBB)))MMM___MMMBBBBBBBBBBBB___MMM___BBBBBBBBBwww333BBBMMM___BBB333˲ˤˤ3ff3ffff3̖wwwUUUBBBUUUBBBBBB̆BBBfffUUUBBBBBBUUUMMM)))___wwwBBBBBB___BBBBBBʦʦʦ̙ff"""ʦʦ̙ʦff)))ʦʦwww)))BBB̙ʦ333333ʦʦʦfff̙ff3̙ffʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦwww))))))wwwwwwBBB___fff"""˖___999fff999˲̆UUUMMM׆̆BBBBBBײwww̲˲̖̀UUŬMMMפwwwʦʦʦ)))ʦʦʦ̙ffffʦʦ)))MMMBBB̙)))MMMBBB̙ffffʦʦ̙BBBʦʦ999BBBBBBf999ʦ___fʦʦʦ"""ʦ̙BBB)))MMM999̙ffffʦʦ)))̙f999BBBfʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦMMM̤UUUwwwfff̆UUUfff̖999999̀fff̀fff̲̤999BBBwwwBBB999̖999999ffffffwww˲˲˖̙̀fffwww̤999BBBˀʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ˲̲̙̀ʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦʦ̙ˤ˲˖www˖˲˲̤ˤˤ̙˖̖̙פ˙̲̙ˤ̙̤̙̲̙̤פˤײ̤̖ˤ̙̲ˆ̤̙˲̙י̲˙̲̙̤ˤ̤˲ˤ˲̲̤̙˲̖UUU3ff3ff3ff3ff3ff3ff)))̲)))"""))))))))))))""""""999""")))))))))"""""")))999"""""""""""""""))))))ˤ̙זזUUU񲲲333)))999f3fffff̤̀י݆ˤ̖̆׆ˤ̙̖̆˲̲̖̤ˤ׆ˤ̆ˤ̖˲˙̤̙̖MMMBBB333333999___www)))ffff׀ˤ̖̀̆׆ˤ̖̲̙̀˙̤̖ˤ̆˙̖̙̖̙ז̲BBBBBB999BBB333MMM))))))wwwff̀ˤ˖˖̲ײ˖יˤ˖˖˖̲˙˖ײˤ̀ז˲˙̙ˤ˙זBBBMMMUUU333www)))UUUffffff̖˙̀˲˲יˆ˙̙פ˖ˤ̙׆̲̤˙ˤ˖˲MMMwwwwww)))333MMM999)))wwwff̐f3ff˲BBBˆײ333"""BBBff̙f̐3ffUUUBBBUUUfffwwwffffffwww ɉ?I"P" I/hyϻY*"$MJ$Mrb<=Ȝs&]L6+>ȧߴ> O&0D9sgٯsvf̒%?៻lߝ|瑕͝{ ҭmĭ96 62&EP˘q+?TO*1E@)"dm4Um``-3%mB[X%G>O<iҥz'>g!ӳ7Inݺ;]*$qxكxy8'4r)G?Nr ~Iy%ʙ~F+j`)fvMRv֮L☔O gyO+llꭓ𭤠~ꮊpr7Q*^)uEF;%%_ÏKgKSeH3I]o۸,E-\/1r ~EZ K_tSRSukV:`}4k_ '|=yZv- y}o쬞0D^bŒի\~ů?G]N/=яcO+VO]wI^`D5 J'!F9?)0#eJ=lEI&rbKHKB,| P _Owş|uԭ CD$?1oʒɚ5k4\t饗^74>Wsy|7C=;J5hu@T9uHTdۨ{GR}?0yT0[c"8E8l\!PʞR;b@,OrרN.h+B-vOэĎ$jM6AFy./ֶtB~:"#_tE_0<8V` lp瞒6lsjvxt:mAyԇ@-aH`"J ? QJtbe1/ ;@ f `@E \PR e/o.VȁԮǷ~3NШbhn$SjOm&4meRI%><&]zрFu0WE̓͆Po9o$˛4т"䜨ly1hlQoȈcrdD% a'+bdQu |ڬ!$͕ziN8nlLpÅ$4#dHO2O_W&~_z\=av+FfeҪ  CZ(t@z>P?-@%PzȀ.Yt T%5E08Gp#iQ T8oH]yPS?–_@`DŽ-Uh4+E?2֙W"AR) OJEVF+%R SUe0( $t&c\:)\VȱvKy/1֍\2hBa4dԘ7@U$&8KىUvm#56h'hlĶ3w.=y(hqGO|CYh`v'] 77oy[P0>U/QN]X@S?W^y0 y$A ܟTBR DOɔ-1RXR pUj&?%#111wH7CiՉƔܥgA~ᩖD洖$ ڃ_0CYpEQQPjϘ[ؐI^d)K}ם$/Nf#+܌6dJM$"H<ߔ)m)U\3}DrA"!8c~Cٟ!%>X+)I}ḽX0|"=Î?mYs㍅ җD÷3>ic Ҝ#D0/"jԴetCܓ~\ ,(.kŻH,},$ɉgz>WYD1.e*G*[SI9 EXh,lS<ؼѲ\aR*̀Iqsmc-}6ICoѷcJb%}( egq؏~ 4x7á0Rx+nյI?ʃ=7Mq*A' jpzmո^4n$v3z>FOȢxʹjH܌Us$m4}7[6D|};$٦FeχZL1.ld7-/UqM[~5n"| p)'217JZ3Oaa` n^|v!>%s쐎N0-l{CmImC;b!9drBg[ԤҎm4~L|ց1?R`n;1ydc}2°*N[<&L.wLݶ֪^k)_:΄}tͱqacc[vHog=Xmx a zfV8aWzlE K` jұ E&7A&ʸ-]j:)H"Qfv:eBdOky$iJd!IgN;d!t,#!I7t9,[o}/\qw 䝨x?O@w(D~Yw[nu͔Zgo~WvO;E|ft8jK2^uյnzgrFn@oh9lmq4MM4֘nIg!~2#i9~2ma9.;ACLT@iD>~rf*N$*KE\ȉR Sa80q(hnU*T{=r$t~N;ĝ0ʐ$`YU.R`P¼&;`qYҖiAmUHx2K%djMB@]J t%(zij=74#z-n+#drmؙxWO;d!vȴC % i^> Rx^\5Cm{F\\e3y ɢk9ع x̽i$?it#$g92QCOĸǥMVp=`ah\fc-G`e+X0"QJjlɤY#O@m}jjiL;kM 'Of!PՖ–ȕ2(҇D/\P㶪-by z`/qAOrwojv8s>.cGM*i}l,u%a9r ?ON_56:a@u]\3+[V/ckUE1)eqmBAzz)79T6I^ܴCP!|&?=o*_5 rl@.0EJ a5>ꨣH dȸ6Wq{bCU׎d1wr]!wݘr$ۢ*1g۸A ^LB]=#Fǻ*cyޓ ~HQz6X;ڠNӓdƖP69פHOʶݓP.HIg(nޘ@>^1f0,AnB?#E7:גj쐆 DZ?ΌtʑS~j'/rDC4RItҷJN+~=AUjf%0KAAtȜo_}ỊaO ;_d #<7}COSr k6ȩI |7/=ck58(+a)nMJa,>n֍z(IO2#k<{ C,蓼N[?ʻK/Jثmecs&!V{.Ij!!jk,ǧ4y#@2}\roG3 Ʈ@n$#(n칳D6 ]tN=T"O8yG@mC<";N&qYG ?'q+L7pR\:ٳ~J{a=' _ѵlK>Ӳi7 z{ȍk׮=\}]w4 1?.IV[5yH.S/O._{..Qŷ򘎃c7N8zx}{ǧO"ַN`H&j~G]PIKxj 8(fkQMjL6,-2FʚF[a}j Ws9/{,|+JX=/B^x᱘ 3Ndc=@AVַK_Goy-yEk){UW!:кV~04n)}79{ ,b RsWء H$+nt9`v}{Oc؏|#~'| _xGS瞫qͳ?@ `_7RJyvM7> =d|0@u{(;r Ni mp`=wq׻޵2PgzRM}~7l37鵯}-托9# , w4p])Oy Usx|x0`L%aE)j<餓EA੪y PbjS—dy,sZE&=& `5gWQѝRil%蝮6WYO|'>lɒhoxWB#N=.|pH5!F )ʇ[|bxT噙DŬw'1E:E b-_+?tDbK_zw׿x &$V{](U%3+VHڝt! u_EWA]{>@ Qk-wEnOIF HG?Nw(8[h3 ir|K^*>qK/%iG/H'?h?}+_.'&l ~75KxY@jssܶh=")Lg^|(ee$$_?73ipSJ2f>OAO!aR𽠢Mꣀfgum] "g;P2ٍ7nx= #!ǫRXt'>o [}^/KzO0*gaǿy<@|Sʀi9L_p7`'ȇ}iKq q!1ltB3HO>tEzyLB02)T9y?U-ցZ< <&)h.>Ł@u38zlNaBկTHʂ?X?#YLBMC/Q?FHr!gNƴVLZD lG_@|~n<|p5kN+__sIouES4;}~-;ُeGӞ;4k_?|e=d=χ[es |9UB_;]xt=/цÓxR|%׼ #^!ow=!y.P;P=X$ Ft7c7첯([.[=AV"l=|&8] /,+v{꫏}E`txB|;S/Pɭ[o#pt0S1ty/f-cC@&{]&,:N >O=nޣ.F930Nw+.#}?=nG3k>,+WD-Ur@\iT0ݎ7)BRT H#7uu[sSs<`X'e$qi$}8_ʧg$-8O>r";!@Gto~(7|blW dg?{^}9 ^?y %?MIK*s7??~Z}L4Xb'EZ"]q (s|tt`ѷ^d$eG$B/U%#>'nvFW]y$Wj&n|;Mmݷ'ݕ'ϥ'/Ffz]P<ߓН/Vj9u;ٯ@в3 g!V$.UNmVp5w> ԙf5-m[H^2C욕WNǣWrvokuXTZ ο䛲,6'&o{O|w5k`lR7#p. _އ7%HPc FCQo4.n)1b:%ةC-6ں`sN?y/yߪj.| ޠ/ݥ+ɒ3 &Fzs~GN;%#iϘ:̓,63{[ήa],s}_0K}L]#q j _^|}KdWZj*֜J^4^eêQp1/I!M[qT=&>ڇZO4%oÃZȑ?+51<S+\ly@."ZDVFj,wlGvc'0R"萼;:n T {I7N;d:DagW6)}m+p@Wla)N?ö'F)ڳH:,A&ڏ/Q?`Ś57B9mf=^xΝkK׭P*v½~@#bpzT,ݓ9ꢋǜv٤ aI)N+V3V]o\EKW[X7_ EpKqh;+trKezxd& ;N O86@y{ \iTxjCQo#yD7^mCp5ϑV&ڋo0UzQ"WVTjZ}nsm SUq`ÎBujrN#~C[/(Ra41Aа#ZaY\RuI'Qא<.j_2?^ދr 'm_2j.0A_vE{8 z! j<kA49n(gO©Xl]8?3 9U*ԫ}Hx /#Z:H_w48}N7W<Ml`?5dhL-P z;jɦ`S0tn参=dRHM#\ j Ot5(;:A3 _'KS$vyg\'5uT4dK,{``XjUE!+s `ʲ#W7.[V5$D~=A҈~Hb(F>y 4SKNbGː o"8fP|M*]Z $Ftqg=*C݅7*;aO>d -82C{?ЏOo)0ga*ȸ8@@|A)tDڊ.xG,_|y%¶QŻsnF|$Ac[j!I7:t?2ngkӕ,|шk AJxݻ>(<%E [H HnT< {Ǔvk{Hn ! [T(4"`ǡ'4`ce &RifFPP6ϔwu$`8s Mgcf9UbZl9Ev<% G<̀BmbW r~͂LP E,>B q*B?OOG#%xcvm?3x;!$@*2.&H'WnK *t=q"=D<ψjVTaCi;IG՛|6t_2;#&`-9[$cA UWW Ռt -W_x&@RoD^REcssb ь[ϫVutȱ7퐤2AӋhWq3 _L;wQXGp#zA+P:yd`a3Hҥ_cj,9AGnOw)1l̒e؆,z/]>#큀<< ״=8=Oo/st#d 41.p[KogViL{`z(Ez]*0 m.e=0iL{"tCZ7!0>%^͊+=^kcFd=lDGHšiݩѫ8w1dBj@/`&y.#}5퐤Ӧ2퐱XčS6'uVDo-;ml$' YDiR"אb}8r9+$q;$ R]ؒ: m!sAy\pX_BI0Y6IhI:@4D1!dWzD،hw3 3[EJ+BqWzvw8T_ M= ؁/CzN_=y?p gx$6M;d:B?i!O?5!mԑ{V # gq!1,"SŎ0~^cYK466f4(3OACޫQw]xvJw&~9V?\- +ήE"EE4Aߚ21 Q~A+*H0,o6.GH>|vH"'äH /ib70  l82! ]h &,1#ǝMl"#X@H\{K6KyH v_"\".ǚthi9[Kl{N;~@RDGgH'-z[yp z"\wgPag!!$}֤qWÁNrRDDq-L 5E- \}mbTƜ.L;$L;d!m_qOF c<.uQA#=PC ɉ!nr~E|C\ٛ@ мHXS|-""Љc8&F-L:(GHܤ ;r:疤ݒnrA@G(b2?{ zktm)~O >{'ұ@W=ӟ4@ؗd~@At/-ъS-ᦽ5 2;Pvۍ`Q T9:=z22yGQ-8qz U>#/d"ϑwNΧ2Éz:B&! C.)!5!>h` gRw !gկP4T~b-X8>sJ%Z ^nM̑F;AOqw!%s1 ARA߉CNugA(2ɡQUu wazgO:<*xk0؇>{G J]w-r%yd]gn#2+T'd(CMhH(Cx#P#^"XB P,X+`#,b[@bDFޡ̱ZCȳS&HLC]rc[e5JKy:xv'ԠTGAE L&*A ~m8Od lN9n:[.۶(Uq:\qO6C]2y Ni<ܥ Eث*oR?XucXK OfO;]]=!yz6>b9<&1 m&AV4>tKp5)m~=\^sK/YrU&7uHme3:^s]n?ڧH|~sFК;9rhkIH9_2_|f!IN;dͰ7aAQ %#KFAb9AR~[3ijB&EIrȁ4r:" :u"CDԅMp Go }2퐑tyScVq9qJ$Nfn]s5zЃ0rqYhbuaffv3Iԛ7O$e!IٴCG.!T1Yw7pg 0vqG w;z:Bot_8Y>FO{`hT r<ys4rpx@u7=)?u??|!x__R炃~N%w}$٢ , ??|Me]MptS ]rg]6zݤ<'ފ- n~M7oZSO;d!i$p>:o t +9 _jfXǻFBOկv@bwW\g<}$8E%g D!'=|@&kNY1\WjA'\K?7ݲJw[nAgdwY.x+TS%llY궩n?/~vf8bTL;9!7>dA a$t䑯wP~E"F;|~a'> "tD0a̒&ZJ!!OT|3w22@G1^IK,ϿWU5mShCj-kklJ4D^%2퐡7!IߚteЍ iG~Z\,S)1_gdamF[⥗GAPTL6ʕȑhcU%VG[2|5'+2CxzFղi}8!ɀvȴCƒ!Q,anh9jz"g27ҌV|)$nfP1d&U2zkd$jG@5@?~ĿDМvtʐBKfd,RdN'EvF hbQ+3: ~$:Sc+p10fhEMfC  TY 晝3mvL;*Wf0]R @0w9󗴉dxDulD#|:~;T/E˟RqaF* EnQe_2 9 |:)hT s7^nyl`\eҞ#_tLGH-9! g\=΅mM: E\IuIoSlo?աT:V6GRDcAM(pp{)Vz(jN*;Pl6alzXUv ʯ}E0bU)b<̀êa/HcƮtL?$6q:$b@fd=H /L"h՞зx"qWzG>aK9ÙQv饗N.l +[s / Ä%6Ԉ+B*AmQL.5&@) hTӍWBp3vmO;$lxzMGtL?Iy!bM͐Y~qf/ !FzNtĺHVj1NZ$S&9:FD~:8ʕq 9*Fp`kBTu%g${dHmXQʍdmDJd]$Zf>mĮnxSGvȴCiL;d~ey$&P\|1ɲ;&*C=U ^15EeĒU*Dm*VMVѦ2~2g;UG+7~>+>HOSVtr#PQ6/E&i!;ZxAbME)j- < &D9S\*G*T2~%mvw68iL;$#$~8OfJ^PeK1dKT/wcXrw5ZCe3̮Ydٚ%%:>l麤[fe:iH(XKů}õگ8W7yhht"6Y| B`f qD$+~GKPpI]э/c;V5@``2Jޙߣ2d2D9^\ afUEά!DOwޟPZjjW~d9@fv.eEii"2d#K U`SGDbU܂{|忦 a8Fwcp-1ͮ$ sQſ ީCRtL?02$x5-Xdo-%lيe'. !hoe7xŁ"|ԯ֊7bMIGRƘƆW@;G1gM㻰-ҍLCU)JQ B;`gr!-V._QZ KzP(= =~UX:owaPOs1#i@ j53 ҽEf ZE0|Ze# U6K[1cp\ ʜvȴC4ئLN;B2h"ol=RmDGA alE*V( =( QCdf XnfQwnQ aˡ58i*@+D̰P4VJIYQXUYtjm̟rd!+U,i/UD8$HCR8t! /Sa]=8\PUƟ* 8D*6ܸ h^钗e'Q27?~[cEƋ EϱH/[:0CI/P)i| "𕯼#yZZ=ˀ3D,: ;%dwOꕫIl&򖃞}s"¤PNY]=rfgXUO"dXsɉ|vjáW"("ḛ1?ڇ+OߜYIqk L#3n-⌭XU~Jp%~#蠑x׭h kұL3x;|Ճ%UiWR*խ0 _뫛S_W'̆O9#iD%&(G*Ȱ$B.bv^QB[5T4uІ&(VnZt,Z=֣Fı8%/zO|bضիgs9Rv8xv; =4Qn8pkvj>?`uBo <]>gs>?=Db_4׊+gܶGo}tc|g&VD Xʤ}VnrխA4)Az:2 s_zŷ >2_ij6,#nYn u1znJXiò›x*԰ p,2-l-ƃ60f݄u,u%La=B%Ydԩ}+bZm`GkQ[ۘH2ljLqC3+cZ_ch~MYL{XPV-y˂q }R%˶O"|ˣd_ѩ@P Ol14Q-ώ4fU ؐX9(6 *(1$Mȉmu?O q_oR+:R j#s4|?J $Vl'Ynx9Q;Nw曭Q#8S$v)Zq7`B3@;LypWJ,j+[Iƞqn]33'|2eX-0EqtoꢵB`3v?{ŚJ D"蓦Tnܫ>Zny rttܭ1)5pGtaX @k-v;8[FDoB?jVb,0[5P(^0ژd\д-t,a6O<%X=ꨣ:xm-=y8ΉyjGi0zOQ::͡f{rhKNmڊDH^<a!ɨب;{W2tvWETWts#LM |r5N 5˄hbXk}2 DKS&}7$HPM[ @B%=Π!8?J&(]ׅ^HEy{v+kg4ل[`k4 j=LbOd4~\ "DB^9:I~[{Fj͐&UR~5xE$'*)sΉĤ~6fAmmHZɦF!]*w%Эy͉|CHBlxPȡ##gUhEE{BD 5ޔjTtĄX5޼^j nKcڨPðb)P:Tɜơ_).Н`]Xވ;sdjF&K5۶)oL̬ⓟ$QZ> C~ji-*/׾j3Lz&LɇH`sLd14рM6DǭF]va0'1C|q;dTqEOZaQ)amT+ph-ݖX0*mz)&3>(hl o[cJn'Ĺ9K,ΡM9JяROG+CBj!n2@) { 4R) ;rRQ$e,15Ќ 8=n!\̰T_ $A|{<1E5CHfMl&6EK#DU]46؇hyDY#'{|ul]qLn+ Ԇ]nq49mO:q$ Cv.c5{$UR6 i1np,b- 3*[ ˭-EM+j~QLz,j1J֠Je,/-gPEW7~)AhNt\˦$\pAַD*X\' .˗/3)Ι6l- DF"8!(&"%Ā SEe*/ _jӟ4.:"&p\P/ZK)Z91'Y>>CQ }{jEAڃu]9&;ɏn>BU)r }+7u|1+V͎Ie;Hh@n]@F zR6B|0$ mW|{ %r,FX0bp(rĨ?•&LfD9APjc!:JzVV/򕈘T1P2etWK*U XjHWݔ#_zmNx#?TtW2d&l ҪLߞ"|rfCb"-K?Ap 8uq *-2"mC!eOʒsJkTVi7<fi%ƠO"cZLP!*fizOv iJA OM-01.~RRz/Ԋ'iE萀[,[ n,qW?as4CƨZdh4cvK; >o'UpJ?C SekZ=2 X!zL;+FHU-hrVԖ $[V55~H u]YKrf?? X#:1=dA׆>Bę$!E~8Kuq@ S?,Qd" K/=È0,9aywGsڲ2f |Bd2)O1D?/B:={2mG+̉{zqۨqnCHPSKr_V`e- N;3=, |;!0e] >4@ŗtSa"߁fEB?|('{&-M'O:_bbe#͂Ҝ^Y MzT_ESrwEʐ$nUgo N/ TZ7`u}Z`g8q߷E} FR{qVʴ1nsɧ OؾfPaS+YO NS/Y$7L9 +?8K8]q:ʐ'( B$[%Ȭh&+; PoSsQ48DB?]~()]-$"u~Uc)eJ'>@S_%ֲ`F~y# 5u?\[(ȷ3fcHl+ؐve%O֙I(,E) N%M}:q,I*5|3ݱǙ =qfmvFLBeeƠN DAcsI 2!:|/>pUF6[qòDžڻ(W16k.H>GJnYLB @i%j\xğc6T>hU^Je<(+U\@K &5>W=9em#`~hTa=V`SUnTrI59'[1;3Bf ]1x=ۈȀtlOOц-&MFeT\+M㌿÷kx#zEkj2uŶyq˱ũ8͛vHCXai0,S9†r@QI F#^Kc/׺"J%FX0g)]qCDvI ]`4_M uB̩,o?AI9?hѳ{^m+ҟD H ?1( `,n3҄"]"B`ކV84dW,[r"F&;+o ezV5^ka5On,wд^J^/;۬BOS> X{^1X x Y (!?C=_=b %<̈a}dRn'!H +Ę'eOPY(u\Ydԉ6ό%Q'dh`!h0@&za#dVnWS>{ʑo4!<߸l7$lK$0+ ~,<Μtl ˤvy hI̛$ꇔ>CV*Ddi.\dsjUm)}=` 4Yha508V7I1 ;2/ tNz`̲?Na:`X"KwPCsg$q*r a|QWOn~4τy^Z]n̋ ZXrcc¶5n=|&1/G6/.[v VFH4FڈLdV5WG{"9n|f5nsv jD`F p?٬r[hD9]D0c+U'C<装7zjEH +l?`F]'0yZîTޱ)0 rX(FgGFEYKGξᮖF"G^u._{EŲpS`cQ졡Xn ňp OBvۼ JXP@\џP ׾5$(Z<3ѷ$:Y^h9y_2CW̞a6qF4(n NN|؉gO YRƱuԉ*?<̊e+,9agol')5jF90z*P*j0İns!4c?6:_MM$U[0i#` $"CٟT!+ʫXQ۹cb("F#3V"5h\lzr>:( J8#b U1Y+,0n1CZjBln204^m5=<)bMo!_-xyWr*EP6tS) YC_=ъN`ز$⸝0:Z-!•{6p+Vc z DPw 5er6+%LM]U">W̫̲*YW]jHB\AXR BPE21jܓ!js= zͅu97.olaOToB9A<Ü3ZK!dJ)R{0,NBF.ut :-6 &iEҲUb+ \2Z_Yi+1wrH+lsv,r)dE"Sԓ3,V,8@@gא>u$˭mQRla"LR}~zOږ^;)xy%M zwΡRHLK8Gb߰BT#,)qۿUCyC_QZ\9 ::xq2IO>OJV0aI}ABTwK !*`R᮶ TKRYJi+o쬔<^f"p-t<5I}EU9}]wIR3Wc^'n^t 9ZT7B)Rqq/?]JFcu?̘IoWflnqmc|N'/G!]g8n ZIZiִBU@Ce|0VQ:W}¨ m$&qAOqטS>}$~lD\2X*&U+qezUTg&~KK75 eކ>Ͱe!]C5MiV M ]\]drd L.y&-\]-C\?R*+zVڴd b5w{0K<<1@am0YA_/~'?I (M<Z##v^9SρN[uo0A L}X9ETAcNČG?OXh0 fbOhְ"`ƐCL}`L^<1L\Uqy%!$md&>rÁ6:n+VufoEjP$l"e[D0;Y; O$-r< _,Ho!BM.^ '񓲠o ?LlSF5v־|x|` o$%ŅÑj[䉰h|3X#A)8>ŗDK@# ĀBB,nwhAb[`vR5vcہ5k[楅+&vm|긊p&(L?I>9|\̊X@ axcB]o|c(mOz~I*^rRK,'rૅhVG|+Ifr ]КVQc3+*ĎJU04U\殄U3}aǧYFjznul[y ʏГ)?)3`)ݬa]\CfY{E0Y@D] L-ScL[ # ' PoRP,}8,!97c-3/Ԫ|hr^rUu|V@6wr?zpS1QUC慱6hqmzML+Y%: {.#Bӧ=9Rml{nt4suwkH30QdtZJQ 9k,QTǭ׳dGw\e#^'p Wl$"VQ5,{pUe``vq`O<Y- zL؀*0 ʥ.1 z ف"Y(~cX8{o_by?B;X7~HKtBx!{~=Un{wyE/'uWM*Lp*n.YWflLs^Cj1)֫=0 xL1is؀ ~Vm! c)sw_14r`_`f(e ("_2{zȑ4;`$P u[u246f1`h튥 ZBY?BPWe bjPb,Y~c ]% W1eMEqXzcЎ: hL8HKwaB) sBZ3 BEqF*2q:OkT' 4U<)⭬[gYoQORw(C .ab@p=%A2>:DNR TAT 4> W[D(K"G7Z{TRʔ:V0\RDۊX62e80a4S9%o~^>8V4ĴѣU C)Kir}8QɍY=qOud;TЏuXJE9(^ x%t_jc": {IT9n?o;~$BG>Gb+ƛl0Q,UrZt`W-G KEQf]"h",*[~W?AZ` jU]!b,T=.~m>hTQ /+Gvw.!EHJn1+^ĭ4=}GcC'DWa隉KBZV&O{ !gd {f@Bbje}4 `8`㟑:!~s"VJ; ch,1cV@Ϊ._qY_ ^uƉĠ z.R#M*:s3K_U4\i Rw9lVw 8O493Us"!al,{YT6SƋU+tn)Ӻd$gJMFx& ޽!(jf@VXf,5|e͌퉬X9Û 1  sɒ΋1l9=8FAF&ɤ)rf={&u)Lg$B AѼr)K Wf2ryO(^6[,q-1áFJwQh)d/ܐݻ6!#Ec:?|#g#7d lЮ믿b/~ ZDPd+X8vuQ{~ Xgףi:Onh߸5OzPQ!ME{h!ղXEˆ[%jO|YoCL 7Z3B vwffq*lkS6Q\t v V)0dI29B +"+JzPUPN9\ 1OUOU*b2hwCWvq>aaB $:7ᱱ4,hzisɩwYve Nr=Rm3!f^FD ;4ل鯬@ 29LoO@^09 XU>.<D$"g8oyYwwU\GρmPi"y#;;lo=.D.B 3b G"!__ i=,3WQWR8&JSA2Gy;prc? } haaN3{!N%k@lJ<# 5C> z#Eg??)C ee_(W:}c 5$-{Nktwp,}K˒yZoG,C=n˵\ti㭄Z"-tW?/EQ9t[4q_mO@|>yʗ;2!+ϠR" !~9?#,ı6!QtUN}n\K\ DUZR 6Tcshoe6C[uq7}>a7c,["/1?ӝ %:D1 "2- Vl"'qÐ;PX–cuEY@3}[؂ᳱXU/1 ;穹@}df-~d>uo^w!KD@)L*gс`ҥ@ؗdayD]8}q5t;\28i1oXzo;_9I+dDi:f;_-] vhT]/Q?_kw8 ¶+6 NybN0rh|Izvd}քؘ._+Gka~毺Y[THJL|[6VI:Zw{};;o|X%\RAT1 (=@0Cз%Z"FBL@XG< uV>XAyؕhTXQMOq OhZ p g)p]ꉭX-&,46B>[B< 0$VK)9%9t9l*V&Otwb'J)?K8 T_oxoGByZ#@() B~6@W7) "TUfO tH"z%.'oKԼ_"C4FI .-Q%EC+*XG/NȿJLח2_bR<^|| >0%uqZØ?!bӦ؀2o^o%/1VJԠ(ʐf"kذΔ$+'s_̛4dl1_3L,r~Axj:`'8ѷś/d>Y YO,gGN#310GOƣ0@ 8f6>4/=+>p ZQGM'fhҐЅ|j7F<ר8hj8anb]ie {qfO-?Hpd7HD hI9 ]P8.+_ +vY3Kx#Xݧ?0Rz(F@ֳ9P"(IG,"`=(lZ&ᘼU0{ W0/A3U:4O@uy-Yєb0`ar`[7+a0=N4{d(J֡1DeYO eTֳlSr ңuQ̈[>p^wN|nWU ޅ&#;$vf=δy01=I8uH Ld}Fl'Q9'#)ޙ,@=qh 4Q洞xi#_CjaWS.ңV|s*V W{gɸ=cJ83zMSO=U0zI3X\Aq8%G'e^:!J` ɲS0_tt2i'p\Bz6V(Gt!U܎}kJ6>BL 5>)J\]zi3;8% PAxIs\iSBХcI/4\يZH0 7k6r抠Z7+d`/!E׆Moo !Dd3"O,3BN;fkq.ɖJi谻߰? VH&!O"p=&T6hN36d큒oX2S%L`f(j>MVKb[VZ"js,؟ 6c(]HAPIߤ0 ӫa}|Wt h&UQv bF Sg҇~['Q UDjk A90L00aZp%E XHcpsgFbFs1&ܤo=Q9wb阠ݷ<9t&67sN*7i><뻝ᬺc.dώ-B\?:٠q/׋O+Ò&B%թ.aNWsһe`b?ya"sCHK(^{kuX۠0ϐZha~~[G 3i*`Y,,'Ϻ=gh\p͘ƭW/Ś4iӛFR@, [;Yªkf<2 bEA Sn!lD|IlH v9h--PnBiKM80E~q3S>L3sc.L,M+T }YӍ"-Y=ByEupX*AMYz4x cEOB2oDl,}^8ɛ w%$@98AGV7/3a 0LG°zETi. :0mRcg1@a6ͬ9Qi|,kBVsm҅amzX~XϷ RX"IG%{<笯f[bi|= 9@/r:Y- 粟`?L9#uDEKqr#?ruQ+>0CbAբ"ê _!=Hui:Y]|( IA1l&h:dc^aFmFtWtޱm> U3#QEosV]xaPWҴܥ,CnF=,yS5H{x,f_'P7[.'tx `!oau ] ,DɣUq9mpɐ>C,e1'HBZy5E[@"-ERSFD.M ).U? NN]Ⱎ{m6%S@[t0eyLjަA7% م93y6jd)|r#dԖ$Z>l1jV2[2GW#!kY6ótzkbI+sn-ta$Fz$"7n $H-,BDra,? Lqt4*j/||0]CŒ {i뼮׮ʼnzmy:e?VX,&ܢ 9dtQ%h'y mȥ`_"'>L24|SBã m=qp?`U >U:n?6 X2%BN/AWCXuۿMi|$pI'( _?}\(c"$'mY;aE%`00egw\SK9KC=KfI0ѮXֵ4jxڞ$›T0hIhԘI5V:㙡љ"3CF(s|t/r]Njd;nZBtBtʖ[gwHHK!@ AO]Th DjtD|q-sI$̪xsM4*Z`L:W. P[y:ڥ A *t'@E@/-[{ٓ.3/ZU/ꂹQBc](l4l]ٽV٨`9^ܡpk=Q:lgF3cOV;\xW#"!9 dUի 5Ԯܦg=irD¢ %s5QSoDʔ~=f1!zKτ3/|0x;-e HpۑO<ڽ3Î/yOwsIkNYgp?kl!Sܚ ur[ĵOQĂ>&msl^[qݪXODj8wA)̧ۓmD`}I5™>>8 r뜌oIdĔW Gs5jQQƺ:^P["̭OjnzvHa  ya;Ojp'3XEZ`lؒ"Z;Bb{{1YqWx< Adv x Ok*?ǙY*7FKb>הW"M{@Ƃv|yUEU-Rd)h ylKz@}Q8B%x5 mc&0i?E~7ɬo@ \4``4K-BWՆҳ#:$xȪWku' op]0`bTӊV>E8(2eS8y]vYۤ | [>.KH15í %C$PQJfl46eN5RG '(qd>%`KhJGv(+`w#^X)J՗3%3JjT(W wPԷ*+U7 LꊖdgEȬ+Ñӏ@zE&-u1vH|}C9H͘ )mx v=r;ug^YGtt2k6{L b+y8.U,Aëy .l;lQbޗ+}lfv8> +Ҧ&ǖy||L}1ヒRL:Ҽ)*JhD%QtH$HWrd->R%vFbZ[ *^P@UN|p ; a`|5%|A7c۷}ᅟ!|4Ј,АDV,j/1 -AҴ?,z fZtK.lNбIZ C X|NoCOO^Z}!X9B Piľq=)pi[SQN%m`˷loІkf<'էK)Dzf٣/0B$9(n.!P"E eLJ>ıQ 1+mjK8_eҙHj_o<^gU&\|sgLU-@VWtʰe$m@IzDx P I0@[:vl.xxXcEr`y-% .m ŚJyGOG:d )ggden%K]޼/%IkxvOmKl*n}^_G7gXY0`|`D#\ndZ:bK7Z?rK+ Шm+DLbVGr-GDKFHns#sbҌȧ`R=,\*m5N-q+aŝ:$Fk4d*uF3@I9*7Txb7͂~$ȗp1%,Q`ދQtя>o+30{7%nhKrK;2%e> _Bৌ`4&|ԍ0d̸>$Aj!̍W 34Ҙ3cR!c.y-Z!] mH9Λnx&kB|'!7~/95B*W_PF;D -&&€` P.F@xpr#ᵸ;r#@H0 M[v_qFX"-a4Zk`i&lI:QS E# <<`L.yp1ĴȒvԇ9QH:0jtcTF"l?o ZҮ œm@Dr0կ& 3S ؾdIO`1!p7T Iirlf)9zs /4fDM$/!4)Yƞ7 HsA8GX+R[)Ţ T8!ޢxH4>2mFz! '|VRQzh[.BBL'a i V(CoOtf7e' pzsy6$t﹙b)J 8c Ұ>o c\>ch9vWtbM)'?ǹ MPQە#Qo*`NhZV PPنĢ16Enɒ h ("޲O}*gh" xH1eC ['`R[[x4 7eR#ՌK>rHSk c1H&%8P[iDMdYR9*PaNh5+y#hgD&堺OE6>چ bːw\~P,n]Cb?P%b]`pPΩؗyjb.Jh|-mΆ茷pJwalOVk҇7DizX^P5AL@PV9C;gnCdd+c Z.M#K,rBDzu9vymFqn_nd54EK=F 3EZqƖ&|qV E[#m{fmL[P*1`zF+gn!QHKbvqvTf-3.۳C*e|v[bPh7P/a#[v1ɺ+7Lޡ "n1[A5JgCO^x!HOJ8#jQ| T|[ 7G_X]xáAd>K?ט* w%˦J K@>en*i{B1,0'?]LA.̘1(OkU0ji)I%%c~ŜK\E=qZ 3KrYL5̍ܤXH8I#,u1\ƙkL#:r ȢiݢΚo!8#^iuTQǢ`vIemKVȐ*!G5Y`rKqzXD9Vz( DEl.#D ӊ]pBuD鐨JN8]8/]HStms&'o=#GtྈKXV "n{BJn/m) bDr^rMWE-!vtnH@ hv6ȼ=ιo}ǒnM}GQg}L [= 񭗩#M΁ 7N;Mzjm `H:9D'_2R ե8f⾥[a!k=?X 08WjnF/a&s׍~|}"+`1+,gcL#(S u 3ꝿMSĈ4ʡ?ljm FEnL>zX_Qm~o} %ҷB + N)c 08iIJ#0A:F/[͒X'!!BK/Ӷ3̰(I ۨ$o=sȧSl~_svr tEgʾ4*"hcȖ_Q*G[t]z:H4w_rO0U4,*_rD2V~b( ,Ł|zU[{ShtE,s|zsUߎESkC5Jx$.DZՋ0ClZ}oU]duBG~n8眱٪7- D:np|3|ifjHz;,+.￟L"=A $}#"Ӓ >i Xx tZD q)9z&FnSsbNIC1Ţ5 3\W^YXބ@b-KFHߊH( 4UbFTzP&h0lFi?'0fu-aS },)xl}OeHs>X0!wE̒:Ӓdroʟr(('~hץJ.`A|ÜV" ,|:S1Nql"9fa[.,T6ւң(H$gf`?&AJ"1ܺꪫ(Nk+ZlFp H*GiȀIvka'-CP5U21<E졒wH>%]Q7 rوp F,uނgU6yX*i1^vI'^0}'?!c2呇aŠrLGEb5;# .Poi2Ah/jI j0AoY(zՑsa%ꣷiҸ4S lOֻ֘Y=/D["Hp]f4mF+L2EL%J֍X<\Mj3!Y\bEA4EK?3HeSDml'<;K,2oR2#+R,wT[o=,:bKl,XC^*+MBumtEXYUWdn&C`PTaO8A&7v˨300Fl8m^(x&b6tOI1=GXg< V(*$![b<:SgFcXDSxe>.y_"紜i楩t:}d䖵b -wK8S&s^WbcK8y.s`;AkS l83X*ò߻\Kn$-tP|wIA[PVJ_iHRHH"Dqr QTu\!S"APRw"J149a#<96$ZQ[V7C&\8kȊNNl Tݰ09H/x-P3os k$>8,I `s9lA`hfe|5Jn>38piO{v `;yjdחy\uu~B.EıGPAd6PEIq4?閯xš{oug+Oz"N̩fȤɧj\"`+=:K6auh`SgE&)̠ۚ'B-I]Ls'X rj2G3tV-•Xi|31ۄƭM+95Vy|'L{C[,Э*"Sd6v?-C)Cj)dc6F*^PqY/rKÕ0ɏ Z=;֎`9Ha R.$)nH=&kVFÚE`EDze M+Z/i4AwQzE馛0g@5/Z L/Eu {*?EW.  4  u/]Dγ𼰕W$e*^aut̹/P̨? .4˖C=cAc")'1@U+N8ᄹ46hJ36L95h("ۄ |wJ%hil ]Ho496zNTI (5]u R1'>P8d),_;yK==i8Dp\W^H3x HF,^*,{ЈI1$?~-ҁ0'\ ȑD(+0@OCP"8y}CX\4q]QkυHO11AcnE⨖IF:: |m!gfi\LȼEq/.8#=* #DŅQD9ǻX]ut zҩ4m~M逋QSQ"Ćv,VUg^ajBAA9dMjXJh PP2!(<hjhs,Bɛbz~:{ųZ̤p@ ⮜>DIn6lpԁ|qݎm bɡ]}:<4%+Ta{ !SH-jOvh?*LH"H}=Ȋ#{ Qٙ``;I'ĭob_3`\DG!`3Ba3n5jr=`͏4fe[Eg̏DjG?1`E h<{E2$J1,Xc#z'm .Ǭ D&KҖxlƢ{k/BX\{dzc^+N;SbpLP/m|7|eN&UiS0s} sOt`FF>=&}Ip0K//8c0÷qk=FU䱦U1K{ x2 Di Ac.3qK{u*|(K< J?\FE-n lD-cLJ{I?S #;$J65kPp?!@̴!5i)Nz/2DwQR*1nf o[؆vP# U{[E%agODa0%9#DjbY:+Lb0b(@#Rl@\lqQTDaLמ*$;RXc_<{y T_jqO;` q+>++aIy4Uo j^&4(5,֞46>).@knf^ berF* ,w?m*b {)Rф]FT(14x=iH/ĺӱ h7ˡ\Gb3/vs=Fǽ&|V =bwUֳL6rHo<;|7ХK&wq-POK-#\ ؠgZ0f-c=8~Lg[Ns, A't!:nce3%/ӹ6ρvz}}Pe] u%HIA~x5$ DHxΜ=ZIN>G!a@jg[B% c6F =kbLlD(%V4uE̶WHž[ۀaQM-GlZ* ̐Yz$0Zh39Bu44T‰D-yr<ЌGb{_hGgXBКY<7+y=lQflĹM ԅΊ S| `UgZ2dS#8\HQOw1pL+z 0R/LMzy5lG^u ^\,fH+"4Ym6um u2A/o_'4q1b/j&N6ě|1Fa=ИhNұUZ ۶lЫ듗0 e4- HDXCqZR7s͌<iUvHKP!k}>*P`^ɮ^F`$^n"gLXPUy1i%xxJc<gdŗZظN.Bq緅 ^! *~"R{* 3>6u֓"C!pN&cgя~44y512!fx&Rx^`S>4ٹEqS8D‰,UL氈2oW/i^<hOB/maQalNlH]rN)uϛ_׶`QDsHA0O@sMGXbgĎE66/E$Dݶ\ A85P&!W{]  -_lC3 R^N@4 4>rֆ:0v$ؒ%.T 9r~F>͸G㕴5&!YEJKT!H`[b#Fk[9 qEJVkW@m^A.y|!U| wwUtt44|.LI'@u11٘XR|9Q:NG!NLTiiE@UŒSǬCBGhƊOW"-ltlGy=W-bHҞSE,2)mldޱ>/m2i끉!bPaO4.CZ[.9 nA-< 1?<l0 ̗%=}m}DM`xT%$;e" 6#X3D-׫Upv/1,Jՠ+qh᭽Cĭ-,'a(k.fAF2<|@u;tG}hJC&F"p>Þ*4Laam6!JQ/%mV1*3Ûs}Yѽ3|U')ٸ=g{ ,zR Hjӌ1p^KY[~/2E aK$|PPhr|AlQ<0)Aêa-Iv:`@-y"*$ b7)UԞ BhJߛaՀ+RPY9ЯCF 5Q ćLE\̘0FA'T 6JXEBQptȈLD;Q>C|&Tsդ\MnoQ _I<>i4icTys* ~;7GS&<{f4; KOD>|]_r bO4GH+[R7ߕ֨a-*iVXnBup DtvHqAɐH+Wx:_$a8!~kK!C1*C E$VJX8$Т ÁD3$kg6&!MjstKM{YUƊ+\xVz `q5b-^l?b?w#@D-|WrCk!vGGqA}͠EhܑۨikF#X59k0|9XC 6~ɧ+𛇌!f(9>a_ìq@#ڪ>6Bⷢ0*jɡ GJ^ 2cIH9Ǎ={8|ҟq:FNi{;%s u!=xw/2YhbZ9bWEb3LHE%` gauTl9._=җh.Vj'aRD:f5tX(ب/FE-6OD=շ^&)R^zk_M G,[eL4&D" C,hTg} .Bs 8c3MNl`+$80Ɏ&7Vئ`^Q5x ֻo=k\&və;h}dVƥSxJoHo= d(0soBs`[,EP-kE l#ƈo=O[L| Z~ceȸT.5Bi5, bKR-WևRԇ QEeBY!HCn1QPEA贚D`дPFM[lƺ s 6F @/7u&PF]ɦ`vÐ zUr|P43,Ŷ98ssUp$ڕVW+^?ZE~%=#֧)nai,l+ _5?.:8C#cSpa caIA4aGB JeQGwS pClkI(U'@[x oV3ۜaCiϧ\AR@kʓƬDq1jG r5ѩJ$mҟL e().Ϥ}pn:X͖(oTg.-xd`ܵWjxOA$h-m|0S02p}XńԺ8ǤO{mn|#Swк| t uh닞^:Pz= a0]%&t婄h"l-EfSD S('%ʤJ萱}:@p:ȡ8I};ɪY斃)]cp{^ {)Œ]|3dLXc1^8V(EC=DSN<02ub V:On2rOA cDpb"fR!͟eq\Nn A =R>em[J}rGڻb7q0I!X>E+nxXF&d%@X!pDO:P}E[;fm2앉⌶RK.s㘈z^b1y2rG /vnaLcv5>,w% "|(֫N!jl>1b,hJBу)1b ƿ7ITE>vEkm8nQq]*֫xZ?(̭mEfX_&1Fۅ€_JD'sjHfK*je >"O0#6tC&0>"^0۶-hbs=Lma\]JC0^UC-cAcC59k@"u[wL{ Wt)?qb"FZE`!jk?9|h2(y`њw9q2!e%BZ쥍T>dw1ͮ::?*g؎gKZ4L)Q'i]YQ+rB:zEP-!iH'cƪ 1+}lv\2/"Pb:< \83Ѹ{j ^[Smy  r` 3=Ɍz~r.%Ev?_)ƴv(#yt)z0\c(J)L8% "IEp%ެ:"IS l^#ېcF#lc]}뭇 HNsp`O^*XEfam#JEJzuHwzT0r}aG1 RYR0[ৄ; 7%"XG>> 4XN8On+1y#OQH[mA 81 JRHU;Z nT-$@%_;jF)+(veAfKڙĭ:zbYkeWwӝP+ 9_m0& O=S>Mֳ^>}y;Ŧ{;,F2!Y:w{}{EoK* ӢIn9ƪ5ޡ {?җRhLpOطAc&{Z^#qp]Csv"*qyD{'26z qiᇻŮ/$)2EOdpB2ʺ:HS!<- "/|ķX@@5~ b~`hB@nc}CN:]oy0uBV?цܓ{l\ bSZ E`_32U+T|Oo8'f*1"F9֕XKZ奯¢T$+}l-AAX*^,˦uU0|TȈ;f&lJ#.gŠĮn$Z69Ú׮] D͒X>)h%@2V"fr 4*EffzMO]aA>*{|UҷX XAe$DrZͱU^|É81DȶX4u<6uMN26H!=Syy˥+CY1m4< gzg4J%:[%TP-]Y8+GƼfVHkضDբHe -Z;.%2 MK%8@D?w1>t,m U 9t~*4Qༀ/kOd OYW RTOHSjW_#Q\x*A{صZ.<ΛF4fz+O@T\:hx* +0#k rW z.e7Xk=^(4>ǧc#K| i(Vvfkx7OG+QR<CMe6c[Ro¶<~t,-:,@|^9@4%ַBVHaO}WBԄWWDZ4V܁}t'ҏp/6u/g0E$q'z\)blĚPƩc'H/}Iz-2EɀR=":4 balN:$4W۸i@C-ypAirv(N=joMk%#T$D0$ I31'aYǭ}^B:D-9:әUM^ $$@iY?sD+C :GՕ&"܊$]t4`X8F㎒^'23 ,Źug9ہ% ׿uX#z_eqT+$9I&R =^(b !L(.?(0 W˧>s%v'[L)1[Zrtn"d^<ռvghkURpżCxaWg A7H"4R&E=eRXjbes銗8fc//dt]9_0f.b:AP *w%vB̃db9ql^iz>jLP[G c Ԁ7&5ŰL}-C0{ODc&=L=N'PVh [⟚`ѫ~rXj(Rcֵ߱F Tt}E I@$}%y5ƭ/4'qYfKq3VPX׌V*㸋+_Wy~rmαzÀ4LH3)Zt)GEzƭwipd)XY[l69B#30 ب ̀`4bBHa&rHb37*Ɩ'ΪùR 18`V_;`A5n,h+܍9`0u5r,~.sk_G`-o'/~6 EЪ\ k+16FnxE!+b֗+*2KgE/ {*7ROh[IK@CQq-ku(3B rXAR7 r:WS9@&Kؚ E;ǹ1{6Ky.>LK&{wӿp1F xF|zU2SiYx;^w}t4JoJ.F$5$gd]o!CҰIoȷ^-%OBcABBp2֞ÖEڡþ梩 pH!S$Y_8_?*=;dD_^Xzs؏F88O/B-b^*i䞄P"!}`ӰB8#1y:8Qh~"|YL49ǹQD =%zs(HoV:ʗPӌޖYWLF C@U}s uM WSowoLrwJuAsȹ%9}o9Vݧ,:@CҎ:J@E8(@Bx+BZd5/<+K[N$nUPhĊէCF-v8o_ĊesDGb`cC[j]GSѮpa y$H;d{_͉: + HC8ɡh9\+b_oc#[aG]ϼT%FÍSv& ?l![Ѓ^%=0(͕סOFqau}lç#Cmc)d#-ѱկJ)t1E\Tt"y">5+_vJʸ T!#=I6z3q\N&tC1i->n1f)z*E~b!bb۸ m3ZA6{ 7<%Mͅ~;n4$,O<$= -c8<\?Xb@ا7?L|;ߙ.!#ZHTh#N zۮR3@&V$\/L P8Q'xti(S#SIvhJ҄b[EGVDK w**_0D&ZcGvH^apoh?H79F)FyJ!' # .gr:q"׫s%jޓ]'\4--zl!ܺK/i ~ʩo%0~t,Zb0z*ndA@mZן Y7?uѱro9..% oolgAG.c#@(3t$ٽ>`~IXd'c᧝/| ( &pc*&Tu7bC]mT,lKic ̆ZK d(ŸOvJch fDi(jRDTԢsGuêC8ݗ%C+Ҭa;c@es=aLLPc=WF;FQǭn0!æь)JnԡN n9.YA]IgX2W0\NG6">p!%RkBm0'=cVSSn ѫE݂٬6̂ǀjRU)%b0ɎVjœRO-KJ,pf>ǼX(&%LR89nۦb os9g9D20`@]Oo"!5Ru5*[}p9GlI e2R9h`4x+2Q# ꧟%1j*կ*mkS_? w`-UU#'HAV?{c7זvswuڑ'BaavG-CF:*z.ZH.D(+usP&9k [:&$4q&mhF-Ȳ[iDw'GLڋ71Xg XXf1-r RlvEepNХzX-Aj~e'[**=E׏v?aTږT C2+=ҙwh}PS9~M&run!u2^pD1F5e,`|',݅}Jlc63Xv9TZJn;;Jq?k%aR+s9Jiv! VP\oXN8VB:ڊL ʶ 6q@HN1by\O>U,|JarN%f'!`68R;Je*ױb]QѩVj#u%ZlQmxXm'c4X MCLKӳ oqAn%(m@E.nFsj6b׾| s,D(u "Oa[l^PP\"PQ⃤XKAmJX/NI6#-疞}G] c9 [vsK.$X.fMz_ ӡ4VP9J Gƒ x#tx44tmZmt_}Tȡm]d.2hToG눢c)zSIABCgUֺDcX]ڹQ9$OGɣ5ނ* v4#[߆%`fU3 M]5u/դu[qls&'5*̦K;;o9 Pq#BZ$m+s=;$rش )NϏ|/C 4G X;sy `ԩm,,O./asLb;TAʪZ;¦ypN=&`@s&Bw"w߯~S 1pBˆ<)Ttv9+_|)4W >@^h^+`uxI3#[2 Z wu^b6j w{|ЮENF! -fO2_o,ly 7Wi*:bէx/s.Hria*.MJxԥDU* pWQR$*R!9a4cX,oUtK"S~t,~OՇXX,aۓoR(*\?ܵCYEPnd40~F1Ҡ&wjc./A:7L.CHr9ͯa``F7(I~j%9hbc)sN AOQ4]eaG2dS(CU`"Ltaf5D|r24jsnMF0 zD h띳ŚJ;moD5T?"̈C0an#&Lʤ$PX*XQuDJ 1y80@ hcq%6pObރ(l0 K$?N½9g^zb-U|,ʁ nHbW_]Ǫ0sRF=;ęV{60`BeXwej-xPϭ*Q^UnR~ 9k^PQ]4ycjVUh6}~@\6F͎ +$^ nGzR{GH=aFh0EYOhCcOx?7&I]RX;IZfnoF'4W5+7 - *x{MQhm*,c\C@Lރ@@ 7wB/*j /V~!͗Ԣ,oty}L<3ݧOӧOAb)F5! ;@KY=_7ô6@c=ݮk5O^"5l#Yjv{|A \[:SONp+3 #sC^baj}Sѷ_" V%\b^F0.Ԗb֙Ѻ`N.]F.ϽU "[Fbx S{1@FvH`"<ın숤.MȡQ!Zg1 ܊D:"$"0Od~[b(awG|0ϡNd1+@5tX/{}34bk~8QoPM#oF.H "]!$*lA&M9S&[ӠYBUj%IpS\dý;qiP ?I,`ZVC]rl -Rgc#]zLpADRrcvŁR>hƍ(@DҢ\iv㽑ܞ{ ˎ]J]cFɃ;֤@~}8VYQPXR,@F= H`D9)7{J o,nIDATZ7tֱ>ܔ%J?oƜRθ0i =|D2&p:닰ԭl"}53j9|sy~Bv"*^9I}Mek66#m*,eԽR&jݮX,k.;kf@n0hE=ӜPְf+|N%ayvb,-'.@2^=W`Cj3.L,+|5r}Z&5YʴuWrwH7IqG!/u +lT5[ 9e+ *.T!                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  \G?QL-:Mkè]PM{W3-lv@k1(jD2tL.!=laJ2z1yˍX<9y*\.ڊO4( h<ƤX\mu%pU"P_jiVdsKJc`%e͒~eZ5v/ {0. V! %7B)y:BCGҡV:1KVrhS?d 3! .RTd6Dd=ɼVNv{LFWBrw՞*ùA)Vyp z Kn6O#%TψAň=a SQ~G cC8 ê! ؄@};Dgy&)'u/sPÊBx<Ora;.\qtRη"zc /V5ȕ@ 6E%U-!fGR7B*+(hvp[a8.R @bEF8q36n_!F"Jq֍O:h8fX {΀ΰ=u(Ø?.yr7+Ül+o8SyaY2d8?'X9Le]44eAs?H:6KeP{HMz:od03hXA~KS5H+>2|[LkVY{1Y4$F5N0 .X5tb^,G 66֐Y}!|{A`qƐq=⁆A\12Y2/ܵYkF E3x099ApĪ 35|uN<` +Ƈh%f+a2GY3#V{0#7O_V Lr)C7dQ`\XzW\Bn)q~$1fVHsf%@zw=:݀.PyƘ֔k_U-ѱ(%N  I( k2Tf9D0aF#OEȫ"V=δNZgy2O=8c㬳- F"AYFt2BAA{:mȁ#kOGl>ib(~2UԴu,#fQSxY Ѧ=QrB6+*3cRV.0񄃅(!T3˧#ihjT+%uq_*oZ:q iha\5I5>Y*j\sqG I(^zR*aSSڛRHݖXG Cgc xLd :| 'D Y].t.5cu.k&+Yo0r@ "rJ8͞^)aŁ[*zdeLٻ)'.j!8"ܔk$%򳄖JCvs_&ڞk,DvVWmGЂjJPTR١"n/R2^_qIa8p% 5S䡦x1WC]!6& EKNS3P ͦ1926YMQ2?V3)x6ِ];ϴDSUMjUy+%VE@VJd.b\|HKƖAom# k/eJg`FzUK@' JRe4DE"QjxψVN+tSjb )6ld^1oDےg:H9e7N.LH n 'ܣu\3ΰy<4SW|a1@d?qMlql)̋SBv0G&ɒr^&ٹޭ8K8'R"YSݰN\P5hg>w)٘\2!G-qI$z4MH2q.hQPrs~!cmk.ZH Y+j!uph]#ePW11gusU=g8pOk'|.&nz,4@Y`+ d9'x!mZl.UτiԼ ֯Q)`4f5uM7u28ƴW[kF?6fl^k[PZ(ZOT=+G7~ČfzO*E} KR\C3 ٛlr+xBHp͢P4s9:GmOxP\s0LVV D}C9)f@d>剬4, geeı=,Y${F-䋡 H N=X5N@7WOQhzpػyGsb&j0%6S7'8RU9|f+U* TA0_IYuUQoBZ(%W36H $~ 4hn|11 {i=ӣŘ7Zɫm"^+NcYV 9i#'DH0ՔVsX"#Yд--+&pRVJ0jܦ rY9Vк!!) qfXbzAGs)|#MM1^ڇa.wgebFUpGC ٭){T'g.6 <8 STЇQ ?)Oi ,)I=yu2B;bE\GB.uV~x_v=0;ʙd*^{Df 2Xn;|v6_y[. 1 D>+8qez=MTCE'#4 %z=Me/{V-0CE ͸"${}R\RE0%x _pyP,d.U#2gUYDmy Ca+QW(I$V.~'q. _/^O 0'([y_ )xc h?@d )E`o˻\|JEXA y ώSw*/#[/ª CѬps5vI/FC>M#L6?L1nhiMNuuk); }6ǬCD8Lئ1 Ŗ@`BF(Ӏh~q_0 ٤VUVkzJQ AR-fnjM3*Tmf,E)lFSQϣOb-ƾ",W|}$d;Zr3CQJpc,0:rL9sH@W)'xbQ9Pc]#`vYBVPGT'DdZ)[WK\(=I`/2v@_fF Rm)N呯`{&c2#XxQEը5ocbZA'1N6F< +4mbÆ j*s,+0I_f-c]dwi vޭ,5ϰĪORrJEZ!lV#[J[ū?AG!MrU,*v0gP]T<۵-(HlT-VnGgg[ou22j3Ht3 )ߎĸĆb0A"%BحL^Dc&e8='ŅdC: ȐI}R@  ;Fʫ"8vg+eXtٕxdjK^,iG3܁t9kX4La0DҦf(:@L~ pS.qg1 7ʅuAysx=ʶ0; rP@A2 6^5'D`WvS2"\s rt4oEy%2\X嚌#>Lu|I"O`Fh3Aj@.љfFhtR|RO Du9OfJ)9?HkR͋g#=%2YU+?U~,:m[0Vhh5/d%&A=>f]Ջ1F]1d bq}?bee5Z Jl"y2_I刅Y{{jLh<LwdcL#3 in,nOS>{L30'[֘8>M>ȣrDjxqh?pp8d'ëH)ڀO{9fjI^X^X㔭a]KSyb^+D!b1v%'kJ:{ʉ u4Õ'Rʜ[Եv!HI@@9z!>ɤ@c&C7شaY3`ų^-DŽ̭+Pk.ŕۚ'H/duwuW2R퇕o߀^G e a(7 Qi f!j|!֢f!Ğl[BQ4[zQ-rC%eO& {X3Vz)}ͤ3V CfImF"݅Ⱥ+Eٵ{1>J> xB2@<$++7|<5 cb`)3=A| S*RTe7ͅ?gd)}kRnZ&C[;{Espֆ4* a"'Ѣ=hThoho"=&lOc; G4]/|7` @01p_Aɬ6gCBdM U'e)^(^*)%C%ۨiQ a%W1VSM\P䡸O n$+"$^JO4L=K.+z{)1(g2y9)Œ"51!ƙ<$GgXs`B2"8٫N(amU LL{ebn yL' Gxc$lئ 2Ơ~-qBgI>MtV{r6%od%ώx@n]x--b@6pC '~s Hqv$YT/oZSDRdmD)cfHu!̻ƪjt+&rՀĢ" k°2-8crE(pW P`M# Lz񻳗#(RJ;r5Ը䜣% gט?7d!@RLqm&+c.ç? ̘8̸N^'`- n6J\_ae6j&]rF2z$D<(_j9XcʿN`:खW%JUf.E<ǹ'ŒU) 7d&嘿x !?2ȹ+X]Y-6!KK7Ndfa@< WMAiǨ_qxOi );L^xᅄh- x+'i8Dd»{Y^&63fGg1i6-kߺͶGnM)@췸W8 V2tۑG%'2~Zbɒ{L1()OzQFaLZz$ `VYj\) 4f+سY/@#]|[$ p/ؙjӥ#'e@1gتwm%VdިybGa-O:OcCRyy()O|{,>υB!Q` [! ?U·ey1Tĥ)nxkn̉ޭC\V7!gT&g:⦛nO v ?_C#t"82Lvlq+anHŌոaLgQTlOk`OZ}4*T.X:qIafJW|4bdohm|R1}.q'=lчcR7H|pX dYC4+jG~Y#5 UW+XUOEudX[㈪a< ƚeL1c\1 ~°<9B%䈵+`yt!a 'H@[\ox\Ȗ?C ݘ8!QqW @59zuD‰G| [4<0ɠAy6{Њ@ +4K(Lx9&.-pC<%Ʊ+w'xaVi<H'#<ԋ0ee52<-%J' 볞,hN!UP#禶t%5!AB"'EвТ5AQ3O[DKͳҚ ՜0l\mVFh]h.1rZ>CI[GR2K=2pslqJVrB(\'e AѶ@8(S9Q Ů1~Od<\LڃDιؓ'~\3 xD2AS.c Dkt8W#.i nW ٓ9'Jw( 'tRk0luӻo|[ylTY!K4֞ɍ-4(sDW2$BS!Mp浆./Y֋J,7F<52rY}%}9Wg]".8̈́am}=L LfvS#ݕ+7 .UtB&|6Ў!9)2C4%5,$XEO1SN+0^0D1]ՆSb1qGͽϴ W8:֫𠉞Dv&ax pY)VP R2`NJ! " QG"Hvꩧ};WVN|뭇Q @/{0Zn-|osZͤ[mzg~`sNImmGTgߨc,J0lxCI~,: gUcol9s̳:D R!K1n') ^Fqp?PJnra{Y؈J5|tIn˥Mږ.|Db57El&~@rqb0Jk=Xo.#Z^:N;)1T۟W0hO6/+{,#켵a?T'5)I%Xj FȨKVm8'ǷjN$h+yσA5g&xs7Ȯn 6<!xCpRc@ f<ԉ,kjI|)`:|"?cO}FWDHYbɒ{Ȏ bĺi%.r >I.STtJ|@JdD])Zbr7j ã_kGVyeB=!?='6Z=̌:C=UF*4ՐY K%ZP'"k`+ WF#RW[l+;; w~아4>֍ٛ`JJZ<',9%O x^<69,G?Ŏm 5ƳW<+5#NѧW|4XQů,?{5/f=&CL2<'[=c2k<3‰*ecZ ST M~"  MTDEps -ᜰ$W4kRfChÒ&G8M0TM[F55ID(bVQhL&nkQ+(Y` +7=h+o\SD2D sU/Ia)xZFG $1apHL{YIi kHnl λh* mwu1*D ocJ;oꫯQwlm7vHS.OP(AKDpmցfܰvK|@T=\g3)ٰ)hfҏcb)bI8~j'\$j4, |*U(9YZӋl EI$"qL H#qs@Wj]=yq$*UaYOҾ+eGQqDփF(n23r 6WJ*E\Ioҳ]ZK#=r7ۗlJq7}b܍ETU gH1ɘզwZNUm6Z\Tf ҄Rjz$ֆ殲*MuTբUP%FKW0bwk$R -qfFh9E4([;n s@p@Y!#/!X1{=a_X!<"8!%B)}OR`L$@NCoxKը&FB,N}L}ׅ(5|ʟL@?,4ۚs8Vؗ!A,zYM`5UƛP1+(eU̜XKk]EjE3%cAsf'ᶊ ÌF@̃FUB#W٘ulAs~0'0&15SGCs[K}>Xz'ɀo}Ođ: (6U3b6't%P%tU^ tiSڍf- ƲR^*~ᖙ}~X!yNm@y* %VJ2m= PasrJI[bZdxTXJZ"hEs\=܇Mf &Aa 9@Ki=,?ʖR&4E I#!e°ٵ)꿦"C.y(Xa0D~<7w5vO"1D)ZWx]]~cDZ icmZ.U>5zuVX E&m5!d|1 _Kߍru8]ΆE}lnL#Dn' n!D͌W_zos?MH+ z X4Nv"g p@c9;8EdxFYdey/IsĆ+Y^g&)x +$%7=jj=We­nأ@/w9j t )<3.J UҲ[X؏aSIx}}ݖpN˞I|5#0e`2cLtj0իneu 9cV_aP54GK`m Axv+ge3ڎώuwqzp55H[jà@P%ٰxC<U( `?\ދpi/S;t8B  $ɰm  hh2pP&{נּ C l1E;L\Ԫ-l@ "WՂ }/GJBdKh㐹v۽z>N\rɴ6pSĚʃ{ δ|uac2sOk\LĝtFӰ焳YmlZWw҇" {(2&#,ңVEOzBS =;we& G]O;ާ$0?X}M`1"pN^[r^dEFEK0g5ɧc@Ĥ1_jy>̈!7mz6e~*O\5G3u*[ĸaNa 'Av6@EZm)|f~H ōa-qi P(M`pI? 0U)l _I udK>(d@Ԗ:9=.Ɠ,-m%ny}`斲d,10ޢJojK$Ail-4ιDH,wK/c|b 62Zp[] ٢fxk?2AV'U\r:yH'Z%,(R$6f̉QO<c! 7 p noats=㊔Eٱ=f L;SO=DC1"6"$ dذܘl,1'X>Z ZYϋ~ߥa[x{'9dicVr2ԧ> _,-1fwdZT>%@_IE aZ+:1)e) KH@gǐ$1A=ObFy9( T Z$ȡdªN,dqߌp䐩OS2r)PIS}֯g ;]sI22\t.ƶ CŶ 30 $Nccљ+uaa,M#Vj\+34cJdIr<ƭv,=Lq3RA=1K2ӫ&|wM!y,QsRK%[ײGyS)3|+b7cO'i}OV SS1vH"J ={tÕt+ [ )#'h-m`\R)8sy 6%i!iz6. @NA("s$)("$\E3H6U@$\-wsiFo29;&4ƉNB3 {~St$}P"N'@!unΒ7s}YPЮ"&XSvgl㸎mzaYއ8ƪAy°>h]*u%os||܏]nG2 ]b t"p2<'u2 Dj!tfWF)[W3\v.dgŎ5.V;"`"'cn3x)EX:qiG60<$y°a "J3U"M)9ٹd(UXca̠A+-w(XcSVhJl#agaU[I'1_\!LֲܑOMI>$\ Eq8;iɮZ媕E$DR9%2-;\.,‹$l?Kn ÆƑf:z+h ? J Nz( KRG&me4. ͓-t,nt2X. b-dHkXP*{Z"'} `0`HzR} ED4bg>EPu8M6^T[]v娣Z`lj[M`+>a־Wк?pٮf`0e@WdyJe6a`L8-Z `َ(EƟ<`" ?y躟?^vۨi)bJ'k?j5Yo,ib9K{JP El rB_]uIC6l}ꧮXtb,[@AE&f:]Z=blƒ~E2Q<}$RbrH<$Dd4mdy%E ?{e5Qoa"_֮ZִXqM+,_WFK<6azXg>fjG6iq{>׉;oܸ} 袋P %=lb9o&vvmGm !A7^iʒwTH1G6@RG[@hq~6賿Ryv=%Kb&t\eY*E\yRkc_a h\ftxIxp}b<4ltU!+&NL YK)瀨w# ƕXdb:SĞ$}5&^"=% KByz=di$*Ohhkphf#uSxb"d>| TIݟ5(8ff6U- cPTU/wE20;U8k-pꊎ_|!d:f0l~.]a@`ak!r끫oZA1Q4 ܆UUk"\/cdK_R^_:px Pğ !OWzBS'55!iXo`"% t?&q/yKFV.)˖3Cϸe Dĕ@$KJZĶ3 }P0f#.)؂1P-18E}ti7%0TA+ӆ8筟g-D/D!7E3fVg,vYU(+RuV !Ѷ9R P0 WnS`ڢCn$TJM"܋8g#Efp) yUnEĨ%AnAOZ-jBO'3Ka&>7WiK>ZL ĵ/5mNfחU'&QlU4C]yW7)é]WWAT$4E?#.6UJ??@\ @yMJSA.{F$zi€nh˻hNO:]lϋXc sT.J#p8(V!QzX~-,Hűo!"LYH1 ++XiX(fD=,a8,@30+ λe|K稇E̸4= %)|tˁA%ګ"p4)o4劝;q*rUR0ln|>E+{L fzYiѭ?=-WMyGez'L&2J2z1 ΗJ?, ='> k j׀ ]V H2j[SIk#(\q)|3 kwFF.^^1[g\W_}gE!YIk5qLbKՔ:ڹ,>i<ʔ iQMԨiNAF,pLA RA{.Y.+5?VF h3TGH|Cͧ/֣-0k>;;;E84KCchOĚ?JQ駟կ~5.~3d-e'C?e-'hb 9ޠ#C WU yJa5CFX$%[U*W2FyΙs)ɺ yn_-&@ Ih+ <Ee'm^(o!=2zX+lxF@2?m'S!xx{%st*q^.|3TB}>ʼn0 WREoR!Dir>c+hN&JjTDt 3=aPPhᦚx@D 18c>#AvwsvO:jJ]>CbbMmYqA9!)õs/ǎ54c/x3b'?L!W]u#;ıp^-|Wp;MN8jT `+KDg z10HO0 \L{IA Z!PtdD{7{'c>Q~-Q2LDZwʼ-DMn? &7BO2d=6Aƨ-k3pg ôvcIN' U#;jJ <3"&ꊫVհcau-ڊXi"V+|MTt|ԺbF6^"*~°\$D_Rs[w Ue/{hl###=_*x¬C?4 s?9眳뮻&18( {ٯ jvȨe^z~޲az/[g 0Ɇ2i+3MO/0a 5˧,Zݽ;sSkڱda:ZURw*0U$lHkcVn\J4C90ݛf4+@[EL0BH:hQ=@zVF!DLtFvZ_N7&44/:,h?tI'tWd@(= 5Tŵ@]pOѶ;e/fnj%O2ɨF j浘Og|#'0laPNGy [Y:.i"$c2~xy~ox[㌩:|7 ߀^ R ςU,&*ѭPbBP`mopbVc.N?.>Ԕ*@dd P#x3qJѐS 6ұ bD?C3TJq EE{c á_{,7A]zPl HEKƬ!1I@[J1{5rL"v I_DI9[JƒƸq!0FK' 0K_R(5װ-QxBIAl3eSR[ᴵQЬ|tXegmQ3NV#MhVHlrSkJL1o&Q,ڷf"h ?A{Ҩk ]~|7 l˧`U=̈s{9R‰X姳y+;dWy$+aÝEʺ^"̼}bUG_!2:PS6NGk]x%1:6Jt&Rڧ/3g|EzXK |tq ZmtW%F:n@O7Fu5ٶ}]Vu%(b\ `Ia &=l9cғ6\EP~7?,$#,`< }onJeZ8r%W"'ҎRT4zM $:NcIiRL uƹB q OW3'i|c5\-!"̹Wb]"'JU~zbu'WxحÎlq)@r Sd,9W%kݮQ6OgVDP*hf,_ I[z02+D28q\SAW`q'f\jb5-g]?ϓKZFq=r,0Pj`OLYX1n[p^3&$i2I 5>t yhպF d;1KuVqY2mV03ț lbkHI (~3OEǦ]AX{XG?^)u);Rfvc*^9\@br-x$ gS%[/ sh\mJT̅AՄ(V>U2K с;2HN%pYm6?ڤ+UVaz'=,o1q2f)xq.0Cp$o {\1JCpz7@#%I%_ cuGtKOR`"ވXnYzX{%*Q+,Q*Γeօ4W\ 6ԜAfX)ӓtMh#\g̅Fyd̻|` C 3EL=m'&GuT_ Fu"N V9ٝW{lIބ2Y$n&;;d3~ӯ\'Y@󤔄 獵Y< *5)Pq7IĞl[^js $wP 9?/| sZQ)$\Xׯ]EAѮ,t0b٬>b[HVU@DQG#Ì4$0I` {V)!{\*^rbSdr)9>5Y:Y)uS+VRtVu4DB`Q{ BI1]eȢSRL$K |X̢lZC;ij6Z46FMͩ"ՌD(rfXDX~PS.B`gfذ@R@د}k }Ϗ:\L AD_n]1M}U)+ѓ<(Wk^el[GCDokM&D9LJY4ߺj~p|5MN:ߝ zyK cTRM ˢ Re]ƹIy% lHU 9$`D\%3bIF,9 h?NU6%2 2#$I -NO[ptSîbmkcH#^"g)8@3۰aå^$΋W>RK'҂aZTc. 824eE$Agh+}7Hv?陱FiH. &:jkXyiڃE`Vs.> vEq70@l36 ]'+E$9^%'mV/u敤mCq <%o~A.:(Qݼ~NK}Mӟi($}I OL!=CB]& &ƨ/F~<,L!ky(tnAH0*%ysRIQ|srP3ědneΰp`&R CBUȔNX\Bwi<,+,1U8\)F@?=MDS)%JMJ "N]J5jPPW5I RY &ۘN-dt0v3^*FϤzǧAvr]:OT?Oz]5%$c4œ%< +ëD;rmC4X(G+وVMǞ-A"<'TI jTuZ$z[F 4j_kCگ7'F෿(n=yѧ㑏#-hSe)}(Kb $QvUkFZ w0LI4 dHFZȿ˿<-1Yza(UFJWO&3f-f8Ys3PF?$<`؎;glHed NZHZBn!:2A:?ltC<u%nPwI& Lش8K==έ~abdDdI~bCV"S;D7IU,ODBIΌ)(ˊCgRՉky:HODgWVH3o:$J2Sqj!I2 $Z| ڷ޵Tͥ <޻aJ=O8)&ym]2{^y?<]jL06o|`7 3s%⧫F#Ւ8`|m|EP+ܱmo{ۑG{h0w>f,kOli=Y)}~ 7OtW_xzPFc! qWɥ,y#qFȒo%/yI7 =34-(%sH&ڑ6>dg~m i`L_<)_Eu썹(DE9c; [ wyg )$Iԧw[#5[~w~cx~'&M*"XHNI~+_yk_KC9L>37 s~?IޏG=*>^W~;!Tǡ9| AmAzNp3K'uU$2Ynyc8U`L9_j­?(r5| ,&x9@S稱_}3I 0\#[6('ebvuWdXACr)5:ݞ aô331C?WE[~3gx-@2r1>^~{Fv€@ spvl\,0CCQG.2,Y17t Vz0 ~mA?묳>{T6yWBU@Ԏ p15a+:|0c Sc\$?C2βBJ~K_R=W%zK .$<0po,G?ё~oo1d+0{8|S'P?;+%1G ,80l}om׋ɸ$=vaRrO.*nܸRб~>7C+h $f1'.R߼% A#4-IrdSs=(g8 ~Tt*r}`#vNnCF@K/{0%"X,C.=9yli'DO ف7 a'Akt>]HM^bQ뫨D&a%r5fkTZl2柾 6r!6ni@+%(\.yd,:i;cy8x;__-#2 >*x XrP5IaqūN>ⷾ9yγ L@ ^v(9D%c9,oHt#eꍂ}xd6Dnze)|Kb*1 nLI0nbnE. P=TcC-833jɒq|Z]{<,|Yuh{(W]u}Yt8=cCH,O JIJДχ!F-.1LpfeeS 2 [[0ĉ.]Ne鉧apy0G'pJz%k$KQ I}/]L.|+"Z qpK_JC'仳 zu>H]qeupbjGӟ1Cz`k?\sKp#[2Ly*}LY9_㡳m~)-E,/ÞBgLyj׉a8ӺugKӼmI˔mx|hO W]pAʛW?⧵1_S[]OA]< cC'>8\.v?8;Fy2&j^@ gY cuߪJHnB.p>uߪPNG  IHDRrkU8sBIT3 sRGBIDATx^5I߉/ t8k`4F5f.S(ȐFތ#u{]tM4)G\Ы6QE@Ď! X Q <?O䯛}q'"3D~w_ @ɟcП٧Ԃ @[W_~' yk  @_&U @ 8Wb6}8O*i[{u~08$?Pg}Z^;kO?(v?C~$i*vÏ~a9<gV㉒1nW* GȊG㸞1 a㙏,riK/ yM)M䋫ҎXV{,nJkelVfg<|,d- Ts+ˬ9|UA{nGw'hG@ 0q*W|H}k+a|ܙJ3Eٵ4pq-}As,ݩXȽmUIɇN|W 0ZH^X>2Ǔeyck~(q{:ׅsv&LWçsp>}M||^6_K6_KUV&?n{xmA{< ׫ǽ} g)\҇a:dz5Rڕjj:M׮*'f4Ft.}o? wġ~?wcU1]f:-P.bhmc?K|:.([&ռ9pcɓ|4gA6>3i.N$gV1o&왿<>VCj#G.u+X U!3\gby:ˇyCk3@$r]_AV4Ip:rzJ a:r}x\sZ4P5zȕJ~mzM~iB?ȇѦ59nǍׄXhÚI^ƫ|͙j׫OU!&I>Y*F5Ǖp?Z̵tN PqSnr ^O}w>>iGXvz#vYcE8?OWx<ɧrs0 _VIF۟G?4GqV>c>2X>KO)I#ЃCmV#u8&#-jN)bDL("ȽDD3)Fm4ڲ|{SxϦFg"6GDȱ\%7ikWǷgOWWzpDLڧ@&+W|yuN#C)<ųGk$&<}ht/|b[ݢz5a]0}#7of-zJw1ɻes3w}hGɭYzo9GN;GbZ"&{Qt[8YV4Rekߦf~f䜄PǏ}WO"l鋿Ǐ_~a sȳCYfOB9Kq YY^ͅ\RƎYX$۪#K?%y@gOEBVz-d.KG^N*Fkn/0?TP>!eyw^v$,T5fs9| r S g>̱M?4JUS,DY-BVnT {4ƨn6Q8n*'&لN| l|I}݇fhw>(1DxSHl0 "Xire #)|dB̜wj>&$L2s^VV%f3ͯ2h~ӹf;s<%ɬjt6MkBn&'%<\!%L#)7 w /%bGiS<^q7`&@5X|T,0A|L| ̮n{]HNE]UC/hAh?C곟N {t<4-JEn>:"=%_yzꏱd=u-d7>LУGǒEmr:*1>L駱xgOr,Yc#mQI)J=ǥd_/?| %\^j3IOc|6v\16$+}>ooR8N"2ԗdN~y̜%J-d\zlfw<cr?R^tM 3%FtFi=<͑YOsj֞YWGʔ?ٙJ^>BZs73ujl;ܐF-9nNquB:3FMWwEkWz< i9v7_ͱOx-HU٦XSYG:}p<Axc)Z<Ǔ-ûV-ocO03:QF:KΗ9|VM4&q(36U%RxmZGZkJC萇F4d--ZC5@~>:j:n_Gľx˽,Ձr=ʇ3KڟgsZӹ}9BGh,{K/~/KI=%x(5z_Y5C pC%f43wcU$\n* 9I,?¡? A=zGm+V·kÈ4C.pix<ӱCQȻfٌ19vCĞ󡇚)cX\g4У)T竴s|o{ȇ+D.Џ[#QNZRßjx B_:KOF󧖡DwkI~'_ )LPP7`R y* A osSZDϙd>G(FHtk#2 ëH^9?)Q'c9bH69}F1 U /H\u?}>ɣFPk1C$𐨳տ Oh#[zCv(m_"O_8QI=&O55>HdʡD O=r48zK"g};1P`{^k9oΚ #2m_ &7M=?h9=ƤMd: fiѺKcfIZ$80]hz<GkD%Ǐ~D|GD3hNbӱFcyOGdN␸k4zDwST ZhYe ->fs9e$MsVl5j!8"f_%-j<WzxDf#(OwL˧{t>2s;dYH󷩖Uz/ߦN׈ʖF1Dvo;;xz1Oͷgui^%GQ2;H_UL鬚9m#ӵkީC稶| 7^dÏjDZFm_WGV*$ h/&)kŭ!r,ï!<o%/8 ͜{h6rͮP252?|P8g/$A\"vq!<$u %o:zAKu6h>DZʥC"z<׹D2:9Ec`m_!Rst\wۘ +dj `[\>}W&m{xf5M9k|y~(Ow<[;M9xoIZw s;r<e{~A8]3n(ME5__o]|Mcc$TיډMWN`vzy|j]LMGt7= 9\vxFFoڥ_jnc[/QD.2q .?1X9?*:8. '$xoGy7H ï&&s( uC/%OZO3#?xCKf"ʱT߬Vy: k-V0 &td5Yp*b?|'CkO9dfh54#?o'\»Dy1~?j!H)o<;_$7G-?CtyxУEX3ԏ?Sy8k ;'3ldz΁Ɍ7ġC:D-SnX'DQ鿝sD%m-?v=CdgFgXMG|h7=m#F3QV4Џ3D5:K>4z}~f|Cxفh.92Cb?gVPhbbcR8@?ظZ;6zzyh)|p7BJVA 'aCLjT?o'DJ#yFΟL2{"x}?dû* OےHGjZ <'S:Qx#KJt8ROOq72Џާ/HZqlC:hСD="2'oH[LK>t$VFhMё/ ɇ3HΣ6S,\jj^heVc^Sd4_<JRyw\߅WfhCQdIOO<cQ=h6hhgۿơӞ;u`@kIˏCk=Z~6#fȐCe" D#i*m>g<69mȚ<ԔسL2zDr|ޑ#C?9=JI"xC?6-ɇYit|8N#C' ͱ{(%s ѦMu@|h57ZΣ|hhnovp|:ۏrC{ӽL#CJFWr9~6+~6DՐ1:ep<}<^ a#G 1;.K~rB)gJ$D|6%c;xDO(TS,gGYOǏܣܻ!Nq $?Ú$|hɇC}|tXkm{ ɯW|/?-vޘvL0wh97MqZ^Zwspг(/[yطӒqY/ qK?g?+l"f×xK #:8&e |scZ\"O۵H>PSc iyy勰y%UNxRc&Tѿ Ϊ9[g|R[:?6]zsb3~“x:e?X8o"19 P/Ǐl2i0xCG*t |?%.=꒙'U "Ƿ\5t JC$XWCݝ@M>>Zu6vkzZ|Astf剘=o'yszsV=?:9 k8|= &9q,wޖ2vcs@6pP{taq{={@nrIn-/.*ױkC9\2?оEM{HCTxTnH7CgK;XՏ8(rU+_HzaW 7|SXshڱq{R"J^&? s4]kzo9GBe|*'ÖvɱnK7aivp])<1N\xf4zY}BY]Y Zg}5o|Ҙd.4Sk[@Ԙrac՚7dN?]d.xaMH˫#^ΓPti ==GUz zIoЯe=f8>+ZwZ?d=\R'Ma:}DM2pt?G==Lḓh}R{9??E٩@ί0sζͪ 2Go2{BǬLqλGOoqڟdz,h,+MyF>"]Y@WFmZ]g0a$dǧt-2~(oPx+a\9$̤[50>qM}ɷ}1ߘډ=3%r?nrY/M]uL+X3ܙ| 7c@g]?eʽh^Uqo_P!rSZhJ4ڜ}xAɂ2g#:WWtl|_"eBY+ (?}`n GR4z:7o*|D?le"әhɶ+3Zus#wwB4z\9Fha:s4uȧt;:|ײQm&gĹyxG;T݌ڰGCN,9F罏?s辏߲_j!XOm)fy'3mpã$tvŤsI*2iKC>G5:4t΅02OEZ<>>2ZnO9>c|i͐ SW&:>sM7 <8u9JJ>XKF4Z&E }t@ aC_o4x @ "M? @w!L2@ "M? @w!PC˃m=GJM@ p{ =vffI؝OqceJEX6n@ {X΂dEVO՚M6sۿD< )a * !պlMX[;![q[!~VnToi,A ا7zf@ VWNq)3e2E{̦jf V0 @x. }[@  *c1@ G [,C ܓʨ @#7a/~a @%O? g0h 7$>GAL]+ zuťX M.1/ _D\fvv3`CH |8cVR:8#xC/'$MJqKCkeI}55-w2M\T!9ҝUՍf(͌ӷ<·Ƨ6Wط<ֲuү1]%Tz5\9mshm m([JЬģeKz[n-Gro_ZBcjGdU{)#E_Owks:ѼhG&t- e[+d%[?k\ ʌM"QlIPLV_ #*]~8p,9*WyKK5C(:O|8Tr WP~».pH`*N+WNη5uZ73XS;lvGkO>tH6][[M7ޤթa!ۛMHU 0YMgK@>%/ɛ(PcNoi^ "*yf+ 8@8 8k(kn{ďn "p|r'Y_0m^ =%yjZPoڹBoߊ>ȵ~o!_b5\k:9՚QܣVѺىodvʲƣI}ސ{Fw ͇z1F4,G41ž/wNtZhhh4Zo1TzwΖSF;QMֺpJ^-k{:wf 5KPi&]C̑te]d \ P! :58qY%!,1wg%oސF2:κZ h eb?]tl妬zDGXjVo+Q$:XdMCz\%~vuJ+>!][^ZUI/Jt61޻#uo5/ӡ?Qhvխԯ2('ġjl!=x8*62_ .Qj>:@PzUw/C_7K߇cԶZxOUy4 g K D2۔#C40Uc&~8Kʕ MjP; %Yo9ś%\O,|: U5=?n4)T*(9z˦8+ؔ%jVlבԬmVNZhAK] ~4JX`& ࿴ڍ8VڷU:ܬUdG>:Z駳 G>̄svZ&*?].  5Nf׾OC ui;EQ(pe*t jv.GuEg]M@zMHR\j,D7\~yCL  ,%r6K W<;L1V# .pXGǬb>\?fH@ ] 4@ XwٗL @@hhE@ >h>^Ԇ @5@ >h>^Ԇ @5@ >h>^Ԇ @5@ > ?IIaZ"TzjNN/Vf};c;AQ  pǡכ-]Vv6 zȇ:O>A@jZtGSY] @x}qh8=^*(w ONd3awc]z8.?ۣ]frfD [W gPԁ @I%4CwlQJfDKu:DܝNՋιVRz(X/Ξv]d!k9T @I/Chq*Rx99{y5;Z[UɚNAI+_fp p3|f 0&Jʬ.UӾGF1Bhk%@Xp^xR 5J N\Zo bA+u\ ,U~:=b#ĕa.‚&+9 @%}命gZ5gŊN<$2^1kS8_S@:;Ώ+ىܮ(FkiGi y%*C $1?O7ͪ節>KK8yY7@J_8J'h33>@.D)d\aT!@ |/?gOC: x+4'hnv @Bx1>l|\쒐h BV0gA0k ,L%  ܃7-ds9&:*@ ܓ@ǕEC4?;k:'i;tD@ w / C/k7hYLlm)KdMH5S_C @: sY]P  @GpihuheftHX\ފJtizIj⒳SA7~D@B˂ٚ{4_Бu>;ڶe tZNjaEMrM(w+51U#΋Q 0J( $]WvrR(XH8hjhFQayF8 V Х|l;UhGN0}AE EWϝ;+{#ZI+(Ct(l׸ֽm2zB,\7(5xesS_WC7 *,K^*7KkzC! ܃@V:LSVHϸfBOC{R$AYB_~~˘VP<b%!O=@`\?%o^)^빿tbt:7Τ D ԝ堅>g*]qhػ#G@YQlppMw7&%;;2YQZH?u,@B Y }z7]@Xm]m3p{u }84  @G@KsC@ hhh︾3 @#sšǑt= @@7}͡S_춏L-@ w!{:lǑ;]{\dT0q. yA샨=7]Gv*"+pJ(ۈb ~XKCԈvYsuY-zׯ=7}E_@`8R> -KQ&1)GoVjֱsP/g5-)gq+ujf:6#5Մf,Y ٞ2ٝzSyNDY 0[vq5sמREE'{*H<-49r Ej^.M"gz9ܵFzӢ#l9%Hx*K>> ͶYuXfظd|يNYMlU7)t۸5՗{,vѶWW!YɊrUGY8k%OW 4_՛gEy-=XIA6uX]$U`!I6]cJg(d1',{ 8"meյB #mm.$zBNB7 P!Fi{Iqfht9t5WVn%65+~%!)u gcsHeEaSVSmZ[{ִM< v*FlD YQaiۦE.VX+ ǮK8z:6Ydh)"&ZE\,si֋-M~>ˢTJ2" Jy WNO B% Y-+־eEr<.&CT"֌zLIC62ZV=%pI@ԒTZhÖr\E=^I 4:uQgcj9Gx#Ü.2+\fi[`6] xC!~Ub}- F/?G5f.oBFPaQd@ѫi k87Tgm,j9h~ fWZl0Bk_5D_V i ih-Ak TW&v\\^ +$N?!q@<X : @8@_.Dz|egA @"VHJhCsӄ: @ieev;[í4=fzZْ.`j?Qgiq%u,**8SVXwIm=HKיI{,]l͛ 稩ihD*(ѠnP6vy>U^.ͶP/AC_Kڴ֬'>-2:Իs'lszKh"zpb "PZɕ~tg=S{"Z5‚B-Id[QFM):Su*rDd~n^ U&T @z uYw!(ΈrJС EKYJ4C:ͰҨj6cV-Xo,N\ĝm(Y᭵ITiorxU\.L{"Ҫ;.V.C/]zdm6Cu/%$(e*|}fG$og+ d/6lȾW)mp1u0> (VW`4da^/Q55lGMg_xVFP[{֌z_\փhu=d K&u D{y墷GC`?}zM2Ja4{_(.hY^+RUĉ^,4D]D\j*OƲX .Yj~8YVH xYn˾\OA3Q5͹\pv\@^^Hi[fTK+gGj$x]7;v"il8 7j(Pi,Kb߮7(rIXmԾ]U`l%PW~ٳuA:KM p-jF\躴j2`0nyrqw 1Oo~MW_~ߗF dt{0O8.¤蒐0H*||e(_A# z;? oE'rL堅>g*O> _ܸ4! Hlib$ix .p@ 9em&/ @U8*;C1X@݅ @XE/}WA1 @ ieV?~܃vdkt,4=`b @OC-ɽyGx@ 4?l=s z1H;F;;k @4> }pZtgxUZ*dlMLEȬ+yTpJK/h @Έr䷧C(-0-I1IJT[h$%ӆ%S}QGѩ%5H(RN+. @u i5qhi٥¥akVYǡ^0%+K=uRϛ & @4'’VWޙSҵS=,~ pYqrYCԄ @w"Чġ+ԬT`ԍl81v4o,7@@ pi}zMz'L赱^-UDK*0(Πvi>FONY@ p!}z8t)ٖUEʻQrBdkP2UG}A4W}tѠRu,Iex @U4 ЯG @oKOC~[  @44q+1>C lKOCޖ> @HOC3 @44qmc>/x$=Yl㉧D=Y&UzW/+ x!> _Z76⭱IצQcv/Qޕ@}?cUE'}[j07W Uu 6]rDxlB6$ЧwC۝Kj%qh'i$9-{LQ`~(2k;q6 t%YwIgyLw4GN J狟`nmngkFô>GΗQkO,kfsZÌf3~Y˿R8@/}-rFeVv-^ $RPwI=u^j[9i;btޣO_[}֔YhWfKk>K~ZMyn%AлơW9CBޕO.=+vT6y;΋Qse{<` , ݯ3UrF='JKd}IWHM_a.gg]\ud-&KoAilneHߔ>T n^_ss'͇4N'TԆǜfG`:h] i5qhi>5&X KRbt6d[Tǡ^· noys1cFWe].4fZɔ9sd_N'phTi5qhiVY,Mtu~ 퍫E_] R6mCoQ.1[YN+;V,lMySDs檶n򌢌TEg6l4س#N\Bu4vvR J8;Gaג]ٵ<7u{ F 48z_pB(5Y+!²Mdv͓*Ƴk_V-oT!W2o#59ҹyF%u tEnDLҳ2ŕp*u}+j7:N-f:]7KcrNEOCC/ǝue5V1:k+|}j@b6b !kšK1JeV2mN4NQ猑iv3 k?[ x~w~, i  @XLOC^<B @`}8Cw @'$ЧCp q  @`}8Cw @'$ЧCp q  @`}z8] h\S'uɦ;@ Mi]v7$m\ӒAD.|c @`=> _zHha[u~E @HOC⋞-[}]Mk&M)t>?m2ޒz_{x#O2< @/$Чšϟ: k|LY/sqX@ šK /JjrSF6Cߊ*Z"K'^TGkڎX˶$s!@N4qVfoo5  i{m@B` @`[}8@ pE}8x?}lB 3ġ<N5; u@EOC୕idZt\ Zb*U}L:]@ Ч=qh} &,ꢫ=ܳaUŽٚZ(maŦ/-93.| @:ĞKJ#]{udWmή52ή+5HX Rӓd}b (UC9(ܼ |,0ؕ$ib7 @pihRk̦^T+mS7;pWjsR㴰]{'K ,&Чw#4MȖd{)5Ti}K EΖ~͆}:gc64rؔhДtkl*H)H B1؄ @ "`Kvpױ |ՄUNߊZj∃Yʇd'[鵓fhX-Vrm>97!@@WC#gGN:izmJI&Y7] Ր @`^`:4܃?yY˺.y%̍^׌I'nK~xBP@ i JdI]EFQThfZzjI)7+#O^zp ']ɚжZٖjLG:#qoTTjWDg͎+=W- @%͡; @^B[7#qf8];Z3 @ %Ч=~=uݚԄH7}C x+}z8[~Uq3Sv=WE=YO[Ce=<爧yF'CNA vƪ+)+u~_=mnF.bQ ?$Η&~ UCG&mRs4-/)Gumn ՓlRSjnIrvD[gkޒ AOC{;Vu-)ٶ@o'DF.:k=?`$]wF_j@Fd+ks]vV#E COV@gO,.]P4toZ\-Yr0i*IGa$mT3L{)y hu̪h8UQVt[[鞼e^2M.5̖۾JJIUf?!'PIHOm0rSx9> -qҫ0iԶ> Wțwr/ @NBOCK?4ytMHۖpۚk%MW=SZo!@R}VY?0UTzlIzҿSΎfS0@ w Ч7CXvPn_2giI/: @О85̅l6_I'o@ @)r 4 @4Nq#L_ @XIOC^ @7 ЧC` @J}lQ+zi@ e4qhm  @Y}4;mS @[ЋizFo†IK[E ij` @@iqh}6*ڴD 7}ַ5NM AF!@6$Ч%]zu.k7O&'d)@ > -qk3{M^/!@ 4|h?ynh?|jB xihg>[ͦ8k(V9%S6aClFlu @ P'Ч=qhfF.je[^2%l/ @"Чq譜 |'/fj?j!*)ovDnd ֱmZS(4 .A ihO& L_jC)?V.7zkkfOoM{:R^E pu}8$6Z*H_şlͬP׏I7 @44qhG(MXm.K^m+hRڣMc ,> MeTѠ禎|-ے{2ek&IS"/Zb@xg}8;U/F2%FZkMZꮔzl @؊@ġ͡eONZe-{@Tz69q~u$bKԯșQ vbmT @`C} 7W{X{WoVv6闘JiVK҃xQl1Bۯ)ʳG6F4FiS@z ihO_'FgmIX?wKJ6Clx8*Pt\rْzm@8tNhOI}2" ¨aWx85tvכ6 @AOC;Ъ5)+GqrfŠM[!ul2?*ӮD @@DOCKZYix8%mmVYC @oNOCK6`\q WzS @Mi/ĺ@Fd6p @^-*V~$ݢ^J󡭅&_N1]w^w  @g#Ч=ql K;`f$Jk.%WDqQ;;iJu*myp뭭nh,4n:F]mZ3Ñҁz/Mˀ.ފ@,t(Y ў_V`!.}w% -j詄.څݕ6 5 :-NZ#YS?[dSA:R%a#J?0u1HO {X?7+ٞ#kz"k'@g&Ч=q3vo^kI@v۪M5BV^?fNT Pqm^MTGOC uD*wnl.K.m+fy#ߣ] <;lrh!c8?> qU<,e\s;Bɽ|?pO!WrD 6зYH "ЧCjԯEE%r˴9lbzC+@@_q%ЧC_w_D>ud aϮUDM3p^JêG)i\k_K>+uoylVFky; p0> MewӼ4#YbKMf/'j`ju`_ 8@&}ܣ/Ipʾt*=4uYa/l5zN[Q9*@`1e~}EW`{s! p]}8ug䞧4d%A3@%/%c_{.EʣlM+a{ifm䳏{ 5Z [l4ʥ,ѶkܞS[Q{ v"Ч=qh9zXJ5u t%cMH߭ܤ^[-Q,<7YEeÞHv*KȮla)]YlҚ ^@G ihgZB[EE[ v;@7e<^q@~<+l߸ > C[|< @oBOC;Yv *7ߪWh\im&kaB  i8tڷdMOQyKEpV2ڦDG ovT@ @OCKƀaȸ/zNm>ӱ' !@] ihC^*v5z?NT @.> ݛ]dyv(*guׁspsb= ݄L7BwTr)9rQmo`?gjB pf}ڙ)]Ur ?Q,U+~j';Cjg=|]<ù<@[SE kԛN3Zp)9|#RߴVu @IihO`O<|mmJ=+YCGN2mWwCi>xPVaG]>c)=9 @{8Nc~L,hb'v ; @4'}u"@)8Xznx2:Mw##iNR ] ihлNƥ NT'rNx!0 @+ ih+qߦʰ?f9 @"}VO;A8@BOC;YjūˁԵkRa+>Zr:}QFڋ_zTּ6^w.؛@vCם>>fSDYVcYYlB~E=籯;1T]KmM1݅:4֩wTr)upC#Vu&zh#jۻYM:̨쫍>Yv6OVמմyzr klsg@oKOCC۰HOK.մ\ڶф:\*R~-yMOM۽VY/QYt,2.C[j)RG/ehuB~O()p 8-> CG 5Udʁӈlj[[-[GAߍ?f`;:ӮŎm"]"{khoV;amSw% S%kfql~)`\@JOCơ! Tv)$(Y?#M7R^7lͬA^Y mߜDIVU(6D@cXOOC{}½ 0zN×P}t]Q].kT&Л` $ЧC;RM Hb50a,^gG~fiRk&SBJK:mnK'͙V@ ihoDrlNZhߦݭSW֌X gQ[n=dmlGٚǬ z i?f #.PY5 y^BOC~$]SO:7ے챦%m lh<*Guy3BC߲^-vn w"`la6]+gmz߉f!ġo0 k x>WW<\cw@64t3>?>B}\vgnF -qҫYp=#նekԃٱy{`wl{jIɸ#uvuMîW' @}ZХW6Z; 5+nTLi0;]yRv0]IvTKѻ8 @'ЧКM;~Ɏh(ŸSbsfH:zܵ<"! N4X%}@Cؒv , @4|hQH@HX RMkvIcGM^qAx|V}ZǂJ y& @ ihgZ%kPժ&ERJ6B+V遭cn'ևt,%'y1E8S}үSv\3v@484oL@5h68JD!X#A 4? {7Cie:t`$Ӟ @BOCftHiXK:j ,RDB]2 @&ЧC{5tNͶ${lwƈ+$Qݥ.{,2:TW!@4> Mғ @ġ7@ KО8ylkSm;^y8@KOC;v/3Ka./_]C X}/ @MOC;)2I) Jlx[1]4r'ZgtԶrT @NBOC;6%:zʷOȏj߮ 8E=[y.9eifi|.>iJJi/Sʭ?l.M+:ςZ| 0 OҹE5weMs9d/,ƒ p!}ZХW͇b;wى^W]֤Փ4mzN_=g FMu-?tz;jem<$9ĕ>r']j0[semAIOCK!*\ZВMb6̼x1U" c-D),nbC 4?O?枏+<2|'> 8 7ML]K_4=qQ?"{^ rVJmL^dbb=L,@Ts\W6?7v%ЧеpTRY"+bVy 4Jpםry{֞enNGV~[QО8tV(B+%ZMHy ndc*ZNH"W3t4RO6w>=G2R{ >}X34IFTUp{hL.?dk?? ?goHyY(nis[$] g!C}WRDqAN7+ڳ$`s֒ ҾІmat,79 0^K@ 9eTf ~fkڿ@h~b{Z\6-OzNNOC,}򹹍{;[=;cDti&IT"Vzwm/]xo3 m dӴ t)+=V6_pP išY p0';@)> M5@ > M@ > Cs% jG7Mvd@ @ "Чqh .j=;Qgko5ۥY@ @О8eo7\@vCk*ĞT@VYE%%E^6Ǹ'KI19=G2z޷ 4k8@ġ+y["(2k0RQHkF͕[R^i/A\ޛ;r_җ$?*=ίL.N{_u &RUܖ8S,d& ` ihgĭo,7o?O4 %A}+Dma\}4DBm:ic{Of0{f)ld3m%lB!Ч=qh4%~Y4kKvg踮bm2eJ⏗k^bm$@6M+[ B_Ws{םgr!Ti 'aH!;šOK @ ġYC @ġY1 @8|XI!.K.)yem➧S@ $Ч=qhky&d٭l.slmt'Mh~-e`i@BOC;{~;Ioacov vZ!zA[ng^{׈B*R&!@О8t$ȻiVFTb+W&F[)/um|( $,"N ʦTkV XU,[b6-vTjnmv$?ʶ]B֥#/%A@V+?Y Ӭ(,ZSڋz7@l/ϯ(ѰRkF?=1Igdj6)Y6,_2"޷ZK],DC@*4ġKk@{3{ O׽6m+M*o& >ll aR{}G|$8m'k .c;m._o j ~6׾.Nn>@EfD[@k򡝾4 fzz멩urQeMՄf ^iևAhއ53&\JIezE}@*4'&.galKJR2[gmYWm4hzn02<[$aSn}EIjl_ g@x+}D2QLw5m(BP_={`-7فx܎,W2ҷnK*:lUl1W-I~ӟ#W%-D?᷐6 j+S}nb @;О8NlV"M=}W;uWУޝ'WmIXw+dizIGN)}v]TsM9zvP;@N43GztȾ*#ݠ/@ p}}W? @8@~83A @W!ЧC_e^ @`?}8~3e@ 8A@ Hjs%^#!@AOC{^Ri6#=۝G[\^CŻ:>[,}t4}t,wun]yJ] ,:h?䵰d0%gdg>evTV<=gok ihgi-NzW8ݞ] ոmvg7xȯѦ֙htҥQG,uGWⰦ#;"#;tCmfP_:rS ɮHgltُk p2 'Ч=qJߒ>l 361#sPjn_St[޹־ kƞLî/gV48U,h[2] gYc6čHjJh[m)m?FGqgoB@R/2_3曌#%ihC^YT;qt_;^o_R_3Ǯ;K?mE7~zHҴj_J>F.,އ@^GߦlD8X_(%O.ZSGOJ(z,;* "9'|eK_T8P봹-YBV6?A!Ч=6XV26mԇl2f ^mZ"ˢ̇ȠT{(:8}9l>QgWg㒶Y Qa![U.#jDdmފ@vơ5X%cVF՚W yJJә.kz˖Xˈf5O4iKunJ_6@5;Jk;Iشu^`6GGENg!\l梢'B0G+Wr;*A%Ч=q UbgP<'|Ym3p@`[}EH.kPoadb > }8[M$ @8@>y0jt@ 44qw^+ @@ihЬ@ ihgZ7ia%klZNj0*ɶ/`_p6yKjME[}eݳREV:T8~t)"K# A *5łhJԬOn'r}etϬ^C,n@'$Ч=qhi)A~Zz~WO2ֻ$OYZ-ػ]U[v!fmwvvȎjt֔[{Ȧu[vGN}jjGvLyZXHM+= y*¶+LOm{]Y-A7#Чqk1I[NAG}4L+eTf6c@O`fCES Ȃ\ܻmNcbhܞ@ġKl7ʣ~hm$50L`~7Q}"UFt]_7}GnTSz@'ޯґ '<[( y:}Dِ lZ$һ\JVGzV;lOՑ*(%+I1(4@ "MJA3LgnYyg|Kf淜&ihC^ơ#iOq)Y4n)CڶZ<[VC#QD(#uo7d0i;JmrX/ߊJ[f@ Ч%]zږnkŸ+^? ^a_{-ZMX,74̮J0ӎߒ7:W˚g@4]c(jSNlR~B[pj[ *n@GkuTԕIJwU`s4Ւ` fb3};n$W{(:8}>#7T#*F \ oYi$j=]$Z[a_{P?̞t)24'Z2"fKaT"E%Z z[ 'D`+NnǓGmIXw@*}٤(9-q{Hʢ_S5Rq^O-Kcos;䈛5U2<7'B0G+G]v1^@`> C\*c=w6J:ugM%xTQwYOFc\0a4 puՕ1l~uz@ġO20܀ @N43k)!@ p> M) @ ;šO @ ` ihЬ@ ihЬ??qWqjD+D{G{6fiqK’IO40K>G]w񴎩Ů JyW/DKH]%:4/-״yqx > Cq>R$[ҶniBs>Ă 6I˛d =la áʎTv? цǑYi:͒uZuI6 $ոB5;̒]:wUYAG{ua%+]O}֞Y^N!CGYU}VG,nxu%i>C˅fU;.ziҠ- Ȋj~VwWz+rv P'Ч=qП ]c$ӯB6U6g/5Sma*2c\= gSkfǾ%x$ > >}ZRXT*ǓP-D;x=MfFTfn`jGs)D(-P= OO܏<.-mihgZ6A>\$bmK9Z_( t ܳUy7Hd)v{М4"*X}=K=8צu~Wya:JYSLww"Rl~'.z:{l6߯7)%`R?_s`cyozOlVFe:J^Ա~ niyY(-YV61(@NOCKj{xjըs3d/X.%2glNZ !^K!m,r?iVj6ujVDÉe{TH%m%}y4B S-*[3KLUm^ɢbU@^cGZ\=.kO: pڒ챦NJȁ?Ec_l6kZѱ2:է$r9}3Mgp JNOH6m]+{v_;NB"Ч- C_H)Vki  @8@~83A_ @W!Ч-}YO@ # ihG67^ 6öݨ8=Nf]ƣƨÌc_ =6UxfmzeGq%Em\󥅔6^C2J44qhVnoۥXEBq1[(XgfWhIs Qfy:iԻHyK]("XgDm jfۿJ5u "]\Yxa~4'>OG,mܤ9m>N-j:mGm=ɰ|W,(t1~/yeiV>V%g,0{0epB;f]< !C/"p[V۝utF{ߕwJO~+mӯW|gl~KHd\3ԁ@WFʫL >4'-Wd]LS2Y6T_axu,AJT70u5JZH*1M/KYtjLygpŰ6KW6dxC}z}:JZ-?Niڃ6v4}BۗW6rud>B8;}jzGL3 `PٜN}Yӥy [XW6+ 43c 2Jf%|h[V+.J >&tП75J/\ٔ?*=MIjN++#T6ղ]ZfOTRtBe4o?_ H ihC^=|{:j##Pb4+4%f ZJa](,ᨦՈZ9ԲڑlUGRTSp[&_Ao$h1G'llܬ<:ڶLf 8 > -qҫSm: x~J _ex=f[=֤ݒY,:( Wh}ۗGw:_on=sDDfٚ 6W6,~Ya@0}z}>`S&J2%rɱRn+3#6!ЧSaL ?2\jY  bQi~m-ToIɊ @@ġSgKDlRrHT_kFku$賿Z;2~_gj @8@C3RJY6 $:  @x[}~OK.^Foo˼ @+> MqA  ih~wiPmn͛ӭmt+eF:<9hfIf>h+lTE ;ġ4mTT[66{NnE+kĸvyr UW)[6*IwNy#;\2i@8@&}ܸ/XQpuc>3.gGSkXس/B.MOC;/yfmMعZ/=LjKGva@syiä& > CG &Oٝpi6?yv^m(6$a@NNp  p}V4vUjc pW}Ofu#.։,D:]3KĨ@8> CgGhҚtL"`1$Z$Zt|lIڋu8D ;fNKlNZ è`"tTA0KVF;($-,͑ڴXn @}ZХWM=n9UTZG^2ʓa2mIXw+dICq89mbΨ@Qai,>oWk6r ' 3> -qUYc  @4D=ɡ7""kuQoU*@ Cҭ4:kj B$;M7VMN2@ :8i_BZ?*SňP%u)XdMDzrh@ p-h.vcV:3wʩW%'; @%z (Ǫ%z*O @J^ЭqvZ!ZV9=wUj93uBH7zϢl.]W:Օ_r2ݸ\zͳאŅa'6#G7WCڝǂD ոTwݤuc=8w}|nYִf}#9+uynfۦ=Og_+ _I[ZSfP%݄I8͓> ]Rl)3ZJ^ n2m ǾR̾'h'lW6 bxOhW:뵮t)_9_ȾvZ~ ժ͉R76K{96h BwKQ\붣*Ed??Wfn k89' p3hM醓MH{`sS> wE.7vdQ~SteӜjS 4mIipWK W7)Dm($[jYlߵ:(;v\$Ar:%=鲧RZy5=xש6g!TY\8-kGneHLl ]5]Gj/I(Ȟ\lnl82R6 44k%\]$|t@ G ͺ @@4t/jC @  @@4t/jC @  @@4t/j VjvYLLw $۰Umӽϥ]ejBHOX=gK)_9xDN&*d~!Y{lZ-z^V-v!fmwk vj}ˎ=^hhKO)욎vN is';9ZުFW} z>M@n/ 5z4|-==>i ؜ʥh;OV6ߜ !@C.ᑢR_vs˿=zuvoȗ{FF]@מ+z% ![UǸ]۹1:],J[+T2p'4{+G*P՛D"u[7wil-1Ax[%V*͏'Ck _ |:O8q]i,9v:W- 7mnK+_sXE " ;$EI/Fʳͳg SߧٚQh|V+;% 'b18ҵvs@~.<iٖd5#}BI x;jA٬JrH3F9Gw_%-,+g}+|< wI@W9 pQO8nCw"l2@ #L @w"l2@ #L @w"l2@ #|>TB}5Y޴Kw>@&Л`|##)UE Z'*Y&K|֥ȍ7f @@n~~z9إe@ >ݺP[z؆^#m{ @= s޷uЬ}[+Lc}~a1e~  k@C_k뭪4q"*? 9mt?;x@x3h7+iC*=,Nr6u @14'C]&ڝB3*̦>[eZ֬dy=M< @4Ч9 B][=6e PK%VUW:%>} #L @w"l2@ #L @w"l2@ #L @w"l2@ #}ӿq}T>'%}Jt_j[bݨ& Al6?>ҼдyT3{ F @Cg.nf@[`-tJ.3+g]ܨ̥n /=_J2Zfk,|crhhy>%5%iØ 4ψbm` (J?r?wiq4nC }@TDQYA6][@V*O wىI8M]ѕ\m@ 8/ is[o8 @CNA 6_-I4\M}^˵0YqIh޹K7ݦO@O{.d c:e4OLgl!@Ct B][=ď:l_I)ĪJڻ,y#4la6]JOd>E[n4- ؋z/؅ , ͙@@Co# @oD FP!@6!#F @ވ&B lB F@ 4MC67^ ˶(:=N[qMzj']2J][SҼz<{ Y\!@Cxr_<4*}ͺZ'*ڡY&Kݬ|֥ȍz(拧!sҚS&[seFT0ܓzQ-|cV.vi1b!}ZumsR|?<O }9*w\#mJZ;Zy@q2ٱl~ 8 lB FtPj֮;eG]c/.S&WQ ;o}Ճ84 &\P&ND%"gQ5]U|83@@yv #ߜkD6u]gT98\M!e4mnK|] g!Chh)4%遆)e$kf%qy&9AT.=칐-̎1[<1m^6\9 p4߽ O: ڒ&~։g MJ%VUW:uƧ}0 Ȧie ARWzʬl'4z<2 p4Asu M7@ 7"~f @@Co# @oD FP!@6!#F @ވ&B lB F@ 4M6C @؄z @x#h7l @ ` |/WVן٧P)}ga1װ†ޙ c @N>pD--O?SLڃ: @w#q7_FCm50@  @[hIxNCa @fZD6@ qh @Em@ f @ @q>^Ԇ @qh d/Vѿc[9fKGdiK$;٩I jټWFd9WVК]ce#PeCӹK,8k[{P*괦%6՞޳'v=ҩv_`Gt OX\3yU?r9כ &}a9lHHRVj+tek)AsN\mVV(ߏ+ט/fϔe5ai<:eqw0["K_.Ӎ) fM +2j)ǚ(Mb*)uu1vMkdMAlDlK_~]uX@qhz˼aܭi{N$v\jsCi^(+b9 ^A'!@$Fn7v~WfִM)*ӾFu2` K\/&;7]@  2HT^h0,RZs=#[ 4*'W{C&[RgיJ}gˆ=b xġg9R ٛe6hk"7Y RX4MvlTjPHӾt؃fp BG]W]ܕ'ʄu>G%'gYUr  nCیmXm1,Ҩ0;vF#ф&?b0آ |hǏ=nkClo@@ p'g}4`Ʋ@2; @ >D'oOH{& Mz @83>@ 84r|"p @b0܅ @x94˧ @.F } ]@ @C| p @b0܅ @x94˧ @.F } ]@ @C| p @b#/6{ 燋yO @Y?K<އ9x9O @ ̳m,ڡ~?gaQ~<' ]zg,f}^KI!@nzEMpa!_K#=u[0bYB/|A@C"r>QǔwZ1wQj~2q)Pqԇ& Q2]{*Gn7::+rq}4[# , ]q]OV[{UE 4;&JNuS&F;,m. Uq&H=u~VC[*l"=vC/;Xj6]voZ㦟~9R z_/ԷoZiX0:=lfg4=X^kq6LuyHzGd7  P!n(+/J%W$5JW[NCK Y*ak,} 6׉(J^UIVϒ&.VVf?ŕO},Lu—]_5@I)/체ͥQD0#>!@ K`8ttjݒY݀TbVVHJVu)lG)ͩ\6@;t 5S]%=M"2 %RXDpJV%jhn MaV*kXB"Zu j,1)*uIVĥXVRi6;j^ q :IEEFc "+SqI^-:RTͅRIR|+?+m߫Sn^TR~ѷ/4Wtk4tEgc~u+DR ]IKb`>7'A"uY"K;zRS%Ԥ^4^M^G5gQE>41f75Uk4t6J"rf]FED*)V%Te@D>ԵBfJ(*Wug}Jϡ")RP'=-ӜJgv THqJvCތC/[!L5/%Rg-bJ ޓAġӛhȏF%b_mۼb'CJ%/. RJhr/oVѥZˢl#Ye}MYgv5Y"I@l*yԳe,9ΙEa-Jzp/ kj]?t3ե6 @ġQ:x;av(_ꛕqGs}0NIf퇏GӠ @@]@/CGIxS}o8 `~5&}? @uy '@ @ K C @oH8+_X@ @C84 @Cw#|: @] 8˧7Ԅ @{_}{QC @`18tՋ Y_ȷ.V ,&pλ9Z yÆǓ9GEC~!ALA@3fu @`sM2۶:=.v`  @- !@6$& @ނ-AB lH !LLA 4[L3 @ؐzC @x h跘f @ !401@ o1  @`Ch ab  @-b$ @ @[@C43H@ 7)@ ~if @>`CӘ`u @`=sMz-O~IC@ ܘhhr9n<  @`C:]lc @#з @4MIENDB`Dd5 0  # AbYĸ>ŻfF,ެHn֬Yĸ>ŻfF,PNG  IHDR#HsBIT3 sRGBpIDATx^%G- 5d1d!@{ 3ۼt8nϛu8{iG֮sZO^= c kp:@ 8@_VEUxU~2##?e7߽O~ˤe?9xj__^o>5 4@@@@MҲ|     p!p}7l޽xZO)?y-}Y^|O>|b*\쐵~Ç)eË>\)'Rlʮy?yZx>N-HO#z!C|Xܮ㹍KtIkVW|$cCzOǫbC>8#!HXCe;ș8/Lqi-KhvR|h;h_|>?=sO>|>ҟ4#˼AhМϋ qG?4ֹ)K~*}NĮljGla$x_y.g{N+6 3 Nם古eyiUct?bFZ.s<`Ji\in]_w5nR qOj"dW)9%1S?]Dt_RK"d'Iq}.SԑR\.Edy]<̟q:O,YXSes-Wǔ2{r9׽I:Z\a/.j'O%}:^|\g6:Y-l9[ns9Y%8_x?)$ќr},@Yz.y8䩒S*,OBR"}my(=-ݥu3օ|L%11q_e[ogJ2uv9/Sκ\tN]_dϩٱ\ٞif&zצMJr-g.B_19׭G +'.#a3\\D_nC`{Kz4AsstS=ע@HUm3"lFe-dzb?Fy4qӗH^ =Tⲯ_>Oo㏿m.ge:b$;1v]l Gd;yBgL'*&+e:F斉@Fjw3^#T(-^,f-놈]#2:{^SeTާy"9+KD\|Y^ ?_,aIȊ%R+"D".*kDVDaj."=j~"ty:t5C~X"tY(rLY("+=a.]"&k#{y,(99GRUC^A1yzN`I~]_ u+~w繢Ckx¦ qxZEvIEH_ͫ^IJY-0S/_)?P)hwW^~&GG|944[)gu0MH|/Y>׏﫣`fLk8)y|lMLrGk`yL/ٯ'~6l;5">_bCTK2bUH7ٱU*.:cen44f8[@>!]*sC: ]0Hya,WeY/!ѻ%R'uRdiJcw~> ޷C Edx¦Quq .2+g~^,/=x1TbQk%v%钼+.ꂱe.~ί:-vGs-eAvh.EeNI?_Ͼ1I)_τ?Sͫtϟ6v+ Y>ċG?oA8^r~-$V;K,v!#E.fJu#^GsZ.sl>zsuIX3,U-,U*M28"mYmN9P~f'빰\‘ ˉw|3X.U .H`/H}G7?a㔒Se^v*թT)E:]T˷<零铎9eݜ[;Nv>?>eA+]DnK5IuK뚭o{$zٔҧѲcvYB@9/#^#+ +1e9 2(,)W9.Kfsv\b!eސծDay/P,;krLع+(,=⵭Y{Dd% kdץ˷K$^~oS5_/,;,_W%J1Ws`sɈv^-yyD-{,,Njjm=;0#h>7䗳cθGK)N,s,-Wq> 2.~Kf ΣQ/t:XhN2]_b7e5zʮ훏iNI)م|!SKgw3=7"B\Otm;Pe9EКKWrycG <*ˌ?3]v{w ?^vɳ$.ese'͖tyϣv seTЉtA!<,esmJ >8MQI_Žr)1ꃯ('Ps0+R~uGBMz"^/R-4r zٔ#-]ugRrؤt~]M(zSr%9#&ds2;_9_'?*}_uK$F'夔2 NkgR)_US)}N_ɾXM5JfwWe ///s)-[JqBGj.(테tsVP-}G(|/6Y^#+by]Ӷ\J뛧R<~qDjS,z%zt6aeVQk2,QVGg[WbY2kY|H+egXUѦ9}]#{$c$*,8·Н%.KeSYMiݝ;^vRcϲVDK`;ٯ)eYvmY۟|)";=+-՟$OH$d9GsDs`\*\?TJp)K+2N̑)NtJ ^/e٫xkWFQK/SD6- g'v^);bkJ_LQ۔,WЮ=~uS9RZYke9.]˙Bd5O?.hߜ>YxbTOx^v^|?ƠjѲښ.b2_9hr; Z)Ueg{Fl^VU..1K$!d\N@x^ 3kVݺu9fe*^<0b''re׵S\(:$ ,`/Yjbm|\ &."zj] y+Z +mq֩VFr$^OmI)%a:YW^XGi7ui.Qr_b,視ok d]Wc,]fū}au_e/\IkaI9Oo~l:qeQ2ѦX#wئ8|w6b筸>>XJwŶ\wx2,yK˰k}%o;ۿ8"r-qzs!q|`9z,(-jX-Ws)ߡ'敵 TJ,o5K/.D^/Kjs90]OcRH e_jڪlfjHz3v^\//A45r=t#=me8jbW ]>UNA; ]. fI~_O>zmS~~mG)ۺ?~m~5hd6{gDHHs9"sF^@@TFÖ!u?-]@9Qu!3.?:wZ\&һ/QEE{r tga/kd;x"ZLD#b]3Sʈ6O*2E֝ycp{N]]=>KU#F&M@d5kli7/;_^`#72egrDV=/n?uoZCN$>GdIfbėZd׋҅w-Dd}CSTTjg9+GIjֈ8Wz"ݿ I3pίQ(#',$_)x>| JFflUZyoR,4$]'f8Rr(8Eb-_v:VY-Sz:./_c3ž8?n iZTirvZûPT: -ʽˌw]~,^]o-X3lQ]aMb {zQ.YLy" Fdi*2Y. r"/-]%(zdy]Gg+7" Y^Ddwl)3\t2~oy³^$v3f&QBUYe"+t\.ֹ^e YsqH=;O-e]"S/Xr=UnJ`]}g m]^Ed|*W{*x9/$w?H Eg'Kl8:Da~\0OJK+zT'=5hf7#Nti^:{uI%:/ظDd/Z/[:Z~ݶcz5:B]mHZ e嵌,pz"Y-{ @@@@ &m _*JQe"z@@@@&-5Q8QQ:,0w,m~    hY:ָf6mkֺd> #vyV&Z @@@@=.oxʦ5I-[y#V~#xBu-0!)qAʎV4?5u>ZkGƌ[ "?-ȣGXU2+!6>Sf^Z #~(Ӄƥ,ZJ/6R?.UNƕَZZm-·jO?Yد8[+ʣ2TKe#"yFmķMJjTPnRl`˞mώk훘ڣ_6q F@$*L$^F581El+$(e\zk)|p\uN9rIt4.|?UB#;g,E75Sݗ >') &dޜ> S&F}_Tǜ̵1,k>%rUp$'K@>V6=b fir3>ߑL9!=OT`2`W"Ms4W;ߪ[ͭ~ 2X^;"jlMFk9Zo35*/A-EI?wӌﮬ(- nI+WLnh tH'm_~RJ:,[Ws9Sh*g:_2N)'}7k/OYiale#m֕@:VY/[0.rՍ' bjrAP>j): jk>[rtќas(Om,ioPhE˃QZ// JJ4\^ $o ҵ?2 +Rb^9O;K@u*^>ۨ nК#ZЩ֘1o-;߭JczHR#x[E vZ{GI\Bz]$ySc# evb&~耣--v ZhY6z6ڃAkFc8ғMrvp$JZ~[5[0Ҩg+Ks\ !v[)s*ޚ>JyVUqR pHH$XyC R6}U8}Kgq qЦn|u aDe)b؍\ͬu2J(qM٦Kݼ/N ֜زI+݂{ӥU'-^Iq%]Mqiv1$ym:.Kr&)h1.kxR4uJOm헜07HZǮ΍\/SaZޑ2Q!r>l)z>G>*EP ʞ.Qp8C^kapV^C⯪Ӭrˏ nݫ˳5n qR7 O3@@.xfby P\G+u*_srzYK?I1K[J;U12=݉>̂Hz;> }*د~5mS@BVi1ٔe[<2A˶F~؝@ M sv̾e)ZkZ\o@@@@ xw-}90 |Nnвh5}k9}9Fe]ݩ lV׾Xi*Vgx;_ؖ+!ʽB`BK-q.5P.͎@#,ӖQ9|@* VkDxxV wCs? SAY-Z6"."e1eUUU'}nUl$\O6-49dHqR8#m\k -QbޖRГgv؏,gT""E;mOHvlXXi٪gJ"jєGfTGzú@Q5lEJ,X oRINq%阄쳇dg!-[~>=e葌ؔnՂj }M>!2>DL2ZTI>j벦T]?B`ˮH*Fd&)zW_U$X)2l+m] i3PevDPOw2@u\ys9Irq SluY 6]e'@/U_֍tʂ 0--?`m:&k9Bj}źڄ5c鄫eDOPQfV.AYTo Ub,)2emǹBxHajZڔYj_%Vdk׭JWTtYۊ\qgͦD  Z"P9Yz\lP,)hSFd9]}MnZ\HPVß\^0U!JHoS,&/|x9m0wF2M?jXckB"],b.:v`?ZPmN>,RxMUL?ӞR?oJdjRJ(V}%rC\UZIs,E)nʎ5+̔D Ua-2>SH  pC)Nn\,K*͖bWr[aa ,N͡t^ҲA'vklyl hN[*cRe)|@ȠrÚղ5{}QVqy@@@Bw9k#9I[eO[[[    ƀ>%#.{nk1& { '"p)0ήU4 < 5su>t^"@Z    pe7,מ    в    JZ^{~@b +矴 j)oK@WdMeӷZp5q  G**N¼@@ l7m4MAyC`pT= ?2}rJsәuݝ  Feڶv|6hVUl[yvG"sI20s̎盶jkCΨ&bM l_`R= 'BS1 "  O e)(_ ͖Ko|f]5CJ eA@tg4z:M9>5x͛_> 4 0|Q#<$lH4 է}=|^}*Yֲ)iZae'I˦qsGM   I ۔:Yejv?L@  &Չ&r+Q).b|wxߑ&k _O8dxhٗ8ȏ)+T<    'Pײ)6/iJTJꅑU FCCY8@]&WҟAGtj dxN!-hr- @W*%O]`\ Vl    GhӲ[y88d6)ϭ  嘥WHUZvt%d4tn@qQ-KTvimJdոԸe]9;beA@@@ ղu-+:9b#Fѡ @@|    <Z\w;    7$Pײ9w:~[ x  ^~QPMl2͹Gd:Y-N( 0@ V쪀:j<TLXx,2骈,ƃDF&wVȦD,jmTdxEۑfIrKxiE˲T+6ZšV^Kd\/KUX;t*ل8<-+$ p8U;Y#SjY)OUj,+T?>( JZP@@ ʵxxN;nU hm{TJy*%l߀~NON-Y[pb\5Ƌm#di@{p)E<<Ӳqj`5x**C?Ր@c e W5rjy֚4-7p-</Ֆex.gNŃeN"u-LrQ83]6eE?큪He!^qt`ݦ\p%(mt@ OۜϹ ( ^~>o}Z7x f;-< 4xHkFl39h#lEඋjwI^}k(.?REjG,,) pڴlp{A@@@@ |p@@@@ڴl_\ j Цe"}!6-a*〾| BM7T     MMEXJu7\Ph;]/(>Vx9HysG#lRnuIqeGj-wlu鎇 d˵1RVvx1g܇s*?[9 5I7sxM-F&ЦeV,X*)3iO#0R|\&-7ӡc)-<"8TYvVF؂4 JT4{o3(E\rgS2OKݞHNgnZԹ#Ƕ:q옗'n9 'iܯG`iپk_)ȫ$SJ-U0eTOJ*}v*7烔06rʅjթ7 mœR aCBeY*|'PR@9VUNqiSTNy(wuM]3On0ԃhӲb)EAIϺ{ 8Wr\$C"=b־ G9IUz.8㖍\h`y ٸ1HYq`Op+r~ۊ 𺥅 lu>עKn`|w([)Mt3_lqmZ/Jrmhz͜[/mAqliҲɂ*T#3K\q\ W}GbzK@W_F~D`TR8AD 0BMF"*UR}20vGI残AY*:ZA^DȤi.g75X9w+ Šcv٩<06-;HV#jElvkd_f7PZ*\M< qYyS)TarGʚm@%V)aL[,@l0J̵+lJj;-u/kQ}#GpO0" ڴNqYwU+uz/sʿRfbɞV֪FYיIh%TU>!-phsҕ^J[E$c,< G$TyL^&u}j$,%ۧ])S0(ضo=ӥzǺ FjQ6ZK" ڴqY =ɥ d'`@@hӲ;eO+M% sV "O'n6&Цe}рց}hӲ^    ڴ,9Jj8'6-9{^shӲ{ewzO2[<em[ ۩iwKH?rƦDu̿rC6mqE@:L)ܜ RX"hmQk8qC!H0 S7 ).^.F'$Цe]/_n;Vr&V㺻{D+$M2'MNpM[\u~)gk L|𨿌l-oQkqoo'rp8y=`Ȟ\RzY<2]6@5.Ko=z-.yTHQu~ḓ6 1wRm Le7~CVZ$Цe˒ͥPX/V|`ΔҩRUveQpY5^ ܍ks0Xֽr`S]VDeo° h,tgL@~*ڴ~qY &*4K2Ѧ$&7%Im)^Pֱ9Ue֬2h7{Ůx$74 @I Nş2+6-{¸t` `   P&Цewˢ@@@@@@E\1DM".S7,@6-lb؉@E\vnYmZv,Jn"Mewi]r'ל̽&`_mĥ)'$Цe>!z4@@@@`@5.D9״/ͽZVVT^![ϖmKW=    xڴqY{tYi0%Z.eUYHuF~i P@@@ ڴH\Ov]o κAJHT+,Z\q YNj`ăhӲ#qY*k? e2$(2su>g-~@@@@aiّ왑>^#儜=o   "ЦeG-$[*q ӑZFU+sx2hӲesBM-ueī JCYVIp#ɟT`vMm+iiEx   ڴq ?ShӲe :     6-&a@@@@`/w߾M| +PS\CJQ9@BSxHPkil`WQiWbኸ,- #c}Ey=.TdnBSMT52MiYI'RxTIx`?6'RMڱ-WQ+ꦇM[=!O趢ڴlԞHO~ Z.TUKmA~x`A'N4dT8<`݈l܂^WΔdEf*T2e)B@'!Цew˦/' SX. ǫh#cX I)\CVUSNuå"bᨢ׹ ~Kb=&:hӲmX_ՍmUJ2D$r"|6Z9'PR,u݊Es!UIZ^Mm]g: őe"rֵWJ 4Dr6V 3t՜hڃ?"뮫 dE'j,SprBA3hӲ#qY*k?\ʉ9ٗ{:jz٠V2bs#I>='%פj/"sb9zLOmEp] ᶔʸֻ\\eݛ`/ hӲrJ> mjI&VQW=a3RY r:]>?.SԱY%Շ(\[rrKe8| iپd*Pr]{x«* *  p 6-nI|iiGxȳElyfU_;sj L'oSoy߿9Y?{\KBSxHP6z46w+`@@@ H Sej;A[ShӲ^T]3M mհ   {hӲ.0ػm    n^i^N;ncz_@@@@} izٗgdMU*&N< MܿC-깦) 7X[vNe:s & u-±_yHu2 nuA@@@, #x2. (T` eWlZl;e|&V+ExlmZv=Wk\KWH2@D^n RDڎ<    Z2p :™[/TmRpYJm8z{$ղ$R ZK;D71ԤT5 U1%#@@@IDlz&n׹՛JuTs+ Z=i{V7@@@@u+U鑺OZP֋VG#Ӷ!o&e   #BZ_6Wki>2ԛ2<ȖW,y EnKrBa(    kYwsYJ-X*&Tk`g0e xE    !6-X>o&[.l*䒵T<:SEx{#s>>-hTa@6.0ѐD?u0N&]2/[pfwf8 ]Ts9':G37oiOd8hӲ%XEY1HĔ.B6.Ԗ#I|rd}εH).5G9(qt=9w:z*Vn 5BT#Du(1_\-nfHmGf@x mZq#[uJeV9[d26-ŹdD+NZD)plYoH?\ ⹋ 6G@ɻUDC Hf-r%{"TLrgGuNjL]uɊS*ga@eGpfϯ'hG({ \嶍* k U _Us5Kɜ`s Z\IB&VQlK1lynmjܥ>XyAV?# Rv73wzF< <ڴaqَ?Ͻ&}7͖SH ,ݤY)#"ۢsBE⹶.F+F Ojhf8g&Цe#qgVA\u{ޯ>R6Yhʼ_G3TKS潙>)6-Nɯ(S:>vVj)x'6Rd; nӤSUnyKI]>| 2D\rKZTf9e ~Edk5\V[dύqdR}.Z;H1޴68s.nk]fKrhf9h3'~rQ~?ooyeYS<@@$r9BN[u[-Tps]4^E <$kFmc{i~~J_-l HE0\0NpF< iWb\Aa]5MRrɇt)GB ڞO pڴ,}AP~EvvOvj FsXYKB$$7@ i٦gW]k,XPڔ\rRX)nH#M}    pڴl$.z|_I}2_i>ӮmVG](OȽ    BMnh\f!'Poݮ.bt*x6mZ6  圷zoķQ6q6aWȨ*}u!ř䮯2T +]BLt{߫=NT~Bv[mmv4qq9|ۤjrr*ρen B6_mZ;.8`eiSyg~}ՠʹҔ\r~(<fq9'Oe>lthӲ}od.ُbB@_+MnzZP#Цe).y)k%X֋    '$Цe[>@~9    p_ڴlp,/ YIj2\#3%(l k kP[hӲ,vC&_YL5Yāl    wDMw~ q{y=G/!`2aLV#Aڴl$.{ڦ±] `Oe멼t&؜tomUmm^,^O>YU 6-u1kLQHdݜnl꫉p͜AkG6%U;&گdT,q.yU5n۫iptP @ڴl0.n,|(<,Ոts<)bQAUR$r-blO9MtwG$'pɳ1=RĠَ eȑ=׶.U{EW`Pz.Okvqgy){EA=iH\v/a.WRdN2kSX?urx`5Ydu)sNi2LT$s`d 6mR+?޴MwDI@ixάjGHRHN€䃧6CM /R6OO1Q\.fJ:Qˑd,z {Bh2@ eYeYJE)g!2r-ۅlV JJ,ؔcrV-_{>7!(Ľ&Bv jCC@@`@lcU+w-pլ9!+mRJq    6-Kq&BYS#ȿ G i7OV!g8VްP5i&釖SvP鸜-;+    9mZ6u˿ RRԲCbIc<0oE gY܍iۧ^M o_ڄ7HS>?/sSoZ⹜]fƏ,r$#ۅ@`@ e}Bqؐ@/lZrNII7}f_Rۃ(7$gGlx &σHg\NM'̼8 hӲi:aW-eEn"]0䫀ԐxMUa$bǗ@ID7Us [ Bce*ܰ)xcA&r{"&seՀ:>_{p ̠W\K<l ڴ,;5!yB^Hb+ni*{8tAnRNz- q; Ux\JvȔTD* v\S+&9iu=)˥W,\,Ŋ g/vj[mu@X,v7#f򽬹úmUf0gn x '$Цe=a%7pߤM~ronQ_')v'p:I0VugʰMg\Ѹێw^`P@E\:w~HW(mVJi2ؔVEZlͿe;sbZ6eHBYx0mZ6=ZxGh [M=@6G=㹘|9d'dRr~ںdJ9y .~QS@gY7}fn) ^Ju`񎋏qs]JWd{3{37+{F#E$.r4>stJ^ TYnL p^~>o}͛_V_- !Hո >MU]Rhu* <$kظ~]H])X5+BN&QڍNϐfQVa@ H P\6iVY5hzsUH%Jr6nGtmB)؃ al|FcA@H^˗}5UJ#,&缕jCU+K:aKhCm~|ߏ-,#hӲCste1G8lK}:ҾJWU-ٸ\2˦ ޲͵H, >.Ej/=b鞆1uv57qk. 9G? @mZ6UՋ#'"}Kg:䔏JgU^'COǭPOs +f7<7'vCRn^$g6'R)W9ɕՆ@s!w^A[8͑͝ lHM㲮,jիkSW A,ߗ6S    ڴlk\GOG-!(|EvlNrV.UVn7,lHMR\6tD`+e\z٠cF\ ڴ,esA_ *CnЁxƑ@@@@`@m]/^Fv05On%Kr;A@@@izY^*>W߲QKI elqX;.`&     !6-?<܌W bv%Q8P݆a @@@@`@ e}BqhӲlVqmZqq    6-Va@@@@`@E\v8,lEM".w'Цe#qYZ U,z    hӲlP2l+ۍcweqCAb7U iH\$`P 8   ڴl0.JF)"轵2"k|h%Цe).u4.1* vR\6lVj=Rj/ thӲ}*'6JиTaZW͒Yը`$lHEA/?(K')AYDUtnKɪ[f%sBE9g\aӊ:e΀>KM˖Y.i9_=s\ s>qz 'tߥ, YeNd9?)t9mcUÙDJ4pmLi6v̸&Fj@rmv@`smZu CuӹU}d^7ERW6koجl " U+>X*9X=9 JhSRI$MTѭƆjv.śOEMF12(rɦz7w-%Mʶ S<4M~XEv֪ձj#{ӽ_tU ڴlk\ O@洫rǵ{[QA0;>lE{hSc}ʿq9na\mZ6hx03}71p,3^W-dZJIi=ZgSm}lUm'%Цe#pT~]FK?GeRۛg-ڪ7QX|rt >6-c:Z ^(Ep&?ז6݊k[fT~ʜeڌSWt%Z6!ݑ݄@E\M؏z-S^tn&*گil.c_fVcMYLI=weW#Z6ݑW]Y8hӲˎFYm ij\n*2Pp/,3j!R JMvein^m-eUV   7'ЦeqYʮ›FZ9BeA@@@ai,;-P(D,+csA^ S8Ef4!    p_ڴl5.[mzyUU2*$TW#ko j&ϑ@@@@@lf%Z^`F7aAV-W8F\\&7/y@ B@rkX70}w`mAբP.nljj.3)sBSb[R+1iY>>*5;/_r\6^&SnjȵFcjcfĽc# ~Jb6TwPW[Qt ٚkL7)'(5Bfؐ@ SU9B[: SjW9Shx.cŹ^/x4 rP oHkXV+f[uSAҮaIir Aa]@XrJU-T}1Dt#%M\ZY>dK&U ?U}쨦ltF>}Vf<ÚJ<C686-˒(ŪQ>WfO)skչ92i˪p=Q3l:xJ4LY{ܸ 'F' UܳfPv] -6ms-:RܥlKMeunK@Gu)ړɭDeFT&pF:h`hӲ~2X~$vB=\O&IU䔫&zs-.S:NƎ"RuNbt kmZqٻ쭜NMyj\ֵNoձIEH.]{FT QǕgTZRnΦEA|j+ewfSE#)# iYeOmKUoݖZcxWի4zl~>; (R|ppAKť+\ Y,%eM)jہ6Ml`q&mOM".{|[[zA jj&mZq&| ޻nG"Цe#qYo&YQ-a"   ڴl0.+=D/e Ukv@@@@aiH\aР!    ''ЦeqYfZx@)2UT;Ó\c3jYe    @ eY^YzO?AR ]Hu(/x+o?ֈt+.oU;MﯷLƽ=yN Sn76w! 5v`;{(؏)lms.m[ B?,'6.'und\;RgF @@hӲ}n[ d ILT]7lcg#R%F\_I7S4f"U.w]ylc ZF;B:yGnAA!6-۽^6B+7l`RǭeOߍpTyU9K~9SYf9,!A&~ko Y96hGTKR_T邪v 轸]OuZ>޼!0hӲwYkM!!X0XV}Z#λ_!K3, ,ݑ(B"wMB%?sE2ݡd;K3qY%UD!(:UḾ,~_hӲ+dzO”~n!qJu1j.'sΊTuKl*9_ZSۛ,#l;Bn ԻA%:X|F, ilЭc :qҮ.x#Xl``qܔȦvdOZWpP[\t׃we !Цe#qHsG*ʓR͘?\ֵo屭(s쭅9kϩ2jDDf]ʭ1`,Q}z1~+ʍgxn瑛6iGHY! G-~rp$6-`qY >G;͒놬EըsREj[*Zα&ۊr_ڹ`Jms"٪7Z-0B5uݠ[=)93]g&Цe/.}mnOK 83XȖ.8@E\AEJA@@%Цeݖ>hӲ,?r|mՔ$9eA@@@v%ЦeqY`,.#/Zl޵3`@@@@@eeϦV5eH&     p 6-\We@QR2EY돴Q[gݵVr;C!W;*#gns6SUCq5Op#V&n{~ɇǭJtOeoe,Pe&L1;=&Diָ wCTZH_)`d[/ZXe@⾴݉0YL|=rF)6~S@l++6i̓;C]zn9LJ)$CtiS[sbd;>쪛s01𦜠Ԅ A`CmZⲹϪ[AXSh[a.EG3&Ѕa46TꁮQu74R놪=.y:;RJ;E_(#- P78C\1 ߜ4HP(@l" ^d7A ғn9"Q U6NClEqbn'ޢxE5@IlQTWw` qrGŭN1 &A@r3T&MH#xyci"-әUg#k\غaqpBSEѤ?F*r;%W{SEvw{-ݶu{Wk<$7 q9%oؠ[Qnr0gSGT tsc>xj+OSeȭWH"nBMFhhGٻ(x 'R2.{+˕攟/Q+6sr@݈$muW(9eEU#*stS'׆B֞YS:BQbYvqS~n`3r}DAڴNqUlB`PCߤ l`*@xmZvF    @M".]&hӲ>Lǣ!    ڴl0.V_:P MnFIRdIky@@@@ڴl$.+JؤV6p0މvɭmo,J@+6-˶:њvPlo7==xQv Xo0含7lEבie (MOeՆdo9EW0p|D]xUNԈ'1Ai mZ6J|}"Ι }ci'W2Zz/cnw,E lȠ,j@WûZV}0J3SUmm$n|+M֎ejKW*r~]$/sJ}jh=5]`sA[>ݜ7&\ hӲqY,mv|eD)Y9]FFq_YBY*GCP66h)8GZG H*bܘJܓxk9Ul?X<䞼ߊ#ّԞoN6liПeJϿnT[;IHΪҮVהA6-XvI(5!E%Цe).ѩ0Rꈝ\"remX7MJi:AySx-n#'gboko(YM^=^fV۹ޖl(@o8f1OS@ӭz[mGcEQt[t,6-;^6H?^3Xƫƣժjz ""umÍ*Cºz 궵w[kr%HWW07<6!QTt~Ɗt #Цe#eVWٕ2%'_dZw̻S颋'1PRn 6A`mZ6mRdkwls ue+dEOgҕnYe""!:).K|uY ]t5g3#{ Y2yv' To3k;lD7Xu`I1%l`qRl-7XMi`\vnkDDo"Ԏ*@@U'0'7@`[mZyR5=i6A@@@%Цeݖ>hӲˎFYm i`\V]<;9ղ58ڴl$.+_ʛ79mM48ZyGSsw9FvreS}Kh}"mAcNBAdצ=s=]nۉEq<7vn+%}Z*v=R(emZ6UE6 68(Rs7#gG\6RQsyhIe_)N+iJqT[~#:t]9w5B<VGN;QY؃@e ^c}ΠoRׂk'bP6Mt,#;,_lD*\p:˅jΥx]5uUټ"6 G!xP\:W{$ Y)gK{q$ȟW-oiPp nS6P "OHMver=Y2ew. {6] ֹ٭(/cZBrlx!fXI6s `ѶEU'3 w\,Cq3xk2ۉqߎJt3XD9goH U?96-Kqg}T;TtFm҄tr?SET\Ɠ\=c7["Y-^@y MC!5`8JKQ*A9n݁ 96-Kqgs򯯚 9C6^]UVݚW4nk:W,vI'k(/l.Ʃ|9Xqϙ{tLMvcyh&%PQᲅxo<[8gïAh`R^[q2nx`F<dDx-ݢ)v71^<\Eq { P B{~NJqڴld\JqJraŪ˵)~/>efuc>馧t5W,ȿRNi+RO3"w4JO8)[WpbgYukgŌ`\Y:#Mrȷ376XE8:e׸c.t.y)gr 9w~/]Ɵ@ ey)*K7WYlU/STH6M=)cW>hOV==cJW\J9=W;rm )tU^\hAQĤͭK8kET? p5f ‰@?<ޣx\ K{:q'yDMFJ13xrށ' F #-, y9X lNM㲛{4d+YvOk#,ڴ}eA@@@$ЦeO=96-; 06-,yi`\7y#6clT)nry.D !rRY+-oEٔ> 6NH١Ra8N.u|];D_VRcDmB0Yaڴl$.+jzp%Jfa}cUrS۸,n*] B8C6kr=bN5Rzχn]j)w _e:M {SuYnEU3'Q̲ΓV-/͡\pRa"x9w 6-~6>ɖw2 E5 RR-ⱟr317'%JgTdN'/A&F tnuYWw9e3;> 2(ڴl$.QX|]lP=W[m F^Yƅ,NU]e.6$/c X8̥sqla03wxTCtYn{8(?k@<T|6j+oz.0E +gӍRǞhӲe_Zz.+,QRV(*@m[kͶaGٔ ХɯT"U\ڬj~͌xmW1"C!ʩ=^xΠKq7 p6-KqN`_spzd}jn+i\WnfEݖﮠ;Asb䪯bns&\f@xqMR/_\S~cWnCۛfptk'㪙nb⒆<6s9K G5" Z2guUğqWnb;-0vkVښa[ļ JTڴld,=U"4B!#XP5[բZjO+RJ#ܐ3q,WjsSd~mۜ\mzW㰜_n5Yoac(ע%O7Y^x{bs{'A{Pryה!8i`\60IرBVWYD Dk_U'RSUzbڈq  C@Iv oV9XVF +6-.hӲl+߻~X؊@E\v+    0NMo,Fz|\DiY>#gH1Ne@7    mZⲹOYd <92AV(   emZv|,{S~/+_5@@@ izY"eR R65ojҚ89ήm|:QA@@@mZ6u%,7`DŨZ2vdYJ/8:&j¦U&v8@-    pڴlS\q(eV)NFw586-WޖRm{B[@@@@}s @@@@}"$Цe}Qx,J[N2[/.sƫR*mdRث>ʲwU&}vGx;exA4mhs+ Z=_G1o5{&Mc#>Y=^(ڴ,ⲏ:% 6-{GqM܂#bQn#H,wK Ԉw/$DqRrU8.sq9y ;carn$YߤAvC^N**u>ע\w(xJǮԳqkE'YDPT]r ,<$6-Ny%*J۶1W9\jH٪cHH$t"~Wܥz \ER8§IsfRM~RA)ڴx\6C*Y\A: L WjgU3]VmKHY )O'EVL܊+'UWNwZJV^j[]V%yH_r @ e9j(Se.ΙSA&eגr[ENI[kmy\]H^)IclPE bu)ry'iQ9<8"m BD#թ<tҎ";5&Цe).`jFlTc^,%C^f(̹mqstA-TJ`]ྰ.ENÂo}/^jO~I$[2D uSRrWUӯ_46j@@@@`o;$>}ײ)_5xp6 Rr6޳t{C?в=   ڴ2nƣ}Bu-wYge@@@`'zٝhlSDh'Ҳi ee1R Ǣ[oC@@@`@]B CH\{A   hYh8L5.K>o7@@@`#-6|3lr ]|A   1f"qYtѽ@@@6%Pײm 8cո,q@@@!ҲT eA@@@`g{Ҟz_l;;Yb6v, 5M~,wһ   "@5$R^Uߜ^eOxZ%-rAL=8@6.{@@@@Fc0eA@@@nIZQ7hz(     pKвA@@@F@ˎCY[%}     0BZvʂܒ-nв#P@@@@^~ҫk酥xU-uy%}'?@@x߿;{O PR(r)wJ|30H=rBnihw>͓H8Յ'tP[6EvXE%< L}_& dA@NK4]_벻5Lȅ)R^G5i=շ>qIwhxFPߚM51 ?F\ {4ɬܮ3ZVG \.R  pfm*AKf(/RrԲMZETV9VEX+\S̹rxrgSeRt3DYy)B]  G`Ǹb)ըT tJ u!,;PmJ+BJ!e_VdV v6Tu\Clu ɝ G2~>[1*%)QwReEk,b  ''U r4'S EqY]NVӝG:- VjV-q@\9b`UZ Ȫ R흂KAljZ{@m%]Sh{qOSjP _ٓ_P  te#WVW 4Ӕ9SV(+ʚ,%5t7M U;*Y?]qIŚrXUamLZ TsAWM Z629峲eѲ,C<qٲ@,_҂,(i0UEUA˖%6ZN굊˲++XkM:L%A4駄Y&p\ӤC뀴R㲬e)TDXNiڋY Џ&Wa< Zv#OU{=9JXjR6Ac5ӝP2mv\o֬(QRm/uYXm]axl_captNve'#.Ylp!70r\*ͣ.t`pK@Z6FyռcWN|#D0qt;Vι7IkeEm$s!v0X{!Y\v+v,&moiЃ=g|L XUzc{Ine#  psA74+/G%raWߤ?C}}0=#4='x/q  J`(.K~T!.؇A8xL X9$> G`(.x8"{!0c8!e⿗     @cq @@@˾L|~6     %7xnjnWq$o >)х @9:CwOe).O_=|x%iYV4@i sV?Wg$Ǔ9FYaNX/ @@@@nNZ]@@@@: @vC1yNвP @@@@eop@@@@l'89hٛw$- @@@@nNZ]@@@@: @vC1yNвP @@@@eop@@@@l'89滏o&WG-xfdx͛_Ҳg @@@@@J,TA!I Lq٤jO W?1&3\ڡIENDB`DyK http://vista.med.va.gov/vdl/yK :http://vista.med.va.gov/vdl/5DyK 0http://vista.med.va.gov/reminders/confcalls.htmyK `http://vista.med.va.gov/reminders/confcalls.htmDyK http://vista.med.va.gov/vdl/yK :http://vista.med.va.gov/vdl/DyK #http://vista.med.va.gov/reminders/yK Fhttp://vista.med.va.gov/reminders/9DyK 1http://vaww.vistau.med.va.gov/vistau/default.htmyK bhttp://vaww.vistau.med.va.gov/vistau/default.htm5DyK 0http://vista.med.va.gov/reminders/confcalls.htmyK `http://vista.med.va.gov/reminders/confcalls.htmaDyK ;http://www.cityofhope.org/prc/web/pdf/pain_audit_tools.pdfyK vhttp://www.cityofhope.org/prc/web/pdf/pain_audit_tools.pdfDyK 'http://www.iasp-pain.org/desirabl.htmlyK Nhttp://www.iasp-pain.org/desirabl.htmlDyK http://www.jcaho.orgyK ,http://www.jcaho.org/MDyK 6http://www.partnersagainstpain.com/html/inst/inst.htmyK lhttp://www.partnersagainstpain.com/html/inst/inst.htmDyK www.vachronicpain.orgyK <http://www.vachronicpain.org/DyK www.vachronicpain.orgyK <http://www.vachronicpain.org/EDyK 4http://www.cityofhope.org/prc/web/html/rn_needs.htmyK hhttp://www.cityofhope.org/prc/web/html/rn_needs.htmMDyK 6http://www.cityofhope.org/prc/web/html/brief_pain.htmyK lhttp://www.cityofhope.org/prc/web/html/brief_pain.htmqDyK ?http://www.cityofhope.org/prc/web/html/rehab_professionals.htmyK ~http://www.cityofhope.org/prc/web/html/rehab_professionals.htmDyK Ohttp://www.cityofhope.org/prc/web/pdf/Knowledge%20and%20Attitudes%20Survey.pdfyK http://www.cityofhope.org/prc/web/pdf/Knowledge and Attitudes Survey.pdfaDyK ;http://www.cityofhope.org/prc/web/pdf/controlling_pain.pdfyK vhttp://www.cityofhope.org/prc/web/pdf/controlling_pain.pdf!DyK +http://mayuday.coh.org/Instruments/k&a.htmyK Vhttp://mayuday.coh.org/Instruments/k&a.htmDyK  www.carf.orgyK *http://www.carf.org/DyK http://vista.med.va.gov/vdl/yK :http://vista.med.va.gov/vdl/DyK #http://vista.med.va.gov/reminders/yK Fhttp://vista.med.va.gov/reminders/9DyK 1http://vaww.vistau.med.va.gov/vistau/default.htmyK bhttp://vaww.vistau.med.va.gov/vistau/default.htm5DyK 0http://vista.med.va.gov/reminders/confcalls.htmyK `http://vista.med.va.gov/reminders/confcalls.htmDyK 'http://vaww.oqp.med.va.gov/DEFAULT.aspyK Nhttp://vaww.oqp.med.va.gov/DEFAULT.aspIDyK 5http://vaww.va.gov/pain_management/508FrameTest2.htmyK jhttp://vaww.va.gov/pain_management/508FrameTest2.htmDyK $http://vaww.va.gov/pain_management/yK Hhttp://vaww.va.gov/pain_management/9DyK 1http://www.oqp.med.va.gov/cpg/pain/pain_base.htmyK bhttp://www.oqp.med.va.gov/cpg/pain/pain_base.htmDyK michael.clark2@med.va.govyK Bmailto:michael.clark2@med.va.govDyK www.vachronicpain.orgyK <http://www.vachronicpain.org/DyK robert.kerns@med.va.govyK >mailto:robert.kerns@med.va.govDyK michael.craine@med.va.govyK Bmailto:michael.craine@med.va.govDyK ruth.markham@med.va.govyK >mailto:ruth.markham@med.va.govDyK julie.jones2@med.va.govyK >mailto:julie.jones2@med.va.govDyK mitchell.nazario@med.va.govyK Fmailto:mitchell.nazario@med.va.govDyK booss.john@westhaven.va.govyK Fmailto:booss.john@westhaven.va.govDyK martha.bryan@hq.med.va.govyK Dmailto:martha.bryan@hq.med.va.govDyK michael.clark2@med.va.govyK Bmailto:michael.clark2@med.va.govDyK audrey.drake@hq.med.va.govyK Dmailto:audrey.drake@hq.med.va.govDyK robert.kerns@med.va.govyK >mailto:robert.kerns@med.va.govDyK ruth.markham@med.va.govyK >mailto:ruth.markham@med.va.govDyK jackrose@umich.eduyK 4mailto:jackrose@umich.eduDyK richard-rosenquist@uiowa.eduyK Hmailto:richard-rosenquist@uiowa.eduDyK ArizonaMD@aol.comyK 2mailto:ArizonaMD@aol.comDyK charles.sintek@med.va.govyK Bmailto:charles.sintek@med.va.govDyK anne.turner@lrn.va.govyK <mailto:anne.turner@lrn.va.govDyK jane.tollett@hq.med.va.govyK Dmailto:jane.tollett@hq.med.va.gov!^'()4EZ[i%:;<GXmno  ""##X(Y(e*u+i0j0 4!4/60688[9\9::A;;=<<<G?H?@@A7B8BBBhDiD EEE9E:EHHTTccYjZj[j\jYlZlllqqDsEsuu%x&xAxBxyyzz{|||uv<=[\ݏޏߏLMϒOP01֗ח{tuR)*MNӥ(78#$yzȳɳʳ˳̳۹ܹ  ./_a-P 9   ?@0ARSefght78RS@lmn=>hij  FG+<MN`abc9:FGghLJtYde    yz8;!!$$X&Y&''v*w*005577;;>>@@FFFEIFIJJMMNN(Q)QTTXX)[*[k\l\^^]`^```PeQe5f6fffgfff/ggggrhshh i&iTi. i8`8 NormalCJ_HaJmH sH tH H@H Heading 1$7$8$@&H$5;CJ\aJ8@8 Heading 2$@& >*CJaJB@B Heading 3 $*$@&5CJOJQJ\BB Heading 4$<@&5CJ\aJFF Heading 5 <@&56CJ\]aJ@@ Heading 6 <@&5CJ\aJ<A`< Default Paragraph Font4>@4 Title$a$5CJ OJQJ4J@4 Subtitle5CJOJQJ, @, Footer  !&)@!& Page Number6B@26 Body Text*$ CJOJQJBBB xl26$dd9D[$\$a$5CJ\aJ4OR4 font5dd[$\$CJaJHR@bH Body Text Indent 2 `CJaJ2%r2 Envelope Return<C@< Body Text Indent ^X$X Envelope Address!@ &+D/^@ CJ.U@. Hyperlink >*B*ph<O< xl22$dd9D[$\$a$CJaJ6O6 xl23dd9D[$\$CJaJ4@4 Header  !CJaJHH xl34%dd&d9DP[$\$CJaJJP@J Body Text 2 56CJOJQJ\]^JaJHQH Body Text 3 1$7$8$H$B* CJaJphL^@L Normal (Web)!dd[$\$B* CJaJph,", FEE MANUAL"CJDS2D Body Text Indent 3 #h^hCJ@B@  Balloon Text$CJOJQJ^JaJJYRJ  Document Map%-D M OJQJ^J>Va> FollowedHyperlink >*B* ph"W@q" Strong5\2@2TOC 1 ( $ mHnHu&@& TOC 2 )^<Z@< Plain Text*CJOJQJ^JaJROR Company Name+d<;CJ&KH$OJ QJ aJfOf Subtitle Cover ,$d $dN@CJ,KHOJ QJ aJO Title Covers-$XXd`$d%d&d'd-D M NOPQ]X^Xa$@CJKHOJ QJ aJ^s89_`abcde2 {zyuv    ^s89_`abcde2      8>.[([\]^);<5O Xq+O~5 t W  ` , [i/ikmv6OPmo%$&$($P$Q$!%"%[%%%%%%''(())C+D+Q+R+++~,,..5/6/7/8//h0i0z0{0Z1[1&3'3P6Q6S666v7w7#;$; ? ?oBpBEEEEIIMM+[,[OcPcddffPiQinioijjzz[\ܤݤժ֪OQpr XYռּ"#mn|}23OP=>67{|bcVWijOP    [\ '9:BWh}~aibiii5l6lCl]lylllllllomnQnRn+o,oppppppqqqrr!r^rxrrrssKsdssss/tltttuuMuNuOu%w&wQwwwwmznzozJ{K{i{||}-}R}u}}}}}}!~5~h~j~k~€Àr WXʉˉ݉މ׊؊QGIjkɌ"-.TVWXYZ[\]^_`9:hlmno*/45c-.GHWKwxmnäL9:k٦Oާɨ45^bcت٪suF߬r]ٮc¯y<޲@;·ϹC.¼-ÿh-0  bP)L?u90p^5JvZ 8PN#<g,al"e 0?Sm 2=v ]   m c .}0uG#R~-"[-  !*""J#0$1$<$z${$$$$%%s%%%%%%%%&&p&&&& ''i'''''$(V((()))^)_));*<*=****-+T+U+V+W+B-D-P-Q----q0r0008111111e222/303\3]3^333t4u4444B55555555555&666677Y7777 8 898j88888888889Q9R99999 :^::;g;;;L<<<F=q==>>>>>>>$>%>Y>Z>[>>>>>>>A?v?w????3@K@L@@@@A0A1AqAAA1B:B;BGBHBBBBBBBBCC*C;CVCgChCCCCDNDDDDDDDDDEE`EEEF(F)F9FJFKFtFuFFFFFG1GDGEGnGoGGGG-H9H:HLHgHHHHHH IIIwIxIIIIIIJ9J:JuJJJJ K=KcKdKKKKLOLPL`LqLrLLLLM[MeMfMMMM"NGNHNqNNN/O?O@ObOyOOOOOO%PfPPPPPPPQQTQQQQQQQRRURRRRRS(S`SSSSSSTNTyTzTTTTTTTT=U?UzUUUUU V+V,VUVVVVVWWW$W%WNWOWWWX!X"X:XRXkX}X~XXXX#Y3Y4YDYUYVYYYYYYYZZ8Z9ZzZ|ZZZ [![1[B[C[l[m[[[0\<\=\T\h\y\\\\\\]U]c]d]]]^5^l^^^^^^7_8_g____`)`*`k`m`````a9aUaVaaaaa?bnbobbbbbbb6c7cpcccd%d\d]ddddddd e e eeee-eTe}eeeee.fyfzf{ffffffggcgfggghggggggggFhGhHh]hphzhhhhiiii+i2iGi]iuiiiiiijj"j;jTjjjjjjjjjjjjjjjk$k/kDkckukkkkkl7lLl`lllllmm'mGmYmmmmmmmmn'n9nnnnnnnnn oVoWoXomo}oooop p p pp'pBpSpgp|pppppqq7qMqbquqqqqqq rr0rDrrrrrrrrrs^s_s`slsssssss tXtYtZtstttttttEuFuGuHuIuJuKuZueufuhuruuuuuuuuv[v\vpvvv>w?wEwwww&xSxTxfxxxxxxxxxxxyAyByVyyyy,zHzIzizzzzz{0{P{h{i{}{~{{{{{{{{|'|;|L|i|j||||||||/}S}w}}}~B~t~~~~~ +0,0000-00000000000000000 0(0 )0 )0 )0 )0 (0 )0 )0 )0 (0 )0 )0 )0 )0 )0 )0 )0 )0 (0 )0 (0 )0 )0 )0 )0 )0 (0 (0 (0 )0 (0 )0 (0 )0 (0 (0 (0 )0 (0 )0 (0 )0 )0 0 0 0  00m0m000= 0= 0= 0= 0= 0= 0= 000m0505050m000000m0m0m000 0 00 $0 $0 $ 0 $ 0 $ 0 $0 $0 $0%*0%*0%*0%0&*0%*0%*0%0)0 $0)+0)+0)+y 0)+y 0)+y 0)+0)+0)+0)+0)+0)+0)+0)+0)+0 $0N00N00N00N00N00N00N0 0 00860860860860860860860860860860860860E0E0E0E0E0E0E0E0E0E0E0E0E0E0E08606i06i06i06i06i06i06i06i06i06i06i0860ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ0ߌ086060606060606060606060606060606060606060606060606060860000000000000000860000000000000000000000000000000000000000000000000000000000000000000000000000000000000000860"0"0"0"*0"*0"0Z+0Z+0Z+0Z+0Z+0Z+0Z+*0"08f 08f 08f 08f 08f 08f 0808*0"0<0<0<r 0<r 0<0<0<0<0<0<0<0<0<0860D0D0D0D0D0D0D0D0D0D0D0D0D 00?l0?l0?l0?l0?l0?l0?l0?l0?l0?l0?l0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x0&x*0&x0"0"0"P 0"P 0"P 0"P 0"P 0"0"0"0"0"0"O 0"O 0"0"0"0"0"0"Q 0"0"0"0"Q 0"< 0"< 0"< 0"0"0"0"0"0"Q 0"Q 0"Q 0"0"0"0"0"0"0"0"0"0"; 0"; 0"; 0"; 0"0"0"0"0"0"; 0"0"0"0"0"0"0"0"0"0"0"0"0"0" 0 0000000000[ 00[ 00[ 000000000000000000000000000000000000000000000000000s 00s 00u 0u 0u 0u 0u 0u 0u 0u 0000x 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_000C`0C`0C`0C`0C`0C`0C`3 0C`3 0C`3 0C`3 0C`3 0C`0C`!0C`!0C`^ !0C`R !0C`R !0C`R !0C`R !0C`!0C`0C`*0C`*0C`0in 0in 0in 0in 0in 0in 0i0i0i0im 0im 0im 0i0i0i0i0i0i0i0i0i0i0i0                          ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h j k l m n o p q r s t u v w x y z { | } ~  i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i3 0i3 0i3 0i0i0i0i0i0i0i0i0i0ig 0ig 0ig 0ig 0ig 0ig 0ig 0ig 0i0i0i0i0i0i0i0i0i0i0i0ih 0ih 0ih 0ih 0ih 0i0i0i0i0i0i0i0i0i0i0i0ii 0ii 0ii 0i0i0i0ij 0ij 0ij 0ij 0ij 0ij 0ij 0ij 0i0i0i0iT 0iT 0iT 0iT 0iT 0iT 0iT 0iT 0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0i0ik 0il 0il 0ik 0i0i0i0i 0000000000002 02 02 0000 0 0000000000000000000000000000k 0l 0l 0k 00000000000000000 0 00Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z0Z 0 00$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$0!$ 00;+ 0 00)-0)-06-06-06-06-06-06-+ 06-+ 06-+ 06-06-06-06-, 06-, 06-, 06-, 06-06-06-06-06-- 06-- 06-- 06-06-06-06-. 06-. 06-. 06-06-06-06-06-06-06-06-06-/ 06-/ 06-/ 06-/ 06-06-06-06-0 06-0 06-0 06-06-06-06-1 06-1 06-06-06- `0 00808080808080808080808q 08q 08q 08q 08q 08q 080808q 08q 08q 08q 0 808q 0 8q 0 8000 0 0 0 0 0 0 0 000000000000000000000000000 0 0 0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0*0 0 00000000000000000000000000000000000000000000000000000000000000000000 0 0 0 0 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@0@0@0 000000000000000000000000000000000 00000000000000000000000000000000000000000000000000000000000R w~LTH/D/N$[EgPt~<zL * :dat4U!a0KUo0s?U: 63-@Wkkx{=j:b !"$%&'(*,/012456789;<=?@BIKLNORTVWY[^jklnoqrvyz~`((/:u{W0BBCDWEIksu}?!|0JSTUVXYY][]C^:_ŕ7D SqtK&3EDS`nЀlM QhRL\ b#)+-.3:>ACDEFGHJMPQSUXZ\]_`abcdefghimpstuwx{|}a<TUt0235Tq/JLMOn  *8SUVXw7Qlnoq %()+Ji.ILMOn7]x{|~ / 2 3 5 T x  S n q r t 6 Q T U W v     3 ? Z ] ^ `  & ) * , K ~ :UXY[z<Hcfgi),-/NHcfgiGGG{I|II.MZMpMPQSSSSTTTTT\U]UV{VpYqYYYYxZyZzZZ'[([.^^aaaaabbbbKcLcYeekflffgBg h h5hRhvh1i2iLi(kPkmmmmmInJnnnMpNp]ppp~rrrstuuuIvv y y^y_yjy z z{{||||$}}}~+~K~4h12\tuU!"NքԅƆdž܆$߇9֊ԏ_`mΑefvՕ֕y&'7јJKqr}EPQ<j23W% ţؤ)WBpRSlhiԩѪNLMw D?@K.DvXY}9S/F>GH012=E66 _`65no"VST|PQakop C"#S>?E?DD EcHH3J4JPJJKLLLQQ3S4SHSHYvY]]^__aaacEc[cccddd-ffggAhBhMhhhhhiiiiTjUjllnnnmwww{{){+|| ʀqrԃˆ^: !,Űưε3Զ STNf"#.vw=/|$8Kl#$/0Q9Y  Fe  "YZp/0[\g  i%Be*,-.....////708090D000?3Y3445:::::::;;<<=====>>>CCDDDDDsEtEEEEjFkFFCHgH'I(IBIQRRRRR5S T T?T V#VVVVVVWWWccdnn&o!~1~3~m"Rߑ (Hz,ГWܟK>t)UkŢCyΣ oä HL*7צ)Ljۧ@^+`֪@qef,f7fafwfgIgagg*hDhhhhiiiTjjjwkkkclll\mmmtUtt(uCu X%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕX%ĕ̕XX#QDX#QD#QD#QD#QD#QD#QD#QD#QD#QD#QL#QL#QL#QD#QD#QD#QD#QD#QD#QD#QL#QL#QL#QL#QL#QL#QL#QL#QL#QL#QL#QD#QD#QD#QD#QD#QD#QL#QL#QL#QL#QL#QL#QL#QL#QL#QL#QL X#QD#QD#QD#QL#QL#QL #QL #QD#QD#QD#QL#QL#QL #QL #QL#QL#QL#QL#QL#QL#QL#QL#QL#QLXX#QD#QD#QD#QD#QDX#QL#QL#QL #QL #QL #QDXX#QD#QD#QD#QD#QDXX#QD#QD#QDXX#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QD#QL#QL#QL#QL#QL#QL#QL#QL#QL#QLXX:XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX !!8@X  (  H u # u  H v # v  TB w c $D TB x c $D N y 3  y  H z # z  H { # {  NB | S DTB } c $DTB ~ c $DH  #  H  #  TB  c $DTB @ c $DTB  c $D H  #  H  #  H  #  TB  c $DTB  c $DTB  c $DTB  c $DH  #  H  #  H  #  ^  d,%i- 3  s"*?`  c $X99? d,%i-ZB B S Do ,%,B S  ?T-(vtv8%tuHtyt t% t%t>%>@A@BCEDFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghikjl@m@nopqrstuvw@x@y@z@{@|@}@~@@@(:kO$O$%%P+Q+y0y066EElimino     ##c*d*d****<<<7E7ETTTccccckll@xBx[ܶڹڹsss   777W&W&W&u*u*u*000MMM([([([``ccYjYjYjh{h{h{g~g~g~SSSEF 0$;$;$;$y$])])])A-A-A-O-O-O--011[3[34455 7 7 8 88888#>$>X>FBFBBdd ejjj 3q/M 8VQo )i.M]| 3 x S r 6 U  ? ^ * ~ :YHg-HgH##Z7\7e7l7888888P PSSSSSSSSSSSSSSSSsYwYYYYY9\?\\\ ]]aaaaaaaaaanfsfffhhh"h&h.h4i=i@iEiyy2y:yPyWy?{C{4<>COU$,.4RZuyho)0cjSZdkmr 5<>GȤѤ+2ªʪ˫ӫի٫OVX_afjp*1[bdnJN U_cpqz V`bjnu"-}rvx  # ' \ `   O]py%%%%V'['c'h'A(G(++0+m-v-x--R0X02222 4488D EFFLLLLLLPPPPPP[QaQ]^^'^{^^^^ddgggggg hh+h.h2h:hqz~z/9RWZ`_h޷ýȽнս\crIS_g UY!FKOT-/7BDLNSU_aimuR X [ b ""G&O&Z(h(^,f,i,m,,,,,,,::==>>@@DDuE}ElFvFGG*I4I{KKKKKMUMWM]M_MgMxNNNN PPPPPPQQRRVVWWWWaannyyJOkpOT߬rzLR{ ͲҲųĵ̵зڷ!-Ǹиָ߸ %-5CJPT.7?DhtԿhp 2707=DPUfl $bj}PXag).7<OX`g#<C %EJRW#ho@Ipx~8@T\w*09?JRnsZ_$gnt|<C <A$gq"'$    .HOlv-4:@8Aw~ry07=FSZnzmut{2:=D\clqv ~               ] d         3 ? m w         c i ~  .6}%0;DKT[aeuyV^gn07R[dgmtz&*06<APY-4=C[_ejpy?BMUgi !!""--------z//::BBBBGHEJKJJJJJKLqM}MMMMMMMMM2NNENNNKOXOZO`OOOSSTTTTUUUUUUUUUVV V-X9X@]J]o]y]]]]]@^J^__sgygjjjjlmm\mmmnB a v ##$-$''((w**,,BBJJXX*[F[N]^]ddiZjk lNv\vvvXrܑߑEH=@EFެOqRSٮLcvwegy  ;ڱ^`޲x@UVMζ:pDEƹǹϹ9:Crsκ}.PQ¼ּ,T}ξѾ¿)g|@ 3 XYNTZj|"P"$CDt >?stBmnu Us|0Uwf]pUV^',=Ac&`_$Z~(]eg1p./}01O#(;:CDa:=UW;<PQyFH]+,AB/0:ST`a\34LMkl!2^btu /0_`wy>?R,yHI]`>jv <  L M u v   + , \    &  @ A l m       b c   -  -QRGH|'(LlmFG;9;Qst~e-.[h# $    !|!~!!!!)":#@### % %&&&&y'}'**9 99999E:K:y::::/;5;;; <<<<<<==G=J====>qAtABBBB CCC)C2C:CCCLC^CfCDDTD\DDDDDDDDDDDEEEE F&F1F8FAFIFFFFGG#G9GCGGH3H7HBHKHTHfHoHHHHOIQIIIIIBJKJJJJJJJJJ+K/KEKKKLLXL_LhLpLaMcMnM}MMMMMMN*N1NNN5O=OHOXOjOxOOOOOlPqPPPPPPPQQQQQQRRRRRRSS0Sw>w?w?wwwwwSxSxTxTxxxxxxxxxxxxxxxxxx&y'yAyAyByByyyyyyyi{~{{{{{||||~~  VHACONKERNSRMichael E. ClarkMichael Clark Michae lClark Michael DunnC:\Documents and Settings\lrneesdunnm\Desktop\2003 Pain Management Conference\Pain EOL Conference Presentations\OUTCOME MEASURES TOOL KIT FINAL.doc Michael Dunn~C:\Documents and Settings\lrneesdunnm\Application Data\Microsoft\Word\AutoRecovery save of OUTCOME MEASURES TOOL KIT FINAL.asd Michael Dunn~C:\Documents and Settings\lrneesdunnm\Application Data\Microsoft\Word\AutoRecovery save of OUTCOME MEASURES TOOL KIT FINAL.asd Michael Dunn~C:\Documents and Settings\lrneesdunnm\Application Data\Microsoft\Word\AutoRecovery save of OUTCOME MEASURES TOOL KIT FINAL.asd vhacotollej(P:\outcomes\TOOL KIT OUTCOMES FINAL2.doc John D. Otis]C:\WINNT\Profiles\VHABhsotisj\Personal\Health Psychology\Website\TOOL KIT OUTCOMES FINAL2.docyjzL( o  ~tbne w5 .` ֮*E  /[b B80n&1"lZ$W, f.^xtrL2H!+h .bs&9v w}|\$}`!0K<"&|knQy  % M"%$MK")":$$ >2$W vp;&~O0)>I* :h,vK, M,`@/-:ƺ? .  .R)2`. 6Y./Ԙ{a0Pv{j0Ly60Md0.ֺi ,2{`63v{#3JbJ!z3f 5)5Z05$6x¤8"I~9:X9%$9:u^_;i3gf;> xz; mRH< Gl< '"@cxCnj=rD nF<Œu#'IR7uI COI $kKVpsKꞪfFL2+ƾfLK}M J{7M vM ԽZ/N FNd1 Q#i&fNQ{nERL݀Nu0S -S$KT jL&(X[_o[었|K\rx!{cܳPttd{bz+e.ֺe ]CfLhz #jF,-k mom#z +n"l@oN0Meo )q*1LQs $Ws Nxt2D`,u7Fvt-w7y_X)zئ!p}+   iFB+v3U`P5v h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo( ^`o(hH. ^`hH. L^`LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h88^8`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJ QJ o(hHh  ^ `OJQJo(hHhxx^x`OJQJ^Jo(hHohHH^H`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHhh^h`o(. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h 88^8`OJQJo(h ^`OJQJo(oh   ^ `OJ QJ o(h   ^ `OJQJo(h xx^x`OJQJo(oh HH^H`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h^`OJQJ^Jo(hHoh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH88^8`OJPJQJ^Jo(- ^`OJQJo(o   ^ `OJ QJ o(   ^ `OJQJo( xx^x`OJQJo(o HH^H`OJ QJ o( ^`OJQJo( ^`OJQJo(o ^`OJ QJ o(88^8`o(.^`. L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo(h 88^8`OJQJo(h ^`OJQJo(oh   ^ `OJ QJ o(h   ^ `OJQJo(h xx^x`OJQJo(oh HH^H`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh ^`OJ QJ o(^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH hh^h`o(hH) ^`hH.$ $ ^$ `56o(hH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH. hh^h`OJQJo( hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hh^h`6o(.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(808^8`0o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.hh^h`o(. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH. hh^h`OJQJo(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo(^`CJOJQJo(^`CJOJQJo(opp^p`CJOJ QJ o(@ @ ^@ `CJOJ QJ o(^`CJOJ QJ o(^`CJOJ QJ o(^`CJOJ QJ o(^`CJOJ QJ o(PP^P`CJOJ QJ o(hh^h`o(.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.@0^`0. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH^`CJOJQJo(^`CJOJQJo(opp^p`CJOJ QJ o(@ @ ^@ `CJOJ QJ o(^`CJOJ QJ o(^`CJOJ QJ o(^`CJOJ QJ o(^`CJOJ QJ o(PP^P`CJOJ QJ o(hhh^h`OJQJo(hHh88^8`OJQJ^Jo(hHoh^`OJ QJ o(hHh  ^ `OJQJo(hHh  ^ `OJQJ^Jo(hHohxx^x`OJ QJ o(hHhHH^H`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh 88^8`OJQJo(h ^`OJQJo(oh   ^ `OJ QJ o(h   ^ `OJQJo(h xx^x`OJQJo(oh HH^H`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh ^`OJ QJ o(0^`0o(. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hhh^h`.h88^8`.hL^`L.h  ^ `.h  ^ `.hxLx^x`L.hHH^H`.h^`.hL^`L.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hh^h`.hh^h`o(. hh^h`OJQJo(^`OJQJo(hH^`OJQJ^Jo(hHopp^p`OJ QJ o(hH@ @ ^@ `OJQJo(hH^`OJQJ^Jo(hHo^`OJ QJ o(hH^`OJQJo(hH^`OJQJ^Jo(hHoPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hh^h`o(.h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJ^Jo(hHohpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo(hhh^h`OJQJo(hHh88^8`OJQJ^Jo(hHoh^`OJ QJ o(hHh  ^ `OJQJo(hHh  ^ `OJQJ^Jo(hHohxx^x`OJ QJ o(hHhHH^H`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo(hh^h`o(.88^8`o(.^`. L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.0^`0o(. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h hh^h`OJQJo(h 88^8`OJQJo(oh ^`OJ QJ o(h   ^ `OJQJo(h   ^ `OJQJo(oh xx^x`OJ QJ o(h HH^H`OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHhh^h`o(.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hh^h`o(.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(uu^u`o(.h 88^8`OJQJo(h ^`OJQJo(oh   ^ `OJ QJ o(h   ^ `OJQJo(h xx^x`OJQJo(oh HH^H`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hh^h`o(. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. LOUTCOME MEASURES TOOL KIT0UTCseavamceaveavNormal John D. OtisRES2hnMicrosoft Word 9.0O@@@vn;@vn;  FMicrosoft Word Document MSWordDocWord.Document.89q   SeatDocumentSummaryInformation8 `,CompObj jl/50http://vista.med.va.gov/reminders/confcalls.htmhttp://vista.med.va.gov/vdl/%a+http://vista.med.va.gov/reminders/Pain.htmYd5http://vaww.va.gov/pain_management/508FrameTest2.htm  appendix5c6+http://mayuday.coh.org/Instruments/k&a.htm  appendix4Ghttp://www.jcaho.org/  appendix3  appendix2Fhttp://www.vachronicpain.org/ i appendix1$rf'http://vaww.oqp.med.va.gov/DEFAULT.aspFhttp://www.vachronicpain.org/F http://www.vachronicpain.org/  appendix7  appendix6? _Toc29952465? _Toc29952464? _Toc29952463? _Toc29952462? _Toc29952461? _Toc29952460< _Toc29952459< _Toc29952458< _Toc29952457< _Toc29952456< _Toc29952455< _Toc29952454< _Toc29952453< _Toc29952452< _Toc29952451< _Toc29952450= _Toc29952449= _Toc29952448= _Toc29952447= _Toc29952446= _Toc29952445=} _Toc29952444=w _Toc29952443=q _Toc29952442=k _Toc29952441=e _Toc29952440:_ _Toc29952439:Y _Toc29952438:S _Toc2995՜.+,D՜.+,P  hp   Seattle VAMC4uv OUTCOME MEASURES TOOL KIT Title+ 8@ _PID_HLINKSA*pL0,"mailto:jane.tollett@hq.med.va.gov8)mailto:anne.turner@lrn.va.govS|&!mailto:charles.sintek@med.va.gov/#mailto:ArizonaMD@aol.coml  $mailto:richard-rosenquist@uiowa.edu[nmailto:jackrose@umich.edusZmailto:ruth.markham@med.va.gov`^mailto:robert.kerns@med.va.gov_:"mailto:audrey.drake@hq.med.va.govs!mailto:michael.clark2@med.va.gov@'"mailto:martha.bryan@hq.med.va.gov: #mailto:booss.john@westhaven.va.gov~C#mailto:mitchell.nazario@med.va.gov~ mailto:julie.jones2@med.va.govsZmailto:ruth.markham@med.va.gov@v!mailto:michael.craine@med.va.gov`^mailto:robert.kerns@med.va.govFhttp://www.vachronicpain.org/s!mailto:michael.clark2@med.va.govB21http://www.oqp.med.va.gov/cpg/pain/pain_base.htmoF$http://vaww.va.gov/pain_management/Yd5http://vaww.va.gov/pain_management/508FrameTest2.htm$r'http://vaww.oqp.med.va.gov/DEFAULT.asp50http://vista.med.va.gov/reminders/confcalls.htm1http://vaww.vistau.med.va.gov/vistau/default.htmfk#http://vista.med.va.gov/reminders/http://vista.med.va.gov/vdl/_Ihttp://www.carf.org/c6+http://mayuday.coh.org/Instruments/k&a.htmzT;http://www.cityofhope.org/prc/web/pdf/controlling_pain.pdfPIhttp://www.cityofhope.org/prc/web/pdf/Knowledge and Attitudes Survey.pdf>?http://www.cityofhope.org/prc/web/html/rehab_professionals.htm'6http://www.cityofhope.org/prc/web/html/brief_pain.htmvA4http://www.cityofhope.org/prc/web/html/rn_needs.htmFhttp://www.vachronicpain.org/Fhttp://www.vachronicpain.org/^6http://www.partnersagainstpain.com/html/inst/inst.htmGhttp://www.jcaho.org//*'http://www.iasp-pain.org/desirabl.htmlxd;http://www.cityofhope.org/prc/web/pdf/pain_audit_tools.pdf50http://vista.med.va.gov/reminders/confcalls.htm1http://vaww.vistau.med.va.gov/vistau/default.htmfk#http://vista.med.va.gov/reminders/http://vista.med.va.gov/vd2437:M _Toc29952436:G _Toc29952435:A _Toc29952434:; _Toc29952433:5 _Toc29952432:/ _Toc29952431:) _Toc29952430;# _Toc29952429; _Toc29952428; _Toc29952427; _Toc29952426;  _Toc29952425; _Toc29952424}aVALOGO                 ^`LhH. ^`hH. ^`hH. PLP^P`LhH.hh^h`o(.hh^h`)^`)88^8`)^`()^`()pp^p`()  ^ `.@ @ ^@ `.  ^ `.^`o()^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.^`o(.hhh^h`OJQJo(hHh88^8`OJQJ^Jo(hHoh^`OJ QJ o(hHh  ^ `OJQJo(hHh  ^ `OJQJ^Jo(hHohxx^x`OJ QJ o(hHhHH^H`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( ^` o( ^` o(.0^`0o(..0^`0o(... 88^8`o( .... 88^8`o( ..... `^``o( ...... `^``o(....... ^`o(........ hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH^`o(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.88^8`o(.^`. L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h^`OJQJ^Jo(hHoh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o( hh^h`OJQJo(88^8`OJPJQJ^Jo(- ^`OJQJo(o pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJ QJ o( ^`OJQJo( ^`OJQJo(o PP^P`OJ QJ o( hh^h`OJQJo(h^`OJQJo(hHh``^``OJQJ^Jo(hHoh00^0`OJ QJ o(hHh  ^ `OJQJo(hHh  ^ `OJQJ^Jo(hHoh^`OJ QJ o(hHhpp^p`OJQJo(hHh@@^@`OJQJ^Jo(hHoh^`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJ QJ o(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJ QJ o(hH ^`o(hH) ^`hH. L^`LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.0^`0o(. hh^h`o(hH) ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(hh^h`o(.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(z^`zo(.hh^h`o(.yI~99vpsKE {7M`.COILQs-wKTZ/Nu0Sy K,5v3U=rD1 Q Gl<I*7uIo? .'?":$$Meo,&fNQtdjz^_;mRH<o[+h -k/$}tr)qvp;&om0MK"ZxCgf;!p} vMz3 . iFe{c(XjL2$n 6D`,ua0$Ws]Cf'<"@0 +n1600f.yy          2                                                                               ,Z        R                                              F                                 rƮ                          >2&3h"jLpp%B0q_                                                     >t\ZJXvm:|                                                                                                                                                                                                                                                                                                             ,Z                                                                       @ @< '9:BW}~'()4Z[i:;<GmnT0ARSefght@lmnhij  G+<MN`abc:LJtY;G;>m[ezffgggGhiiijjjjjklmmnWo p ppqrr_sYtFuGuKugu qhS0-0AaAa+)0PC4DatabaseDefault$5J PC4SetupInfo5J PCDelimEnd8:J PCDelimStart@:JPCRefListBookmarkH:J3C:\Program Files\ProCite5\Database\PainCombined.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}{(PCRefList_OUTCOME_MEASURES_TOOL_KIT_rev_@vHIQTVZH_HaHkHmnprItIuIwIyIIIIIIIIIITTVVHIKMQSY^`bmn}    hhmmmmmm8 8ff)))),.349:;<=>P@PLP@PVP@P^P@PlP@PzP@PPP@PP@PP$@PPP`@PPPt@PP@PP@PP@PP@PPP@PxP@P|P@PP@PP0@PP<@PPX@PP@PP@PP@PP@PP@PP@P P @PP,@PP@@P&PT@P.P`@P2Pl@P8Pt@PDP@PLP@P`P@PpP@PtP@PzP@PP@PP@PP@PP@@PPP@PPPPPPp@Unknown Gz Times New Roman5Symbol3& z ArialI6 ??Arial Unicode MSC"MS Sans Serif?1 Courier New71CourierC& Antique Olive5# Tahoma9Garamond;Wingdings"HhMtfMtfJquD!8d0dvs 3qXOUTCOME MEASURES TOOL KITseavamc John D. Otis